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RAC-alpha serine/threonine-protein kinase 
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AP-2 adaptor protein-2  
CDC42 cell division cycle 42 
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FAK focal adhesion kinase  
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Summary 
Integrins are heterodimeric transmembrane proteins, composed of α and β subunits. A 
characterisitc feature of all integrin subunits except one is the presence of a short 
cytoplasmic domain that lacks enzymatic activity and actin binding sites. As a result 
integrins rely on the recruitment of proteins to their cytoplasmic tails to regulate their 
ligand binding affinity, to establish a connection to the actin cytoskeleton, to initiate 
intracellular signaling and even to regulate their intracellular protein trafficking. Thus, the 
cytoplasmic integrin interactors are crucial for the integrin’s ability to regulate various 
cellular functions, including cell migration, cell spreading, and cell survival.  
Integrins undergo allosteric conformational changes characterized by altered affinity for 
their ligands through binding of the intracellular proteins talin and kindlin to the 
cytoplasmic tails of β integrins (inside-out activation). In their inactive state 
transmembrane and cytoplasmic (TMcyto) domains of the two integrin subunits are 
associated, while they become separated upon integrin activation. There is growing 
evidence that integrin inactivation might not be the default state but is actively regulated 
by the binding of intracellular integrin inactivators. Such inactivators may deactivate 
integrins or lock integrins in an inactive state thereby establishing a regulatory 
mechanism to efficiently prevent unwanted integrin activation. Furthermore, interactors 
of inactive integrins would also allow cells to distinguish between active and inactive 
integrins in other processes such as integrin biosynthesis and intracellular integrin 
trafficking.  
We hypothesized such cytoplasmic proteins exist and specifically interact with integrin 
heterodimers in their low-affinity conformation by binding to the associated α-β integrin 
tails. Recently, filamin A has been shown to interact with both α and β tails to retain 
integrins in an inactive state thereby preventing unwanted integrin activation, which is 
particularly important for cells of hematopoietic origin such as leukocytes. However, 
filamin A is the only tail interactor so far to fulfil this criteria.  
In my PhD thesis, I aimed to identify specific and common interacting partners of α and 
β subunits of different integrin heterodimers (α5, αIIb, αM and β1, β2, β3) and to 
characterize conformation-specific integrin tail interactors of αMβ2 integrins in an 
unbiased proteomics approach (Paper I). To achieve this I modified commonly used 
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pull-down protocols in two ways: (i) I incorporated recombinant integrin α or TMcyto β 
domains into bicelles as membrane-mimicking system to strengthen the interaction of 
proteins that require interaction with the plasma membrane to bind integrins. Several 
integrin tail binding proteins such as talin, kindlin and ILK depend on the interaction with 
the plasma membrane for proper integrin binding and function. (ii) I engineered 
recombinant proteins by fusing the TMcyto tails to the Fos and Jun dimerization 
domains as ‘velcro’ to obtain stably associated dimers that mimic the inactive integrin 
conformation.   
Single α- and β subunits as well as the αMβ2-TMcyto complexes were incorporated into 
bicelles and used as baits to pull down interacting proteins from bone marrow derived 
macrophage cell lysates, which were analyzed by high-resolution mass spectrometry. 
This approach allowed me to systemically identify and compare cytoplasmic interactors 
of the single α- and β integrin subunits and proteins binding preferentially to dimerized 
αMβ2 integrin tails.    
Candidate proteins were further characterized for their involvement in the regulation of 
integrin activation, signalling and integrin trafficking. The protein KN motif and ankyrin 
repeat domains 2 (Kank2) was pulled-down with β1 integrin tails and my initial analysis 
indicated that Kank2 localized at focal adhesion and Kank2 depletion in fibroblasts 
increases cell migration speed. This project was continued by the PhD student Zhiqi 
Sun under the supervision of Prof. Dr. Reinhard Fässler (Paper IV). I selected one 
protein that showed increased binding to the associated αMβ2 dimer compared to the 
single subunits, lymphocyte cytosolic protein 1 (LCP1). Regarding, LCP1 we were able 
to show that LCP1 co-IPs strong with αMβ2 integrins in resting macrophages while 
activation of the macrophages leads to reduced LCP1-αMβ2 interaction confirming our 
proteomics data of preferential LCP1 binding to the associated (inactive) αMβ2 integrin 
tails. Knock-down of LCP1 in macrophage cells (Raw264.7) and in differentiated 
neutrophils (PLB-985) increases αMβ2 surface levels and enhances cell adhesion of 
non-activated macrophages (paper I) indicating a role of LCP1 in regulating integrin 
surface levels and/or integrin activation.  
In the second paper, we described a novel cytoplasmic β1 integrin interactor, sorting 
nexin 17 (SNX17), and its role in the regulation of β1 integrin stabilization. SNX17 
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directly binds to the membrane-distal NxxY motif of β1 integrin tails in early endosomes 
to prevent β1 integrin degradation and thereby enables integrin recycling back to the 
cell surface. Depletion of SNX17 or disruption of the SNX17-β1 integrin interaction 
causes rapid degradation of integrins and decreases migration speed of fibroblast on 
fibronectin-coated surfaces. Thus, the membrane distal NxxY motif of the β1 integrin tail 
is part of a spatial-temporally controlled series of β1 integrin-protein interactions that 
controls β1 integrin activation and signaling at the plasma membrane and subsequently 
their sorting from early endosomes back to the plasma membrane. 
We showed that the interaction of SNX17 with β1 integrin tails is mediated by the 
SNX17-FERM (4.1, Ezrin, Radixin, and Moesin) domain (paper II). As the mammalian 
genome encodes for three SNXs proteins that harbour FERM domain, SNX17, SNX27, 
and SNX31, the other FERM-SNX family members could also bind β integrin tails to 
regulate integrin functions. However, we could show that only SNX17 and SNX31 but 
not SNX27 interact with multiple integrin β tails in early endosome in a 
phosphatidylinositol 3-kinase-dependent manner (paper III). This interaction depends 
on the FERM domain within the SNX proteins and the conserved NxxY motif in the β 
integrin tails. Consequently, SNX31 can rescue the reduced β1 integrin surface levels 
and stability in SNX17-depleted cells. While SNX17 is ubiquitously expressed, SNX31 is 
an integrin trafficking regulator with a restricted expressed pattern, expressed mainly in 
bladder and melanoma tissue. 
Finally, in the proteomics integrin interactor screen, I identified the ubiquitin-modifying 
enzyme TNF receptor-associated factor 6 (TRAF6) as an interactor with the integrin β1 
subunit. In parallel, Dr. Roy Zent (Vanderbilt University, USA) showed that integrin α3β1 
modulates Akt activation in the developing collecting system and that Akt activation is 
PI3K-independent but requires K63-linked polyubiquitination. Together with the Zent 
group we showed that integrin α3β1-dependent K63-linked polyubiquitination of Akt is 
mediated by TRAF6. The role of TRAF6 in collecting duct development in kidney was 
further supported in TRAF6-deficient mice, which displayed similar kidney defects as α3 
integrin knockout mice (paper V). 
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Introduction 
1. The integrin receptor family 
Multicellular organisms assemble cells and extracellular matrices (ECM) into 
distinct organs and tissues using different sets of adhesion molecules. Integrins are a 
major class of transmembrane cell adhesion receptors in metazoan cells conserved 
from sponges, corals, nematodes, and echinoderms to mammals (Burke, 1999; Hynes, 
2002; van der Flier and Sonnenberg, 2001). Integrins exist as non-covalently interacting 
heterodimers with one α and one β subunit. Structurally they consist of three major 
parts: (1) a large extracellular domain, (2) a single-membrane-spanning transmembrane 
(TM) domain, (3) and a generally short cytoplasmic tail between 40 and 60 amino acids 
(except β4 integrin which has a long tail of 1018 amino acids).  
One of the main roles of integrins is to link the ECM to the actin cytoskeleton. 
The extracellular domain binds to ECM proteins such as collagens and fibronectins, or 
to cellular counter-receptors like vascular cell adhesion molecule-1 (VCAM-1) and the 
intercellular cell adhesion molecule (ICAM) family on adjacent cell surfaces (Hynes, 
2002; Plow et al., 2000) while the cytoplasmic tail binds to adaptor proteins to create the 
linkage between integrins and the actin cytoskeleton. Apart from adhesion and linkage 
to cytoskeleton, integrins also modulate different signal transduction pathways to control 
a wide range of biological and cellular events including cell adhesion, migration, 
proliferation, cell differentiation, and apoptosis, which are crucial for embryonic 
development and homeostasis of multicellular organisms (Giancotti and Ruoslahti, 
1999). Based on the ability to ‘integrate’ cues from the extracellular ligands with the 
cells’ interior cytoskeleton, the term ‘integrin’ was coined (Tamkun et al., 1986). Notably, 
integrins do no possess enzymatic activity or actin-binding domains but serve as a hub 
to assemble and cluster adaptor and regulatory proteins in response to external or 
internal signals. In addition, the interaction of intracellular proteins with integrin 
cytoplasmic tails can induce conformational changes in the ectodomain characterized 
by altered affinity for their ligands (‘inside-out’ signalling). Thus, the cytoplasmic tail of 
integrins and their binding partners are crucial for the unique ability of integrins to signal 
bi-directionally across the plasma membrane. 
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1.1 Integrins and their ligands 
 Mammals express 18 α and 8 β subunits, which combine to form 24 integrin 
heterodimers. Heterodimerization takes place in the endoplasmic reticulum (ER) and is 
a pre-requisite for integrin transport to the cell surface (Rosa and McEver, 1989). The 
different combinations of αβ integrin heterodimers are characterized by distinct ligand 
binding specificity and tissue distribution. Integrins can be grouped into four classes 
depending on their binding specificity: 1. RGD (arginine, glycine, aspartate)-binding 
integrins. 2. Collagen (Col)-binding integrins. 3 Laminin (LN)-binding integrins. 4. 
Leukocyte-specific integrins (Figure 1 and Table 1): 
1. RGD-binding integrins bind to ECM molecules, which contain exposed RGD motifs 
such as fibronectin (FN), vitronectin (VN), fibrinogen (Fg). This group includes all 
five αV heterodimers (αvβ1, αvβ3, αvβ5, αvβ6 and αvβ8); two β1 integrins (α5β1, 
α8β1), and the platelet integrin αIIbβ3. Additionally, β1 integrin also dimerizes with 
α4 and α9 subunits, which binds to the functionally related Leu-Asp-Val (LDV) motif. 
These receptors recognize both FN and Ig-superfamily proteins such as VCAM-1.  
2. Collagen (Col)-binding integrins consists of the β1 heterodimers α1β1, α2β1, α10β1 
and α11β1. They recognize Gly-Phe-Hyp-Gly-Glu-Arg (GFOGER; O represent 
Hydroxyproline) peptides. The different heterodimers vary in their preference to 
different Col types. Importantly, all of these α-subunits contain a special αI domain 
in their extracellular domain, critical for ligand binding (discuss in section 1.3).  
3. Laminin (LN)-binding integrins consist of α3β1, α6β1, α7β1, and α6β4 integrins. 
The binding motif in LN recognized by the integrins varies depending on the integrin 
heterodimer (Humphries et al., 2006).  
4. Leukocyte-specific integrins atr defined by their specific expression in leucocytes to 
establish cell-cell contacts with endothelial cells by interacting with cellular counter-
receptors such as ICAM and VCAM (Hynes, 2002; Ley et al., 2007). This group 
consists of β2 integrin-containing family αLβ2, αMβ2, αXβ2, αDβ2 as well as α4β7 
and αEβ7 (specific for E-Cadherin). Similar to the Col receptors, the leukocyte-
specific integrins evolved by the insertion of the αI-domain. 
Besides the classical integrin ligands, additional integrin ligands also have been 
described (Table 1). These ligands include ADAM family members interacting with 
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α4β1, α5β1, α6β1, α9β1, αVβ3 and αVβ6, which are involved in ECM remodeling during 
cell adhesion and migration (Legate and Fassler, 2009). Proteolysis derived protein 
products, such as Endostatin (from Col XVIII), endorepellin (from perlecan, known as 
heparin sulfate proteoglycan 2) tumstatin (from Col α3) (Bix and Iozzo, 2005; Wickstrom 
and Keski-Oja, 2005), Milk fat globule-EGF factor 8 (MFGE8) and complement factor 
iC3b participate in phagocytosis of apoptotic cells and pathogens. More of these integrin 
ligands, along with their respective integrin partners, are known (Table 1 (Humphries et 
al., 2006).) 
 
 
Figure 1. Mammalian integrin receptor family and their main ligands. 8 β subunits can associate with 18 α 
subunits to form 24 distinct integrin heterodimers. The αβ subunit combination determines the ligand-
binding specificity. Many cell types express more than one integrin heterodimer. 
(taken from Hynes 2002) 
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Table 1 Characteristics of human integrin heterodimers (modified from Barczyk et al., 2010) 
Integrin heterodimer α subunit 
characteristics 
 αI Ligands Additional 
ligands 
α1β1 (CD49a, VLA1 ) 1151 aa   collagens (collagen IV > 
collagen I > collagen IX) 
Semaphorin 7A 
α2β1 (CD29b, VLA2) 1181 aa   collagens (collagen I > 
collagen IV; collagen IX) 
E-cadherin, 
endorepellin 
α3β1 (CD49c, VLA3) 1051 aa, splice 
variants α3A, 
α3B 
 V laminins (LN-511 > LN-
332 > LN-211) 
 
α4β1 (CD49d, VLA4) 1038 aa   fibronectin, VCAM-1  
α5β1 (CD49e, VLA5) 1049 aa  V fibronectin (RGD) endostatin 
α6β1 (CD49f, VLA6) 1073 aa, splice 
variants α6A, 
α6B 
 V laminins (LN-511 > LN-
332 > LN-211 > LN-411) 
 
α7β1 1137 aa, splice 
variants α7X1, 
α7X2 
 V α7X1β1: laminins (LN-
511 > LN-211 > LN-411 > 
LN-111) 
α7X2β1: laminins (LN-
111 > LN-211 > LN-511) 
 
α8β1 1025 aa  V fibronectin, vitronectin, 
nephronectin (RGD) 
 
α9β1 1035 aa   tenascin-C, VEGF-C, 
VEGF-D 
osteopontin 
α10β1 1167 aa   collagens (collagen IV > 
collagenVI > collagen II; 
collagen IX) 
 
α11β1 1188 aa   collagens (collagen I > 
collagen IV; collagen IX) 
 
αLβ2 (CD11a, LFA1) 1170 aa   ICAM-1, -2, -3, -5  
αMβ2(CD11b,MAC1) 1153 aa   iC3b, fibrinogen + more  
αXβ2(CD11c) 1163 aa   iC3b, fibrinogen + more  
αDβ2(CD11d) 1162 aa   ICAM-3, VCAM-1  
αIIbβ3 (CD42,GpIIb) 1039 aa  V fibrinogen, fibronectin 
(RGD) 
 
αVβ1 1048 aa  V fibronectin, vitronectin 
(RGD) 
 
αVβ3   V vitronectin, fibrinogen, 
fibronectin (RGD) 
tumstatin 
αVβ5   V vitronectin (RGD)  
αVβ6   V fibronectin, TGF-β-LAP 
(RGD) 
 
αVβ8   V vitronectin, TGF-β-LAP 
(RGD) 
 
αEβ7(CD103,HML1) 1178 aa  V E-cadherin  
α4β7    MadCAM-1, fibronectin, 
VCAM-1 
 
α6β4   V laminins (LN-332, LN511)  
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Table 1 (continue) (Modified from Barczyk et al., 2010) 
Integrin β chain β subunit 
characteristics 
Notes 
β1 (CD29, GpIIa)  798 aa, splice 
variants β1A-D 
Splice variants β1B and 
β1C not present in mice, 
minor variants with unclear 
function 
β2 (CD18)  769 aa   
β3 (CD61, GpIIIa)  788 aa, splice 
variants β3A, β3B, 
and β3C 
β3A major form 
β4  
(CD104,TSP-180)  
1875 aa, splice 
variants β4A-E  
β4A and β4B major forms, 
similar function  
β5  
 
799 aa, splice 
variants β5A, β5B 
Both splice variants have 
similar 
functions 
β6  788 aa   
β7 798 aa  (LPAM-1, βP) 
β8 769 aa  
 
Cells frequently express splice variants of integrins contributing to the complexity 
of the integrin family. Variable sequences have been found in the extracellular domain 
of many integrin subunits that might regulate integrin activity or ligand-binding affinity 
while cytoplasmic variation affect integrin activity, connection to cytoskeleton, and 
signaling. The integrin heterodimers and their splice variants are expressed in distinct 
tissues and embryonic developmental stages suggesting vital functions although not all 
the functions of these splice variants are well-characterized (de Melker and 
Sonnenberg, 1999; van der Flier and Sonnenberg, 2001). Best characterized examples 
are the four cytoplasmic β1 subunit variants: β1A, β1B, β1C, and β1D. β1A is 
ubiquitously expressed in all tissues except mature cardiac and skeletal muscle, in 
which β1D is expressed instead. Splice variants β1B and β1C are not present in mice 
and their function is still unclear. Expression using genetically modified mice revealed 
different roles of β1A and β1D in embryonic development. Expression of β1D instead of 
β1A leads to early embryonic lethality, while replacement of β1D with β1A in mice 
causes mild abnormalities in striated muscles (Baudoin et al., 1998) indicating a non-
substitutable role of β1A during development.   
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1.2 Integrin and mouse development 
Integrins have multiple functions, which are reflected by the diversity of 
phenotypes observed in mice lacking individual α or β subunits (Table 2) despite the 
fact that integrins have overlapping ligand preferences (Bouvard et al., 2013; Hynes, 
2002). This diversity originates from the different spatial and temporal expression 
pattern, different functional regulation and different signaling properties of individual 
integrin heterodimers. Genetic ablation of β1 integrin leads to peri-implantation lethality 
characterized by a failure of the inner cell mass (ICM) to form (Fassler et al., 1995; 
Stephens et al., 1995). The α4, α5, and αv integrin KO phenotypes are less severe but 
still embryonic lethal at different developmental stages: α5 KO embryos die between 
embryonic day 9.5 (E9.5) and E10 due to extraembryonic and embryonic vascular 
defects (Yang et al., 1993); α4 deletion leads to death between day E11 and E14 as the 
result from the defective choriallantois fusion and abnormal cardiac development (Yang 
et al., 1995); αv KO embryos die between E10 and E12 because of a placental defects 
or cleft palate and massive hemorrhages (Bader et al., 1998). The KOs of α3, α6, α8, 
β4, or β8 are lethal perinatal due to various phenotypes (See Table 2). Genetic deletion 
of other integrins leads to the defects in hematopoietic cell function (α2, αIIb, αL, αM, 
αE, β2, β3 and β7), inflammation (β6), angiogenesis (α1 and β3) and muscular 
dystrophy (α7).  
KO mice serve as models for abnormal integrin functions, which are the 
underlying cause of several human diseases. Glanzmann thrombosthenia is a human 
disorder characterized by platelet dysfunction and bleeding caused in some patients by 
mutations in αIIb and β3 integrin subunits. Deletion of both integrins in mice also results 
in defective platelet aggregation (Hodivala-Dilke et al., 1999; Hogg and Bates, 2000; 
Tronik-Le Roux et al., 2000). Ablation of β2 integrin in mice mimics the adhesion defects 
detectable in human leukocyte adhesion deficiency (LAD)-I patients (Hogg and Bates, 
2000; Scharffetter-Kochanek et al., 1998). LAD is currently divided into three subtypes, 
LAD-I, -II and –III. LAD-I results from mutations in the β2 integrin subunit (Kishimoto et 
al., 1987). Leukocytes from these patients either lack the integrin heterodimers such as 
αMβ2 and αLβ2 or express only very low levels preventing firm adhesion. LAD-III is also 
known as LAD-I variant is characterized by LAD-I like immunodeficiency and additional 
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Glanzmann’s thrombasthenia-like bleedings. Mutations within the KIND-3 gene (see 
section 2.1.1) are responsible for LAD-III, resulting in the combined defects in β1, β2, 
and β3 integrin activation in all hematopoietic cells. Whilst defects in integrin function 
are the underlying causes of LAD-I and –III, defects in the posttranslational fucosylation 
of selectin ligands lead to a loss of selectin ligands on the cell surface dramatically 
reducing leukocyte rolling and resulting in LAD-II (Schmidt et al., 2013).  
Finally, mutations in α6 and β4 in humans result in junctional epidermolysis 
bullosa with skin blistering (Takizawa et al., 1997; Vidal et al., 1995). These phenotypes 
can be also observed in α6 (Georges-Labouesse et al., 1996) or β4 (van der Neut et al., 
1996) integrin KO mice.  
1.3 Integrin structure and activity  
Structurally, each integrin subunit consists of a large extracellular domain (80-
150kDa), a single strand spanning the membrane and a short cytoplasmic tail of about 
20-50 amino acids (aa). The only exception is the β4 integrin subunit with a long 
cytoplasmic domain of 1072 residues (Wegener and Campbell, 2008). The cytoplasmic 
tail domains of β subunits except β4 are highly conserved, while the α-subunit tails are 
more divergent.  
A unique feature of integrin heterodimers is their ability to regulate their affinity 
for ligands through an allosteric conformational switch by converting the unbound form 
of integrins from the low affinity (the “inactive” state; bent extracellular domain, 
associated TM domains and cytoplasmic tails) via an intermediate ligand binding affinity 
(or primed state) to the ligand-bound, high affinity (the “active” state; extended 
extracellular domain, separated TM domains and cytoplasmic tails) state. Long-range 
allosteric rearrangements underlie the transitions between these states that allow 
integrins to signal bi-directionally across the plasma membrane (section 2). A large 
number of structural studies revealed the mechanism of ligand-binding and affinity 
regulation including crystal structures of the complete αvβ3 (Xiong et al., 2001; Xiong et 
al., 2002), αIIbβ3 (Zhu et al., 2008) and αxβ2 (Xie et al., 2010) extracellular domains 
and of different integrin fragments. Crystal structures were strengthened by NMR and 
electron microscopy (EM)-imaging of complete extracellular domains as well as full 
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length αIIbβ3 integrins embedded in nanodiscs (section 5.3) (reviewed in (Campbell and 
Humphries, 2011)). The following chapters describe the three main integrin domains in 
more detail: 
 
Table 2 Integrin knockout mice: phenotypes and the connection to human disease.  
(taken from Bouvard et al., 2012) 
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1.3.1    Extracellular domain 
The first crystal structure of an integrin extracellular domain (integrin αVβ3) 
showed that the heterodimer assembles into an ovoid "head" and two "legs" and that it 
is severely bent at a defined region in its legs, reflecting an unusual flexibility that was 
thought to be connected to integrin regulation (Xiong et al., 2001). The domains within α 
and β integrin subunits were defined after this structure. The α subunits generally 
contain a β propeller head domain, a Thigh domain followed by two Calf domains, which 
share structural similarities to immunoglobulin β-sandwich folds (Figure 2). These 
domains bear relatively less structural flexibility. An important flexible interface is 
located between the Calf-1 and Thigh domain connect by a small Ca2+ binding loop, 
termed ‘genu’ as a joint, which extends in switchblade model of integrin activation (see 
below). Furthermore, as indicated in the previous chapter some α subunits (α1, α2, α10, 
α11, αL, αM, αX, αD) carry an additional insertion of ligand binding competent αI 
domain (Figure 2B), a 200 aa insertion into second and third β-sheet of the β propeller, 
also known as von Willebrand factor A domain, which is associated to ligand binding 
affinity (see below). 
The structure of β integrin subunits are more sophisticated. They consist of a PSI 
(plexin, semaphorins, and integrins) domain inserted by a hybrid domain, which is 
inserted by a ligand binding βI domain forming the headpiece (Figure 2). The βI domain 
includes two segments: the first forms the interface with the β-propeller in α subunit and 
the second is essential for specific ligand binding, known as the specificity determining 
loop (SDL). While the headpiece is relatively stiff, the leg piece is structurally flexible 
and consists of four tandem cysteine-rich EGF-like repeats interconnected with disulfide 
bond and a membrane proximal β tail domain (Figure 2). Highest flexibility is observed 
between EGF-1 and EGF-2, which are in close proximity to the ‘genu’ of α subunits and 
critically contribute to ligand binding through unbending of the integrin headpiece.  
The αI and βI domains are structurally homologous. Both domains harbor a 
conserved ‘metal-ion-dependent adhesion site’ (MIDAS), which is occupied by Mg2+ 
under physiological conditions (Xia and Springer, 2014). In integrins composed of an αI 
domain-containing α subunit, the ligand binding will be mediated by the αI domain while 
the ligand binding site of the βI domain is associated to a β-propeller in the α subunit 
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(Figure 2B) (Zhu et al., 2013). The MIDAS in the βI-domain is flanked by two additional 
Ca2+ binding sites, which participate in integrin-ligand affinity regulation: ADMIDAS 
(adjacent to metal-ion-dependent adhesion site) and LIMBS (ligand-induced metal ion 
binding site or Synergistic Metal ion Binding site (SyMBS)). ADMIDAS has inhibitory 
effect and LIMBS is named because this site is only formed after ligand binding and 
functions to stabilize ligand binding. Owing to the existence of these sites, integrin 
activation is influenced by divalent cations: (1) Mg2+ has an activatory role (contributed 
to MIDAS). (2) High concentrations of Ca2+ (>1mM) negatively affects ligand binding 
and (due to inhibitory effect by ADMIDAS) (3) it is speculated that Mn2+ induces a high 
affinity integrin confirmation through replacement of Ca2+ at the ADMIDAS site of the βI 
domain although the underlying mechanism is still not clear. Conversely, incubation of 
cells with metal ion chelators, for example EDTA, affects integrin activity in a 
concentration dependent manner as well. At intermediate concentrations, EDTA causes 
inhibitory effect (probably through removal Mg2+ from MIDAS) while it activates integrins 
at higher concentrations (likely chelates Ca2+ ions) (Humphries et al., 2003; Springer et 
al., 2008; Wegener and Campbell, 2008; Xia and Springer, 2014; Zhu et al., 2013).  
The structural analysis of integrin heterodimers revealed the integrin atomic 
structure and also the conformational changes accompanied by ligand binding. 
Although controversies remain, it is generally believed that the extracellular domain of 
integrins reversibly shifts between three (only two in α5β1) conformations with different 
ligand binding affinities: a bent conformation (low-affinity for ligand, not observed in 
α5β1), a half-extended (intermediate affinity), and an extended (high-affinity) 
conformation. The bent conformation has been observed for the ectodomains of αVβ3, 
αLβ2 and αXβ2 integrins in electron micrograph by negative staining when the C-termini 
were clasped or when samples were prepared in Ca2+-containing buffer (Nishida et al., 
2006; Takagi et al., 2002), while α5β1 integrin prepared with same clasped C-termini 
revealed only extended conformers (Takagi et al., 2001) indicating integrin heterodimer 
dependent differences. This raises the question whether all integrin heterodimers adopt 
a bent conformation. Notably, the images of the bent conformers were obtained by EM-
negative staining of the extracellular domain but without taking contributions of the 
transmembrane and cytoplasmic regions into consideration. Other factors, such as 
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differences in the sample preparation, sampling bias in EM, distinct lipid usage might 
also explain discrepancies between different structural studies. For example, cyro-EM 
data shows the inactive αIIbβ3 integrins isolated from platelet expose an intermediate 
conformation between bent and extended forms (Adair and Yeager, 2002), while αIIbβ3 
integrins inserted into liposomes showed a bent conformation in the presence and 
absence of Mn2+ activation. (Ye et al., 2008). Additional EM study revealed that by 
embedding full length αIIbβ3 into nanodisc (see section 5.2), they adopt an open 
conformation when activated by talin head (Ye et al., 2010). This study agrees with a 
shift in the conformation equilibrium from bent to extended conformations of integrins.  
Despite the controversial studies it is believed that the shift from bent 
(intermediated in α5β1) to extended conformation (integrin activation) is possibly 
induced by the binding of extracellular ligand or mainly regulated by the binding of 
integrin activator proteins talin and kindlin (inside-out signaling, see section 2.1). Two 
models have been proposed to illustrate the underlying structural changes during 
integrin activation: in the deadbolt model, integrin ligand-binding occurs before 
extension of integrin extracellular domain while it happens after extension in the 
switchblade model.  
In the low affinity conformation, the headpiece of the integrin folds over its legs at 
the genu and faces down towards the plasma membrane (Figure 2A-1 and 2B-1). The 
‘switchblade’ model states that during the transition from a bent to the extended 
conformation, the separation of the cytoplasmic and TM domain causes a switchblade-
like knee extension of the bent integrin, which leads to the dislocation from the EGF-like 
repeats within the β leg. In turn, an outward motion of the hybrid domain occurs, making 
an obtuse angle with the βI domain leading to the "opening" of the ligand binding pocket 
on extracellular domain to allow ligand binding (Figure 2). In contrast, the ‘deadbolt’ 
model does not require unbending but, upon a piston-like movement in the tilt of the TM 
domains that results in sliding of the extracellular legs of α and β subunits. As a result 
the interaction between headpiece and β legs is disrupted just beyond the membrane 
and ligand binding site of the head domain (Arnaout et al., 2005; Askari et al., 2009; 
Wegener and Campbell, 2008; Zhu et al., 2008). 
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In the case of αLβ2 integrin, the ligand binding affinities increase from 2mM for 
the bend conformation up to 200nM in the active, extended conformation (Carman and 
Springer, 2003). The strong differences in the ligand binding affinities and their tight 
regulation is especially important for integrins expressed in hematopoietic cells as 
‘unwanted’ ligand interactions could lead to catastrophic effects such as blood clotting. 
In contrast, such a tight control might not be essential for adherent cell types such as 
fibroblasts. Indeed, the clasped α5β1 integrin, adopt a non-bent conformation with high 
affinity to FN (35nM) under non-stimulation condition which only slightly increases to 
6.3nM upon transition into the unclasped, fully extended conformation (Takagi et al., 
2001).   
1.3.2    Transmembrane and cytoplasmic domains 
Conformational changes of the integrin TM domain are crucial to transmit signals 
between the extracellular environment and the intracellular compartment across the 
plasma membrane and to mediate integrin activation as well. Therefore, much effort has 
been devoted to understand the TM domain structure to comprehend the undergoing 
structural changes during integrin activation and integrin-mediated signaling. 
Unfortunately, there is still no high resolution X-ray crystal structure available for the TM 
segments. Among all integrins, the TM domain of αIIbβ3 has been studied most 
extensively. Recent structures of αIIb and β3 integrins TM regions incorporated into 
bicelles model membranes have been solved by NMR separately and in a heterodimeric 
complex (Lau et al., 2008a; Lau et al., 2009; Lau et al., 2008b). Notably, earlier NMR 
studies using micelles could not detect the α-β interaction (Li et al., 2001) while it is 
successfully detected with lipid bicelles (see also section 5.2) as a membrane mimicking 
system (Lau et al., 2009). Meanwhile, a similar structure as αIIbβ3 embedded in bicelles 
(Lau et al., 2009) was also obtained for the TM region of αIIbβ3 using disulfide-based 
distance restraints combined with protein modeling (Zhu et al., 2009).  
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Figure 2. The structure of integrin heterodimers. The scheme depicts the integrin structure in in αI-
less (A) and αI containing (B) integrins in low (1), intermediate (2) and high affinity state (3) and illustrates 
the domain rearrangement during activation. In the bent/inactive state (A-1, B-1), the orientation and 
closed conformation of the headpiece resulting in no ligand binding which is stabilized by tight interaction 
of the hybrid domain and the integrin leg regions. In A-2 and B-2, the integrin adopts an extended, ligand 
binding competent conformation. Ligand binding induces further conformational changes in the 
headpiece, resulting in an “open-extended” conformation coupled to the hybrid domain via pistoning of 
the βI-α7-helix (black cylinder), leading to hybrid domain swing out and stabilization of the “open” high 
affinity conformation (A-3, B-3). The proposed predominant orientation of the flexible β subunit lower legs 
is shown, whereas the less predominant is indicated with dashed lines. (modified from Shatti et al., 2010) 
 
The sequences of the TM regions are well-conserved among integrins 
suggesting that the interactions between consensus reciprocal groups on α and β 
helices are essential for integrin heterodimer formation (Figure 3A-B). In the NMR 
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structure of the αIIbβ3 TM complex embedded in bicelles, the 24 aa long αIIb helix is 
perpendicular into the membrane, whereas the 29 aa β3 helix is ~25° tilted to enable 
the side chains of its hydrophobic residues to embed into membrane (Lau et al., 2009). 
Indeed, NMR analysis of TM domains of αIIbβ3 integrins successfully detected the 
association of αIIb and β3 (Lau et al., 2009). Two interaction areas are observed in (1) 
the ‘outer membrane clasp (OMC)’ formed by the interaction of conserved glycine 
residues, αIIb G972/G976 and β3 G708 allowing close helix packing. (2) The ‘inner 
membrane clasp’ (IMC) is established by an unusual αIIb backbone reversal that packs 
a consecutive hydrophobic interaction of Phe residues (αIIb F992-F993) against the β3 
TM helix (β3 L712, W715, K716, I719) promoting the electrostatic bridge between αIIb 
R995 and β3 D723 residues (Fig. 3C-D) (Lau et al., 2009). This αIIb-D723/ β3-R995 salt 
bridge has previously been proposed to explain the stabilizing effect of these residues 
on the αIIbβ3 integrin inactive state (Hughes et al., 1996).  
 
 
Figure 3. Interactions of TM regions of integrin heterodimers. Sequence alignment of the 
transmembrane segments of all human integrin subunits (A) α and (B) β. Interactions of the TM segment 
of αIIbβ3 integrin in the (C) outer- or (D) inner- plasma membrane clasp. The structures were predicted by 
NMR for the resting conformation of αIIbβ3 integrins embedded in a bicellar lipid environment. (modified 
from Lau et al., 2009) 
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Several mutational studies of the integrin transmembrane domains and molecular 
modeling experiments indicate that dissociation of the α-β integrin transmembrane 
domains results in integrin activation. Mutations in β3 TM domain, G708N, G708L and 
G708I, or the αIIb subunits (G972 or G976 in GxxxG motif in to bulky aa, Leu or Asn) 
activate αIIbβ3 integrin and increase ligand binding affinity (Li et al., 2003; Luo et al., 
2005; Partridge et al., 2005). These studies suggest that the helical packing of OMC 
interaction in TM regions requires Gly residues from both α and β subunit to stabilize 
integrin in low affinity conformation. In contrast, the introduction of an artificial disulfide 
bond in TM region of αIIbβ3 integrin prevents separation of the TM domains and inhibits 
integrin activation (Luo et al., 2004).  
 The integrin cytoplasmic tails are generally short, except for the β4 subunit. 
Nevertheless, given that these tails are the initiation-point of integrin activation induced 
by binding of intracellular proteins (‘inside-out’ activation, see section 2.1), the structure 
of the cytoplasmic domains, especially αIIbβ3 integrins, has been characterized. 
Several NMR structures of the heterodimeric αIIbβ3 cyto domain are available, which 
show a great amount of structural variety. Interactions between αIIb and β3 integrin tails 
were not detected in solution (Ulmer et al., 2001) and with αIIbβ3 TM-Cyto constructs 
embedded into micelles (Li et al., 2001), while another study using purified recombinant 
αIIb and β3 cytoplasmic domain proteins detected weak α-β interaction (Vinogradova et 
al., 2002). The explanation for this inconsistency might be an inherent structural 
flexibility of integrin tails, which only form transient structures or stay unstructured in the 
absence of binding partners. This flexibility might explain how integrin tails are capable 
of serving as a hot-spot for a multitude (approximately 232 proteins associated both 
directly and indirectly with integrins) of structurally divergent adaptor and signaling 
proteins to bind and regulate different functions (Winograd-Katz et al., 2014). Two 
conserved interaction motifs in the β subunits stand out: the membrane proximal NPxY 
and membrane distal NxxY motif, which are critically important for integrin activation, 
signaling and trafficking. Both are recognition sequences for phosphotyrosine-binding 
(PTB) domain containing proteins (Calderwood et al., 2003) and mutations in these 
sequences in mice lead to early embryonic lethality due to impaired integrin function 
(Czuchra et al., 2006). In contrast, the sequences of α subunits are highly divergent 
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except for a conserved GFFKR motif (or even GFFxR sequence) close to the 
transmembrane domain, which is part of the IMC (Figure 3D).  
Importantly, the interaction between arginine (conserved GFFKR) in the α 
subunits and aspartic acid (conserved HDR(R/K)E) in the β subunits are proposed to 
form a salt bridge to maintain αIIbβ3 integrins in the inactive state (Hughes et al., 1996). 
During integrin activation, this salt bridge and the Van der Waal-like inter-subunit 
interactions between TM regions are disrupted (Luo et al., 2004; Vinogradova et al., 
2002). However, the salt bridge is functionally not important for all integrin heterodimers 
as knock in mice with an aspartic acid to alanine exchange in the salt bridge of β1 
integrin (i.e. D759A) show no obvious phenotype regarding integrin activation, 
adhesion, spreading, and migration in vitro (Czuchra et al., 2006).  
In summary, it is believed that the dissociation of integrin TM-cyto domains is a 
key step for integrin activation. In the inactive state, integrins allow interactions of two 
distinct association motifs (OMC and IMC) as well as salt bridge between Arginine 
residue in α subunit and Aspartic acid in β subunit to retain the inactive state. Once 
integrins are activated, the TM-cyto domains also disassociate. In line, mutations 
mentioned above disrupt these associations leading to integrin activation. However, 
structural and mutagenesis studies are mainly done in αIIbβ3 integrins so far. Given the 
reason that the differences between structures of extracellular domains we know so far 
(for instance, α5β1 (Takagi et al., 2001) and αVβ3 (Takagi et al., 2002)), there might be 
also heterodimer specific differences. 
2. Bi-directional regulation of integrin signaling 
Integrins have the unusual property to transmit signals bi-directionally across the 
cell membrane. The extracellular conformation and ligand-binding affinity can be 
adjusted through interaction of intracellular ligands with integrin tails, a process called 
‘inside-out’ signaling or integrin activation. Conversely, binding of extracellular ligands to 
the integrin extracellular domain allows integrins to transmit signals into cells through 
the recruitment of adaptor and signaling molecules which regulate various cell functions 
such as adhesion, polarity, migration and cell division. This process is referred to as 
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‘outside-in’ signaling. Thus, integrins have the ability to signal in both directions (bi-
directionally) across the plasma membrane.      
2.1 Inside-out signaling 
The affinity regulation of integrins for their ligands is a tightly controlled process. 
This is particularly crucial and well-described in cells of hematopoietic lineages such as 
platelets or leukocytes. In non-activated cells of the hematopoietic system it is assumed 
that integrins are inactive with a bent conformation which does not allow integrins to 
engage their extracellular ligands. Upon cell stimulation by different cues, proteins are 
triggered to bind to the integrin tails in their low affinity conformation inducing 
conformational changes that lead to integrin activation and ligand binding. The 
molecular mechanism of inside-out integrin activation are extensively studied and two 
integrin interacting proteins, talin and kindlin take center stage as important regulators 
of integrin activation. A rare hematopoietic disease LAD-III is linked to kindlin. LAD-III 
patients are suffered immunodeficiency and hemorrhages due to combined defects in 
the activation of β1, β2, and β3 integrins on leukocytes and platelets owing to KINDLIN-
3 gene mutations (Kuijpers et al., 2009; Malinin et al., 2009; Svensson et al., 2009; 
Zimmerman, 2009). The other two LAD subtypes have been described above (section 
1.2). 
2.1.1 Talin, kindlins, and integrin activation 
Talin  
Talin was first identified in membrane ruffles and focal adhesions around 30 years ago 
as interaction partner of two other focal adhesion proteins, vinculin and integrins 
(Burridge and Connell, 1983). The vertebrate genome codes for two closely related 
talins: talin1 and talin2 (74% identical) with overlapping but distinct functions. In 
mammalian cells, talin1 is ubiquitously expressed, being most abundant in the heart and 
scarce in brain while talin2 is enriched in the heart and brain with lower levels detected 
in the skeletal muscle, liver and lung. In addition, different splicing variants of talin2 are 
expressed in every tissue examined (Debrand et al., 2009).  
Talin consists of 2541 aa (~270kDa) and is highly conserved throughout 
metazoans. It contains a globular head domain (~50kDa) linked to a carboxyl-terminal 
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flexible region composed of a series of helical bundles known as rod domain (~220kDa). 
The head domain is formed by a N-terminal FERM (4.1, Ezrin, Radixin, and Moesin) 
domain, which can be further divided into three subdomains (F1, F2, F3) and an extra 
F0 subdomain, which is not present in classical FERM domains (Figure 4A). The F3 
domain harbors a PTB-like domain that interacts with the proximal NPxY motif of β 
integrin tails (integrin-binding site-1, IBS1) (Anthis et al., 2009; Calderwood et al., 2002), 
the phosphatidylinositol 4-phosphate 5-kinase type Iγ (PIPKIγ) (de Pereda et al., 2005) 
and the hyaluronan receptor layilin (Wegener et al., 2008). Focal adhesion kinase (FAK) 
(Lawson et al., 2012) and Rac1-GEF T Lymphoma Invasion and Metastasis (TIAM1) 
(Wang et al., 2012a) also have been shown to interact with F3 domain. Meanwhile, the 
helical rod domain contains 11 binding sites for vinculin (Roberts and Critchley, 2009), a 
second integrin-binding site (IBS2) and an actin binding domain at the very C-terminus 
important for talin homodimer formation and for direct actin binding. The homodimer 
formation is proposed to promote integrin clustering (Gingras et al., 2008) (see section 
2.2) (Figure 4A). Finally, through the ability to interact with the actin-binding protein 
vinculin, talin forms an anchoring complex that allows integrins to establish a linkage 
between the extracellular environment and the actin cytoskeleton. 
 
Figure 4 Schematic full-length structure of talin. (A) Talin uses its N-terminal FERM domain and IBS2 
domain in C-terminal rod to interact with β integrin tails. Talin can directly bind actin and contains several 
vinculin binding sites to link to the actin cytoskeleton. Helices that bind vinculin are shown in dark blue. 
(B) F0/F1, F2, and F3 subdomains within FERM domain interact with phospholipids in the plasma 
membrane which is crucial to trigger integrin activation (modified from Calderwood et al., 2013). 
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The role of talin in integrin activation was predominately analyzed in CHO cells 
that exogenously express the platelet integrin αIIbβ3. In this cell system, the PTB-like 
F3 domain of talin was sufficient to activate αIIbβ3 integrins (Calderwood et al., 2002; 
Calderwood et al., 1999) and in vivo studies showed that talin is necessary for integrin 
activation in platelets (Nieswandt et al., 2007; Petrich et al., 2007). Talin1 depletion in 
neutrophils also shows defects to activate αLβ2 and αMβ2 integrins suggesting talin 1 is 
essential for integrin activation in leukocyte (Lefort et al., 2012; Watts, 2015). 
Recent structural studies using αIIbβ3 integrins revealed the underlying 
mechanisms of talin-mediated integrin activation (Anthis et al., 2009; Wegener et al., 
2007). During integrin activation, the PTB-like F3 domain of talin binds to the proximal 
NPxY motif of the β subunit and in then forms an interaction with the conserved Asp723 
(D) of the β tail. This interaction disrupts the salt bridge (R-995(αIIb) and D-723(β3)) 
which stabilizes the αβ heterodimer association, and triggers the disassociation of 
transmembrane and cytoplasmic domains, consequently inducing conformational 
changes in the extracellular region allowing ligand binding (Anthis et al., 2009). 
Importantly, binding of other PTB domains to the proximal integrin NPxY motif, such as 
DOK1 (competes talin binding to integrin; see section 2.1.2) or Numb (regulates integrin 
trafficking; see section 4), is not sufficient to activate integrins indicating that other 
features of talin apart from the NPxY interaction are important for integrin activation. 
Indeed, there is a series of basic residues distributed within the talin FERM domain 
(Elliott et al., 2010) that bind to the negatively charged phospholipids of the plasma 
membrane. Negatively charged PtdIns(4,5)P2 increases the affinity of talin FERM 
domain with for β3 cytoplasmic tail by three orders of magnitude (Moore et al., 2012) 
and the extensive talin-membrane interactions further orientate the talin FERM domain 
and induce a tilting of the bound β integrin tail, which promotes integrin tail separation 
(Figure 4B). Mutations within this basic stretch impair talin membrane binding and 
integrin activation (Anthis et al., 2009; Elliott et al., 2010; Goult et al., 2010).  
Because of its vital role in integrin inside-out signaling, cells tightly control talin 
localization and activity to prevent unwanted integrin activation. Cytosolic talin resides in 
an auto-inhibited conformation in which the interaction of the negatively charged surface 
in rod (R9 domain) with positively charged residues in F3 domain (Figure 4A) block the 
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PTB-like domain inhibiting membrane localization and integrin binding (Goksoy et al., 
2008). The release of talin from this auto-inhibited conformation is a stepwise process 
that requires different components. 1) PtdIns(4,5)P2 in the plasma membrane impairs 
the autoinhibitory interaction and releases the integrin binding pocket to facilitate 
binding to integrin tails (Goksoy et al., 2008). 2) Vinculin binding to the talin rod domain 
results in talin recruitment to the plasma membrane. Expression of talin-binding domain 
of vinculin in cells induces talin membrane targeting (Banno et al., 2012). 3) Talin can 
enhance its own activation and membrane recruitment during early adhesion formation 
via a positive regulatory loop by recruiting phosphatidylinositol 4-phosphate 5-kinase 
type Iγ (PIPKIγ). PIPKIγ increases the PtdIns(4,5)P2 concentration locally to activate 
talin (see point 1). Indeed, depletion PIPKIγ leads to slower recruitment of talin and 
vinculin to FAs (Legate et al., 2011). 4) The small GTPase, Rap1 and its effector Rap1-
GTP-interacting adaptor molecule (RIAM) are involved in talin recruitment to integrin 
cytoplasmic tails (Figure 5) (Han et al., 2006; Lee et al., 2009). RIAM interacts with the 
talin rod domains to localize talin to plasma membrane and also binds to the talin F3 
domain, which disrupts the intracellular autoinhibitory interaction (Chang et al., 2014; 
Yang et al., 2014). 5) The interaction of talin with FAK is required to recruit talin to 
nascent adhesions. However, it is unclear how FAK localization to nascent adhesion is 
achieved (Lawson et al., 2012).  
Next to the release autoinhibitory interaction and the regulation of talin targeting 
to the plasma membrane, talin-integrin interaction is negatively affected by the 
phosphorylation levels of the β integrin tail. v-Src family kinases can phosphorylate the 
tyrosine residue within the proximal and distal NxxY motif of β1 and β3 integrin which 
directly interferes with talin-integrin binding but promotes DOK1 binding to the same 
motif. Exchanging Tyr with Phe can rescue the migration and adhesion defects of v-Src 
transformed cells (Law et al., 1996; Moser et al., 2009b; Oxley et al., 2008; Sakai et al., 
2001).  
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Figure 5. Connection between agonist stimulation and integrin activation. In hematopoietic cells 
agonist stimulation leads to activation of phospholipase C (PLC) and the generation of the secondary 
messenger inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates the release of Ca2+ into 
the cytosol, which together with DAG activates protein kinase C and the Ca²+ and DAG-dependent 
guanine nucleotide exchange factor (Cal-DAG-GEF). PKC and Cal-DAG-GEF convert RAP1, from a 
GDP-bound inactive to an active GTP-bound form which binds to its effector RIAM. The Rap1/RIAM 
complex interacts with talin leading to the unmasking of the integrin binding site on talin and the 
recruitment of talin to plasma membrane (taken from (Shattil et al., 2010)). 
Kindlin 
Although the role of talin in integrin activation is well established, experimental data 
derived from in vivo studies or biochemical approaches questioned if talin is the only 
key player in integrin activation. Indeed, different studies revealed kindlins as important 
regulators of integrin activation together with talin. Kindlins were named after the gene 
(KIND1) mutated in Kindler Syndrome, a rare autosomal recessive genodermatosis 
disorder (Jobard et al., 2003). The kindlin gene family contains three members: kindlin 
1, kindlin 2 and kindlin 3, which exhibit different expression patterns in tissue. Kindlin 1 
is predominantly expressed in epithelia cells of the skin, intestine, and kidneys while 
kindlin 2 is ubiquitously expressed with the exception of the hematopoietic system. 
Kindlin 3 is exclusively expressed in hematopoietic cells (Ussar et al., 2006). Kindlin 
orthologues can be also found in C. elegans (UNC112) and in D. Melanogaster 
(Fermitin-1 and -2) and deletion of kindlin in these two model organisms led to integrin-
mediated attachment defects (Bai et al., 2008; Rogalski et al., 2000). Knockout mouse 
studies firmly established the role of kindlins in integrin activation. Intestinal epithelial 
cells and embryonic stem cells derived from kindlin 1 and kindlin 2 knock-out mice, 
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respectively, fail to activate β integrins (Montanez, 2008; Ussar, 2008). Deletion of 
kindlin 1 in mice leads to defects resembling the phenotypes reported in Kindler 
Syndrome patients, including abnormal pigmentation (poikiloderma), skin atrophy, skin 
cancer and intestinal epithelial dysfunction causing perinatal lethality in mice due to a 
severe ulcerative colitis-like intestinal epithelium detachment (Ussar et al., 2008). 
Furthermore, kindlin 1 controls epithelial stem cell homeostasis and consequently loss 
of kindlin1 leads to enlarged and hyperactive stem cell compartments and aberrant 
stem cell commitment, resulting in severe hair follicle abnormalities. Kindlin1-deleted 
keratinocytes revealed β1 integrin associated adhesion defect as well as a severe 
deregulation of the Wnt/β-catenin and TGFβ signaling pathway, both important for skin 
epithelial stem cell quiescence, self-renewal and differentiation (Rognoni et al., 2014). 
Kindlin 2 deleted mice die at peri-implantation stage due to defective integrin 
activation leading to the detachment of the endoderm and the epiblast from the 
connecting basement membrane (Dowling et al., 2008; Montanez et al., 2008). Similar 
to LAD-III patients who bear KIND3 gene mutations (Kuijpers et al., 2009; Malinin et al., 
2009; Svensson et al., 2009; Zimmerman, 2009), mice lacking of kindlin 3 suffer from 
severe bleeding as well as defective leukocyte adhesion and spreading in the presence 
of unchanged talin expression levels due to defective β1, β2 and β3 integrin activation 
on leukocytes and platelets (Moser et al., 2009a; Moser et al., 2008).  
All three kindlin members are highly conserved on the amino acid level and in 
their overall structure. They have a length of around 680 amino acids and a size of ~75 
kDa. High-resolution structure of intact kindlins are still not available, but partial domain 
structures are reported (Goult et al., 2010; Liu et al., 2011; Liu et al., 2012; Perera et al., 
2011; Yates et al., 2012). Like talin, kindlins contain a FERM domain, composing of F0, 
F1, F2, and F3 subdomains, which share high sequence similarity with the talin FERM 
domain, in particular within the F3 subdomain (Figure 6C). The F3 subdomain forms 
PTB fold that directly interacts with different β integrin cytoplasmic domains (Bottcher et 
al., 2009; Meves et al., 2009). However, kindlins carry an additional insertion of a 
pleckstin homology (PH) domain within the F2 subdomain (Figure 6C). (Kloeker et al., 
2004), which is not present in talin and facilitates the translocation of kindlins toward 
plasma membrane through interaction with PtdIns(4,5)P2 or PtdIns(3,4,5)P3 
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phospholipids (Goult et al., 2009; Hart et al., 2013; Xu et al., 2013; Yates et al., 2012). 
PtdIns(4,5)P2 can also be bound by the kindlin F0 domain (Perera et al., 2011). In 
contrast to talin, kindlin utilizes its F3 subdomain to bind the membrane-distal NxxY and 
the double Thr (in β1 tails) or Ser-Thr (in β3 tails) located between two NxxY motifs 
(Figure 6) (Ma et al., 2008; Montanez et al., 2008; Moser et al., 2009a; Moser et al., 
2008; Shi et al., 2007; Ussar et al., 2008). Importantly, the different kindlin family 
members exhibit differential binding affinities to different β integrin tails. Kindlin 1 
strongly binds to β1 and β6, whereas kindlin 2 interacts with β1 in high affinity but less 
with β2 and β3 tails and shows no binding to the β6 integrin tail (Calderwood et al., 
2013; Rognoni et al., 2014). While kindlin 3 binds to β1, β2, and β3 tails (Huet-
Calderwood et al., 2014; Moser et al., 2009a; Moser et al., 2008). What are the 
underlying mechanisms that regulate the binding affinities of the kindlin family members 
to the different integrin tails? Much remains unknown, but a recent publication 
implicates the charges of the last three C-terminal residues in the β tail as important 
regulators of kindlin 2 binding affinity (Bledzka et al., 2012). 
 
Figure 6 Kindlin domain structure and binding with integrin β tails. (A) Kindlins use F3 domain to 
interact distal NxxY motif and conserved TT (S/T) within β tails. (B) Domain structure of three kindlins. (C) 
Sequence alignment of the F3 subdomains of kindlins and talin shows high similarity. (modified from 
Meves et al., 2009 and Karaköse et al., 2010)    
It is still unclear how kindlins contribute to activate integrins mechanistically. 
Since the binding sites of talin and kindlin in β integrin cytoplasmic tails are in close 
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proximity it has been proposed that talin and kindlin may bind sequentially to β tails and 
function consecutively rather than conjointly to control activation and stabilization of 
integrin ligand binding (Moser et al., 2009b; Ye et al., 2010). Interestingly, recent results 
indicate that the region linking the PH-domain of kindlin to its F2 subdomain (Fukuda et 
al., 2014; Huet-Calderwood et al., 2014) mediates interaction with ILK and is required 
for facilitating kindlin recruitment to focal adhesions, integrin signaling, and integrin 
activation (only in(Huet-Calderwood et al., 2014)). While this interaction is proposed to 
regulate the ability of kindlin to interact with β integrin tails in C. elegans (Qadota et al., 
2014; Qadota et al., 2012), this function cannot be confirmed for mammalian cells 
(Fukuda et al., 2014; Huet-Calderwood et al., 2014) and that the mechanism for these 
functions remain unclear. Furthermore, migfilin binds to kindlin and filamin with its Lin11, 
Isl-1 & Mec-3 (LIM) homology domains (Brahme et al., 2013). The interaction of migfilin 
to filamin competes with the interaction of filamin to β integrin tails and it was therefore 
suggested that kindlin-mediated recruitment of migfilin to integrins may contribute to 
integrin activation by sequestering filamin (Calderwood et al., 2013). However, mice 
deleted for migfilin show no integrin activation defects, raising the question how relevant 
this interaction is for integrin activation (Moik et al., 2011). 
The most recent studies suggests that both proteins fulfill distinct roles in integrin 
activation: In this study only talin could regulate monovalent ligand affinity of αIIbβ3 
integrin (activation) while kindlin increases the multivalent ligand binding by promoting 
the clustering of talin-activated integrins (clustering) (Ye et al., 2013). Talin 1 depletion 
neutrophils are deficient in both slowly rolling and arrest, whilst kindlin 3 deficient 
neutrophils can still mediate slowly rolling, indicating that these different integrin 
regulators serve different roles in αLβ2 integrin activation (Lefort et al., 2012). Neither 
talin 1 nor kindlin 3 deficient neutrophils were able to adopt the high-affinity 
conformation (extended/open extracellular domain) of the αLβ2 integrin, whilst only talin 
1 -/- cells were deficient the first step of integrin activation to the intermediate affinity 
form (extended/closed extracellular domain) (Lefort et al., 2012). On the other hand, 
nascent adhesions (see section 3) can form in the absence of talin (Lawson et al., 2012) 
and fibroblasts lacking talin 1 and talin 2 still show limited adhesion and spreading on 
FN (Zhang et al., 2008). Taken together, talin and kindlin fulfil essential roles during 
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integrin activation although the mechanism how they cooperate to regulate integrin 
activity still remains unclear. 
2.1.2 Other integrin binding partners inhibit integrin activation 
Integrin activation requires talin and kindlin binding and a lot of effort has been 
devoted to clarify the underlying mechanisms. In contrast, the transition of integrins from 
an active to an inactive conformation is much less well understood and studied. The 
inactive conformation has long been considered as ‘default state’ but recent studies 
indicate that the inactive conformation is actively regulated by the binding of intracellular 
integrin inactivators, including ICAP1, filamin, DOK1, SHARPIN, and MDGI (Figure 7). 
This suggests that integrin affinity regulation machinery might be even more complex 
and that integrin activation might not only be regulated by the breaking of the associated 
TM and cyto domains, extending bent conformation to increase the affinity but also by 
the maintenance of integrins in the inactive conformation to prevent unwanted 
activation.   
  
 
Figure 7 Integrin inhibitors binding sites on α (A) and β (B) integrin cytoplasmic tails. The integrin 
subunits that bind to each molecule are indicated in brackets. The residues form the inner membrane 
clasp (IMC) between the α and β subunitsTM domain are shown in green, and the proximal NPXY and 
distal NXXY motifs are shown in blue (modified from Bouvard et al., 2013). 
ICAP1 (integrin cytoplasmic domain-associated protein 1) 
ICAP1 is a PTB domain containing protein that specifically binds to the distal NxxY motif 
of β1 (but not to β2, β3 and β5) (Chang et al., 1997). It localizes with β1 integrins in 
peripheral ruffles but not in focal adhesions suggesting a role in integrin inactivation 
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(Fournier et al., 2002). Indeed, it has been shown that ICAP1 inhibits β1 integrin 
activation through simultaneous competition with talin and kindlin (Bouvard et al., 2003; 
Brunner et al., 2011). How ICAP1 competes with talin is still not fully understood, as the 
crystal structure of ICAP1-β1 integrin complex shows that the talin-binding proximal 
NPxY is not involved in the interaction interface (Liu et al., 2013). This would suggest 
that ICAP1 prevents talin binding indirectly. In contrast, ICAP1 directly competes with 
kindlin binding to β1 tails to impair β1 activation (Brunner et al., 2011). ICAP1 binding to 
integrins is further regulated by its interaction with KRIT1 (Krev interaction trapped 1), 
which relieves ICAP1 from the distal NxxY motif on β1 integrin, allowing kindlin binding 
and integrin activation (Liu et al., 2013).   
Filamin  
Another molecule whose direct interaction with integrin tail inhibits integrin activity is 
filamin. Filamin is a huge rod-like protein (about 280 kDa) containing an actin binding 
domain and 24 Ig-like domains to connect various proteins. Dimerization through the 
24th Ig-like domain results in a flexible parallel homodimer that can promote high-angle 
branching of actin filaments and is essential for stabilizing the actin networks (Flanagan 
et al., 2001). This permits assembly of complex networks linking integrins with signaling 
proteins and the actin cytoskeleton and that is important for integrin outside-in signaling. 
There are three isoforms of filamin; filamin A and B are ubiquitously expressed, while 
filamin C expression is restricted to cardiac and skeletal muscle (Das et al., 2011). The 
filamin binding interface on the β integrin tail overlaps the talin binding site and thus 
filamin-binding to β integrins antagonizes talin-mediated integrin activation (Kiema et al., 
2006). Indeed, depletion of filamin in cells enhances integrin activity (Kiema et al., 2006) 
and regulates cell spreading and migration in multiple cell lines (Baldassarre et al., 
2009; Das et al., 2011; Kiema et al., 2006; Xu et al., 2010). Similar to KRIT1-ICAP1 
interaction, migfilin, a filamin-binding protein, can displace filamin from β1 and β3 tails 
and thereby enhance integrin activity by promoting talin binding when overexpressed 
(Ithychanda et al., 2009; Lad et al., 2008). Interestingly, a recent structure of the 
cytoplasmic domain of human integrin αIIbβ3 and the immunoglobin repeat 21 of filamin 
A (FLNa-Ig21) revealed an unexpected ternary complex. FLNa-Ig21 not only binds to 
the C terminus of the integrin β3 cytoplasmic tail but also engages N-terminal helices 
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from both αIIbβ3 integrin cytoplasmic tails to stabilize an IMC and promote 
heterodimerization that helps restrain the integrin in a resting state (Liu et al., 2015).  
DOK1 (docking protein 1) 
The PTB domain-containing protein DOK1 binds to the proximal NPxY motif in β integrin 
tails and inhibits integrin activity (Calderwood et al., 2003; Wegener et al., 2007). DOK1 
binding to the β integrin cytoplasmic tail can be increased by Src kinases-mediated Tyr 
phosphorylation of the NPxY motif in β1and β3 integrins. As the integrin-binding affinity 
of talin decreases upon Tyr phosphorylation, this phosphorylation event might provide a 
switch for integrin inactivation and a transition from talin-dependent to DOK1-dependent 
integrin signaling (Oxley et al., 2008; Wegener et al., 2007).  
SHARPIN (SHANK-associated RH domain-containing protein) 
Most integrin inactivators described so far bind to β integrin tails, however, few α 
integrin interactors have also been shown to inactivate integrins. SHARPIN (SHANK-
associated RH-domain containing protein) is a ubiquitously expressed cytosolic protein 
that forms a linear ubiquitin chain assembly complex (LUBAC) to regulate NF-κB 
activation in response to stimuli like tumor necrosis factor (TNF) (Wang et al., 2012b). 
SHARPIN has been identified as an important inhibitor for integrin activation (Rantala et 
al., 2011). SHARPIN co-localizes with inactive integrin β1 to membrane ruffles but not in 
focal adhesions and depletion of SHARPIN in PC3 prostate cancer cells increases the 
active β1 integrin levels on the surface without altering the total integrin surface 
expression. SHARPIN binds integrin at the highly conserved WKxGFFKR sequence 
within integrin α subunits. Since this Arginine (R) has been shown to form a salt bridge 
with a conserved aspartic acid (D) the β integrin tail, SHARPIN is believed to stabilize 
the salt bridge and thereby keeps integrin heterodimers in the inactive state (Bouvard et 
al., 2013). However, as the mutation of the salt bridge aspartic acid (D) in β1 integrins 
does not affect integrin activation (Czuchra et al., 2006), this hypothesis might not be 
correct for all integrin heterodimers and needs further analysis. Alternatively, SHARPIN 
might function by inhibiting talin and kindlin recruitment to the β integrin cytoplasmic 
domains (Rantala et al., 2011). So far, SHARPIN has been established as an inhibitor of 
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β1 and αLβ2, whether this is also true for other integrins still needs further investigation 
(Bouvard et al., 2013; Pouwels et al., 2013; Rantala et al., 2011) 
MDGI (mammary-derived growth inhibitor) 
MDGI is found in lactating bovine mammary glands and has growth inhibitory propertied 
in human mammary carcinoma cell culture (Bohmer et al., 1987). MDGI is ubiquitously 
expressed (Haunerland and Spener, 2004). Like SHARPIN, MDGI interacts with several 
α subunits (α1, α2, α5, α6, α10, α11) via the WKxGFFKR sequence. MDGI 
overexpression leads to cell adhesion defects on different substrates and impairs 
migration and invasion specifically in human breast cancer cell lines but not in other cell 
types (Nevo et al., 2010). These phenotypes are accompanied by the reduction of 
active integrin β1 on the surface and inhibited kindlin recruitment to active β1 integrin by 
in situ proximity assay upon expression of MDGI in human breast cancer lines (Nevo et 
al., 2010). However the mechanism of MDGI function requires more studies as it is not 
clear why MDGI inhibits integrin activity only in mammary epithelium cells.  
2.2 Integrin clustering and catch-bond formation 
Once integrins are activated, they are ready to bind to their ligands. However, a 
single integrin-ligand interaction is too weak to maintain the adhesion to ECM. 
Therefore, integrins associate laterally at the site of adhesion so that multiple weak 
individual non-covalent linkages to the ECM join in a synergistic manner to generate 
stronger adhesion force. The relevance of this process, termed integrin clustering, for 
adhesion strengthening and the transmission of signals from the ECM into the cell has 
been shown (Roca-Cusachs et al., 2009; Shi and Boettiger, 2003). The underling 
mechanism of integrin clustering is still unknown but a recent model put forward an 
inter-relationship between integrin catch bond formation, clustering and signaling 
(Boettiger, 2012; Paszek et al., 2014). This model is based on the fact that cell surface 
integrins are surrounded by a dense network of glycosylated proteins, called glycocalyx, 
which extends from the cell membrane typically between 30-50nm. This distance is 
longer than the extension of integrins from the plasma membrane (around 20nm) (see 
Figure 8). The glycocalyx effectively reduces the initial ligand-integrin interaction but 
after the initial contact is formed it brings the cell surface closer to the ECM (as the 
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glycocalyx gets compressed) facilitating the association of further integrins (Paszek et 
al., 2014). Consequently, integrins cluster around the initial contact as soon as the 
contact is stabilized (Boettiger, 2012). In addition to its role in integrin activation and 
outside-in signaling it was suggested that talin could also potentially play role in integrin 
clustering while talin contains two distinct integrin binding sites can also dimerize and 
thereby act as a scaffold for integrin clustering (Gingras et al., 2008) (see section 2.2.1). 
In Drosophila, talin stabilizes the integrin adhesion complex by promoting integrin 
clustering distinct from its ability to support inside-out activation (Ellis et al., 2014). A 
recent study also suggests that kindlin can regulate integrin clustering through an 
unknown mechanism (Ye et al., 2013). 
Figure 8. The role of glycocalyx for integrin clustering. The 
glycocalyx is formed by extracellular, membrane bound 
glycoproteins (blue/black lines). Integrins (red) cannot reach to the 
ECM when the glycocalyx is too far away. The local exclusion or 
compression of glycocalyx and a membrane deformation are 
required for initial contact formation. Once such a structure forms, 
other integrin molecules can quickly form further ECM contacts. 
(adapted from (Paszek et al., 2014)) 
  
In addition to integrin clustering, two additional actin-dependent adhesion 
strengthening mechanisms are described for specific integrin heterodimers: catch-bond 
formation and cyclic mechanical reinforcement. These mechanisms seem to be integrin 
subtype specific and have only been demonstrated so far for α5β1 and αLβ2 integrins 
not for αvβ3 or αIIbβ3 integrins (Chen et al., 2010; Friedland et al., 2009; Kong et al., 
2009; Kong et al., 2013; Litvinov et al., 2011; Roca-Cusachs et al., 2009). For most non-
covalent bonds the half-life of the binding between molecules decrease when pulling 
force is applied (slip-bond). In contrast, a catch-bond is a type of non-covalent bond 
whose dissociation lifetime increases with tensile force applied to the bond before 
decreasing again with further higher force. In the case of α5β1 integrins, a study from 
Friedland suggests that engagement of FN synergy site in response to myosin II-
generated cytoskeletal force controls the catch bond behavior (Friedland et al., 2009). A 
distinct mechanism from catch-bond formation suggests applications of cyclic force to a 
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fibronectin-integrin α5β1 bond switch the bond from a short-lived state with 1 s lifetime 
to a long-lived state with 100 s lifetime. This observation was named cyclic-mechanical 
reinforcement (Kong et al., 2013), however, the underlying mechanism is still unclear. 
2.3 Outside-in signaling 
Integrins activate signaling pathways and connect to the actin cytoskeleton after 
ligand binding to regulate many cellular processes, such as adhesion, migration, and 
cytoskeleton organization. However, due to their short cytoplasmic, non-enzymatic tail 
domains they rely on the recruitment of proteins to transmit signals into the cell, to 
cross-talk with other signaling pathways and to the dynamically regulate the actin 
network. Upon integrin activation (section 2.1), ligand binding and clustering (section 
2.2) integrins assemble a multi-protein complex around their cytoplasmic domains 
(termed outside-in signaling). The initial adhesion complexes, also referred to as 
nascent adhesions, are either quickly disassembled or mature into focal adhesions, 
fibrillar adhesion or podosomes (see below section 3). The signaling outcome depends 
on the composition of these signaling complexes, which changes over time and is 
further influenced by the size, shape and sub-cellular localization of the signaling 
complex. Literature-based analyses of adhesion complexes and proteomic studies have 
identified a highly connected network of over 232 proteins directly and indirectly 
associate with integrins (collectively termed integrin ‘adhesome’) (Winograd-Katz et al., 
2014). These proteins can further divide into 148 intrinsic components (reside mainly in 
the adhesion site) and 84 components that transiently associate with the adhesion 
(Winograd-Katz et al., 2014). More than 40 molecules bind non-simultaneously with β 
integrin tails, while much fewer α tails’ interactors were reported (Legate and Fassler, 
2009).  
Integrin outside-in signaling results in downstream signaling events which can be 
subdivided in three temporal stages, immediate early (0-10 minutes), short term (10-60 
minutes) and long term effects (Figure 9A) (Legate and Fassler, 2009). The immediate 
consequences of integrin activation and signaling are up-regulation of lipid kinase 
activity, including Phosphatidylinositol 3-kinase (PI3K) and PIPKIγ that enhance the 
local concentration of the phosphoinositide second messengers PtdIns(4,5)P2 and 
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PtdIns(3,4,5)P3 as well as rapid phosphorylation of specific protein substrates. This 
local enrichment of PtdIns(4,5)P2 also further promotes talin activation and its 
recruitment to plasma membrane (see section 2.1.1). This subsequently leads to the 
recruitment of many adhesion proteins such as Numb, Src homology containing protein 
(Shc), Tensin and in the time range of several minutes, these changes lead to the 
activation of diverse multiple signaling pathways. Among many cell adhesion-mediated 
phosphorylation events, the one initiated by focal adhesion kinase (FAK) and Src 
kinases are the most crucial. Phosphorylation of FAK at the autophosphorylation site 
Tyr397 enables the interaction with Src family kinases via their SH2 domain. This 
interaction in turn releases an auto-inhibitory interaction to activate Src. Full Src 
activation is finally achieved by its auto-phosphorylation at Tyr416. Activated Src in turn 
further promotes FAK activity by phosphorylation of FAK on several Tyr residues. The 
activated FAK/Src complex is able to phosphorylate other early focal adhesion proteins 
such as paxillin and p130Cas, generating highly divers signaling platform (Legate and 
Fassler, 2009).   
As a short term effect, these signals translate into rearrangement of the actin 
cytoskeleton and myosin mediated force generation induced by the activation of Ras 
homolog (Rho) family GTPases and other actin regulatory proteins. Consequently, 
activation of rapidly accelerated fibrosarcoma (Raf) / extracellular signal-regulated 
kinase (ERK) / mitogen-activated protein kinase (MAPK), Jun N-terminal kinase (JNK) 
and Akt signaling pathways. Finally, in a long-term scale, integrin-activated signaling 
pathways coordinately will lead to changes in gene expression to regulate proliferation, 
survival and to induce genetic programs that control cell fate (Figure 9) (Legate and 
Fassler, 2009). 
An additional level of regulation of integrin-mediated signaling pathways is the 
cross-talk with different growth factor receptor signaling pathways. The signaling events 
initiated by the two receptor classes intersect at multiple levels thereby changing the 
activity of the integrin-associated signaling proteins or downstream effectors (Figure 
9B). For example, αVβ3 integrins can induce specific phosphorylation on the Epidermal 
Growth Factor (EGF)-Receptor (EGFR) required for downstream signaling events in the 
absence of EGF (Moro et al., 1998). In addition, αVβ3 integrins mediate growth-factor 
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independent clustering of growth factor receptors, such as the VEGFR2 (Soldi et al., 
1999), Platelet Derived Growth Factor Receptor (PDGFR) (Borges et al., 2000; DeMali 
et al., 1999; Schneller et al., 1997).  
In summary, ligand-binding, the formation of a highly complex and dynamic multi-
molecular adhesion complex as well as the cross-talk with growth factor receptor 
pathways regulates the integrin mediated outside-in signaling machinery. 
 
Figure 9. Integrin inside-out activation. (A) The three temporal stages of integrin signaling downstream 
events. (B) Integrin-mediated signal transduction pathways. The growth factor receptors (GFRs) and the 
growth factor environment coordinated outside-in signaling of integrins. Integrin-mediated signaling 
interacts with growth factor signaling on multiple levels: (I) integrin affinity for ligands, (II) the activity of the 
integrin-associated signaling proteins (FAK, Src, and PI3K), and (III) the activity of the downstream 
effectors (ERK, Akt, JNK, and the Rho GTPases). The central signaling module downstream of integrins 
is the Src/FAK complex that activates ERK and JNK to regulate cell survival, proliferation, and 
differentiation. In addition, the Src/FAK complex regulates Rho GTPase activity through activation of 
Crk/Dock180 or PIX/GIT pathways, resulting in cytoskeletal reorganization and leading to regulation of 
cell migration, adhesion, and polarity. Integrins also activate PI3K, which in collaboration with mTOR and 
possibly ILK regulates cell survival through Akt. The alternative activation pathways and cross-talk 
between the various depicted pathways are not presented. (GFR) Growth factor receptor; (PI3K) PI-3-
kinase; (ILK) integrin linked kinase; (TORC) mammalian target of rapamycin complex; (FAK) FA kinase; 
(ERK) extracellular signal regulated kinase; (Cas) Crk-associated substrate; (JNK) Janus kinase; 
(DOCK180) dedicator of cytokinesis 1; (PIX) PAK interactive exchange factor; (GIT) G protein-coupled 
receptor kinase-interacting protein. (taken from Legate et al., 2008) 
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3. Assembly of integrin-dependent adhesion structures  
Upon activation, integrins increase their affinity toward ligands; however, each 
individual integrin-ligand interaction is relatively weak. The firm adhesion of a cell to 
ligand requires the collective binding of multiple integrins, also referred to as clustering 
(see section 2.1), to establish strong adhesion with ECM. The adhesion structures differ 
between cell types and are classified by morphology, molecules composition, and 
dynamics. Moreover, they also localize in different areas in the cells (Figure 10D) 
(Geiger et al., 2009). 
The very initial integrin-based adhesions are termed nascent adhesions. They 
are dot-shaped with approximately 100 nm in diameter (Geiger and Yamada, 2011) and 
are mostly assembled along membrane protrusions that promote the activity of Rho-
GTPases such as Rac1. Most nascent adhesions disassemble very fast, however, few 
nascent adhesions subsequently mature by further integrin clustering and recruitment of 
actin-linker multi-protein complexes to the cytoplasmic platform into a punctate structure 
(>100 nm in diameter) named focal complexes (FXs). FXs are located close to the edge 
of the lamellipodium and if further stabilized, they will mature and form focal adhesion 
(FA) structures (commonly ∼1 μm wide, 3–5 μm long) (Figure 10A). The transition from 
FXs to FAs activates Myosin II which in turn exerts contractile force on the adhesion 
structures resulting in adhesion reinforcement and recruitment of more molecules to 
FAs that further increase myosin II activity (Geiger et al., 2009). One marker for 
maturation of focal adhesions is zyxin, as it is recruited to FAs but does not appear in 
nascent adhesion and FXs (Zaidel-Bar et al., 2003). Our group (Schiller et al., 2011) 
and Waterman’s lab (Kuo et al., 2011) have further analyzed the changes of myosin II 
activity-dependent proteins recruitment by treating myosin II inhibitor, blebbistain, and 
then by quantitative mass spectrometry. This provided the ample data of adhesion site 
maturation process of fibroblast seeded on FN (Kuo et al., 2011; Schiller et al., 2011). 
Interestingly, many ‘core adhesome’ proteins including talin and kindlin do not change 
their stoichiometry to β1 integrin during the adhesion maturation process (Schiller et al., 
2011). Rac specific GEF β-pix stays in nascent adhesion sites and that plays a crucial 
role in lamellipodial protrusion (Kuo et al., 2011). In contrast, vinculin (Humphries et al., 
2007b) and filamin (Ehrlicher et al., 2011) which can stabilize integrin-actin linkage and 
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thereby increase tension as well as testin which activates RhoA (Magno et al., 2011) 
leading to increased myosin II activation are relatively increased in the progression of 
FAs maturation.  
In certain cell types (eg. fibroblasts) FAs further mature into centrally localized, 
elongated fibrillar adhesions (FBs) during adhesion to FN (Figure 10B). The maturation 
process is characterized by the recruitment of tensin as well as centripetal translocation 
of α5β1 integrin containing FAs, accompanied by the stretching of FN fibrils (Pankov et 
al., 2000). Another adhesion structure called podosome is mainly observed in highly 
migratory and invasive cell lines such as osteoclasts, macrophages and dendritic cells. 
They are composed of a ring-like assembly of matrix adhesion components surrounding 
an F-actin core (Gimona et al., 2008) (Figure 10C). 
  
Figure 10. Diversity of integrin-mediated adhesion structures.  (A) FA (arrows) and FX (arrowheads) 
formed in a human foreskin fibroblast stained for paxillin (red) and actin (green). (B) FB (arrows) formed 
by a WI38 human lung fibroblast, stained for tensin (red) and fibronectin (green). (C) Podosomes in a 
cultured osteoclast derived from murine bone marrow, stained for paxillin (red) and actin (green). (D) 
Localization of different adhesion structures in the cell. (modified from Bouvard et al., 2013 and 
Wolfenson et al., 2013) 
Introduction 
48 
 
Notably, the different adhesion structures have been described in cell culture on 
rigid 2D surfaces and their existence in vivo and in 3D matrices have been 
controversially discussed. Embedding most of cells in 3D matrices can lead the 
formation of 3D adhesion structures which resemble FBs as they are α5β1 integrins-rich 
but on the other hand contain proteins mainly found in FAs such as α-actinin and 
phosphorylated paxillin (Berrier and Yamada, 2007; Harunaga and Yamada, 2011) 
(Figure 11). Only few in vivo integrin-mediated adhesion structures have been 
characterized including FAs of endothelial cells at sites of fluid shear stress in blood 
vessels and in smooth muscle dense plaques (Geiger and Yamada, 2011).  
 
Figure 11.  Differences between focal adhesions, fibrillar adhesions, and adhesions in a 3D matrix.  
Different adhesion structures do not only recruit a distinct set of cytoplasmic proteins but also show 
difference in the phosphorylation of those proteins. For instance, FAK Tyr-397 is highly phosphorylated in 
FAs but lower in FB and 3D adhesion structures. In contrast, Paxillin phospho-Tyr 31 and FAK phospho-
Tyr 861 levels are high in both FAs and 3D adhesions but are lower in FB. Distinct protein complexes are 
likely to form within each type of matrix adhesion leading to the activation of specific signaling pathways. 
(taken from Berrier et al., 2007) 
Introduction 
49 
 
3.1  Integrin-actin connection 
One key function of the integrin outside-in signaling is the linkage to and the 
regulation of the cell actin cytoskeleton to modulate cell morphology, to initiate cell 
migration but also to convert mechanical stimuli into chemical activity, in a process 
termed mechanotransduction. FA proteins are divided into four classes based on their 
involvement in establishing and maintaining the integrin-cytoskeleton linkage: (1) 
integrin-interacted proteins that directly bind actin, such as talin, α-actinin and filamin; 
(2) non-integrin-associated actin-binding proteins, such as vinculin; (3) integrin-bound 
proteins that indirectly associate with/regulate the cytoskeleton, such as kindlin, ILK, 
and paxillin and (4) scaffolding/signaling molecules that tune integrin signals but are not 
associated with integrin or actin (Legate and Fassler, 2009) 
The initial linkage of integrin to the actin cytoskeleton is mediated through the 
recruitment of talin to β integrin tails upon ECM binding. Thereby, a talin-dependent 2-
pN slip bond is established, providing the initial force from the cytoskeleton to the ECM 
(Jiang et al., 2003). Several in vivo studies corroborate the key role of talin to connect to 
cytoskeleton. For example, depletion of talin 1 in mice leads to lethal phenotype during 
gastrulation because of defects in cytoskeletal organization and cell migration (Monkley 
et al., 2000). Furthermore, deletion of both talin1 and talin2 in skeletal mouse muscles 
impairs muscle development comparable to a β1 integrin knock-out (Conti et al., 2009). 
Importantly, functional active β1 integrin are still detectable on skeletal muscle cells and 
adhesion of isolated cells to ECM is not affected, suggesting that the observed defects 
are due to disruption of integrin actin connections rather than an inability to activate 
integrins (Conti et al., 2009). Talins have a cryptic actin binding site (ABS) in the C-
terminal region of their rod domain (Figure 4). This Talin/HIP1R/Sla2p actin-tethering C-
terminal homology (THATCH) is also required for homodimer formation (Gingras et al., 
2008).  
After the binding of talin to actin to generate the first connection, vinculin is 
rapidly recruited to the talin rod region to reinforce the linkage. There are 11 vinculin 
binding sites within talin rod domain (Figure 4) (Roberts and Critchley, 2009) which are 
buried in helical bundles if talin is not under tension (termed as cryptic binding site) and 
mechanical stretching is required to expose these sites allowing vinculin binding 
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(Papagrigoriou et al., 2004). Vinculin is required to strengthen the linkage by acting as a 
crosslinker and by stabilizing the talin-actin interaction. Expressing the talin head 
domain in talin-null cells activates integrins but only full-length talin restores the ECM-
cytoskeleton linkage and normal cytoskeleton organization (Zhang et al., 2008). This 
shows that talin head itself is able to interact with β integrin cytoplasmic domains but it 
is not sufficient to maintain the actin linkage. Vinculin knockout cells display fewer and 
smaller FAs and close a wound more rapidly (Coll et al., 1995; Volberg et al., 1995; Xu 
et al., 1998). Conversely, in vinculin-overexpressing cells, the number and size of FAs 
are increased and cell motility is reduced (Rodriguez Fernandez et al., 1992). 
Nevertheless, the observation that vinculin-null cells have focal adhesions suggests that 
vinculin is required to stabilize FAs once they have formed but not their assembly. 
The talin-vinculin axis is a major contributor for the integrin-actin linkage. Vinculin 
itself can be recruited to β integrin adhesion sites via directly binding to paxillin (Turner 
et al., 1990). However, several other proteins contribute to the establishment and 
maintenance of this linkage. As force is generated, the actin binding protein α-actinin is 
recruited to FAs via vinculin, talin and direct β-integrin interaction as well (Laukaitis et 
al., 2001). Besides, α-parvin also harbors two actin binding Calponin homology (CH)-
domains (Olski et al., 2001). Together with ILK and PINCH, it constitutes a protein 
complex termed as IPP (ILK/PINCH/parvin) complex. The link to the integrin β tails is 
made by ILK which also binds to paxillin, a direct integrin interactor. The IPP complex 
exemplifies the elaborate interactions of FA proteins linking integrins to the actin 
cytoskeleton. In summary, the integrin-actin connection is established and coordinated 
on multiple levels and the individual actin-binding components within FAs are highly 
interconnected (Humphries et al., 2007a; Legate and Fassler, 2009). A topographical 
study (using super resolution microscopy) revealed the nanoscale architecture of 
integrin-based adhesions. Integrins and actin are vertically separated by a 40 nm FA 
core region consisting of a membrane apposed integrin signalling layer (integrin 
cytoplasmic tails, FAK, paxillin), an intermediate force transduction layer (talin and 
vinculin), and an uppermost actin-regulatory layer (Zyxin, VASP, α-actinin) 
(Kanchanawong et al., 2010). 
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3.2  Dynamic regulation of the actin cytoskeleton 
Apart from establishing a physical anchorage of the actin cytoskeleton at the 
plasma membrane, cell adhesion proteins also regulate actin distribution and dynamics. 
The spatiotemporal control of actin dynamics is crucial for many processes such as cell 
morphology, cell polarity, as well as tissue homeostasis, wound healing, and embryonic 
development (Jaffe and Hall, 2005).  
The key regulators of actin dynamics and distribution within cells are members of 
the Rho family of small GTPases (Rho GTPases). The Rho family comprises more than 
22 members in mammals, which cycle between an active GTP-bound state and an 
inactive GDP-bound state and thereby function as molecular switches (Bustelo et al., 
2007). They are controlled by three classes of regulatory proteins: GEFs (guanine 
nucleotide exchange factors), GAPs (GTPase activating proteins), and GDIs (guanine 
nucleotide dissociation inhibitors). GEFs activate the GTPases while GAPs promotes 
inactivation by stimulating the intrinsic GTPase activity of the Rho proteins. GDIs 
sequester inactive GDP-bound Rho-GTPases into the cytoplasm and thus remove them 
from their activation cycle by GEFs at the plasma membrane. The best-studied 
representatives are RhoA (Ras homologous), Rac1 (Ras related C3 botulinum toxin 
substrate 1) and Cdc42 (cell division cycle 42). When activated by cellular signals these 
Rho GTPase promote and regulate formation of prominent and morphologically distinct 
actin-based structures, namely protrusive lamellipodia (Rac1), protrusive actin-rich 
filopodia (Cdc42) and stress fibers (RhoA). While Rac1 and Cdc42 both promote 
morphologically distinct actin-based protrusive structures (Rac1 promotes dendritic actin 
organization in lamellipodia and Cdc42 is thought to be the main mediator of the parallel 
linear actin filaments constituting filopodia), they both initiate peripheral actin 
polymerization through the Arp2/3 complex. In contrast, RhoA stimulates actin 
polymerization through formins (Jaffe and Hall, 2005).  
Regulation of myosin-based contraction by RhoA, Rac and Cdc42 is antagonistic 
and that is related to cell spreading. Initial cell adhesion and spreading occurs in parallel 
with an inhibition of RhoA activity and the simultaneous activation of Rac and CDC42, 
which results in suppressed myosin II activity leading to suppression of contractility and 
enhanced actin-mediated protrusion leading to spreading. At later phases, the activities 
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of Rac1 and Cdc42 decrease, whereas the activity of RhoA gradually increases, and 
that activates ROCK (Rho-associated kinase), which phosphorylates and inactivates the 
MLC phosphatase that dephosphorylates MLC or directly phosphorylates MLC, 
resulting in increasing the activity of myosin II and contractility. This drives FAs 
maturation. Besides, the actin stress fiber is mainly regulated by myosin II contraction 
that pulls antiparallel actin fibers past each other, thus creating the force. (Geiger and 
Yamada, 2011).  
Integrins regulate Rho GTPase activity by recruiting different GEFs and GAPs to 
the adhesion sites. For instance, integrin outside-in mediated FAK/Src activation 
recruits a complex composed of Dock180 (180 kDa protein downstream of CRK) and 
ELMO1 (engulfment and motility 1) serves as unconventional GEF for Rac which is 
crucial for phagocytosis and cell migration in mammalian cells (Brugnera et al., 2002).  
In addition, the activated FAK/Src complex can also phosphorylate paxillin which is 
important to recruit a complex consisting of the ArfGAP PKL(paxillin-kinase linker)/GIT 
(G-protein-coupled receptor kinase interacting protein) and β-PIX (PAK-interacting 
exchange factor-beta), which as a GEF for Rac1, which mediates Rac1 targeting to 
membrane ruffles and to FAs as well as Rac1 activation and Rac1-mediated cell 
spreading (ten Klooster et al., 2006). As spreading ends, RhoA activity gradually 
increases leading to stress fiber formation and FA maturation. The GEFs p115RhoGEF 
(also known as Lsc and Gef1), LARG (also known as Gef12) (Dubash et al., 2007), and 
p190RhoGEF (Lim et al., 2008) are involved in these processes.  
In summary, integrin-mediated adhesion provides the linkage from ECM to actin 
cytoskeleton and profoundly regulates the spatiotemporal coordination of actin 
cytoskeleton dynamics through Rho GTPase. Indeed, the adhesion structures formation 
as well as protrusion and contractility mediated via Rho GTPases need the delicate 
balance for appropriate cell spreading and migration. 
4. Integrin trafficking  
It is known that integrins reside only for a short time on the cell surface because 
they constantly undergo exo-endocytic cycle, a process also referred as integrin 
trafficking. The intracellular trafficking not only regulates integrin availability and 
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distribution on the cell surface, but also affects integrin stability and signaling of integrin-
associated growth factor receptors. Thereby integrin trafficking profoundly influences 
integrin-dependent cell adhesion, spreading, and migration in adherent cells as well as 
cancer cell invasion (Bridgewater et al., 2012). It includes several separated processes 
of targeted protein transport such as the cell surface delivery of newly synthesized 
integrins by biosynthetic-secretory pathways, integrin internalization, recycling of 
internalized integrins as well as regulation of their degradation.  
        Biosynthetic-secretory pathways 
In the late 80s it was shown that β1 integrin precursor form α-β heterodimers in 
the ER and that only heterodimeric integrin can exit the ER to be transported via the 
Golgi apparatus to the plasma membrane (Heino et al., 1989). Excess single α or β 
integrin subunits in the ER will be degraded through the ERAD pathway (Darom et al., 
2010). During the synthesis and transport through the ER and Golgi, integrins undergo 
glycosylation in a series of tightly controlled, step-wise processes that starts in the case 
of β1 integrin with the synthesis of a 88 kDa polypeptide that undergoes sequential 
glycosylation in the ER and in the Golgi (Akiyama and Yamada, 1987) giving rise to 
incompletely glycosylated β1 integrin subunit of 105 kDa and a complete or ‘mature’ β1 
subunit of around 125 kDa that moves to plasma membrane together with α subunits 
(Gu et al., 2009). However incomplete glycosylated integrins also appear on cell 
surface. In human fibroblasts culture in the presence of N-linked oligosaccharide 
processing inhibitor, immature integrin α5β1 appeared at the cell surface but adhesion 
on FN is greatly reduced (Akiyama et al., 1989; Janik et al., 2010). Experiments using 
conformation-specific antibodies suggested that the newly synthesized and assembled 
αxβ1 integrin heterodimer adopts the inactive conformation in ER and maintains the 
bent conformation on the way until it reaches membrane by binding Ca2+ (Tiwari et al., 
2011b). We still know surprisingly little about the process of integrin maturation on a 
molecular level. However, several protein-protein interactions are required to shuttle 
integrins to the cell surface that include ER-resident chaperons such as calnexin, the 
transmembrane protein LRP-1 but also cytosolic proteins binding to the integrin tails 
(Hotchin et al., 1995; Martel et al., 2000; Salicioni et al., 2004). An early study suggests 
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that talin-integrin interaction in ER might regulate delivery of newly synthesized integrin 
to plasma membrane along actin filament. Talin binding in the β1 tail exposes a GFFKR 
motif in α subunit, which was proposed to function as ER-export signal of integrins 
(Martel et al., 2000). Indeed, mutations within this sequence in αIIb integrin lead to 
redcued integrin surface level in some Glanzmann thrombosthenia (GT) patients 
(reviewed in (Margadant et al., 2011)).  
Although integrin biosynthesis and exocytosis are fundamental to integrin 
function, the underlying molecular mechanisms regulating these processes are only 
incompletely understood. However, integrin conformation and protein binding to the 
integrin ecto- and cytosolic domains regulate these steps. 
        Integrin internalization 
Once integrins reach the cell surface they reside in their inactive conformation or 
become activated, bind to their ligands and cluster to form cell adhesion sites. However, 
independent of their conformation the resident time of integrins on the cell surface is 
short because they are constantly internalized into the endosomal system. Integrin 
internalization occurs both through clathrin-independent and clathrin-dependent 
pathways or by macropinocytosis from dorsal ruffles. Integrins can follow more than one 
route to internalize (Figure 12A). For example, α5β1 integrins internalization is caveolin-
dependent during FN assembly (Shi and Sottile, 2008), but is clathrin-dependent in 
migrating cells (Nishimura and Kaibuchi, 2007). Besides, α5β1 integrins also have been 
shown to internalize through macropinocytosis during stimulated cell migration (Gu et 
al., 2011). 
Clathrin-dependent integrin internalization is thought to be the predominant form 
of integrin endocytosis in most cell types. It often requires clathrin-associated sorting 
proteins [CLASPs; for instance, Dab2, Numb or ARH (also known as LDLRAP1)] to 
interact with the integrin cytoplasmic domains (Ezratty et al., 2009; Nishimura and 
Kaibuchi, 2007; Teckchandani et al., 2009). The PTB-domain containing protein Numb 
has been shown to localize at FAs and can directly interact with the proximal NPxY 
motif of β1, β3, and β5 integrins via its PTB domain to regulate α5β1 and αVβ3 integrin 
internalization (Calderwood et al., 2003; Nishimura and Kaibuchi, 2007). Although Dab-
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2 uses PTB domain binds to the distal NxxY motif in β integrin tails knockdown of Dab-2 
predominantly affects β1 integrins surface levels as determined in proteomics 
approaches (Teckchandani et al., 2009) Additionally, Dab-2 localizes at or near FAs 
together with clathrin shortly before their disassembly (Chao and Kunz, 2009) and 
interacts with Eps15 and Itsn which also regulate integrin internalization (Teckchandani 
et al., 2012). While the role of Dab-2 in integrin clathrin-dependent endocytosis is 
undisputed there are conflicting observations on the role of Dab-2 for the internalization 
of specific α5β1 integrin conformations. Using antibodies against the active α5β1 
conformation (12G10) Chao and Kunz showed that active integrins (FN occupied) are 
preferentially internalized via Dab-2/clathrin mediated integrin internalization during 
disassembly of focal adhesions (Chao and Kunz, 2009) while another study shows Dab-
2-mediated-clathrin-dependent endocytosis of non-occupied (inactive) β1 integrins that 
are not engaged with the actin cytoskeleton or the ECM and lie outside of adhesion 
sites (Teckchandani et al., 2009). While this needs further clarification, the importance 
of the proximal NPxY and distal NxxY in β integrin tails for associated sorting protein 
binding is highlighted in cells expressing mutant β1 integrin with Tyrosine to 
Phenylalanine substitutions in both proximal NPxY and distal NxxY motives which show 
reduced clathrin-dependent endocytosis of β1 integrins (Pellinen et al., 2008).  
While clathrin-mediated integrin internalization is important in migrating ECV304 
and HeLa cells (Nishimura and Kaibuchi, 2007), integrins can also be internalized by 
the clathrin-independent pathways such as caveolin-dependent or using clathrin-
independent carriers (CLICs). Rab21 directly binds to α integrin cytoplasmic tails to 
induce β1 endocytosis via caveolin-dependent routes and that overexpression of Rab21 
rescues the impaired β1 endocytosis in β1YY/FF cells probably through increasing 
clathrin-independent endocytosis to compensate for the block of Dab-2 and Numb 
induced clathrin-dependent internalization. (Pellinen et al., 2008). β1 integrins can follow 
clathrin-independent endocytic routes that depends on caveolin (Shi and Sottile, 2008) 
macropinocytosis (Gu et al., 2011), and clathrin-independent carriers (Howes et al., 
2010; Lakshminarayan et al., 2014) (Figure 13A). Several studies support the role 
caveolae in integrin endocytosis pathway such as for α5β1 internalization in 
myofibroblasts (Shi and Sottile, 2008) and for α2β1 whose endocytosis is mediated by 
Introduction 
56 
 
direct interaction of protein kinase Cα (PKCα) with the cytoplasmic tail of β1 integrin (Ng 
et al., 1999). In addition, αVβ3 can internalize by macropinocytosis, from PDGF 
(Platelet Derived Growth Factor)-induced dorsal ruffles to recycle back the basal side to 
form new focal adhesions (Gu et al., 2011). Finally, the carbonhydrate-binding protein 
galectin-3 can interact with glycosylated extracellular domain of β1 integrin to promote 
clathrin-independent endocytosis through CLICs by mechanical deformation of plasma 
membrane (Lakshminarayan et al., 2014) 
        Integrin recycling 
Once internalized, integrins are delivered to early endosomes (EE), which are the 
key organelle to route integrins in different recycling or degradation pathways. Most 
internalized integrins are not degraded but recycled back to cell surface in different 
routes. In comparison to the long protein half-life of integrins (estimated >18 h) (Lobert 
et al., 2010), integrin recycling is fast (about every 15-30 minutes dependent on the cell 
type) (Roberts et al., 2004). This highly efficient spatiotemporally regulated integrin 
recycling does not only save energy, which would otherwise be necessary for synthesis, 
but also allows a continuous redistribution of integrins being an essential prerequisite for 
cell migration. 
The molecular mechanisms underlying integrin trafficking have been the topic of 
multiple studies and several cytosolic integrin interactors have been shown to regulate 
the processes; many of those however in a cell type-dependent manner. For example, 
αVβ3 but not α5β1 integrins recycle via the Rab4-dependent short loop after PDGF 
stimulation. This short loop requires direct protein kinase D1 (PKD1) binding to β3 tails 
to C‐terminal 14 amino acids of the integrin to recycle rapidly αVβ3 integrins from EEs 
to the plasma membrane into newly forming focal adhesions during cell spreading and 
migration (Woods et al., 2004). Integrins can also be routed in the so-called long loop 
from EE to the cell surface via a perinuclear recycling compartments (PNRC) in a 
process involving Rab11 and Arf6. α5β1 integrins take the Rab11-dependent loop in 
non-stimulated and serum stimulated fibroblast while αVβ3 integrin only in the absence 
of growth factors. This trafficking route requires the inactivation of glycogen 3 kinase 3 
beta (GSK3β) by phosphorylation through Akt/PKB (Roberts et al., 2004). Akt also 
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phosphorylates ArfGAP With Coiled-Coil, Ankyrin Repeat And PH Domains 1 (ACAP1), 
which then associates directly with the β1 integrin tail for α5β1 integrin recycling (Li et 
al., 2005).  
 
Figure 12. Integrin trafficking. (A) Canonical integrin trafficking. Integrins can be internalized in several 
functional distinct ways: Macropinocytosis from dorsal ruffles, clathrin-dependent internalization, caveolin-
dependent, and via CLICs induced by galectin-3 binding to the extracellular domain of integrins (indicated 
in yellow star). Once integrins are internalized and reach early endosomes, α5β1 integrins mainly 
recycles through a Rab11-positive perinuclear recycling component (PNRC) long-loop αVβ3 integrin is 
mainly recycled via a Rab4-dependent short loop. (B) Representation of the trafficking routes of active 
and inactive α5β1 integrins. Endocytosis: Both active and inactive internalize in Dab-2/clathrin dependent 
pathways depending on the cell type. Active α5β1 integrins are also internalized from FBs in the complex 
with Nrp1-GIPC1-Myo6-APPL in endothelia cells. Recycling: Inactive integins are rapidly recycled back to 
plasma membrane in Rab4-dependent manner. Degradation: Upon binding of SNX17 (or SNX31, not 
shown) to β integrins tails in early endosome α5β1integrins are routed back to plasma membrane while in 
the absence of SNX17 binding α5β1 integrins are sent for lysosomal degradation. In late endosomes/ 
lysosomes, active α5β1 integrins traffic back to plasma membrane in present of CLIC3. (modified from De 
Franceschi et al., 2015) 
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While most cytosolic proteins interact with the β integrin subunits to regulate integrin 
recycling few proteins bind to the α integrin subunit. Rab21 and p120RasGAP bind to 
the same motif present in different integrin α subunits and their knockdowns affect 
integrin recycling. Rab21 regulates the trafficking from the cell surface through EE and 
PNRC. In the PNRC p120RasGAP replaces Rab21 at the α integrin subunits to promote 
the recycling back to the plasma membrane (Mai et al., 2011). It is becoming evident 
that integrin engagement affects the trafficking of receptor tyrosine kinases, which in 
turn affects cancer cell invasion. For example, mutant p53 or disruption αVβ3 function 
by cilengitide weakens the Rab-coupling protein (RCP), a Rab11 effector, and β3 tail 
association but conversely strengthens to β1 binding. α5β1 integrin and RCP 
coordinately recruits receptor tyrosine kinase, such as EGFR1, and both recycle back to 
plasma membrane where activates EGFR1 downstream signaling to promote tumor cell 
invasion through Akt activation (Caswell et al., 2008; Muller et al., 2009).   
As integrins reside in an active and inactive conformation on the cell surface the 
question arose whether the integrin conformation affects the way integrins are trafficked 
within cells. In endothelia cells a complex consisting of Neuropilin1 (Nrp1) and GAIP 
interaction protein-C-terminus membrane 1 (GIPC1) promotes endocytosis and fast 
recycling of active integrin α5β1 from FBs while inactive α5β1 integrins traffic in a 
Neuropilin1-independent mechanisms (Valdembri et al., 2009) (Figure 12B). A recent 
study from the Ivaska lab made use of conformation-specific α5β1 integrin antibodies to 
follow the trafficking routes of active and inactive β1 integrins in NCI-H460, PC-3 and 
MDA-MB-231 cells (Arjonen et al., 2012). They show that active and inactive β1 
integrins can be internalized to Rab5 or Rab21 positive early endosomes. While inactive 
α5β1 integrins predominantly recycle rapidly via the Rab4-dependent loop active β1 
integrin is seen in Rab4a- and Rab11-positive compartments, but more careful studies 
in respect to active β1 integrin recycling are needed (Arjonen et al., 2012)  (Figure 12B). 
This study also shows that only active β1 integrins (not inactive) are observed in Rab7 
positive late endosomes, suggesting the existence of additional recycling pathways. 
Indeed, ligand bound active α5β1 integrins are sorted to late endosomes/lysosomes in 
Rab25-expressing A2780 ovarian carcinoma cells, from where they are recycled back to 
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the plasma membrane in a CLIC3 (Chloride intracellular channel protein 3) -dependent 
manner (Dozynkiewicz et al., 2012). A recent paper by the same lab shows the 
internalization of active α5β1 integrins from FBs directly to late endosomes without prior 
trafficking through EEs (Rainero et al., 2015). These examples indicate that integrin 
internalization and recycling is tightly and spatially regulated in the cell and is dependent 
on different factors such as the specific integrin heterodimer, the integrin conformation 
and cell-type specific factors.  
        Integrin degradation 
Compared to integrin recycling the mechanisms underlying degradation of 
integrins is less studied. The Parker lab was the first to show the delivery of integrins to 
late endosomes (LE) (Ng et al., 1999). The half-life of integrins is long (>20 h for α5β1 
integrin) and therefore researchers did not pay much attention towards the sorting of 
integrins into a degradation pathway. Nevertheless, it is becoming more evident that 
integrin internalization might be more than just a start point of integrin recycling, but part 
of a quality control mechanism for integrins. Functional integrins enter the recycling 
process, while defect molecules are routed to lysosomal degradation.  
Proteins such as syntaxin-6 or CLIC3 were shown in cell depletion studies to 
regulate lysosomal β1 integrin degradation (Dozynkiewicz et al., 2012; Riggs et al., 
2012; Tiwari et al., 2011a). However their loss likely affects more general aspects of 
endosome function such as vesicle fusion or maintenance of intracellular membranes 
rather than specific functions of integrins. In contrast, two factors have been shown to 
specifically regulate integrin protein stability: Ligand-binding to the integrin ectodomain 
(Dozynkiewicz et al., 2012; Lobert et al., 2010) and the interaction of the endosomal 
proteins SNX17 and SNX31 to the integrin cytoplasmic tail (Bottcher et al., 2012; 
Steinberg et al., 2012; Tseng et al., 2014). After internalization into EEs, 
unligated/inactive integrins are rapidly recycled back to plasma membrane while ligand-
bound/active α5β1 integrins are ubiquitinylated and subsequently sorted into 
LEs/lysosomes for degradation in the absence of CLIC3 (Dozynkiewicz et al., 2012; 
Lobert et al., 2010) (Figure 12B). The molecular mechanism underlying CLIC3 function 
and the E3 ligases mediating integrin ubiquitination are unknown. It is also still unclear 
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why cells degrade active integrins over integrins in their inactive conformation. One 
explanation for the degradation of active integrins could be the need to recycle ligand-
free integrins to the plasma membrane (Lobert et al., 2010). On the other hand, it is 
reported that the endocytosis of active integrins to the lysosome in tensin-dependent 
manner is necessary to maintain a population of centrally located late 
endosomes/lysosomes capable of recruiting and activating mTOR in response to 
nutrient. This spatially restricted trafficking of a particular subpopulation of integrins 
between FBs and lysosomes provides evidence for mechanistic links between ECM 
internalization and nutrient signaling. (Rainero et al., 2015). 
Conversely, inactive α5β1 integrins are routed to EEs where the endosomal 
protein SNX17 utilizes its FERM domain to bind to the membrane distal NPxY motif 
within β1 integrin to save inactive β1 integrins from lysosomal degradation (Bottcher et 
al., 2012; Steinberg et al., 2012) (Paper II). The SNX17-integrin interaction prevents 
integrin degradation and enables integrins to recycle back to the plasma membrane by 
an unknown mechanism, while integrins are degraded rapidly in SNX17 knockdown 
cells. SNX31, another member of the FERM-domain containing subfamily of SNX 
proteins, also binds different β integrin tails and can rescue β1 integrin surface levels 
and stability in SNX17-depleted mouse fibroblasts (Tseng et al., 2014) (Paper III). This 
indicates that SNX17 and SNX31 play a similar role to regulate integrin β1 degradation. 
The SNX proteins will be further discussed in the following part.  
In summary, there is accumulated evidence for the importance of integrin 
trafficking to modulate integrin function. From these studies it is also clear that the 
mechanisms underlying integrin trafficking and degradation differ between different 
integrin conformations, amidst distinct integrins, even between cell types. Since proteins 
binding to the cytoplasmic domains of the integrin α and β subunits are key to 
understand the different trafficking routes and mechanisms it merits to search and 
identify new proteins interacting with integrins in a conformation-specific and spatially 
defined manner.  
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4.1 Sortin nexins 
Sorting nexins (SNXs) are a family of proteins that contain a Phox homology (PX) 
domain which serves as phosphoinositide-binding motif to guide the SNX proteins to 
phosphatidylinositol-3-monophsphate (PI3P)-enriched membranes found in endosomes. 
Members of this protein family have been identified from yeast (10 SNXs) to mammals 
(33 SNXs) (Seet and Hong, 2006) and are mainly implicated in endocytosis and 
endosomal sorting (Cullen, 2008). The name SNX was introduced by Kurten et al. to 
highlight the sequence similarity within their PX domains (Kurten et al., 1996). Besides 
the PX-domain SNXs carry different protein-protein and protein-lipid interaction domains 
and are divided into subfamilies according to their additional protein domains (Teasdale 
and Collins, 2012). The best studied SNX family members are those that are part of the 
retromer complex, which associates with endosomes and mediates the retrograde 
transport of transmembrane cargo from endosomes to the trans-Golgi network (Hierro 
et al., 2007; Wassmer et al., 2009). 
 The SNX-FERM subfamily contains three members: SNX17, SNX27, and 
SNX31, which are conserved in metazoans, but not in yeast (Gallon and Cullen, 2015). 
All members of this subfamily are characterized by an atypical FERM domain right after 
the SNX-PX domain (Ghai et al., 2013) and are involved in cargo trafficking. 
Importantly, the FERM domain interacts with NxxY motives in transmembrane proteins, 
including β integrins (Bottcher et al., 2012; Steinberg et al., 2012). SNX27 contains an 
additional PDZ domain that can engage PDZ binding motifs at the C-terminus of 
transmembrane proteins (Balana et al., 2011).  
 Most of SNX17 interactors are transmembrane proteins that rely on SNX17 to 
regulate their trafficking between endosome and plasma membrane by a yet 
unidentified mechanism. The cargo proteins of SNX17 include integrins (Paper II) 
(Bottcher et al., 2012; Steinberg et al., 2012), low density lipoprotein receptor (LDLR) 
(Stockinger et al., 2002), low density lipoprotein receptor related protein 1 (LRP) 
(Stockinger et al., 2002; van Kerkhof et al., 2005), and P-selectin (Knauth et al., 2005). 
SNX17 also interacts with some cytosolic proteins such as krev 1 interaction trapped 1 
(KRIT1) (Stiegler et al., 2014) and kinesin microtubule-motor (KIF1B) (Seog and Han, 
2008); however, the functional impact of these interactions for SNX17 function are still 
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unknown. SNX31 is the least-characterized member in this subfamily but seems 
functionally very similar to SNX17 as it binds integrins and regulates integrin surface 
level similarly to SNX17 (Paper III)(Tseng et al., 2014). SNX31 also functions in 
lysosomal degradation of uroplakins, a transmembrane protein group in urothelial cells 
(Vieira et al., 2014). In contrast to SNX17 and SNX31, SNX27 is not involved in the 
regulation of integrin protein stability and surface levels (Steinberg et al., 2013; Tseng et 
al., 2014). Instead, SNX27 prevents lysosomal routing of β2 adrenergic receptors and 
transmembrane proteins required for maintaining cellular nutrient homeostasis through 
binding to the SNX-BAR retromer (Steinberg et al., 2013; Temkin et al., 2011), a protein 
complex that transports transmembrane proteins from endosomes to the trans-Golgi 
network (Hierro et al., 2007). In line with its role in trafficking, loss of SNX27 is also 
shown to contribute to excitatory synaptic dysfunction in Down's syndrome patients by 
affecting glutamate receptor recycling (Wang et al., 2013).  
5. Membrane mimicking systems 
The typical biological membrane is a complex structure primarily composed of 
lipids and proteins. Such membranes surround every living cell and form stable barriers 
between two compartments. These compartments can be either the inside or the 
outside of the cell in case of the plasma membrane or different compartments within the 
cell such as cytosol and endoplasmic reticulum or Golgi lumen.  
The fundamental structure of the plasma membrane is the phospholipid bilayer 
with a hydrophilic exterior and a hydrophobic core. Phosphatidylcholine (PC) is the most 
prevalent phospholipid and accounts for 40%–50% of the total phospholipid content; 
Phosphatidylethanolamine (PE) ranges from 20% to 45%, and Phosphatidylinositol (PI), 
Phosphatidylserine (PS), and Phosphatidic Acid (PA) are present in lesser amounts. 
The lipid composition of different membranes varies throughout the cell. (Leventis and 
Grinstein, 2010; van Meer et al., 2008). In addition to be a hydrophobic barrier, plasma 
membranes also serve other functions such as import and export of nutrients and for 
cell-cell communication. These functions are mainly carried out by transmembrane 
proteins embedded within the plasma membrane or by proteins linked to the 
membranes via lipid anchors. Indeed, transmembrane proteins play crucial roles in 
many processes such as connection between extracellular matrices and intracellular 
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molecules like actin, transmit signals and transport molecules. It is therefore not 
surprising that mutations in membrane proteins are the underlying cause of many 
diseases (Sanders and Myers, 2004). However, structural studies of transmembrane 
proteins are challenging as the correct structure and function of transmembrane 
proteins depend on their membrane embedding (review in (Kim et al., 2009b)). 
Transmembrane proteins are naturally embedded in a native lipid bilayer to maintain 
proper conformation and function. For most studies, the transmembrane protein has to 
be extracted from its native environment. Therefore the researchers need proper 
systems to study these proteins. As the generation of native membranes is difficult 
several minimal artificial membrane systems have been established over the past 
decades that mimic certain properties of native membranes thereby preserving the 
integrity, stability, and native structure of transmembrane proteins once extracted from 
their native environment (Sachs and Engelman, 2006). In case of integrins studies have 
used micelles, bicelles and nanodiscs (see below) that allowed studying in αIIbβ3 
integrins transmembrane structure (Lau et al., 2009; Yang et al., 2009) and integrin 
αIIbβ3 activation process (Ye et al., 2010) (also see section 1.3.2). 
Membrane mimicking systems have a second advantage in 
interacting/proteomics studies of transmembrane proteins: proteins binding to the 
cytoplasmic domain of transmembrane proteins frequently interact with lipid 
components of membranes. The lipid interaction either strengthens the protein-protein 
interacting and/or allows the proper orientation of the proteins. Because of the short 
integrin cytoplasmic domains it is even more likely that proteins directly binding to 
integrin tails are affected by the plasma membrane. Indeed, it has been shown that the 
interaction of talin (Anthis et al., 2009; Goult et al., 2010), kindlin (Goult et al., 2009; Liu 
et al., 2011; Perera et al., 2011), and ILK (Widmaier et al., 2012) with integrins and their 
functions  also rely on the interaction with phospholipids in the plasma membrane. 
The membrane mimicking systems used in the integrin field, namely micelles, 
bicelles, and nanodiscs, will be discussed briefly. 
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5.1 Detergent micelles 
One of the most common approaches to solubilize membrane proteins is the use 
of detergent-micelles. Micelles consist of detergent molecules that aggregate above a 
defined threshold concentration called the critical micelle concentration (CMC), while 
detergent stays as monomer in aqueous solution when they are below the CMC. The 
increase in the detergent concentration above the CMC results in the assembly of more 
micelles in a highly dynamic equilibrium with detergent monomers. The classical 
micelles characterize with a hydrophilic head oriented to solution and hydrophobic 
single tail in the core (Figure 13A). In general, micelles have a relatively small diameter 
(ranging from 2 nm to 20 nm depending on the detergent (Garavito and Ferguson-Miller, 
2001)) and the membrane curvature (Lipfert et al., 2007; Prive, 2007). Micelles are still 
used because of their ease to prepare. Still, they are generally not optimal to preserve 
the integrity and stability of transmembrane proteins for two reasons (Tate, 2010). First, 
micelles are highly dynamic in solution and this intrinsic instability can trigger proteins 
aggregation and degradation. Second, the differences of lateral forces and curvature of 
micelles compared to planar plasma membrane can affect the protein conformation and 
even lead to protein unfolding (Lu et al., 2012).  
Dodecylphosphocholine (DPC) micelles have been used to investigate the 
interaction between αIIbβ3 TM/cyto interactions but failed to detect associations 
between the two integrin subunits (Li et al., 2001). It was suggested that under micelle 
condition the relatively weak interaction between α and β TM/cyto was weakened to the 
point that no specific interaction was detectable by NMR anymore (Li et al., 2001).  
5.2 Bicelles 
Bilayered phospholipid micelles (bicelles) represent a new category of biological 
model membrane characterized by their liquid-crystalline phase behavior which was 
established as a membrane model system for structural NMR studies (Sanders and 
Landis, 1995). Classical bicelles are discoidal zwitterionic phospholipids mixture 
structures: long-chain phospholipids (dimyristoylphosphatidylcholine, DMPC) retrain the 
bilayer feature to better imitate plasma membrane and short-chain phospholipids 
(dihexanoylphosphatidylcholine DHPC or 6-cyclohexyl-1-hexylphosphocholine, 
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Cyclofos-6) coat the rim of the bilayer and isolate the hydrophobic core from the water 
phase (Figure 13B). The bicelles size can be varied and is defined by the total 
concentration and the molar ratio of long-chain and short-chain phospholipids (q value). 
Bicelles have disc-like shape at low q values that are edge-stabilized at the rim by short-
chain phospholipids while the bilayer-ordered long-chain phospholipid are in the center. 
At higher q value (q>3), bicelles show a “Swiss cheese”-like morphology, in which the 
holes are edge-stabilized by short-chain phospholipid (Figure 13B).  
Bicelles share the advantages of detergent micelles, such as water solubility, 
optically transparency and easy generation. On the other hand, they overcome the 
disadvantages of micelles especially the high global curve tension and bicelles also 
better represent plasma membrane features as they are lipid-rich (Andersson and 
Maler, 2006; Chou et al., 2004; Kim et al., 2009a; Lu et al., 2012; Whiles et al., 2002; 
Wu et al., 2010). In many studies, bicelles have also been proved to have several 
advantages over the use of micelles. For instance, diacylglycerol kinase retains its 
activity in bicelles, but not in micelles (Sanders and Landis, 1995) and 
bacteriorhodopsin refolds into native conformation in bicelles (Booth and Farooq, 1997; 
Booth et al., 1996). Furthermore, incorporation of the HIV-1 envelope peptide into 
micelles induces a strong curvature, which is not observed in bicelles (Chou et al., 
2002). Bicelles have also successfully been used in NMR studies aimed to determine 
the structure of TM domains of integrins. While earlier studies utilizing DPC micelles for 
NMR and other biophysical methods failed to detect the interaction between the TMcyto 
domains of αIIbβ3 integrin (Li et al., 2001), incorporation of the TM domains of αIIbβ3 
integrin into bicelles allowed to determine the first TM α/β regions complex structure 
(Lau et al., 2009). Additionally, β1 integrin TMcyto domains embedded in bicelles also 
have been shown in NMR (Lu et al., 2012). This suggests the environment provided by 
bicelles allow the integrin α-β heterodimer TM segment to retain native-like interactions.  
5.3 Nanodiscs 
 Nanodiscs contain phospholipids assembled noncovalently as bilayer, which are 
surrounded by amphipathic apolipoproteins (Figure 13C). They were developed by 
Sligar and colleagues to solubilize transmembrane proteins (Bayburt and Sligar, 2002). 
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They made use of natural structures, which are used to assemble high-density 
lipoproteins (HDLs) into bilayered, spherical shapes surrounded by the scaffold protein 
apolipoprotein A1 and to transport HDLs to the liver for degradation (Schmitz and 
Grandl, 2009). The size of nanodiscs is determined by the length of apolipoprotein A1, 
also called Membrane Scaffold Protein (MSP), which can be modified in vitro to 
generate nanodiscs with various diameters (Borch et al., 2008). Nanodiscs can 
generate a native-like bilayered plasma membrane and allow access on both sides of 
membranes similar to bicelles. However, unlike bicelles, nanodiscs require the MSP ring 
around the lipid core to stabilize the lipid bilayers. This increases the membrane stability 
and minimizes size variations within a specific population of membrane particles when 
transmembrane proteins are incorporated but hampers a fast variation of the particle 
size compared to bicelles.  
The structures of several transmembrane proteins have successfully been 
determined using nanodiscs as membrane-mimicking models including a potassium 
channel (KcsA) (Shenkarev et al., 2009) or the voltage-dependent anion channel 
(VDAC-1) (Raschle et al., 2009). Others used nanodiscs in functional assay for example 
to determine ligand binding to the β2-Adrenergic receptor (β2AR) (Leitz et al., 2006). An 
EM study used full length αIIbβ3 integrins embedded into nanodiscs to show that talin 
head binding could induce conformational changes of integrin extracellular domain (Ye 
et al., 2010).  
 For our proteomics study we have chosen to incorporate integrins into bicelles as 
membrane system for several reasons. (1) Structural studies have shown that 
incorporation of the αIIbβ3 integrin transmembrane domains does not interfere with its 
native, inactive conformation. (2) The Sanders’ lab developed bicelles systems that can 
still preserve the bicelles properties when diluted below 1% in solution (Lu et al., 2012) 
which is favorable for pull-down experiment. (3) Bicelles can be supplemented with 
extra lipids such as negatively charged lipids (MOPS) or phospholipids to closer mirror 
the endogenous plasma membrane composition (Struppe et al., 2000). This is important 
as many protein-lipid interactions rely in the negative membrane charge (Anthis et al., 
2009; Goult et al., 2010; Goult et al., 2009; Liu et al., 2011; Perera et al., 2011; 
Widmaier et al., 2012) (4) In contrast to nanodiscs, bicelles do not contain an additional 
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protein, which reduces the risk of non-specific protein-protein interaction in the 
biochemical and proteomic analysis.  
  
 
Figure 13. The structure of detergent micelles, bicelles, and nanodisc. (A) Detergent micelles are 
small, global structures. Their size can be varied by changing the detergent. (B) Bicelles are discoidal 
zwitterionic phospholipids mixture structures that display bilayer features. Their size can be controlled by 
modulating the ratio of long-chain phospholipids/short-chain phospholipids (q). In low q values, bicelles 
have disc-like shape. When q > 3, bicelles are “Swiss cheese”-like structures. (C) Nanodisc-embedded 
integrin heterodimer. Nanodiscs are protein−lipid particles which size is regulated by Membrane Scaffold 
Proteins (MSP) (indicated in grey). Integrins are shown in blue (α subunit) and red (β subunit). (modified 
from Prosser et al., 2006, Ye et al., 2010) 
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Aim of the thesis 
Integrins are a family of heterodimeric transmembrane proteins consisting of a large 
ectodomain and a short cytoplasmic tail. Proteins binding to the cytoplasmatic tails of 
integrins are fundamental for integrin function. They regulate the integrin affinity for 
ligands, allow integrins to connect to the actin cytoskeleton and to initiate intracellular 
signaling pathways, and regulate intracellular integrin trafficking and protein stability. 
Like other cell surface receptors integrins signal in response to ligand binding, however 
they can also regulate their affinity for ligand. The shift between low and high 
conformations for ligand during integrin activation requires the binding of the cytosolic 
proteins kindlin and talin to the β integrin tail. In the inactive, low affinity conformation 
the transmembrane and cytoplasmic domains associate with each other while they 
become separated in the active, high affinity state. While integrin activation is studied 
extensively, the inactive conformation has long been considered as ‘default state’ but 
growing evidences indicate that the inactive conformation might also be actively 
regulated by the binding of intracellular integrin interactors. We speculate that cells have 
protein(s), which bind clasped α/β tails to keep them in a low affinity conformation. Such 
proteins could serve to strengthen the association, which might be particularly important 
for leukocytes, or to regulate other processes important for integrin function such as 
internalization, recycling, degradation, etc. Integrin trafficking and stability control is 
coupled and is believed to determine their cell surface distribution and the signaling 
crosstalk with growth factor receptors. However, the mechanisms controlling integrin 
trafficking and stability are poorly understood. 
 
The aim of my PhD project was to identify and characterize integrin tail binding proteins 
that bind to specific integrin conformations. I focused on cytoplasmic interactors that (i) 
only bind α/β heterodimeric and not to the isolated tails and might prevent unwanted 
signaling as well as (ii) proteins may play a critical role for the recycling and/or 
degradation of integrins. 
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Therefore the aims of the thesis were:    
1. To establish a biochemical/proteomics method that allows screening for 
cytoplasmic conformation-specific integrin and supports protein-lipid 
interactions. 
2. To systemically identify and compare cytoplasmic interactors of the single 
α- and β integrin subunits as well as of associated αMβ2 integrin tails. 
3. To characterize these new candidates for their roles in integrin-mediated 
functions. 
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Short summaries of publications 
Paper I: A proteomic approach reveals conformation specific cytoplasmic integrin 
interactors 
 
Integrins exist in at least two distinct conformations; a high (‘active’) and a low affinity 
(‘inactive’) state for ligands. In their inactive state the transmembrane and cytoplasmic 
(TMcyto) domains of the two integrin subunits are associated while they become 
separated upon activation. Although several cytoplasmic integrin interactors have been 
identified only filamin A has been shown to bind to associated α-β integrin TM-cyto 
domains. We hypothesize that more such proteins exist that only bind α/β heterodimeric 
tails and might serve as regulators of integrin activation or allow cells to distinguish 
between active and inactive integrins in other processes, such as integrin trafficking. In 
order to identify such conformation-specific integrin interactors by mass spectrometry 
we generated recombinant proteins for pull-down experiments that mimic associated 
integrin TM-cyto domains by fusion the αMβ2 TMcyto domains to the Fos-Jun hetero-
dimerization domains as “velcro”. Furthermore, we incorporated the αMβ2 TM-cyto 
complex into bicelles to sustain the native protein conformation and to support protein-
lipid interactions. In a first set of experiments we used the single α5, αM and αIIb as well 
as β1, β2 and β3 integrin incorporated into bicelles to pull-down interactors from bone 
marrow derived macrophages lysates. Subsequent identification of the cytosolic binding 
proteins by liquid chromatography–tandem mass spectrometry (LCMS/MS) allowed us 
to determine the compositional differences between binding proteins associated with 
different integrins. Using the Jun-Fos-mediated associated αMβ2 TMcyto baits we we 
identified several conformation-specific integrin interactors including L-plastin (LCP1). 
Further experiments implicated LCP1 in the regulation of αMβ2 surface levels in 
leukocyte cell lines. LCP1 knock-down increases integrin αMβ2 surface level and 
enhances cell attachment to fibrinogen and ICAM in unstimulated cells. Our proteomics 
data provide a resource for the global view on cytoplasmic proteins interacting with 
different integrin classes and provides evidence for the presence of several 
conformation-specific integrin interactors.  
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Paper II: Sorting nexin 17 prevents lysosomal degradation of β1 integrins by 
binding to the β1-integrin tail 
 
Integrin function is controlled by the interaction of proteins to their cytoplasmic tails 
which regulate integrin affinity for ligands, intracellular signaling as well as integrin 
trafficking through the endosomal system.  
Here we demonstrate that the kindlin-binding site in the β1 integrin cytoplasmic domain 
serve as a molecular switch enabling the sequential binding of two FERM-domain-
containing proteins in different cellular compartments. Kindlins occupy the membrane 
distal NPxY and adjacent Thr residues on β1 integrin at the plasma membrane. During 
integrin internalization kindlins dissociated and the FERM-domain containing protein 
SNX17 directly binds to the free binding site in early endosomes. The interaction of 
SNX17 with β1 integrin prevents integrins routing into the lysosomal, degradative 
pathway and promotes sorting of the integrins into recycling pathways back to plasma 
membrane. In the absence of SNX17, β1 integrin is sent to lysosomes and rapidly 
degraded leading to reduced surface availability of β1 integrin and slower cell migration 
velocities when cells were plated on fibronectin. Our results identify SNX17 as a novel 
β1 integrin tail binding protein in early endosomes to prevent integrin degradation. 
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Paper III: Sorting nexin 31 binds multiple β integrin cytoplasmic domains and 
regulates β1 integrin surface levels and stability 
 
In paper II, we showed that the trafficking of α5β1 integrin to lysosomes and its 
subsequent degradation is regulated by direct binding of SNX17 to the cytoplasmic 
domain of β1 integrin in early endosomes. This interaction requires the SNX17-FERM 
domain and an intact membrane-distal NxxY motif in the β1 integrin tail. Two other SNX 
family members, SNX27 and SNX31, also contain a FERM domain next to a phox 
domain, which could potentially enable them to bind β integrin tails. We therefore 
investigated the SNX-FERM subfamily members for their ability to bind integrins and to 
control integrin recycling and stability. 
Here we demonstrate that the SNX-FERM family members SNX17 and SNX31 but not 
SNX27 are able to bind several β integrin tails in early endosomes in a PI3-kinase-
dependent manner. While SNX17 is ubiquitously expressed, SNX31 expression is 
restricted to predominantly bladder and melanoma cells. SNX31 needs intact FERM 
domain to directly interact with β tails in early endosomes and to rescue β1 integrin 
surface levels and stability in SNX17 depleted cells. All together, these results 
demonstrate that SNX31 is tissue-specific endosomal regulator of β1 integrin protein 
stability.  
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Paper IV: Kank family proteins comprise a novel type of talin activator 
 
In this paper, we demonstrate the evolutionarily conserved Kank family as a novel focal 
adhesion molecules and is concentrated at the border of FAs (termed FA belt) and FBs 
but not in nascent adhesions. The conserved KN motif is essential to localize Kank to 
FAs belt and central FBs. We demonstrated that Kank2 and talin was co-recruited to 
integrin β tails in a talin-dependent manner. Unlike kindlin2 and c-Src,which profoundly 
binds to β1 and β3 tails respectively,  Kank2 binds equally with β1 and β3 tails. The 
recruitment induces and/or maintaines the formation of active integrins at sites 
uncoupling with actomyosin. The further analysis reveales Kank2 directly binds to talin 
R7 domain via KN motif and that promotes talin activation to induce and/or maintain 
integrin β tails binding in a force and actin-independent manner. Subsequently, Kank2 
destabilized talin-actin connection. Altogether, we have identified Kank family as a new 
FA proteins, a novel talin activator, which specifically stabilized integrin-talin complex 
that are uncoupled from actomyosin system.  
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Paper V: Integrin α3β1 regulates kidney collecting duct development via TRAF6-
dependent K63-linked polyubiquitination of Akt 
 
Integrin-mediated signaling plays vital roles during various developmental processes 
including branching morphogenesis during kidney development. Laminin-binding 
integrins are highly expressed in the ureteric bud (UB) and α3β1 integrins was shown to 
be crucial for UB branching to form the collecting duct system of the kidney. However, 
the laminin type and the signaling pathways initiated though laminin-integrin α3β1 are 
not well characterized. In this study, we show that integrin α3β1 interactions with α3 
chain-containing laminins are important for Akt activation in collecting duct cells. 
Mechanistically, we identified TRAF6 as novel binding partner of β1 integrin cytoplasmic 
tails required to induce K63-linked polyubiquitination of Akt and to promote Akt 
recruitment to the plasms membrane. Furthermore, laminin-integrin α3β1 inactivates 
Phosphatase and tensin homolog (PTEN), thereby increasing PtdIns (3,4,5)P3 levels 
which further enhances Akt translocation and then full Akt activation. The importance of 
TRAF6 for kidney development is underlined by developmental defects of TRAF6- and 
integrin α3-depleted mouse kidneys.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference 
75 
 
Reference  
Adair, B.D., and M. Yeager. 2002. Three-dimensional model of the human platelet 
integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray 
crystallography. Proc Natl Acad Sci U S A. 99:14059-14064. 
Akiyama, S.K., and K.M. Yamada. 1987. Biosynthesis and acquisition of biological 
activity of the fibronectin receptor. J Biol Chem. 262:17536-17542. 
Akiyama, S.K., S.S. Yamada, and K.M. Yamada. 1989. Analysis of the role of 
glycosylation of the human fibronectin receptor. J Biol Chem. 264:18011-18018. 
Andersson, A., and L. Maler. 2006. Size and shape of fast-tumbling bicelles as 
determined by translational diffusion. Langmuir. 22:2447-2449. 
Anthis, N.J., K.L. Wegener, F. Ye, C. Kim, B.T. Goult, E.D. Lowe, I. Vakonakis, N. Bate, 
D.R. Critchley, M.H. Ginsberg, and I.D. Campbell. 2009. The structure of an 
integrin/talin complex reveals the basis of inside-out signal transduction. Embo J. 
28:3623-3632. 
Arjonen, A., J. Alanko, S. Veltel, and J. Ivaska. 2012. Distinct recycling of active and 
inactive beta1 integrins. Traffic. 13:610-625. 
Arnaout, M.A., B. Mahalingam, and J.P. Xiong. 2005. Integrin structure, allostery, and 
bidirectional signaling. Annu Rev Cell Dev Biol. 21:381-410. 
Askari, J.A., P.A. Buckley, A.P. Mould, and M.J. Humphries. 2009. Linking integrin 
conformation to function. J Cell Sci. 122:165-170. 
Bader, B.L., H. Rayburn, D. Crowley, and R.O. Hynes. 1998. Extensive vasculogenesis, 
angiogenesis, and organogenesis precede lethality in mice lacking all alpha v 
integrins. Cell. 95:507-519. 
Bai, J., R. Binari, J.Q. Ni, M. Vijayakanthan, H.S. Li, and N. Perrimon. 2008. RNA 
interference screening in Drosophila primary cells for genes involved in muscle 
assembly and maintenance. Development. 135:1439-1449. 
Balana, B., I. Maslennikov, W. Kwiatkowski, K.M. Stern, L. Bahima, S. Choe, and P.A. 
Slesinger. 2011. Mechanism underlying selective regulation of G protein-gated 
inwardly rectifying potassium channels by the psychostimulant-sensitive sorting 
nexin 27. Proc Natl Acad Sci U S A. 108:5831-5836. 
Baldassarre, M., Z. Razinia, C.F. Burande, I. Lamsoul, P.G. Lutz, and D.A. Calderwood. 
2009. Filamins regulate cell spreading and initiation of cell migration. PLoS One. 
4:e7830. 
Banno, A., B.T. Goult, H. Lee, N. Bate, D.R. Critchley, and M.H. Ginsberg. 2012. 
Subcellular localization of talin is regulated by inter-domain interactions. J Biol 
Chem. 287:13799-13812. 
Baudoin, C., M.J. Goumans, C. Mummery, and A. Sonnenberg. 1998. Knockout and 
knockin of the beta1 exon D define distinct roles for integrin splice variants in 
heart function and embryonic development. Genes Dev. 12:1202-1216. 
Bayburt, T.H., and S.G. Sligar. 2002. Single-molecule height measurements on 
microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. 
Proc Natl Acad Sci U S A. 99:6725-6730. 
Berrier, A.L., and K.M. Yamada. 2007. Cell-matrix adhesion. J Cell Physiol. 213:565-
573. 
Bix, G., and R.V. Iozzo. 2005. Matrix revolutions: "tails" of basement-membrane 
components with angiostatic functions. Trends Cell Biol. 15:52-60. 
Reference 
76 
 
Bledzka, K., J. Liu, Z. Xu, H.D. Perera, S.P. Yadav, K. Bialkowska, J. Qin, Y.Q. Ma, and 
E.F. Plow. 2012. Spatial coordination of kindlin-2 with talin head domain in 
interaction with integrin beta cytoplasmic tails. J Biol Chem. 287:24585-24594. 
Boettiger, D. 2012. Mechanical control of integrin-mediated adhesion and signaling. 
Curr Opin Cell Biol. 24:592-599. 
Bohmer, F.D., Q. Sun, M. Pepperle, T. Muller, U. Eriksson, J.L. Wang, and R. Grosse. 
1987. Antibodies against mammary derived growth inhibitor (MDGI) react with a 
fibroblast growth inhibitor and with heart fatty acid binding protein. Biochem 
Biophys Res Commun. 148:1425-1431. 
Booth, P.J., and A. Farooq. 1997. Intermediates in the assembly of bacteriorhodopsin 
investigated by time-resolved absorption spectroscopy. Eur J Biochem. 246:674-
680. 
Booth, P.J., A. Farooq, and S.L. Flitsch. 1996. Retinal binding during folding and 
assembly of the membrane protein bacteriorhodopsin. Biochemistry. 35:5902-
5909. 
Borch, J., F. Torta, S.G. Sligar, and P. Roepstorff. 2008. Nanodiscs for immobilization of 
lipid bilayers and membrane receptors: kinetic analysis of cholera toxin binding to 
a glycolipid receptor. Anal Chem. 80:6245-6252. 
Borges, E., Y. Jan, and E. Ruoslahti. 2000. Platelet-derived growth factor receptor beta 
and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin 
through its extracellular domain. J Biol Chem. 275:39867-39873. 
Bottcher, R.T., A. Lange, and R. Fassler. 2009. How ILK and kindlins cooperate to 
orchestrate integrin signaling. Curr Opin Cell Biol. 21:670-675. 
Bottcher, R.T., C. Stremmel, A. Meves, H. Meyer, M. Widmaier, H.Y. Tseng, and R. 
Fassler. 2012. Sorting nexin 17 prevents lysosomal degradation of beta1 
integrins by binding to the beta1-integrin tail. Nat Cell Biol. 14:584-592. 
Bouvard, D., J. Pouwels, N. De Franceschi, and J. Ivaska. 2013. Integrin inactivators: 
balancing cellular functions in vitro and in vivo. Nat Rev Mol Cell Biol. 14:430-
442. 
Bouvard, D., L. Vignoud, S. Dupe-Manet, N. Abed, H.N. Fournier, C. Vincent-Monegat, 
S.F. Retta, R. Fassler, and M.R. Block. 2003. Disruption of focal adhesions by 
integrin cytoplasmic domain-associated protein-1 alpha. J Biol Chem. 278:6567-
6574. 
Brahme, N.N., D.S. Harburger, K. Kemp-O'Brien, R. Stewart, S. Raghavan, M. Parsons, 
and D.A. Calderwood. 2013. Kindlin binds migfilin tandem LIM domains and 
regulates migfilin focal adhesion localization and recruitment dynamics. J Biol 
Chem. 288:35604-35616. 
Bridgewater, R.E., J.C. Norman, and P.T. Caswell. 2012. Integrin trafficking at a glance. 
J Cell Sci. 125:3695-3701. 
Brugnera, E., L. Haney, C. Grimsley, M. Lu, S.F. Walk, A.C. Tosello-Trampont, I.G. 
Macara, H. Madhani, G.R. Fink, and K.S. Ravichandran. 2002. Unconventional 
Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol. 
4:574-582. 
Brunner, M., A. Millon-Fremillon, G. Chevalier, I.A. Nakchbandi, D. Mosher, M.R. Block, 
C. Albiges-Rizo, and D. Bouvard. 2011. Osteoblast mineralization requires beta1 
integrin/ICAP-1-dependent fibronectin deposition. J Cell Biol. 194:307-322. 
Reference 
77 
 
Burke, R.D. 1999. Invertebrate integrins: structure, function, and evolution. Int Rev 
Cytol. 191:257-284. 
Burridge, K., and L. Connell. 1983. A new protein of adhesion plaques and ruffling 
membranes. J Cell Biol. 97:359-367. 
Bustelo, X.R., V. Sauzeau, and I.M. Berenjeno. 2007. GTP-binding proteins of the 
Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 29:356-
370. 
Calderwood, D.A., I.D. Campbell, and D.R. Critchley. 2013. Talins and kindlins: partners 
in integrin-mediated adhesion. Nat Rev Mol Cell Biol. 14:503-517. 
Calderwood, D.A., Y. Fujioka, J.M. de Pereda, B. Garcia-Alvarez, T. Nakamoto, B. 
Margolis, C.J. McGlade, R.C. Liddington, and M.H. Ginsberg. 2003. Integrin beta 
cytoplasmic domain interactions with phosphotyrosine-binding domains: a 
structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A. 
100:2272-2277. 
Calderwood, D.A., B. Yan, J.M. de Pereda, B.G. Alvarez, Y. Fujioka, R.C. Liddington, 
and M.H. Ginsberg. 2002. The phosphotyrosine binding-like domain of talin 
activates integrins. J Biol Chem. 277:21749-21758. 
Calderwood, D.A., R. Zent, R. Grant, D.J. Rees, R.O. Hynes, and M.H. Ginsberg. 1999. 
The Talin head domain binds to integrin beta subunit cytoplasmic tails and 
regulates integrin activation. J Biol Chem. 274:28071-28074. 
Campbell, I.D., and M.J. Humphries. 2011. Integrin structure, activation, and 
interactions. Cold Spring Harb Perspect Biol. 3. 
Carman, C.V., and T.A. Springer. 2003. Integrin avidity regulation: are changes in 
affinity and conformation underemphasized? Curr Opin Cell Biol. 15:547-556. 
Caswell, P.T., M. Chan, A.J. Lindsay, M.W. McCaffrey, D. Boettiger, and J.C. Norman. 
2008. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and 
EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol. 183:143-
155. 
Chang, D.D., C. Wong, H. Smith, and J. Liu. 1997. ICAP-1, a novel beta1 integrin 
cytoplasmic domain-associated protein, binds to a conserved and functionally 
important NPXY sequence motif of beta1 integrin. J Cell Biol. 138:1149-1157. 
Chang, Y.C., H. Zhang, J. Franco-Barraza, M.L. Brennan, T. Patel, E. Cukierman, and 
J. Wu. 2014. Structural and mechanistic insights into the recruitment of talin by 
RIAM in integrin signaling. Structure. 22:1810-1820. 
Chao, W.T., and J. Kunz. 2009. Focal adhesion disassembly requires clathrin-
dependent endocytosis of integrins. FEBS Lett. 583:1337-1343. 
Chen, W., J. Lou, and C. Zhu. 2010. Forcing switch from short- to intermediate- and 
long-lived states of the alphaA domain generates LFA-1/ICAM-1 catch bonds. J 
Biol Chem. 285:35967-35978. 
Chou, J.J., J.L. Baber, and A. Bax. 2004. Characterization of phospholipid mixed 
micelles by translational diffusion. J Biomol NMR. 29:299-308. 
Chou, J.J., J.D. Kaufman, S.J. Stahl, P.T. Wingfield, and A. Bax. 2002. Micelle-induced 
curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar 
coupling measurement in stretched polyacrylamide gel. J Am Chem Soc. 
124:2450-2451. 
Reference 
78 
 
Coll, J.L., A. Ben-Ze'ev, R.M. Ezzell, J.L. Rodriguez Fernandez, H. Baribault, R.G. 
Oshima, and E.D. Adamson. 1995. Targeted disruption of vinculin genes in F9 
and embryonic stem cells changes cell morphology, adhesion, and locomotion. 
Proc Natl Acad Sci U S A. 92:9161-9165. 
Conti, F.J., S.J. Monkley, M.R. Wood, D.R. Critchley, and U. Muller. 2009. Talin 1 and 2 
are required for myoblast fusion, sarcomere assembly and the maintenance of 
myotendinous junctions. Development. 136:3597-3606. 
Cullen, P.J. 2008. Endosomal sorting and signalling: an emerging role for sorting 
nexins. Nat Rev Mol Cell Biol. 9:574-582. 
Czuchra, A., H. Meyer, K.R. Legate, C. Brakebusch, and R. Fassler. 2006. Genetic 
analysis of beta1 integrin "activation motifs" in mice. J Cell Biol. 174:889-899. 
Darom, A., U. Bening-Abu-Shach, and L. Broday. 2010. RNF-121 is an endoplasmic 
reticulum-membrane E3 ubiquitin ligase involved in the regulation of beta-
integrin. Mol Biol Cell. 21:1788-1798. 
Das, M., S.S. Ithychanda, J. Qin, and E.F. Plow. 2011. Migfilin and filamin as regulators 
of integrin activation in endothelial cells and neutrophils. PLoS One. 6:e26355. 
de Melker, A.A., and A. Sonnenberg. 1999. Integrins: alternative splicing as a 
mechanism to regulate ligand binding and integrin signaling events. Bioessays. 
21:499-509. 
de Pereda, J.M., K.L. Wegener, E. Santelli, N. Bate, M.H. Ginsberg, D.R. Critchley, I.D. 
Campbell, and R.C. Liddington. 2005. Structural basis for phosphatidylinositol 
phosphate kinase type Igamma binding to talin at focal adhesions. J Biol Chem. 
280:8381-8386. 
Debrand, E., Y. El Jai, L. Spence, N. Bate, U. Praekelt, C.A. Pritchard, S.J. Monkley, 
and D.R. Critchley. 2009. Talin 2 is a large and complex gene encoding multiple 
transcripts and protein isoforms. Febs J. 276:1610-1628. 
DeMali, K.A., E. Balciunaite, and A. Kazlauskas. 1999. Integrins enhance platelet-
derived growth factor (PDGF)-dependent responses by altering the signal relay 
enzymes that are recruited to the PDGF beta receptor. J Biol Chem. 274:19551-
19558. 
Dowling, J.J., E. Gibbs, M. Russell, D. Goldman, J. Minarcik, J.A. Golden, and E.L. 
Feldman. 2008. Kindlin-2 is an essential component of intercalated discs and is 
required for vertebrate cardiac structure and function. Circ Res. 102:423-431. 
Dozynkiewicz, M.A., N.B. Jamieson, I. Macpherson, J. Grindlay, P.V. van den Berghe, 
A. von Thun, J.P. Morton, C. Gourley, P. Timpson, C. Nixon, C.J. McKay, R. 
Carter, D. Strachan, K. Anderson, O.J. Sansom, P.T. Caswell, and J.C. Norman. 
2012. Rab25 and CLIC3 collaborate to promote integrin recycling from late 
endosomes/lysosomes and drive cancer progression. Dev Cell. 22:131-145. 
Dubash, A.D., K. Wennerberg, R. Garcia-Mata, M.M. Menold, W.T. Arthur, and K. 
Burridge. 2007. A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA 
activity downstream of adhesion to fibronectin. J Cell Sci. 120:3989-3998. 
Ehrlicher, A.J., F. Nakamura, J.H. Hartwig, D.A. Weitz, and T.P. Stossel. 2011. 
Mechanical strain in actin networks regulates FilGAP and integrin binding to 
filamin A. Nature. 478:260-263. 
Reference 
79 
 
Elliott, P.R., B.T. Goult, P.M. Kopp, N. Bate, J.G. Grossmann, G.C. Roberts, D.R. 
Critchley, and I.L. Barsukov. 2010. The Structure of the talin head reveals a 
novel extended conformation of the FERM domain. Structure. 18:1289-1299. 
Ellis, S.J., E. Lostchuck, B.T. Goult, M. Bouaouina, M.J. Fairchild, P. Lopez-Ceballos, 
D.A. Calderwood, and G. Tanentzapf. 2014. The talin head domain reinforces 
integrin-mediated adhesion by promoting adhesion complex stability and 
clustering. PLoS Genet. 10:e1004756. 
Ezratty, E.J., C. Bertaux, E.E. Marcantonio, and G.G. Gundersen. 2009. Clathrin 
mediates integrin endocytosis for focal adhesion disassembly in migrating cells. J 
Cell Biol. 187:733-747. 
Fassler, R., M. Pfaff, J. Murphy, A.A. Noegel, S. Johansson, R. Timpl, and R. Albrecht. 
1995. Lack of beta 1 integrin gene in embryonic stem cells affects morphology, 
adhesion, and migration but not integration into the inner cell mass of 
blastocysts. J Cell Biol. 128:979-988. 
Flanagan, L.A., J. Chou, H. Falet, R. Neujahr, J.H. Hartwig, and T.P. Stossel. 2001. 
Filamin A, the Arp2/3 complex, and the morphology and function of cortical actin 
filaments in human melanoma cells. J Cell Biol. 155:511-517. 
Fournier, H.N., S. Dupe-Manet, D. Bouvard, M.L. Lacombe, C. Marie, M.R. Block, and 
C. Albiges-Rizo. 2002. Integrin cytoplasmic domain-associated protein 1alpha 
(ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and 
both proteins are targeted to newly formed cell adhesion sites upon integrin 
engagement. J Biol Chem. 277:20895-20902. 
Friedland, J.C., M.H. Lee, and D. Boettiger. 2009. Mechanically activated integrin switch 
controls alpha5beta1 function. Science. 323:642-644. 
Fukuda, K., K. Bledzka, J. Yang, H.D. Perera, E.F. Plow, and J. Qin. 2014. Molecular 
basis of kindlin-2 binding to integrin-linked kinase pseudokinase for regulating 
cell adhesion. J Biol Chem. 289:28363-28375. 
Gallon, M., and P.J. Cullen. 2015. Retromer and sorting nexins in endosomal sorting. 
Biochem Soc Trans. 43:33-47. 
Garavito, R.M., and S. Ferguson-Miller. 2001. Detergents as tools in membrane 
biochemistry. J Biol Chem. 276:32403-32406. 
Geiger, B., J.P. Spatz, and A.D. Bershadsky. 2009. Environmental sensing through 
focal adhesions. Nat Rev Mol Cell Biol. 10:21-33. 
Geiger, B., and K.M. Yamada. 2011. Molecular architecture and function of matrix 
adhesions. Cold Spring Harb Perspect Biol. 3. 
Georges-Labouesse, E., N. Messaddeq, G. Yehia, L. Cadalbert, A. Dierich, and M. Le 
Meur. 1996. Absence of integrin alpha 6 leads to epidermolysis bullosa and 
neonatal death in mice. Nat Genet. 13:370-373. 
Ghai, R., A. Bugarcic, H. Liu, S.J. Norwood, S. Skeldal, E.J. Coulson, S.S. Li, R.D. 
Teasdale, and B.M. Collins. 2013. Structural basis for endosomal trafficking of 
diverse transmembrane cargos by PX-FERM proteins. Proc Natl Acad Sci U S A. 
110:E643-652. 
Giancotti, F.G., and E. Ruoslahti. 1999. Integrin signaling. Science. 285:1028-1032. 
Gimona, M., R. Buccione, S.A. Courtneidge, and S. Linder. 2008. Assembly and 
biological role of podosomes and invadopodia. Curr Opin Cell Biol. 20:235-241. 
Reference 
80 
 
Gingras, A.R., N. Bate, B.T. Goult, L. Hazelwood, I. Canestrelli, J.G. Grossmann, H. Liu, 
N.S. Putz, G.C. Roberts, N. Volkmann, D. Hanein, I.L. Barsukov, and D.R. 
Critchley. 2008. The structure of the C-terminal actin-binding domain of talin. 
Embo J. 27:458-469. 
Goksoy, E., Y.Q. Ma, X. Wang, X. Kong, D. Perera, E.F. Plow, and J. Qin. 2008. 
Structural basis for the autoinhibition of talin in regulating integrin activation. Mol 
Cell. 31:124-133. 
Goult, B.T., M. Bouaouina, P.R. Elliott, N. Bate, B. Patel, A.R. Gingras, J.G. 
Grossmann, G.C. Roberts, D.A. Calderwood, D.R. Critchley, and I.L. Barsukov. 
2010. Structure of a double ubiquitin-like domain in the talin head: a role in 
integrin activation. Embo J. 29:1069-1080. 
Goult, B.T., M. Bouaouina, D.S. Harburger, N. Bate, B. Patel, N.J. Anthis, I.D. 
Campbell, D.A. Calderwood, I.L. Barsukov, G.C. Roberts, and D.R. Critchley. 
2009. The structure of the N-terminus of kindlin-1: a domain important for 
alphaiibbeta3 integrin activation. J Mol Biol. 394:944-956. 
Gu, J., T. Isaji, Y. Sato, Y. Kariya, and T. Fukuda. 2009. Importance of N-glycosylation 
on alpha5beta1 integrin for its biological functions. Biol Pharm Bull. 32:780-785. 
Gu, Z., E.H. Noss, V.W. Hsu, and M.B. Brenner. 2011. Integrins traffic rapidly via 
circular dorsal ruffles and macropinocytosis during stimulated cell migration. J 
Cell Biol. 193:61-70. 
Han, J., C.J. Lim, N. Watanabe, A. Soriani, B. Ratnikov, D.A. Calderwood, W. Puzon-
McLaughlin, E.M. Lafuente, V.A. Boussiotis, S.J. Shattil, and M.H. Ginsberg. 
2006. Reconstructing and deconstructing agonist-induced activation of integrin 
alphaIIbbeta3. Curr Biol. 16:1796-1806. 
Hart, R., P. Stanley, P. Chakravarty, and N. Hogg. 2013. The kindlin 3 pleckstrin 
homology domain has an essential role in lymphocyte function-associated 
antigen 1 (LFA-1) integrin-mediated B cell adhesion and migration. J Biol Chem. 
288:14852-14862. 
Harunaga, J.S., and K.M. Yamada. 2011. Cell-matrix adhesions in 3D. Matrix Biol. 
30:363-368. 
Haunerland, N.H., and F. Spener. 2004. Fatty acid-binding proteins--insights from 
genetic manipulations. Prog Lipid Res. 43:328-349. 
Heino, J., R.A. Ignotz, M.E. Hemler, C. Crouse, and J. Massague. 1989. Regulation of 
cell adhesion receptors by transforming growth factor-beta. Concomitant 
regulation of integrins that share a common beta 1 subunit. J Biol Chem. 
264:380-388. 
Hierro, A., A.L. Rojas, R. Rojas, N. Murthy, G. Effantin, A.V. Kajava, A.C. Steven, J.S. 
Bonifacino, and J.H. Hurley. 2007. Functional architecture of the retromer cargo-
recognition complex. Nature. 449:1063-1067. 
Hodivala-Dilke, K.M., K.P. McHugh, D.A. Tsakiris, H. Rayburn, D. Crowley, M. Ullman-
Cullere, F.P. Ross, B.S. Coller, S. Teitelbaum, and R.O. Hynes. 1999. Beta3-
integrin-deficient mice are a model for Glanzmann thrombasthenia showing 
placental defects and reduced survival. J Clin Invest. 103:229-238. 
Hogg, N., and P.A. Bates. 2000. Genetic analysis of integrin function in man: LAD-1 and 
other syndromes. Matrix Biol. 19:211-222. 
Reference 
81 
 
Hotchin, N.A., A. Gandarillas, and F.M. Watt. 1995. Regulation of cell surface beta 1 
integrin levels during keratinocyte terminal differentiation. J Cell Biol. 128:1209-
1219. 
Howes, M.T., M. Kirkham, J. Riches, K. Cortese, P.J. Walser, F. Simpson, M.M. Hill, A. 
Jones, R. Lundmark, M.R. Lindsay, D.J. Hernandez-Deviez, G. Hadzic, A. 
McCluskey, R. Bashir, L. Liu, P. Pilch, H. McMahon, P.J. Robinson, J.F. 
Hancock, S. Mayor, and R.G. Parton. 2010. Clathrin-independent carriers form a 
high capacity endocytic sorting system at the leading edge of migrating cells. J 
Cell Biol. 190:675-691. 
Huet-Calderwood, C., N.N. Brahme, N. Kumar, A.L. Stiegler, S. Raghavan, T.J. 
Boggon, and D.A. Calderwood. 2014. Differences in binding to the ILK complex 
determines kindlin isoform adhesion localization and integrin activation. J Cell 
Sci. 127:4308-4321. 
Hughes, P.E., F. Diaz-Gonzalez, L. Leong, C. Wu, J.A. McDonald, S.J. Shattil, and M.H. 
Ginsberg. 1996. Breaking the integrin hinge. A defined structural constraint 
regulates integrin signaling. J Biol Chem. 271:6571-6574. 
Humphries, J.D., A. Byron, and M.J. Humphries. 2006. Integrin ligands at a glance. J 
Cell Sci. 119:3901-3903. 
Humphries, J.D., P. Wang, C. Streuli, B. Geiger, M.J. Humphries, and C. Ballestrem. 
2007a. Vinculin controls focal adhesion formation by direct interactions with talin 
and actin. J Cell Biol. 179:1043-1057. 
Humphries, J.D., P. Wang, C. Streuli, B. Geiger, M.J. Humphries, and C. Ballestrem. 
2007b. Vinculin controls focal adhesion formation by direct interactions with talin 
and actin. J Cell Biol. 179:1043-1057. 
Humphries, M.J., P.A. McEwan, S.J. Barton, P.A. Buckley, J. Bella, and A.P. Mould. 
2003. Integrin structure: heady advances in ligand binding, but activation still 
makes the knees wobble. Trends Biochem Sci. 28:313-320. 
Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-
687. 
Ithychanda, S.S., M. Das, Y.Q. Ma, K. Ding, X. Wang, S. Gupta, C. Wu, E.F. Plow, and 
J. Qin. 2009. Migfilin, a molecular switch in regulation of integrin activation. J Biol 
Chem. 284:4713-4722. 
Jaffe, A.B., and A. Hall. 2005. Rho GTPases: biochemistry and biology. Annu Rev Cell 
Dev Biol. 21:247-269. 
Janik, M.E., A. Litynska, and P. Vereecken. 2010. Cell migration-the role of integrin 
glycosylation. Biochim Biophys Acta. 1800:545-555. 
Jiang, G., G. Giannone, D.R. Critchley, E. Fukumoto, and M.P. Sheetz. 2003. Two-
piconewton slip bond between fibronectin and the cytoskeleton depends on talin. 
Nature. 424:334-337. 
Jobard, F., B. Bouadjar, F. Caux, S. Hadj-Rabia, C. Has, F. Matsuda, J. Weissenbach, 
M. Lathrop, J.F. Prud'homme, and J. Fischer. 2003. Identification of mutations in 
a new gene encoding a FERM family protein with a pleckstrin homology domain 
in Kindler syndrome. Hum Mol Genet. 12:925-935. 
Kanchanawong, P., G. Shtengel, A.M. Pasapera, E.B. Ramko, M.W. Davidson, H.F. 
Hess, and C.M. Waterman. 2010. Nanoscale architecture of integrin-based cell 
adhesions. Nature. 468:580-584. 
Reference 
82 
 
Kiema, T., Y. Lad, P. Jiang, C.L. Oxley, M. Baldassarre, K.L. Wegener, I.D. Campbell, 
J. Ylanne, and D.A. Calderwood. 2006. The molecular basis of filamin binding to 
integrins and competition with talin. Mol Cell. 21:337-347. 
Kim, H.J., S.C. Howell, W.D. Van Horn, Y.H. Jeon, and C.R. Sanders. 2009a. Recent 
Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral 
Membrane Proteins. Prog Nucl Magn Reson Spectrosc. 55:335-360. 
Kim, H.J., S.C. Howell, W.D. Van Horn, Y.H. Jeon, and C.R. Sanders. 2009b. Recent 
Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral 
Membrane Proteins. Prog Nucl Magn Reson Spectrosc. 55:335-360. 
Kishimoto, T.K., N. Hollander, T.M. Roberts, D.C. Anderson, and T.A. Springer. 1987. 
Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and 
p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell. 50:193-202. 
Kloeker, S., M.B. Major, D.A. Calderwood, M.H. Ginsberg, D.A. Jones, and M.C. 
Beckerle. 2004. The Kindler syndrome protein is regulated by transforming 
growth factor-beta and involved in integrin-mediated adhesion. J Biol Chem. 
279:6824-6833. 
Knauth, P., T. Schluter, M. Czubayko, C. Kirsch, V. Florian, S. Schreckenberger, H. 
Hahn, and R. Bohnensack. 2005. Functions of sorting nexin 17 domains and 
recognition motif for P-selectin trafficking. J Mol Biol. 347:813-825. 
Kong, F., A.J. Garcia, A.P. Mould, M.J. Humphries, and C. Zhu. 2009. Demonstration of 
catch bonds between an integrin and its ligand. J Cell Biol. 185:1275-1284. 
Kong, F., Z. Li, W.M. Parks, D.W. Dumbauld, A.J. Garcia, A.P. Mould, M.J. Humphries, 
and C. Zhu. 2013. Cyclic mechanical reinforcement of integrin-ligand 
interactions. Mol Cell. 49:1060-1068. 
Kuijpers, T.W., E. van de Vijver, M.A. Weterman, M. de Boer, A.T. Tool, T.K. van den 
Berg, M. Moser, M.E. Jakobs, K. Seeger, O. Sanal, S. Unal, M. Cetin, D. Roos, 
A.J. Verhoeven, and F. Baas. 2009. LAD-1/variant syndrome is caused by 
mutations in FERMT3. Blood. 113:4740-4746. 
Kuo, J.C., X. Han, C.T. Hsiao, J.R. Yates, 3rd, and C.M. Waterman. 2011. Analysis of 
the myosin-II-responsive focal adhesion proteome reveals a role for beta-Pix in 
negative regulation of focal adhesion maturation. Nat Cell Biol. 13:383-393. 
Kurten, R.C., D.L. Cadena, and G.N. Gill. 1996. Enhanced degradation of EGF 
receptors by a sorting nexin, SNX1. Science. 272:1008-1010. 
Lad, Y., P. Jiang, S. Ruskamo, D.S. Harburger, J. Ylanne, I.D. Campbell, and D.A. 
Calderwood. 2008. Structural basis of the migfilin-filamin interaction and 
competition with integrin beta tails. J Biol Chem. 283:35154-35163. 
Lakshminarayan, R., C. Wunder, U. Becken, M.T. Howes, C. Benzing, S. Arumugam, S. 
Sales, N. Ariotti, V. Chambon, C. Lamaze, D. Loew, A. Shevchenko, K. Gaus, 
R.G. Parton, and L. Johannes. 2014. Galectin-3 drives glycosphingolipid-
dependent biogenesis of clathrin-independent carriers. Nat Cell Biol. 16:595-606. 
Lau, T.L., V. Dua, and T.S. Ulmer. 2008a. Structure of the integrin alphaIIb 
transmembrane segment. J Biol Chem. 283:16162-16168. 
Lau, T.L., C. Kim, M.H. Ginsberg, and T.S. Ulmer. 2009. The structure of the integrin 
alphaIIbbeta3 transmembrane complex explains integrin transmembrane 
signalling. Embo J. 28:1351-1361. 
Reference 
83 
 
Lau, T.L., A.W. Partridge, M.H. Ginsberg, and T.S. Ulmer. 2008b. Structure of the 
integrin beta3 transmembrane segment in phospholipid bicelles and detergent 
micelles. Biochemistry. 47:4008-4016. 
Laukaitis, C.M., D.J. Webb, K. Donais, and A.F. Horwitz. 2001. Differential dynamics of 
alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of 
adhesions in migrating cells. J Cell Biol. 153:1427-1440. 
Law, D.A., L. Nannizzi-Alaimo, and D.R. Phillips. 1996. Outside-in integrin signal 
transduction. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by 
platelet aggregation. J Biol Chem. 271:10811-10815. 
Lawson, C., S.T. Lim, S. Uryu, X.L. Chen, D.A. Calderwood, and D.D. Schlaepfer. 2012. 
FAK promotes recruitment of talin to nascent adhesions to control cell motility. J 
Cell Biol. 196:223-232. 
Lee, H.S., C.J. Lim, W. Puzon-McLaughlin, S.J. Shattil, and M.H. Ginsberg. 2009. RIAM 
activates integrins by linking talin to ras GTPase membrane-targeting sequences. 
J Biol Chem. 284:5119-5127. 
Lefort, C.T., J. Rossaint, M. Moser, B.G. Petrich, A. Zarbock, S.J. Monkley, D.R. 
Critchley, M.H. Ginsberg, R. Fassler, and K. Ley. 2012. Distinct roles for talin-1 
and kindlin-3 in LFA-1 extension and affinity regulation. Blood. 119:4275-4282. 
Legate, K.R., and R. Fassler. 2009. Mechanisms that regulate adaptor binding to beta-
integrin cytoplasmic tails. J Cell Sci. 122:187-198. 
Legate, K.R., S. Takahashi, N. Bonakdar, B. Fabry, D. Boettiger, R. Zent, and R. 
Fassler. 2011. Integrin adhesion and force coupling are independently regulated 
by localized PtdIns(4,5)2 synthesis. Embo J. 30:4539-4553. 
Leitz, A.J., T.H. Bayburt, A.N. Barnakov, B.A. Springer, and S.G. Sligar. 2006. 
Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling 
Nanodisc technology. Biotechniques. 40:601-602, 604, 606, passim. 
Leventis, P.A., and S. Grinstein. 2010. The distribution and function of 
phosphatidylserine in cellular membranes. Annu Rev Biophys. 39:407-427. 
Ley, K., C. Laudanna, M.I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of 
inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 
7:678-689. 
Li, J., B.A. Ballif, A.M. Powelka, J. Dai, S.P. Gygi, and V.W. Hsu. 2005. Phosphorylation 
of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 
to control cell migration. Dev Cell. 9:663-673. 
Li, R., C.R. Babu, J.D. Lear, A.J. Wand, J.S. Bennett, and W.F. DeGrado. 2001. 
Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and 
cytoplasmic domains. Proc Natl Acad Sci U S A. 98:12462-12467. 
Li, R., N. Mitra, H. Gratkowski, G. Vilaire, R. Litvinov, C. Nagasami, J.W. Weisel, J.D. 
Lear, W.F. DeGrado, and J.S. Bennett. 2003. Activation of integrin alphaIIbbeta3 
by modulation of transmembrane helix associations. Science. 300:795-798. 
Lim, Y., S.T. Lim, A. Tomar, M. Gardel, J.A. Bernard-Trifilo, X.L. Chen, S.A. Uryu, R. 
Canete-Soler, J. Zhai, H. Lin, W.W. Schlaepfer, P. Nalbant, G. Bokoch, D. Ilic, C. 
Waterman-Storer, and D.D. Schlaepfer. 2008. PyK2 and FAK connections to 
p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal 
adhesion formation, and cell motility. J Cell Biol. 180:187-203. 
Reference 
84 
 
Lipfert, J., L. Columbus, V.B. Chu, S.A. Lesley, and S. Doniach. 2007. Size and shape 
of detergent micelles determined by small-angle X-ray scattering. J Phys Chem 
B. 111:12427-12438. 
Litvinov, R.I., V. Barsegov, A.J. Schissler, A.R. Fisher, J.S. Bennett, J.W. Weisel, and 
H. Shuman. 2011. Dissociation of bimolecular alphaIIbbeta3-fibrinogen complex 
under a constant tensile force. Biophys J. 100:165-173. 
Liu, J., M. Das, J. Yang, S.S. Ithychanda, V.P. Yakubenko, E.F. Plow, and J. Qin. 2015. 
Structural mechanism of integrin inactivation by filamin. Nat Struct Mol Biol. 
Liu, J., K. Fukuda, Z. Xu, Y.Q. Ma, J. Hirbawi, X. Mao, C. Wu, E.F. Plow, and J. Qin. 
2011. Structural basis of phosphoinositide binding to kindlin-2 protein pleckstrin 
homology domain in regulating integrin activation. J Biol Chem. 286:43334-
43342. 
Liu, W., K.M. Draheim, R. Zhang, D.A. Calderwood, and T.J. Boggon. 2013. Mechanism 
for KRIT1 release of ICAP1-mediated suppression of integrin activation. Mol Cell. 
49:719-729. 
Liu, Y., Y. Zhu, S. Ye, and R. Zhang. 2012. Crystal structure of kindlin-2 PH domain 
reveals a conformational transition for its membrane anchoring and regulation of 
integrin activation. Protein Cell. 3:434-440. 
Lobert, V.H., A. Brech, N.M. Pedersen, J. Wesche, A. Oppelt, L. Malerod, and H. 
Stenmark. 2010. Ubiquitination of alpha 5 beta 1 integrin controls fibroblast 
migration through lysosomal degradation of fibronectin-integrin complexes. Dev 
Cell. 19:148-159. 
Lu, Z., W.D. Van Horn, J. Chen, S. Mathew, R. Zent, and C.R. Sanders. 2012. Bicelles 
at low concentrations. Mol Pharm. 9:752-761. 
Luo, B.H., C.V. Carman, J. Takagi, and T.A. Springer. 2005. Disrupting integrin 
transmembrane domain heterodimerization increases ligand binding affinity, not 
valency or clustering. Proc Natl Acad Sci U S A. 102:3679-3684. 
Luo, B.H., T.A. Springer, and J. Takagi. 2004. A specific interface between integrin 
transmembrane helices and affinity for ligand. PLoS Biol. 2:e153. 
Ma, Y.Q., J. Qin, C. Wu, and E.F. Plow. 2008. Kindlin-2 (Mig-2): a co-activator of beta3 
integrins. J Cell Biol. 181:439-446. 
Magno, A.L., E. Ingley, S.J. Brown, A.D. Conigrave, T. Ratajczak, and B.K. Ward. 2011. 
Testin, a novel binding partner of the calcium-sensing receptor, enhances 
receptor-mediated Rho-kinase signalling. Biochemical and biophysical research 
communications. 412:584-589. 
Mai, A., S. Veltel, T. Pellinen, A. Padzik, E. Coffey, V. Marjomaki, and J. Ivaska. 2011. 
Competitive binding of Rab21 and p120RasGAP to integrins regulates receptor 
traffic and migration. J Cell Biol. 194:291-306. 
Malinin, N.L., L. Zhang, J. Choi, A. Ciocea, O. Razorenova, Y.Q. Ma, E.A. Podrez, M. 
Tosi, D.P. Lennon, A.I. Caplan, S.B. Shurin, E.F. Plow, and T.V. Byzova. 2009. A 
point mutation in KINDLIN3 ablates activation of three integrin subfamilies in 
humans. Nat Med. 15:313-318. 
Margadant, C., H.N. Monsuur, J.C. Norman, and A. Sonnenberg. 2011. Mechanisms of 
integrin activation and trafficking. Curr Opin Cell Biol. 23:607-614. 
Reference 
85 
 
Martel, V., L. Vignoud, S. Dupe, P. Frachet, M.R. Block, and C. Albiges-Rizo. 2000. 
Talin controls the exit of the integrin alpha 5 beta 1 from an early compartment of 
the secretory pathway. J Cell Sci. 113 ( Pt 11):1951-1961. 
Meves, A., C. Stremmel, K. Gottschalk, and R. Fassler. 2009. The Kindlin protein family: 
new members to the club of focal adhesion proteins. Trends Cell Biol. 19:504-
513. 
Moik, D.V., V.C. Janbandhu, and R. Fassler. 2011. Loss of migfilin expression has no 
overt consequences on murine development and homeostasis. J Cell Sci. 
124:414-421. 
Monkley, S.J., X.H. Zhou, S.J. Kinston, S.M. Giblett, L. Hemmings, H. Priddle, J.E. 
Brown, C.A. Pritchard, D.R. Critchley, and R. Fassler. 2000. Disruption of the 
talin gene arrests mouse development at the gastrulation stage. Dev Dyn. 
219:560-574. 
Montanez, E., S. Ussar, M. Schifferer, M. Bosl, R. Zent, M. Moser, and R. Fassler. 
2008. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev. 22:1325-
1330. 
Moore, D.T., P. Nygren, H. Jo, K. Boesze-Battaglia, J.S. Bennett, and W.F. DeGrado. 
2012. Affinity of talin-1 for the beta3-integrin cytosolic domain is modulated by its 
phospholipid bilayer environment. Proc Natl Acad Sci U S A. 109:793-798. 
Moro, L., M. Venturino, C. Bozzo, L. Silengo, F. Altruda, L. Beguinot, G. Tarone, and P. 
Defilippi. 1998. Integrins induce activation of EGF receptor: role in MAP kinase 
induction and adhesion-dependent cell survival. Embo J. 17:6622-6632. 
Moser, M., M. Bauer, S. Schmid, R. Ruppert, S. Schmidt, M. Sixt, H.V. Wang, M. 
Sperandio, and R. Fassler. 2009a. Kindlin-3 is required for beta2 integrin-
mediated leukocyte adhesion to endothelial cells. Nat Med. 15:300-305. 
Moser, M., K.R. Legate, R. Zent, and R. Fassler. 2009b. The tail of integrins, talin, and 
kindlins. Science. 324:895-899. 
Moser, M., B. Nieswandt, S. Ussar, M. Pozgajova, and R. Fassler. 2008. Kindlin-3 is 
essential for integrin activation and platelet aggregation. Nat Med. 14:325-330. 
Muller, P.A., P.T. Caswell, B. Doyle, M.P. Iwanicki, E.H. Tan, S. Karim, N. Lukashchuk, 
D.A. Gillespie, R.L. Ludwig, P. Gosselin, A. Cromer, J.S. Brugge, O.J. Sansom, 
J.C. Norman, and K.H. Vousden. 2009. Mutant p53 drives invasion by promoting 
integrin recycling. Cell. 139:1327-1341. 
Nevo, J., A. Mai, S. Tuomi, T. Pellinen, O.T. Pentikainen, P. Heikkila, J. Lundin, H. 
Joensuu, P. Bono, and J. Ivaska. 2010. Mammary-derived growth inhibitor 
(MDGI) interacts with integrin alpha-subunits and suppresses integrin activity and 
invasion. Oncogene. 29:6452-6463. 
Ng, T., D. Shima, A. Squire, P.I. Bastiaens, S. Gschmeissner, M.J. Humphries, and P.J. 
Parker. 1999. PKCalpha regulates beta1 integrin-dependent cell motility through 
association and control of integrin traffic. Embo J. 18:3909-3923. 
Nieswandt, B., M. Moser, I. Pleines, D. Varga-Szabo, S. Monkley, D. Critchley, and R. 
Fassler. 2007. Loss of talin1 in platelets abrogates integrin activation, platelet 
aggregation, and thrombus formation in vitro and in vivo. J Exp Med. 204:3113-
3118. 
Reference 
86 
 
Nishida, N., C. Xie, M. Shimaoka, Y. Cheng, T. Walz, and T.A. Springer. 2006. 
Activation of leukocyte beta2 integrins by conversion from bent to extended 
conformations. Immunity. 25:583-594. 
Nishimura, T., and K. Kaibuchi. 2007. Numb controls integrin endocytosis for directional 
cell migration with aPKC and PAR-3. Dev Cell. 13:15-28. 
Olski, T.M., A.A. Noegel, and E. Korenbaum. 2001. Parvin, a 42 kDa focal adhesion 
protein, related to the alpha-actinin superfamily. J Cell Sci. 114:525-538. 
Oxley, C.L., N.J. Anthis, E.D. Lowe, I. Vakonakis, I.D. Campbell, and K.L. Wegener. 
2008. An integrin phosphorylation switch: the effect of beta3 integrin tail 
phosphorylation on Dok1 and talin binding. J Biol Chem. 283:5420-5426. 
Pankov, R., E. Cukierman, B.Z. Katz, K. Matsumoto, D.C. Lin, S. Lin, C. Hahn, and K.M. 
Yamada. 2000. Integrin dynamics and matrix assembly: tensin-dependent 
translocation of alpha(5)beta(1) integrins promotes early fibronectin 
fibrillogenesis. J Cell Biol. 148:1075-1090. 
Partridge, A.W., S. Liu, S. Kim, J.U. Bowie, and M.H. Ginsberg. 2005. Transmembrane 
domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state. J 
Biol Chem. 280:7294-7300. 
Paszek, M.J., C.C. DuFort, O. Rossier, R. Bainer, J.K. Mouw, K. Godula, J.E. Hudak, 
J.N. Lakins, A.C. Wijekoon, L. Cassereau, M.G. Rubashkin, M.J. Magbanua, K.S. 
Thorn, M.W. Davidson, H.S. Rugo, J.W. Park, D.A. Hammer, G. Giannone, C.R. 
Bertozzi, and V.M. Weaver. 2014. The cancer glycocalyx mechanically primes 
integrin-mediated growth and survival. Nature. 511:319-325. 
Pellinen, T., S. Tuomi, A. Arjonen, M. Wolf, H. Edgren, H. Meyer, R. Grosse, T. Kitzing, 
J.K. Rantala, O. Kallioniemi, R. Fassler, M. Kallio, and J. Ivaska. 2008. Integrin 
trafficking regulated by Rab21 is necessary for cytokinesis. Dev Cell. 15:371-385. 
Perera, H.D., Y.Q. Ma, J. Yang, J. Hirbawi, E.F. Plow, and J. Qin. 2011. Membrane 
binding of the N-terminal ubiquitin-like domain of kindlin-2 is crucial for its 
regulation of integrin activation. Structure. 19:1664-1671. 
Petrich, B.G., P. Marchese, Z.M. Ruggeri, S. Spiess, R.A. Weichert, F. Ye, R. Tiedt, 
R.C. Skoda, S.J. Monkley, D.R. Critchley, and M.H. Ginsberg. 2007. Talin is 
required for integrin-mediated platelet function in hemostasis and thrombosis. J 
Exp Med. 204:3103-3111. 
Plow, E.F., T.A. Haas, L. Zhang, J. Loftus, and J.W. Smith. 2000. Ligand binding to 
integrins. J Biol Chem. 275:21785-21788. 
Pouwels, J., N. De Franceschi, P. Rantakari, K. Auvinen, M. Karikoski, E. Mattila, C. 
Potter, J.P. Sundberg, N. Hogg, C.G. Gahmberg, M. Salmi, and J. Ivaska. 2013. 
SHARPIN regulates uropod detachment in migrating lymphocytes. Cell Rep. 
5:619-628. 
Prive, G.G. 2007. Detergents for the stabilization and crystallization of membrane 
proteins. Methods. 41:388-397. 
Qadota, H., Y. Luo, Y. Matsunaga, A.S. Park, K.M. Gernert, and G.M. Benian. 2014. 
Suppressor mutations suggest a surface on PAT-4 (Integrin-linked Kinase) that 
interacts with UNC-112 (Kindlin). J Biol Chem. 289:14252-14262. 
Qadota, H., D.G. Moerman, and G.M. Benian. 2012. A molecular mechanism for the 
requirement of PAT-4 (integrin-linked kinase (ILK)) for the localization of UNC-
112 (Kindlin) to integrin adhesion sites. J Biol Chem. 287:28537-28551. 
Reference 
87 
 
Rainero, E., J.D. Howe, P.T. Caswell, N.B. Jamieson, K. Anderson, D.R. Critchley, L. 
Machesky, and J.C. Norman. 2015. Ligand-Occupied Integrin Internalization 
Links Nutrient Signaling to Invasive Migration. Cell Rep. 
Rantala, J.K., J. Pouwels, T. Pellinen, S. Veltel, P. Laasola, E. Mattila, C.S. Potter, T. 
Duffy, J.P. Sundberg, O. Kallioniemi, J.A. Askari, M.J. Humphries, M. Parsons, 
M. Salmi, and J. Ivaska. 2011. SHARPIN is an endogenous inhibitor of beta1-
integrin activation. Nat Cell Biol. 13:1315-1324. 
Raschle, T., S. Hiller, T.Y. Yu, A.J. Rice, T. Walz, and G. Wagner. 2009. Structural and 
functional characterization of the integral membrane protein VDAC-1 in lipid 
bilayer nanodiscs. J Am Chem Soc. 131:17777-17779. 
Riggs, K.A., N. Hasan, D. Humphrey, C. Raleigh, C. Nevitt, D. Corbin, and C. Hu. 2012. 
Regulation of integrin endocytic recycling and chemotactic cell migration by 
syntaxin 6 and VAMP3 interaction. J Cell Sci. 125:3827-3839. 
Roberts, G.C., and D.R. Critchley. 2009. Structural and biophysical properties of the 
integrin-associated cytoskeletal protein talin. Biophys Rev. 1:61-69. 
Roberts, M.S., A.J. Woods, T.C. Dale, P. Van Der Sluijs, and J.C. Norman. 2004. 
Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of 
alpha v beta 3 and alpha 5 beta 1 integrins. Mol Cell Biol. 24:1505-1515. 
Roca-Cusachs, P., N.C. Gauthier, A. Del Rio, and M.P. Sheetz. 2009. Clustering of 
alpha(5)beta(1) integrins determines adhesion strength whereas alpha(v)beta(3) 
and talin enable mechanotransduction. Proc Natl Acad Sci U S A. 106:16245-
16250. 
Rodriguez Fernandez, J.L., B. Geiger, D. Salomon, I. Sabanay, M. Zoller, and A. Ben-
Ze'ev. 1992. Suppression of tumorigenicity in transformed cells after transfection 
with vinculin cDNA. J Cell Biol. 119:427-438. 
Rogalski, T.M., G.P. Mullen, M.M. Gilbert, B.D. Williams, and D.G. Moerman. 2000. The 
UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell-
matrix adhesion structures required for integrin localization in the muscle cell 
membrane. J Cell Biol. 150:253-264. 
Rognoni, E., M. Widmaier, M. Jakobson, R. Ruppert, S. Ussar, D. Katsougkri, R.T. 
Bottcher, J.E. Lai-Cheong, D.B. Rifkin, J.A. McGrath, and R. Fassler. 2014. 
Kindlin-1 controls Wnt and TGF-beta availability to regulate cutaneous stem cell 
proliferation. Nat Med. 20:350-359. 
Rosa, J.P., and R.P. McEver. 1989. Processing and assembly of the integrin, 
glycoprotein IIb-IIIa, in HEL cells. J Biol Chem. 264:12596-12603. 
Sachs, J.N., and D.M. Engelman. 2006. Introduction to the membrane protein reviews: 
the interplay of structure, dynamics, and environment in membrane protein 
function. Annu Rev Biochem. 75:707-712. 
Sakai, T., R. Jove, R. Fassler, and D.F. Mosher. 2001. Role of the cytoplasmic tyrosines 
of beta 1A integrins in transformation by v-src. Proc Natl Acad Sci U S A. 
98:3808-3813. 
Salicioni, A.M., A. Gaultier, C. Brownlee, M.K. Cheezum, and S.L. Gonias. 2004. Low 
density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation 
and transport to the cell surface. J Biol Chem. 279:10005-10012. 
Sanders, C.R., 2nd, and G.C. Landis. 1995. Reconstitution of membrane proteins into 
lipid-rich bilayered mixed micelles for NMR studies. Biochemistry. 34:4030-4040. 
Reference 
88 
 
Sanders, C.R., and J.K. Myers. 2004. Disease-related misassembly of membrane 
proteins. Annu Rev Biophys Biomol Struct. 33:25-51. 
Scharffetter-Kochanek, K., H. Lu, K. Norman, N. van Nood, F. Munoz, S. Grabbe, M. 
McArthur, I. Lorenzo, S. Kaplan, K. Ley, C.W. Smith, C.A. Montgomery, S. Rich, 
and A.L. Beaudet. 1998. Spontaneous skin ulceration and defective T cell 
function in CD18 null mice. J Exp Med. 188:119-131. 
Schiller, H.B., C.C. Friedel, C. Boulegue, and R. Fassler. 2011. Quantitative proteomics 
of the integrin adhesome show a myosin II-dependent recruitment of LIM domain 
proteins. EMBO Rep. 12:259-266. 
Schmidt, S., M. Moser, and M. Sperandio. 2013. The molecular basis of leukocyte 
recruitment and its deficiencies. Mol Immunol. 55:49-58. 
Schmitz, G., and M. Grandl. 2009. The molecular mechanisms of HDL and associated 
vesicular trafficking mechanisms to mediate cellular lipid homeostasis. 
Arterioscler Thromb Vasc Biol. 29:1718-1722. 
Schneller, M., K. Vuori, and E. Ruoslahti. 1997. Alphavbeta3 integrin associates with 
activated insulin and PDGFbeta receptors and potentiates the biological activity 
of PDGF. Embo J. 16:5600-5607. 
Seet, L.F., and W. Hong. 2006. The Phox (PX) domain proteins and membrane traffic. 
Biochim Biophys Acta. 1761:878-896. 
Seog, D.H., and J. Han. 2008. Sorting Nexin 17 Interacts Directly with Kinesin 
Superfamily KIF1Bbeta Protein. The Korean journal of physiology & 
pharmacology : official journal of the Korean Physiological Society and the 
Korean Society of Pharmacology. 12:199-204. 
Shattil, S.J., C. Kim, and M.H. Ginsberg. 2010. The final steps of integrin activation: the 
end game. Nat Rev Mol Cell Biol. 11:288-300. 
Shenkarev, Z.O., E.N. Lyukmanova, O.I. Solozhenkin, I.E. Gagnidze, O.V. Nekrasova, 
V.V. Chupin, A.A. Tagaev, Z.A. Yakimenko, T.V. Ovchinnikova, M.P. 
Kirpichnikov, and A.S. Arseniev. 2009. Lipid-protein nanodiscs: possible 
application in high-resolution NMR investigations of membrane proteins and 
membrane-active peptides. Biochemistry. Biokhimiia. 74:756-765. 
Shi, F., and J. Sottile. 2008. Caveolin-1-dependent beta1 integrin endocytosis is a 
critical regulator of fibronectin turnover. J Cell Sci. 121:2360-2371. 
Shi, Q., and D. Boettiger. 2003. A novel mode for integrin-mediated signaling: tethering 
is required for phosphorylation of FAK Y397. Mol Biol Cell. 14:4306-4315. 
Shi, X., Y.Q. Ma, Y. Tu, K. Chen, S. Wu, K. Fukuda, J. Qin, E.F. Plow, and C. Wu. 
2007. The MIG-2/integrin interaction strengthens cell-matrix adhesion and 
modulates cell motility. J Biol Chem. 282:20455-20466. 
Soldi, R., S. Mitola, M. Strasly, P. Defilippi, G. Tarone, and F. Bussolino. 1999. Role of 
alphavbeta3 integrin in the activation of vascular endothelial growth factor 
receptor-2. Embo J. 18:882-892. 
Springer, T.A., J. Zhu, and T. Xiao. 2008. Structural basis for distinctive recognition of 
fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3. J Cell Biol. 
182:791-800. 
Steinberg, F., M. Gallon, M. Winfield, E.C. Thomas, A.J. Bell, K.J. Heesom, J.M. 
Tavare, and P.J. Cullen. 2013. A global analysis of SNX27-retromer assembly 
Reference 
89 
 
and cargo specificity reveals a function in glucose and metal ion transport. Nat 
Cell Biol. 15:461-471. 
Steinberg, F., K.J. Heesom, M.D. Bass, and P.J. Cullen. 2012. SNX17 protects integrins 
from degradation by sorting between lysosomal and recycling pathways. J Cell 
Biol. 197:219-230. 
Stephens, L.E., A.E. Sutherland, I.V. Klimanskaya, A. Andrieux, J. Meneses, R.A. 
Pedersen, and C.H. Damsky. 1995. Deletion of beta 1 integrins in mice results in 
inner cell mass failure and peri-implantation lethality. Genes Dev. 9:1883-1895. 
Stiegler, A.L., R. Zhang, W. Liu, and T.J. Boggon. 2014. Structural determinants for 
binding of sorting nexin 17 (SNX17) to the cytoplasmic adaptor protein Krev 
interaction trapped 1 (KRIT1). J Biol Chem. 289:25362-25373. 
Stockinger, W., B. Sailler, V. Strasser, B. Recheis, D. Fasching, L. Kahr, W.J. 
Schneider, and J. Nimpf. 2002. The PX-domain protein SNX17 interacts with 
members of the LDL receptor family and modulates endocytosis of the LDL 
receptor. Embo J. 21:4259-4267. 
Struppe, J., J.A. Whiles, and R.R. Vold. 2000. Acidic phospholipid bicelles: a versatile 
model membrane system. Biophys J. 78:281-289. 
Svensson, L., K. Howarth, A. McDowall, I. Patzak, R. Evans, S. Ussar, M. Moser, A. 
Metin, M. Fried, I. Tomlinson, and N. Hogg. 2009. Leukocyte adhesion 
deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. 
Nat Med. 15:306-312. 
Takagi, J., H.P. Erickson, and T.A. Springer. 2001. C-terminal opening mimics 'inside-
out' activation of integrin alpha5beta1. Nat Struct Biol. 8:412-416. 
Takagi, J., B.M. Petre, T. Walz, and T.A. Springer. 2002. Global conformational 
rearrangements in integrin extracellular domains in outside-in and inside-out 
signaling. Cell. 110:599-511. 
Takizawa, Y., H. Shimizu, T. Nishikawa, N. Hatta, L. Pulkkinen, and J. Uitto. 1997. 
Novel ITGB4 mutations in a patient with junctional epidermolysis bullosa-pyloric 
atresia syndrome and altered basement membrane zone immunofluorescence 
for the alpha6beta4 integrin. J Invest Dermatol. 108:943-946. 
Tamkun, J.W., D.W. DeSimone, D. Fonda, R.S. Patel, C. Buck, A.F. Horwitz, and R.O. 
Hynes. 1986. Structure of integrin, a glycoprotein involved in the transmembrane 
linkage between fibronectin and actin. Cell. 46:271-282. 
Tate, C.G. 2010. Practical considerations of membrane protein instability during 
purification and crystallisation. Methods Mol Biol. 601:187-203. 
Teasdale, R.D., and B.M. Collins. 2012. Insights into the PX (phox-homology) domain 
and SNX (sorting nexin) protein families: structures, functions and roles in 
disease. Biochem J. 441:39-59. 
Teckchandani, A., E.E. Mulkearns, T.W. Randolph, N. Toida, and J.A. Cooper. 2012. 
The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate 
integrin beta1 endocytosis. Mol Biol Cell. 23:2905-2916. 
Teckchandani, A., N. Toida, J. Goodchild, C. Henderson, J. Watts, B. Wollscheid, and 
J.A. Cooper. 2009. Quantitative proteomics identifies a Dab2/integrin module 
regulating cell migration. J Cell Biol. 186:99-111. 
Reference 
90 
 
Temkin, P., B. Lauffer, S. Jager, P. Cimermancic, N.J. Krogan, and M. von Zastrow. 
2011. SNX27 mediates retromer tubule entry and endosome-to-plasma 
membrane trafficking of signalling receptors. Nat Cell Biol. 13:715-721. 
ten Klooster, J.P., Z.M. Jaffer, J. Chernoff, and P.L. Hordijk. 2006. Targeting and 
activation of Rac1 are mediated by the exchange factor beta-Pix. J Cell Biol. 
172:759-769. 
Tiwari, A., J.J. Jung, S.M. Inamdar, C.O. Brown, A. Goel, and A. Choudhury. 2011a. 
Endothelial cell migration on fibronectin is regulated by syntaxin 6-mediated 
alpha5beta1 integrin recycling. J Biol Chem. 286:36749-36761. 
Tiwari, S., J.A. Askari, M.J. Humphries, and N.J. Bulleid. 2011b. Divalent cations 
regulate the folding and activation status of integrins during their intracellular 
trafficking. J Cell Sci. 124:1672-1680. 
Tronik-Le Roux, D., V. Roullot, C. Poujol, T. Kortulewski, P. Nurden, and G. Marguerie. 
2000. Thrombasthenic mice generated by replacement of the integrin alpha(IIb) 
gene: demonstration that transcriptional activation of this megakaryocytic locus 
precedes lineage commitment. Blood. 96:1399-1408. 
Tseng, H.Y., N. Thorausch, T. Ziegler, A. Meves, R. Fassler, and R.T. Bottcher. 2014. 
Sorting nexin 31 binds multiple beta integrin cytoplasmic domains and regulates 
beta1 integrin surface levels and stability. J Mol Biol. 426:3180-3194. 
Turner, C.E., J.R. Glenney, Jr., and K. Burridge. 1990. Paxillin: a new vinculin-binding 
protein present in focal adhesions. J Cell Biol. 111:1059-1068. 
Ulmer, T.S., B. Yaspan, M.H. Ginsberg, and I.D. Campbell. 2001. NMR analysis of 
structure and dynamics of the cytosolic tails of integrin alpha IIb beta 3 in 
aqueous solution. Biochemistry. 40:7498-7508. 
Ussar, S., M. Moser, M. Widmaier, E. Rognoni, C. Harrer, O. Genzel-Boroviczeny, and 
R. Fassler. 2008. Loss of Kindlin-1 Causes Skin Atrophy and Lethal Neonatal 
Intestinal Epithelial Dysfunction. PLoS Genet. 4. 
Ussar, S., H.V. Wang, S. Linder, R. Fassler, and M. Moser. 2006. The Kindlins: 
subcellular localization and expression during murine development. Exp Cell 
Res. 312:3142-3151. 
Valdembri, D., P.T. Caswell, K.I. Anderson, J.P. Schwarz, I. Konig, E. Astanina, F. 
Caccavari, J.C. Norman, M.J. Humphries, F. Bussolino, and G. Serini. 2009. 
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function 
in endothelial cells. PLoS Biol. 7:e25. 
van der Flier, A., and A. Sonnenberg. 2001. Function and interactions of integrins. Cell 
Tissue Res. 305:285-298. 
van der Neut, R., P. Krimpenfort, J. Calafat, C.M. Niessen, and A. Sonnenberg. 1996. 
Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null 
mice. Nat Genet. 13:366-369. 
van Kerkhof, P., J. Lee, L. McCormick, E. Tetrault, W. Lu, M. Schoenfish, V. Oorschot, 
G.J. Strous, J. Klumperman, and G. Bu. 2005. Sorting nexin 17 facilitates LRP 
recycling in the early endosome. Embo J. 24:2851-2861. 
van Meer, G., D.R. Voelker, and G.W. Feigenson. 2008. Membrane lipids: where they 
are and how they behave. Nat Rev Mol Cell Biol. 9:112-124. 
Reference 
91 
 
Vidal, F., D. Aberdam, C. Miquel, A.M. Christiano, L. Pulkkinen, J. Uitto, J.P. Ortonne, 
and G. Meneguzzi. 1995. Integrin beta 4 mutations associated with junctional 
epidermolysis bullosa with pyloric atresia. Nat Genet. 10:229-234. 
Vieira, N., F.M. Deng, F.X. Liang, Y. Liao, J. Chang, G. Zhou, W. Zheng, J.P. Simon, M. 
Ding, X.R. Wu, R. Romih, G. Kreibich, and T.T. Sun. 2014. SNX31: a novel 
sorting nexin associated with the uroplakin-degrading multivesicular bodies in 
terminally differentiated urothelial cells. PLoS One. 9:e99644. 
Vinogradova, O., A. Velyvis, A. Velyviene, B. Hu, T. Haas, E. Plow, and J. Qin. 2002. A 
structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as 
regulated by its cytoplasmic face. Cell. 110:587-597. 
Volberg, T., B. Geiger, Z. Kam, R. Pankov, I. Simcha, H. Sabanay, J.L. Coll, E. 
Adamson, and A. Ben-Ze'ev. 1995. Focal adhesion formation by F9 embryonal 
carcinoma cells after vinculin gene disruption. J Cell Sci. 108 ( Pt 6):2253-2260. 
Wang, S., T. Watanabe, K. Matsuzawa, A. Katsumi, M. Kakeno, T. Matsui, F. Ye, K. 
Sato, K. Murase, I. Sugiyama, K. Kimura, A. Mizoguchi, M.H. Ginsberg, J.G. 
Collard, and K. Kaibuchi. 2012a. Tiam1 interaction with the PAR complex 
promotes talin-mediated Rac1 activation during polarized cell migration. J Cell 
Biol. 199:331-345. 
Wang, X., Y. Zhao, X. Zhang, H. Badie, Y. Zhou, Y. Mu, L.S. Loo, L. Cai, R.C. 
Thompson, B. Yang, Y. Chen, P.F. Johnson, C. Wu, G. Bu, W.C. Mobley, D. 
Zhang, F.H. Gage, B. Ranscht, Y.W. Zhang, S.A. Lipton, W. Hong, and H. Xu. 
2013. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by 
modulating glutamate receptor recycling in Down's syndrome. Nat Med. 19:473-
480. 
Wang, Z., C.S. Potter, J.P. Sundberg, and H. Hogenesch. 2012b. SHARPIN is a key 
regulator of immune and inflammatory responses. J Cell Mol Med. 16:2271-2279. 
Wassmer, T., N. Attar, M. Harterink, J.R. van Weering, C.J. Traer, J. Oakley, B. Goud, 
D.J. Stephens, P. Verkade, H.C. Korswagen, and P.J. Cullen. 2009. The 
retromer coat complex coordinates endosomal sorting and dynein-mediated 
transport, with carrier recognition by the trans-Golgi network. Dev Cell. 17:110-
122. 
Watts, L., and Craig, L 2015. The Role of Talin-1 and Kindlin-3 in Neutrophilic Mac-1 
Activation Faseb J. 29. 
Wegener, K.L., J. Basran, C.R. Bagshaw, I.D. Campbell, G.C. Roberts, D.R. Critchley, 
and I.L. Barsukov. 2008. Structural basis for the interaction between the 
cytoplasmic domain of the hyaluronate receptor layilin and the talin F3 
subdomain. J Mol Biol. 382:112-126. 
Wegener, K.L., and I.D. Campbell. 2008. Transmembrane and cytoplasmic domains in 
integrin activation and protein-protein interactions (review). Mol Membr Biol. 
25:376-387. 
Wegener, K.L., A.W. Partridge, J. Han, A.R. Pickford, R.C. Liddington, M.H. Ginsberg, 
and I.D. Campbell. 2007. Structural basis of integrin activation by talin. Cell. 
128:171-182. 
Whiles, J.A., R. Deems, R.R. Vold, and E.A. Dennis. 2002. Bicelles in structure-function 
studies of membrane-associated proteins. Bioorg Chem. 30:431-442. 
Reference 
92 
 
Wickstrom, S.A., and J. Keski-Oja. 2005. [Degradation products of endothelial 
basement membranes: their role as tumor suppressor]. Duodecim; 
laaketieteellinen aikakauskirja. 121:1829-1837. 
Widmaier, M., E. Rognoni, K. Radovanac, S.B. Azimifar, and R. Fassler. 2012. Integrin-
linked kinase at a glance. J Cell Sci. 125:1839-1843. 
Winograd-Katz, S.E., R. Fassler, B. Geiger, and K.R. Legate. 2014. The integrin 
adhesome: from genes and proteins to human disease. Nat Rev Mol Cell Biol. 
15:273-288. 
Woods, A.J., D.P. White, P.T. Caswell, and J.C. Norman. 2004. PKD1/PKCmu 
promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. 
Embo J. 23:2531-2543. 
Wu, H., K. Su, X. Guan, M.E. Sublette, and R.E. Stark. 2010. Assessing the size, 
stability, and utility of isotropically tumbling bicelle systems for structural biology. 
Biochim Biophys Acta. 1798:482-488. 
Xia, W., and T.A. Springer. 2014. Metal ion and ligand binding of integrin alpha5beta1. 
Proc Natl Acad Sci U S A. 111:17863-17868. 
Xie, C., J. Zhu, X. Chen, L. Mi, N. Nishida, and T.A. Springer. 2010. Structure of an 
integrin with an alphaI domain, complement receptor type 4. Embo J. 29:666-
679. 
Xiong, J.P., T. Stehle, B. Diefenbach, R. Zhang, R. Dunker, D.L. Scott, A. Joachimiak, 
S.L. Goodman, and M.A. Arnaout. 2001. Crystal structure of the extracellular 
segment of integrin alpha Vbeta3. Science. 294:339-345. 
Xiong, J.P., T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S.L. Goodman, and M.A. 
Arnaout. 2002. Crystal structure of the extracellular segment of integrin alpha 
Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 296:151-155. 
Xu, W., J.L. Coll, and E.D. Adamson. 1998. Rescue of the mutant phenotype by 
reexpression of full-length vinculin in null F9 cells; effects on cell locomotion by 
domain deleted vinculin. J Cell Sci. 111 ( Pt 11):1535-1544. 
Xu, Y., T.A. Bismar, J. Su, B. Xu, G. Kristiansen, Z. Varga, L. Teng, D.E. Ingber, A. 
Mammoto, R. Kumar, and M.A. Alaoui-Jamali. 2010. Filamin A regulates focal 
adhesion disassembly and suppresses breast cancer cell migration and invasion. 
J Exp Med. 207:2421-2437. 
Xu, Z., J. Gao, J. Hong, and Y.Q. Ma. 2013. Integrity of kindlin-2 FERM subdomains is 
required for supporting integrin activation. Biochemical and biophysical research 
communications. 434:382-387. 
Yang, J., Y.Q. Ma, R.C. Page, S. Misra, E.F. Plow, and J. Qin. 2009. Structure of an 
integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides 
insight into integrin activation. Proc Natl Acad Sci U S A. 106:17729-17734. 
Yang, J., L. Zhu, H. Zhang, J. Hirbawi, K. Fukuda, P. Dwivedi, J. Liu, T. Byzova, E.F. 
Plow, J. Wu, and J. Qin. 2014. Conformational activation of talin by RIAM triggers 
integrin-mediated cell adhesion. Nat Commun. 5:5880. 
Yang, J.T., H. Rayburn, and R.O. Hynes. 1993. Embryonic mesodermal defects in alpha 
5 integrin-deficient mice. Development. 119:1093-1105. 
Yang, J.T., H. Rayburn, and R.O. Hynes. 1995. Cell adhesion events mediated by alpha 
4 integrins are essential in placental and cardiac development. Development. 
121:549-560. 
Reference 
93 
 
Yates, L.A., C.N. Lumb, N.N. Brahme, R. Zalyte, L.E. Bird, L. De Colibus, R.J. Owens, 
D.A. Calderwood, M.S. Sansom, and R.J. Gilbert. 2012. Structural and functional 
characterization of the kindlin-1 pleckstrin homology domain. J Biol Chem. 
287:43246-43261. 
Ye, F., G. Hu, D. Taylor, B. Ratnikov, A.A. Bobkov, M.A. McLean, S.G. Sligar, K.A. 
Taylor, and M.H. Ginsberg. 2010. Recreation of the terminal events in 
physiological integrin activation. J Cell Biol. 188:157-173. 
Ye, F., J. Liu, H. Winkler, and K.A. Taylor. 2008. Integrin alpha IIb beta 3 in a 
membrane environment remains the same height after Mn2+ activation when 
observed by cryoelectron tomography. J Mol Biol. 378:976-986. 
Ye, F., B.G. Petrich, P. Anekal, C.T. Lefort, A. Kasirer-Friede, S.J. Shattil, R. Ruppert, 
M. Moser, R. Fassler, and M.H. Ginsberg. 2013. The mechanism of kindlin-
mediated activation of integrin alphaIIbbeta3. Curr Biol. 23:2288-2295. 
Zaidel-Bar, R., C. Ballestrem, Z. Kam, and B. Geiger. 2003. Early molecular events in 
the assembly of matrix adhesions at the leading edge of migrating cells. J Cell 
Sci. 116:4605-4613. 
Zhang, X., G. Jiang, Y. Cai, S.J. Monkley, D.R. Critchley, and M.P. Sheetz. 2008. Talin 
depletion reveals independence of initial cell spreading from integrin activation 
and traction. Nat Cell Biol. 10:1062-1068. 
Zhu, J., B.H. Luo, P. Barth, J. Schonbrun, D. Baker, and T.A. Springer. 2009. The 
structure of a receptor with two associating transmembrane domains on the cell 
surface: integrin alphaIIbbeta3. Mol Cell. 34:234-249. 
Zhu, J., B.H. Luo, T. Xiao, C. Zhang, N. Nishida, and T.A. Springer. 2008. Structure of a 
complete integrin ectodomain in a physiologic resting state and activation and 
deactivation by applied forces. Mol Cell. 32:849-861. 
Zhu, J., J. Zhu, and T.A. Springer. 2013. Complete integrin headpiece opening in eight 
steps. J Cell Biol. 201:1053-1068. 
Zimmerman, G.A. 2009. LAD syndromes: FERMT3 kindles the signal. Blood. 113:4485-
4486. 
 
 
 
 
 
 
 
Acknowledgement 
 
94 
 
Acknowledgement 
During the years of my PhD study, I have benefited from the knowledge, support, help 
and advices of so many excellent people around me in Max-Planck-Institute of 
Biochemistry. This thesis would not be possible without help and support by all of you. I 
would like to express my sincere gratitude here:  
First of all, I am greatly thankful to my supervisor Prof. Reinhard Fässler for giving me 
the great opportunity to study the extremely interesting subject in his laboratory. I would 
like to thank him for all the encouragement and the continuous support throughout the 
entire period of my study. Importantly, he created such an amazing scientific 
atmosphere in the lab with many gifted scientists, which inspired us for the excellent 
research. 
Second, I want to thank Prof. Christian Wahl-Schott, who agreed to be the second 
referee of my thesis as well as Prof. Markus Sperandio, Prof. Martin Biel, Prof. Stefan 
Zahler, and Prof. Karl-Peter Hopfner for their willingness and time to evaluate my work. I 
am also grateful to Dr. Thomas Wollert and Prof. Christian Wahl-Schott to be my thesis 
committee member to discuss and give suggestions to my project all the time. 
Third, I am specially, truly thankful to Dr. Ralph Böttcher for his invaluable supervision, 
endless support and patiently discussing about everything throughout my entire doctoral 
work. I really learned a lot from him in all respects. I especially have to thank Prof. Roy 
Zent to always bring up so many good ideas and suggestions in the bicelles project and 
the excellent collaboration in TRAF6 paper to make it come true. Moreover, to Prof. 
Ambra Pozzi for nice discussions and suggestions all the time. 
Fourth, I have to thank the people in our ‘Böttcher group’: Dr. Ralph Böttcher, Dr. Tilman 
Ziegler, Dr. Valeria Samaralli, and Hildegard Reiter (Mischa) for not only all the support 
in all difficult moments in the lab but also great time we have in and out of the lab.  
Furthermore, I would also like to thank for my all my former labmates in department of 
Molecular Medicine, Anika, Korana, Esra, Johannes, Eloi, Sara, Ondrej, Rosi, Moritz, 
Emanuel, Alex (Meves), Johannes, Kyle, Josie, and so many more people. You really 
help a lot and cheer me up in the lab all the time. Of course, I have to thank to all the 
Acknowledgement 
 
95 
 
current labmates. Especially Raphael for the great help for FACS and great time, Sarah 
and Prof. Karim Dib for the help of the cells, Madis and Maili for the nice discussion and 
suggestions, Verawan, Marina,  Despina, Manndoph, Maik, Patricia, Maria, Gerogina, 
Zhiqi, Anita, Julien, Franzi, Julia, Markus and Armin for all the great time. Besides, 
certainly I have to thank Prof. Marc Schmidt-Supprian and his people who are current in 
TUM, especially Klaus, Yuanyuan, and Valeria S. for the great help in FACS and 
discussion. 
I would also like to thank to Dr. Nagarjuna Nagaraj and Dr. Cyril Boulègue from core 
facility for the help of Mass spectrometry and data analysis. Dr. Stephan Uebel for the 
help of the Dynamic Light Scattering experiment. Elisabeth Weyher-Stingl (Lissy) for the 
great help in LC-MS of my lipid samples.   
I also want to thank Dr. Walter Göhring and Klaus Weber for constant technical and 
administrative support, Ursula Kuhn for help in experiments in the lab. Carmen Schmitz, 
Ines Lach-Kusevic, and Lidia Wimmer for help with administrative work and also the life 
in Germany.      
Last, I want to thank my family for their continuous support although they more than 
9000km away, on the other side of the earth, they are always the strength for me to 
stand in all these years. 
 
 
 
 
 
 
 
 
Curriculum Vitae 
 
96 
 
Curriculum Vitae 
Personal Data 
Full name: Hui-yuan Tseng 
Born: in Tainan, Taiwan, on August 6th, 1983 
Nationality: Taiwan 
Email: huiyuan@biochem.mpg.de 
Education: 
 Max Planck Institute of Biochemistry, Department of Molecular Medicine 
PhD (5/2009-present) 
 National Taiwan University, Department of Plant Pathology and 
Microbiology, Taiwan  
Master degree of science (9/2005 – 6/2007)  
Cell Biology Laboratory (Mentor: Dr. Tang-Long Shen) 
“The interaction between focal adhesion kinase (FAK) and integrin β4 in 
carcinoma cells.” 
 National Taiwan University, Taiwan 
Bachelor degree of science (9/2001 – 6/2005) 
 National Tainan First Senior High School (9/1998-6/2001) 
 
Publications:  
1. Hui-yuan Tseng, Ralph T. Böttcher, Charles R. Sanders, Roy Zent, and Reinhard 
Fässler. A proteomic approach reveals conformation specific cytoplasmic integrin 
interactors. (Manuscript in progress) 
2. Ralph Thomas Böttcher, Christopher Stremmel, Alexander Meves, Hannelore Meyer, 
Moritz Widmaier, Hui-Yuan Tseng and Reinhard Fässler. Sorting nexin 17 prevents 
lysosomal degradation of β1integrins by binding to the β 1-integrin tail. Nat Cell Biol. 
2012 14(6):584-92 
Curriculum Vitae 
 
97 
 
3. Hui-Yuan Tseng, Niko Thorausch, Tilman Ziegler, Alexander Meves, Reinhard 
Fässler, and Ralph T. Böttcher. Sorting nexin 31 binds multiple β integrin cytoplasmic 
domains and regulates β1 integrin surface levels and stability. J Mol Biol. 2014 Sep 
9;426(18):3180-94 
4. Eugenia M. Yazlovitskaya , Hui-yuan Tseng, Olga Viquez, Tianxiang Tu, Glenda 
Mernaugh, Karen Riggins, Vito Quaranta, Peter Yurchenco, Arnoud Sonnenberg, 
Ralph T. Böttcher,  Ambra Pozzi, Roy Zent. Integrin α3β1 regulates kidney collecting 
duct development via TRAF6-dependent K63-linked polyubiquitination of Akt. Mol. 
Biol. Cell May 15, 2015 vol. 26 no. 10 1857-1874 
5. Zhiqi Sun, Hui-Yuan Tseng, Sally J. Deeb, Dirk Dedden, Maik Veelders, Naoko 
Mizuno, Matthias Mann, Reinhard Fässler. Kank family proteins comprise a novel 
type of talin activator. (Manuscript in progress) 
Appendix 
 
98 
 
Appendix 
In the following, papers I to V are reprinted. 
I. Hui-yuan Tseng, Ralph T. Böttcher, Charles R. Sanders, Roy Zent, and 
Reinhard Fässler. A proteomic approach reveals conformation specific 
cytoplasmic integrin interactors. (Manuscript in progress) 
II. Ralph Thomas Böttcher, Christopher Stremmel, Alexander Meves, Hannelore 
Meyer, Moritz Widmaier, Hui-Yuan Tseng and Reinhard Fässler. Sorting nexin 
17 prevents lysosomal degradation of β1integrins by binding to the β 1-
integrin tail. Nat Cell Biol. 2012 14(6):584-92 
III. Hui-Yuan Tseng, Niko Thorausch, Tilman Ziegler, Alexander Meves, Reinhard 
Fässler, and Ralph T. Böttcher. Sorting nexin 31 binds multiple β integrin 
cytoplasmic domains and regulates β1 integrin surface levels and stability. 
J Mol Biol. 2014 Sep 9;426(18):3180-94 
IV. Zhiqi Sun, Hui-Yuan Tseng, Sally J. Deeb, Dirk Dedden, Maik Veelders, Naoko 
Mizuno, Matthias Mann, Reinhard Fässler. Kank family proteins comprise a 
novel type of talin activator. (Manuscript in progress) 
V. Eugenia M. Yazlovitskaya , Hui-yuan Tseng, Olga Viquez, Tianxiang Tu, 
Glenda Mernaugh, Karen Riggins, Vito Quaranta, Peter Yurchenco, Arnoud 
Sonnenberg, Ralph T. Böttcher,  Ambra Pozzi, Roy Zent. Integrin α3β1 
regulates kidney collecting duct development via TRAF6-dependent K63-
linked polyubiquitination of Akt. Mol. Biol. Cell May 15, 2015 vol. 26 no. 10 
1857-1874 
 
A proteomic approach reveals conformation specific 
cytoplasmic integrin interactors 
 
Hui-yuan Tseng1, Ralph T. Böttcher1, Anna V. Samarelli1, Tilman Ziegler1, Nagarjuna 
Nagaraj1, Charles R. Sanders2, Roy Zent3, and Reinhard Fässler1 
 
1Department of Molecular Medicine, Max Planck Institute for Biochemistry, 82152 Martinsried, 
Germany 
2 Department of Biochemistry, Center for Structural Biology, and Institute of Chemical Biology, 
Vanderbilt University School of Medicine, Nashville, Tennessee USA 
3[1] Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University, 
Nashville, Tennessee, USA [2] Department of Medicine, Veterans Affairs Hospitals, Nashville, 
Tennessee, USA 
 
  
Abstract 
Integrins rely on the interaction with cytosolic proteins to induce a conformational shift, which 
is required for their activation, to initiate intracellular signaling, to establish a connection to the 
actin cytoskeleton and for their trafficking through the endosomal system. They exist in at least 
two distinct conformations: a high affinity (‘active’) and a low affinity (‘inactive’) state for 
ligands. In their inactive state the transmembrane and cytoplasmic (TMcyto) domains of the 
two integrin subunits are associated while they become separated upon activation. In this study 
we developed a screening approach for the isolation and identification of cytoplasmic integrin 
interactors, which combines the expression of conformation-specific integrin TMcyto domains, 
their incorporation into bicelles as membrane mimicking system, pull-downs and high 
resolution mass spectrometry. We compared binding proteins of distinct integrin α or β subunits 
and identified proteins that interacted specifically with associated α/β TMcyto, including L-
plastin (LCP1). Knockdown of LCP1 in macrophages increased αMβ2 integrin surface level 
and led to increased adhesion on fibrinogen and ICAM under non-stimulatory conditions. Our 
proteomics data offers a global view on cytoplasmic proteins interacting with different integrin 
classes and provides evidence for the existence and functional relevance of conformation-
specific integrin interactors.    
 
 
 
 
 
 
 
 
 
Introduction 
Integrins are α/β heterodimeric cell surface receptors that function throughout development and 
adult life to establish cell-cell and cell-extracellular matrix (ECM) interactions and thereby 
control migration, proliferation, differentiation and survival. α and β integrin subunits are 
composed of a large extracellular domain, a single transmembrane segment (approx. 25 amino 
acids) and a short cytoplasmic tail (10-70 amino acids). The consequence of integrin-ligand 
binding is the assembly of a large protein complex at the short cytoplasmic tails of integrins, 
which themselves lack enzymatic and actin-binding activity, to initiate signal transduction and 
to establish a connection to the actin cytoskeleton (Hynes, 2002; Wegener and Campbell, 
2008). 
Like other cell surface receptors integrins signal in response to ligand binding (outside-in 
signaling), however they can also regulate their affinity for ligand (also called integrin 
activation or inside-out signaling). The allosteric affinity switch is characterized by converting 
the unbound form of integrins from the inactive (low affinity) via an intermediate ligand 
binding affinity (or primed state) to the ligand-bound (high affinity) state. In their inactive state, 
the transmembrane and cytoplasmic domains of the two integrin subunits are associated and 
the extracellular domain is bent. Upon binding of the two adaptor proteins, Talin and Kindlin, 
to the β integrin cytoplasmic domain, the proximal leg domains, transmembrane domains and 
cytoplasmic tails of the α and β subunits become unclasped, leading to a “swing-out” of the 
hybrid domain and full opening of the ligand binding pocket (Campbell and Humphries, 2011; 
Kim et al., 2011; Shattil et al., 2010). The association of integrin α-β TMcyto subunits in the 
inactive conformation is stabilized by interaction between GxxxG dimerization motifs in the 
outer half of the plasma membrane and by hydrophobic and electrostatic bridges together with 
a salt bridge in the inner half of the plasma membrane (Lau et al., 2009; Yang et al., 2009). 
Recently, there is growing evidence that integrin inactivation might not be the default state but 
is actively regulated by the binding of intracellular integrin inactivators, such as Sharpin or 
Filamin (Bouvard et al., 2013). Integrin inactivators may deactivate integrins or lock integrins 
in an inactive state thereby establishing a regulatory mechanism to efficiently prevent 
unwanted integrin activation which is particularly important for cells of hematopoietic origin 
(Schmidt et al., 2013). Furthermore, interactors of inactive integrins would also allow cells to 
distinguish between active and inactive integrins in other processes including integrin 
biosynthesis and intracellular integrin trafficking, which affect the integrin surface levels and 
modulate signaling pathways (Bouvard et al., 2013; De Franceschi et al., 2015). 
Plastins are a family of three actin-bundling proteins with distinct expression patterns: T-plastin 
(plastin 3) is broadly expressed, including all cells with replicative potential (Lin et al., 1993), 
I-plastin (plastin 1) is restricted to intestine and kidney, while L-plastin (plasin 2, LCP1) 
expression occurs in leukocytes and in many types of malignant human cells of non-
hematopoietic origin (Lin et al., 1988). Plastins consist of two aminoterminal EF-hands, 
implicated in Ca2+-binding, and two tandem actin-binding domains each divided into two 
calponin homology (CH) domains. Although plastins are primarily involved in regulation of 
the actin cytoskeleton, they possess additional properties and are involved in several cellular 
functions such as cell migration, neutrophil function, DNA repair, and endocytosis (Delanote 
et al., 2005). LCP1 has been linked to integrins, yet the precise mechanism how LCP1 binds 
integrins and regulates integrin function is unclear. LCP1 has been shown to interact with β 
integrin subunits (Le Goff et al., 2010) and to activate αMβ2 integrin in polymorphonuclear 
neutrophils (PMNs) (Jones et al., 1998) and αVβ3 integrins in K562 cells (Wang et al., 2001). 
In contrast, LCP1-/- neutrophils exhibit no integrin activation defect but fail to mount an 
efficient integrin adhesion-dependent respiratory burst (Chen et al., 2003).  
Since integrin activity, signaling, and trafficking rely on the interaction of proteins with their 
cytoplasmic tails (Legate and Fassler, 2009) we aimed to identify cytoplasmic integrin 
interactors by quantitative proteomics. For this, we established a screening assay which 
combined the generation of conformation-specific integrin tail constructs incorporated into 
bicelles, pull-downs and high resolution mass spectrometry to isolate and identify novel α and 
β intgrin tail interacting proteins. We identified LCP1 as interactor of associated integrin 
TMcyto, and further analyzed its role in the regulation of integrin functions.  
 
 
 
 
 
Results 
Bicelle-incorporation of recombinant integrin bait proteins for pull-down experiments 
Due to the short cytoplasmic domains of integrin α and β subunits direct integrin interactors 
such as Talin, Kindlins and ILK are in close vicinity to plasma membrane and frequently 
require the plasma membrane interaction to fulfill their function (Anthis et al., 2009; Goult et 
al., 2010; Goult et al., 2009; Liu et al., 2011; Perera et al., 2011; Widmaier et al., 2012). 
Previous studies employed two-hybrid or pull-down experiments with either single α or β 
integrin cytoplasmic domains to identify specific interacting partners (Legate and Fassler, 
2009; Morse et al., 2014; Raab et al., 2010). However, these approaches fail to detect binding 
partners that require interaction with the plasma membrane for integrin binding. We therefore 
reasoned that the incorporation of recombinant integrin TMcyto into a membrane-mimicking 
system may strengthen the interaction of binding partners with the integrin tails and support 
the integrin TMcyto structure. We used bicelles as mimetic membrane model as they form 
discoidal nanostructures that have been successfully used to study the structure of different 
integrins by NMR (Lau et al., 2008a; Lau et al., 2009; Lau et al., 2008b; Lu et al., 2012; Surya 
et al., 2013). The bicelles were composed of the long-chain phospholipid 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC) and 6-cyclohexyl-1-hexylphosphocholine (Cyclofos-6) as 
short-chain phospholipid that compose flanking rims (Figure 1A). As biological membranes 
contain negatively charged lipids (Leventis and Grinstein, 2010) we replaced 10% of DMPC 
with phosphatidylserine (POPS) to provide a negative charge (Figure 1A) and confirmed the 
correct ratio of the individual phospholipids by LC-MS (Supplemental Figure 1). By changing 
the ratio of DMPC and Cyclofos-6, referred to as q-value, we obtained bicelles with 
hydrodynamic radii ranging from 3.16±0.08 nm (q=0.25) to 19.95±0.64 nm (q=4), which was 
in line with a previous study (Lu et al., 2012; van Dam et al., 2004) (Figure 1B). 
In a next step, we determined the incorporation of integrin TMcyto domains into bicelles by 
Dynamic Light Scattering (DLS) measurements. α5 and β1 integrin TMcyto domains were 
successfully incorporated into bicelles with a 0.25 q-value however their direct integration into 
bigger bicelles (q>2; > ~9 nm radius) failed (data not shown). As in silico modeling Kindlin 
Talin recommends a bicelles radius of >8 nm to support membrane interactions of Kindlin and 
Talin in a complex with β3 integrin (data not shown) we tested the possibility of increasing the 
radius of small bicelles by incubation with bigger bicelles. Indeed, incubation of q=0.25 
bicelles with 5.2 times volume of q=4 bicelles resulted in a homogenous solution of bicelles 
with a hydrodynamic radius of 8.88±0.51 nm (q=2*) (Figure 1B and Supplemental Figure 2B). 
Using this approach we incorporated α5 or β1 integrins TMcyto into q=0.25 bicelles and added 
5.2 times volume q=4 bicelles resulting in q=2* bicelles containing our protein of interest with 
a hydrodynamic radius of ~10 nm (Supplemental Figure 2A, B). 
To investigate if the presence of a negatively charged membrane increases the affinity of 
proteins to integrin cytoplasmic tails, we analyzed the pull-down efficiency of Talin and 
Kindlin-2, which require plasma membrane interactions for optimal integrin binding (Anthis 
et al., 2009; Goult et al., 2010; Goult et al., 2009; Liu et al., 2011; Moore et al., 2012; Perera 
et al., 2011). For this, we used his-tagged TMcyto domains of α5 and β1 integrin either 
incorporated into bicelles or left without bicelles to pull-down Talin and Kindlin-2 from whole 
cell lysate. As expected no interaction of the two proteins was detected to α5 integrin TMcyto 
or empty beads but Western blot analysis revealed that bicelles incorporation increased the 
interaction of Talin (48%) and Kindlin-2 (38%) with the β1 integrin TMcyto domain (Figure 
1C).  This indicates that the presence of negatively charged membranes increases the affinity 
of proteins for the integrin cytoplasmic domains and thereby could promote the identification 
of novel cytosolic integrin interactors in pull-down assays.  
Proteomic analysis of cytoplasmic α and β integrin interactors using bicelle-incorporated 
TMcyto domains 
To identify interacting partners of α and β subunits of different integrin heterodimers and to 
determine compositional differences between binding proteins associated with different 
integrins, we determined and compared the interactome of α5, αM and αIIb as well as β1, β2 
and β3 integrin cytoplasmic domains using our bicelles pull-down approach (Figure 2). Integrin 
α and β TMcyto constructs were expressed in and purified from E. coli and incorporated into 
q=0.25 bicelles. The bicelle diameter was increased by incubation with q=4 bicelles before 
incubation of the integrin TMcyto incorporated bicelles with cell lysates derived from mouse 
bone marrow derived macrophages (BMDM). To avoid incorporation of transmembrane 
proteins into bicelles, the BMDM were lysed by hypotonic shock and only the soluble fraction 
was incubated with the bait proteins. After pull-down, the interacting proteins were resolved 
by SDS-PAGE and identified by LC-MS/MS. 
Proteomic analysis identified about 1000 proteins (Table 1). Label-free quantification 
demonstrated good reproducibility and consistency between data from replicates 
(Supplemental Figure 3). 5, 56 and 161 proteins significantly bound to α5, αM, and αIIb 
cytoplasmic tails, respectively (Figure 3A, B, C and Table 2). This number is in line with a 
previous proteomic study comparing interacting proteins of α5 integrin and αIIb integrin in 
peptide pull-down experiments (Raab et al., 2010). Compared to α integrin subunits, 74, 60 
and 111 proteins were identified in β1, β2 and β3 pull-downs, respectively (Figure 3A, B, C 
and Table 2). Interestingly, no common interactors were identified for all three integrin α 
cytoplasmic tails while all tested β subunit had 16 common interactors, including Talin and 
Filamin-A (Figure 3D and Table 2). This is in line with the presence of conserved motives 
within the β integrin cytoplasmic domains while the α integrin tails are highly divergent (Figure 
3E). In summary, these data demonstrate that we have successfully established a bicelle-
incorporated integrin TMcyto screening method to identify cytoplasmic integrin interactors. 
Identification of conformation-specific αMβ2 integrin interactors  
Various proteins bind to α or β cytoplasmic tails to regulate integrin-mediated functions 
(Legate and Fassler, 2009). Yet, only recently Filamin A was shown to simultaneously bind α 
and β cytoplasmic tails of inactive associated αIIbβ3 integrin to maintain its inactive state (Liu 
et al., 2015). Besides their role in integrin inactivation, proteins that specifically interact with 
inactive integrin might also allow cells to distinguish between active and inactive integrins in 
other processes such as integrin biosynthesis and intracellular integrin trafficking (De 
Franceschi et al., 2015). A shortcoming of earlier screening approaches is the use of single α 
or β integrin cytoplasmic domains which fail to detect interactors that require both integrin tails 
for binding. We hypothesized that cytoplasmic integrin interactors exist that bind 
predominantly or exclusively to associated α-β cytoplasmic domains of integrins and therefore 
we modified our pull-down to identify conformation-specific integrin interactors. To this end 
we developed a strategy to mimic the heterodimeric integrin cytoplasmic tail conformation in 
its inactive, associated state based on the Jun-Fos dimerization domains as a ‘velcro‘ to mediate 
heterodimer formation, which have been used to recombinantly express heterodimeric integrin 
ectodomains (Eble et al., 1998; Raynal et al., 2006) and related coiled coil domains were used 
to dimerize the cytoplasmic domains of αIIbβ3 integrin (Pfaff et al., 1998; Ulmer et al., 2001). 
We chose αMβ2 because previous fluorescence resonance energy transfer (FRET) study has 
shown that the spatial separation of the αM and β2 subunit cytoplasmic tails activates integrin 
and transmits signal across plasma membrane (Kim et al., 2003; Lefort et al., 2009). We 
expressed recombinant proteins consisting an N-terminal tag sequence (His or Flag for 
purification and pull-down) followed by a Cys-Gly linker, the Jun-Fos dimerization domains, 
a glycine linker and the αM or β2 integrin TMcyto domains (Figure 4A, B). The cystine bridge 
ensures stability, a parallel orientation and a correct stagger of the coiled coil sequences within 
the dimer, while the glycine linker provides flexibility of the integrin tails. These proteins could 
be expressed and purified from bacteria (Figure 4B, lanes 2-4) and when incubated together 
His-Fos-αM and Flag-Jun-β2 formed heterodimers in a one-to-one ratio (Figure 4B, lane 1). 
Similar to single α and β integrin subunits the incorporation of αMβ2 TMcyto heterodimers 
into bicelles was measured by DLS. The bicelles size increased from 8.88 nm to 10.05 nm and 
10.25 nm after αM or β2 incorporation, while αMβ2 integrin TMcyto incorporation further 
increased the hydrodynamic radius to 11.17 nm confirming the successful incorporation of the 
αMβ2 TMcyto heterodimers into bicelles (Figure 4C and Supplementary Figure 2B). 
We used the αMβ2 TMcyto domains incorporated into bicelles to pull-down proteins from 
BMDM lysates as before, identified interacting proteins by LC-MS/MS and compared them to 
the interactome of single αM and β2 TMcyto domains. Isolated proteins were quantified using 
the label-free quantification algorithm of the MaxQuant software. 1561 proteins were identified 
and t-test between β2 and αMβ2 interactors revealed 293 proteins that increase binding to 
associated αMβ2 integrins (Figure 5A, 5B and Table 3), among them Filamin A as reported 
previously (Liu et al., 2015). In contrast, 183 proteins only interacted with associated αMβ2 
integrin tails and 62 proteins that interact with single αM or β2 integrin tails were lost after 
heterodimerization of the αMβ2 cytoplasmic domains (Table 4). Together these results indicate 
that proteins exists that interact predominantly or exclusively with different conformations of 
αMβ2 integrin. 
L-plastin (LCP1) controls αMβ2 integrin surface levels by binding to inactive αMβ2 
integrin   
We observed a highly specific interaction of the hematopoietic-specific α-actinin family 
member L-plastin (LCP1) with inactive, associated αMβ2 integrin cytoplasmic domains. LCP1 
is an actin-bundling that has been implicated in the formation or maintenance of integrin-
associated adhesion structures (Jones et al., 1998; Morley, 2012; Wang et al., 2001). As LCP1 
has been shown to interact to the cytoplasmic domain of β1 and β2 integrins (Le Goff et al., 
2010) we first validated the stronger interaction with associated αMβ2 integrin tails than single 
β2 integrin tails in pull-down experiments. As expected from the proteomics data LCP1 was 
predominantly pulled-down with the Fos-Jun-induced αMβ2 heterodimer in compare with 
single β2 integrin tail while Talin interacted most efficiently with the single β2 integrin tail 
(Figure 5C). To demonstrate the interactions of the endogenous proteins, we performed co-
immunoprecipitation experiments of β2 integrin and LCP1 after protein crosslinking (Figure 
5D). Importantly, LCP1 was strongly co-immunoprecipitated with β2 integrin in cell lysate 
from EDTA-treated cells (resting) macrophages while PMA-induced αMβ2 integrin activation 
reduced LCP1 interaction with αMβ2 integrin (Figure 5D) confirming our mass spectrometry 
data. 
To assess the role of LCP1 for αMβ2 integrin function we depleted LCP1 by short hairpin 
RNAs (shRNA) retroviral expression in the macrophage cell line Raw 264.7 (Figure 5E) and 
the differentiated-neutrophils cell line PLB985 (Supplemental Figure 4A). The two 
independent shRNAs reduced the LCP1 protein levels to ~30% and ~15% in Raw 264.7 and 
PLB985 cells, respectively (Figure 5E, Supplemental Figure 4A). LCP1 depletion increased 
surface levels of αMβ2 integrin in both Raw264.7 cells (Figure 5F) and differentiated-PLB985 
cells (Supplemental Figure 4B) without significantly changing the levels of active αMβ2 in 
differentiated-PLB985 cells (Supplemental Figure 4C). Cell surface biotinylation labeling 
followed by streptavidin pull-down confirmed the upregulation of β2 integrin on the plasma 
membrane of LCP1 knockdown Raw264.7 cells while unrelated transmembrane proteins such 
as transferrin receptor were unaffected (Figure 5G). Importantly, re-expression of shRNA-
resistant wild type LCP1 restored αMβ2 integrin surface levels in LCP1-depleted cells (Figure 
5H, I). Thus, the level of LCP1 determines the amount of αMβ2 integrin presented on the cell 
surface.  
To determine whether LCP1 influences integrin-mediated functions we analyzed cell adhesion 
of LCP1-depleted Raw264.7 cells to fibrinogen or ICAM. Without prior stimulation, LCP1 
depletion leads to stronger adhesion to fibrinogen or ICAM (Figure 6 A, B) suggesting that 
LCP1 might function to prevent unwanted integrin activation. This difference in adhesion was 
lost on fibrinogen upon PMA-stimulated integrin activation (Figure 6 A, B). In summary, LCP1 
modulates several αMβ2 integrin-mediated functions in leukocytes in part by changing the 
surface level of αMβ2 integrin.  
Discussion 
Integrins heavily rely on the recruitment of proteins to their cytoplasmic tails for integrin 
activation and inactivation, to establish a connection to the actin cytoskeleton, to initiate 
intracellular signaling and to regulate their intracellular trafficking (Legate and Fassler, 2009; 
Margadant et al., 2011). Here, we identified and characterized cytosolic proteins that interact 
with active integrins as well as inactive, associated integrins using a combination of pull-downs 
and high resolution mass spectrometry. We determined the interactome of distinct α and β 
integrin subunits and could show that several integrin interactors have a preference to bind 
either to the active or inactive integrin conformation. 
Integrin contain only short cytoplasmic domains and recruit their intracellular interactors in 
close proximity or even in directly contact with plasma membrane. Many intracellular integrin 
interactors, including Talin, Kindlin and ILK, contain membrane binding sites which are 
important for their ability to bind integrin tails with high affinity (Anthis et al., 2009; Goult et 
al., 2010; Goult et al., 2009; Liu et al., 2011; Perera et al., 2011; Widmaier et al., 2012). To 
stabilize such interactions we recombinantly expressed the transmembrane and cytoplasmic 
domains of several α and β integrin subunits and incorporated them into bicelles as membrane 
mimicking system. Three artificial membrane systems have been used to study integrin 
structure which are detergent micelles (Li et al., 2001), nanodiscs (Ye et al., 2010), and bicelles 
(Lau et al., 2008a; Lau et al., 2009; Lau et al., 2008b; Lu et al., 2012). Detergent micelles 
became less popular mainly due to the differences of lateral forces and curvature compared to 
native planar plasma membrane that can affect the protein conformation and even lead to 
protein unfolding (Lu et al., 2012). In contrast, bicelles and nanodiscs form membranes with 
planar lipid bilayer features and were successfully used to study integrin structure (Lau et al., 
2008a; Lau et al., 2009; Lau et al., 2008b; Lu et al., 2012; Surya et al., 2013) and activation 
(Ye et al., 2010). Using integrin bait proteins incorporated into bicelles, we identified 5, 56 and 
161 proteins that were pulled-down with α5, αM, and αIIb cytoplasmic tails, respectively, and 
between 60 and 111 proteins with the different β integrin subunits. The number of potential 
interactors is slightly higher but in the range previous proteomics interaction studies with α or 
β peptides (Raab et al., 2010; Schiller et al., 2013). The increased interactor number could be 
the result of our less stringent washing conditions since the bicelles prevented us from washing 
with detergent containing solutions or the presence of a membrane to facilitate and stabilize 
potential interactions. Indeed, we could show a stronger interaction of Talin and Kindlin-2 to 
the β1 TMcyto domain after incorporation of the β1 bait protein into bicelles (Figure 1C). The 
charged membrane either presents an additional binding motif that adds to the overall affinity 
or favors optimal alignment of the two interactors for high affinity binding as this has been 
shown between talin FERM domain and β3 cytoplasmic tail in the present of Negatively 
charged PtdIns(4,5)P2 (Moore et al., 2012). Despite the different pull-down approaches we 
observe the similar trend in the number of interactors to the individual α or β cytoplasmic 
domains such as only few proteins bind to α5 tails compared to αIIb (Raab et al., 2010) or the 
higher numbers of β3 integrin interactors compared to β1 integrins (Schiller et al., 2013). A 
large number of potential interactors differ between our analysis and previously published 
proteomics studies which in part reflects differences in the approaches (bicelle-incorporated 
recombinant proteins vs peptides; different washing conditions) and also the use of different 
cell lysates (platelet and BMDM).   
The cell has to distinguish between the inactive integrin conformation with associated α or β 
transmembrane and cytoplasmic domains and the active conformation characterized by the 
separation of the α or β TMcyto domains during integrin activation but also for the 
conformation-specific trafficking of integrins through the endosomal system. Growing 
evidence suggests that the inactive integrin conformation is not a default state but is 
dynamically regulated by the binding of intracellular proteins, referred to as integrin 
inactivators (Bouvard et al., 2013). Intracellular integrin inactivators could inactivate integrins 
or retain integrins in an inactive state thereby establishing a regulatory mechanism to efficiently 
prevent unwanted integrin activation. This tight regulation is particularly important for β2 
integrins and αIIbβ3 expressed on cells of hematopoietic system to prevent blood clotting or 
unwanted attachment of leukocytes to the vessel wall with dramatic consequences for the 
immune functions (Schmidt et al., 2013). Active and inactive integrins are also internalized 
and trafficked in different pathways (reviewed in (De Franceschi et al., 2015)). Studies using 
conformation-specific antibodies show that both active and inactive β1 integrins can be 
internalized to early endosomes and inactive α5β1 integrins predominantly recycle rapidly via 
the Rab4-dependent loop (Arjonen et al., 2012). In contrast, the ligand bound (active) α5β1 
integrins are ubiquitinylated and sorted to lysosomes in the absence of CLIC3 (Dozynkiewicz 
et al., 2012; Lobert and Stenmark, 2010). Although the underlying molecular mechanisms are 
still unclear it is suggested that the conformation-specific interaction of cytosolic proteins is 
crucial for the distinct trafficking events.  
To mimic the heterodimeric integrin cytoplasmic tail conformation in its inactive state we 
developed a pull-down approach based on the Jun-Fos dimerization domains, which have been 
used to recombinantly express heterodimeric integrin ectodomains (Eble et al., 1998; Raynal 
et al., 2006). A somewhat unexpected observation was the large number of proteins that were 
pulled-down with associated αMβ2 TMcyto tails compared to the single subunits. We speculate 
that due to the low stringency binding and washing conditions we pull-down low affinity 
binding proteins and complexes as well as unspecific interactors. Among the dimer-specific 
interactors are filamin and moesin, which have been shown to inactivate integrins. Filamin has 
been established as negative regulator of integrin activation by competing with Talin for 
integrin β tails binding (Das et al., 2011; Ithychanda et al., 2009; Kiema et al., 2006). A recent 
NMR structure shows that filamin forms ternary complex with both αIIb and β3 cytoplasmic 
tails rather than only with β integrin cytoplasmic domain, stabilizes the integrin inner 
membrane clasp and restrains the integrin in a resting state (Liu et al., 2015). Filamin is the 
first molecule shown to bind to both α and β tail and that also preferentially interacted with 
associated αMβ2 TMcyto tails in our screen. Mosein a member of ERM protein family (ERMs) 
is activated upon phosphorylation by MAP4K4 and displaces Talin from integrin β tails leading 
to integrin inactivation (Baumgartner et al., 2006; Vitorino et al., 2015). Our proteomics data 
suggest that moesin has binding sites for α and β tails and therefore binds associated αMβ2 
integrins. However, further structural and biochemical analyses are necessary to support this 
hypothesis.  
Our proteomic screen identified LCP1 as interactor of associated αMβ2 TMcyto tails. LCP1 is 
a member of the α-actinin family of actin crosslinking proteins, with a restricted expression 
pattern in hematopoietic cells and cancer tissue (reviewed in (Delanote et al., 2005; Morley, 
2012)). Several members of the α-actinin family of proteins, particularly α-actinin-1 and 
Filamin or the related plectin, link the actin cytoskeleton to the plasma membrane via 
interaction with integrins (Garcia-Alvarez et al., 2003; Geerts et al., 1999; Otey et al., 1990; 
Pavalko and LaRoche, 1993; Sharma et al., 1995). Previous studies have shown that LCP1 
binds to the cytoplasmic domains of β integrin via its actin binding domain (Le Goff et al., 
2010). However, a structural characterization of how LCP1 engages the complete integrin 
cytoplasmic face has not been reported. Our pull-down experiments suggest that LCP1 
predominantly binds to associated αMβ2 TMcyto tails and exhibits a low affinity for the single 
αM cytoplasmic domain which increases once αM cytoplasmic domain is in proximity to the 
β2 tail. A similar increased affinity has been observed for the ternary binding of Filamin A to 
the cytoplasmic domains of αIIb and β3 integrin (Liu et al., 2015). Site-directed mutagenesis 
combined with structural studies will provide further insight into the LCP1 binding sites within 
the αMβ2 integrin tail domains.  
We found that depletion of LCP1 increased αMβ2 integrin surface levels on macrophage and 
differentiated neutrophils cells without changing αMβ2 mRNA levels (data not shown) 
suggesting a role of LCP1 in the trafficking of inactive αMβ2 integrin. Actin dynamics is 
important for vesicle biogenesis, and for propelling vesicles and larger endosomal 
compartments through the cytoplasm to reach their destination. As a result actin-regulatory 
proteins, such as LCP1 or actinin, are frequently involved in transmembrane protein trafficking 
(Burgueno et al., 2003; Foran et al., 2006; Schulz et al., 2004). Serval studies provide evidence 
for a role of LCP1 in the recycling of transmembrane proteins including the co-localization and 
direct binding of LCP1 with Rab5, a critical GTPase for the endocytic pathway(Hagiwara et 
al., 2011). Furthermore, deletion of Sac6P, the yeast LCP homolog, leads to in morphologic 
disorganization of the actin cytoskeleton and inhibits maltose transporter endocytosis (Adams 
et al., 1995; Penalver et al., 1997; Skau et al., 2011) and LCP1 participates in E-cadeherin 
endocytosis in colon cancer cells (Foran et al., 2006). We observed small but significant 
changes of αMβ2 integrin surface level in LCP1 depletion differentiated neutrophils while the 
increase in αMβ2 surface level was more profound in macrophage cell lines indicating that the 
effect of LCP1 on integrin surface levels might be cell type or integrin heterodimer dependent. 
Indeed, in the LCP1-depleted PMNs β2 integrin surface level did not change (Chen et al., 2003) 
and β1 integrin levels were unaffected in colon cancer cells after LPC1 knockdown (Foran et 
al., 2006). 
Finally, a remaining question is whether LCP1 is involved in the regulation of integrin inside-
out activation. Previous work has implicated LCP1 in the regulation of integrin activation since 
introduction of peptides containing the N-terminal 19 amino acids LCP1 into cells leads to 
rapid integrin activation (Jones et al., 1998; Wang et al., 2001). However this is challenged 
because neutrophils derived from LCP1 knockout mice were defective in generating the 
respiratory burst but LCP1-deficient neutrophils adhered and spread without significant defects 
in integrin activation (Chen et al., 2003). A closer look at the adhesion assays in this study 
showed that LCP1-deficient neutrophils adhered slightly stronger to a polyRGD substrate in 
the absence of stimulation agents (Chen et al., 2003). Importantly, we also measured increased 
adhesion to fibrinogen and ICAM in LCP1-depleted macrophages before but not after the 
activation of integrins by PMA. While this might be due to higher surface integrin αMβ2 level 
it can also be explained by the inability of macrophages to properly inactivate αMβ2 integrin 
in the absence of LCP1. Additional work such as the overexpression of LCP1 will be necessary 
to understand the role of LCP1 in integrin activation.  
Taken together, proteomics data from our modified screening approach provide a resource for 
the global view on cytoplasmic proteins interacting with different integrin subunits and 
provides evidence for the presence of several conformation-specific integrin interactors. 
 
Material and Methods 
Antibodies 
The following antibodies were used: Talin (8d4, Sigma; 1: 1000 for WB), Kindlin-2 
(MAB2617, Millipore; 1:1000 for WB), His (2365, Cell signaling; 1:1000 for WB), PAK4 
(3242, Cell signaling; 1:1000 for WB), Flag-M2-HRP (A8592, Sigma; 1:10000 for WB), 
GAPDH (CB1001, Calbiochem; 1:2000 for WB), LCP1 (GTX 114524, Genetex; 1:1000 for 
WB), GFP (A11122, Invitrogen; 1:1000 for WB), β2 integrin (gift from Dr. Melanie 
Laschinger, IP and 1:200 for WB), activated αM integrin (301402, Biolegend; 1:100 for FACs), 
αM integrin (301302, Biolegend; 1:100 for FACs), MAC1-PE (12-0112, eBioscience; 1:200 
for FACs), MAC1-biotin (557395, PharMingen; 1:200 for FACs).  Recombinant Human 
ICAM-1/CD54 (R & D systems ADP4-200)    
The following secondary antibodies were used: streptavidin-Cy5 (016170084; Dianova 1:200 
for FACs); streptavidin-Cy5 (016160084; Dianova 1:200 for FACs); goat anti-mouse 
Alexa546 (A-11003; Life Technologies, 1:200 for FACs), goat anti–mouse Alexa488 (A-
11029; Life Technologies, 1:200 for FACs), Donkey anti-mouse-Alexa 647(A-31571, Life 
Technologies, 1:200 for FACs), goat anti–rat horseradish peroxidase (HRP) (712035150, 
Dianova; 1:10000 for WB), goat anti–mouse HRP (172-1011; 1:10000 for WB) and goat anti–
rabbit HRP (172-1019; 1:10000 for WB) (all from Biorad). 
Plasmids 
For recombinant bacterial expression, integrin-β1-TMcyto (residues from 719 to 799 of the full 
length mouse protein), integrin β2-TMCyto (residues from 698 to 771 of the full length mouse 
protein), β3-TMCyto (residues from 714 to 787 of the full length mouse protein), α5-TMCyto 
(residues from 993 to 1054 of the full length mouse protein), αIIb-TMCyto (residues from 986 
to 1033 of the full length mouse protein), αM-TMCyto (residues from 1106 to 1153 of the full 
length mouse protein), Fos dimerization domain (residues from161-200 of full length mouse 
protein), and Jun dimerization domain (residues from277-318 of full length mouse protein) 
were cloned in frame with the Fos dimerization domain (αIIb, αM, and α5 TMcyto) or Jun 
dimerization domain (β1, β2, and β3 TMcyto) and subcloned into pET15b vector (Clonetech) 
to generate His-fos-α5, TMCyto, His-Fos-αIIb TMCyto, His-Fos-αM TMCyto, His-Jun-β1 
TMCyto, His-Jun-β2 TMCyto, and His-Jun-β3 TMCyto constructs. The 6xHis tag sequence 
was replaced with a 3xflag tag within pET16b vector to generate Flag-Jun-β2.  
For generate a stable LCP1 knockdown in PLB985 cells, shRNA sequences targeting the 
human LCP1 sequences were introduced into the pSuper-Retro vector (OligoEngine) to 
produce retroviral particles: 5’-AGTAGCCTCTCCTGTATTT-3’ (shLCP-1), 5’-
AGAAGCTGCAGTGGTATTA-3’ (shLCP1-2). In Raw 264.7 cells, shRNA target sequences 
directed against the mouse LCP1 sequences were introduced into the pSuper.Retro vector to 
produce retroviral particles: 5’-GATGGCATAGTTCTTTGTA-3’ (shLCP-1), 5’-
CAAGTAGCTTCTGCTATAA-3’ (shLCP1-2). LCP1 were PCR from OCAA human library 
(imaGenes GmbH) clone OCAAo5051D1183D and clone into pJET1.2 cloning vector (Life 
technologies). LCP1 was cloned into pEGFP-N1 and rrl-cPPT-CMV-eGFP-WPRE lentiviral 
vector.  
Cell culture 
Raw 264.7 cells were cultured in DMEM supplemented with 10% (v/v) FBS and PLB985 cells 
in RPMI supplemented with 10% (v/v) FBS at 37°C and 10% CO2. Differentiation of PLB985 
cells into neutrophils-like cells has been described (Pivot-Pajot et al., 2010). Briefly, PLB985 
cell differentiation was induced by incubation in RPMI medium supplemented with 5% (v/v) 
FBS and 1.25% DMSO for five days. The medium was changed once on day three of the 
differentiation period. 
Bone marrow was isolated from C57BL/6 mice and passed through a 70-µm cell strainer (BD) 
to obtain single cell suspensions. 4x106 cells were seeded in 15 cm petri dishes (non-treated) 
and cultivated at 37°C and 5% CO2 in RPMI medium supplemented with 10% (v/v) FBS and 
10% macrophage-colony stimulating factor (M-CSF). Non-adherent cells were removed after 
24 h and cultured for additional six days. The cells were lysed in hypotonic lysis buffer (10 
mM Tris-HCl pH 7.6, 5 mM KCl, 1.5 mM MgCl2, 1 mM (dithiothreitol) DTT, protease 
inhibitor cocktail (Roche), phosphatase inhibitor cocktail 2 and 3 (Sigma)) and cleared by 
centrifugation. 
Transient and stable transfection/transduction 
Cells were transiently transfected with Lipofectamine 2000 or Lipofectamine LTX (Life 
technology) according to the manufacturer’s protocol. To generate stable cell lines, VSV-G 
(vesicular stomatitis virus G glycoprotein) pseudotyped retroviral vectors were produced by 
transient transfection of 293T (human embryonic kidney) cells. Viral particles were 
concentrated from cell culture supernatant as previously described (Pfeiffer et al, 2000) and 
used for infection.  
Adhesion assay 
For cell adhesion and migration assays, the Raw 264.7 cells were washed and resuspended in 
FBS-free growth medium. Adhesion assays were performed in 96-well plates coated for 2 
hours at room temperature with 10µg/ml fibrinogen (Sigma) or 4µg/ml ICAM (R&D systems). 
Unspecific binding was blocked by incubating the wells with 1% BSA/PBS, washed once with 
PBS, and then incubated with the cells (1x105 cells/well). After indicated time incubation at 
37°C, the wells were washed by immersion in a plastic tray containing PBS. Adhered cells 
were fixed with methanol and stained with crystal violet overnight (20% Methanol, 0.1% 
Crystal violet in H2O). After intense washings, cells were solubilized in 0.5% Triton X-100, 
and the number of cells was determined by measuring the absorbance at 595 nm using an 
ELISA reader (Schiller et al., 2013).  
Bicelles preparation 
6-cyclohexyl-1-hexylphosphocholine (Cyclofos-6) was purchased from Anatrace. 1-palmitoyl-
2-oleoyl-sn-glycero-3-phospho-L-serine (PS) was purchased from Avanti Polar Lipids 1, 2-
Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) were purchase from Genezyme 
pharmaceuticals. Bicelles stock solutions were prepared by weighing out 500 mg of DMPC in 
5 mL of cyto buffer (139 mM K2HPO4, 8.8 mM NaH2PO4, 0.4 mM MgCl2, 3.2 mM NaCl, 
pH 7.0), 200 mg of DMPC in 4 mL of cyto buffer and 75 mg of PS in 3.75 mL of cyto buffer. 
For 1 mL 3%, q=4 bicelles, 236 µl DMPC stock, 152 µl PS stock, and 68µl Cyclofos-6 stock 
plus 544 µl cyto buffer were mixed and subjected to a temperature cycle: 45°C for 2 minutes, 
5°C (or ice water) for 5 minutes.  In-between the solution was carefully mixed to avoid 
foaming. The temperature cycle was repeated 10 times until solution becomes clear. For 1 mL 
3% q=0.25 bicelles, 72 µl DMPC stock, 56 PS stock, and 400 µl Cyclofos-6 stock plus 472 µl 
of cyto buffer were mixed and incubated as described above. The stocks were snap frozen in 
liquid Nitrogen and stored at -80°C.  
 
 
 
Expression and purification and incorporation recombinant proteins into bicelles. 
Plasmids encoding His-Fos-αIIb TMCyto, His-Fos-αIIb TMCyto, His-Fos-αM TMCyto, Flag-
Jun-β2 TMCyto, His-Jun-β1 TMCyto, His-Jun-β2 TMCyto, and His-Jun-β3 TMCyto were 
transformed into BL21(DE3) Arctic Express Escherichia coli, and protein expression was 
induced with 1 mM IPTG (30°C 3 h for α tails and 18°C 24h for β tails). Afterwards, bacteria 
were pelleted by centrifugation, resuspended in TBS buffer (50 mM Tris pH 7.4, 150 mM 
NaCl) containing Lysozyme 100µg/ml and DNAse 50 µg/ml and rotated at 4°C for 2 hours. 
After the addition of Empigen (30% solution) (1 ml per 10 ml of lysate) the bacterial lysates 
were rotated at 4°C for 1 hour and centrifuged 4000 rpm 4°C for 1 hour. To purify His-tagged 
proteins supernatants were incubated with Ni-NTA magnetic agarose beads (Qiagen, 36113) 
and ANTI-FLAG M2 Affinity Gel (Sigma, A2220)hours at 4°C followed by extensive washing 
of the beads three times with TBS buffer and twice with pre-equilibration buffer (20 mM 
imidazole, 50 mM, Tris, 150 mM NaCl, pH 6.5 in 1% bicelles, q=0.25, as described (Lu et al., 
2012)). The 6xHis tagged proteins were eluted with elution buffer (250 mM imidazole, 50 mM 
Tris (pH 7.4), 150 mM NaCl in 1% bicelles). The proteins were concentrated using Amicon 
Ultra Centrifugal filters (10 kDa molecular weight cutoff, Millipore) by a factor of 10 to obtain 
a final bicelles concentration of 10%.  
For pull-down experiments, 9 times volume of cyto buffer (139 mM K2HPO4, 8.8 mM 
NaH2PO4, 0.4 mM MgCl2, 3.2 mM NaCl, pH 7.0) was added to bring it back to 1% bicelles. 
To bring the incorporated q=0.25 bicelles into q=2 bicelles, 5.2 x volume of 1%, q=4 bicelles 
was added. Thereby, integrin TMcyto incorporated q=(0.25+4) bicelles incubated with soluble 
fraction BMDM lysate isolated by hypotonic buffer (10 mM Tris, 5 mM KCl, 1.5 mM MgCl2, 
1 mM DTT, protease inhibitor cocktail (Roche)) overnight at 4°C. Afterwards, the bicelles-
lysate mixture was incubated with Ni-NTA magnetic agarose beads for 2 hours at 4°C. After 
three washes with q=(0.25+4) bicelle solution in cyto buffer, proteins were eluted from the 
beads by boiling with 80µl laemmli buffer for 5 min, separated by SDS PAGE and analyzed 
by LCMS/MS or western blotting. 
LC-MS to determine lipid composition of bicelles 
Bicelles samples (1%) were diluted 1:100 for identification by Liquid chromatography-mass 
spectrometry (LC-MS) using a Bruker Daltonik micrOTOF connected to an Agilent 1100 
HPLC. Analyses were performed on a YMC-Pack Butyl 30 mm column with water: acetonitrile 
(0.05% trifluoroacetic acid) gradient from 30%-80% in 15 minute at a mass range from 200-
2000 m/z in positive mode. Extracted ion chromatogram at 350.2, 678.5 and 762.5 m/z were 
used to compare the relative ratio of the individual lipids. 
Mass spectrometry analysis of the pull down samples  
The samples were eluted from the Ni-NTA magnetic agarose beads using 1X final 
concentration of laemmli buffer and separated by SDS-PAGE. The gel was fixed with 50% 
methanol and 10% acetic acid and stained with GelCode Blue Safe Protein Stain reagent 
(Thermo Scientific). Each sample/lane was cut into three bands and digested by the standard 
in-gel digestion protocol (Shevchenko et al., 2006). Briefly, the gel bands were cut into roughly 
1 mm cubes and de-stained in ethanol solution before incubation with 20 mM dithiothreitol 
(DTT) and 40 mM chloroacetamide (CAA) sequentially to reduce and alkylate the proteins. 
The gel pieces were then rehydrated in Trypsin solution (12.5 ng/µl in 50 mM ammonium 
bicarbonate) incubated overnight at 37°C. After overnight digestion, the peptides were 
extracted in 30% acetonitrile and 3% trifluoroacetic acid solution followed by 100% 
acetonitrile solution. The extracted peptides were then desalted and concentrated using C18 
StageTips (Rappsilber et al., 2003) prior to LC-MSMS analysis. The peptides were separated 
by a 120 minute gradient in a 15 cm reversed phase column, 75 µm inner diameter columns 
(New Objective) packed in-house with 3 µm Reprosil C18 beads (Dr Maisch GmbH) using 
EASY-nLC II (Thermo Scientific) and sprayed directly into a LTQ Orbitrap XL mass 
spectrometer via nano-electrospray ion source (Thermo scientific).  
Peptides were analyzed using a top 5 data dependent acquisition method. Survey scans were 
acquired in the Orbitrap at resolution of 60,000 (m/z=400) after accumulating a target of 1E6 
ions within a maximum injection time of 1000 ms. From the survey scan up to top 5 most 
abundant precursors were selected and fragmented in the linear ion trap by collisional induced 
dissociation (CID) with automatic gain control AGC target value of 10000 within a maximum 
injection time of 150 ms and the fragmentation spectra were recorded in the ion trap. The 
peptide precursors selected for fragmentation were dynamically excluded for 90 s after a repeat 
count of 1 in order to minimize the repeat sequencing.  
For each set of integrin heterodimer pull downs, the raw files were processed using MaxQuant 
computational platform (Cox and Mann, 2008) version 1.5.1.8. The peak lists generated were 
searched against the Mouse Uniprot proteome sequence database (59375 entries) using the 
Andromeda search engine (Cox et al., 2011). The peptide precursors were searched with an 
initial mass tolerance of 7 ppm and the fragment ions were searched with a tolerance of 0.5 Da. 
Carbamidomethlylation of cysteine was used as a fixed modification and oxidation of 
methionine and N terminal protein acetylation were set as variable modification for the 
database search. Minimum peptide length was set to six amino acids and the identification were 
filtered at 1% for the peptide level and 5% for the protein level and the q value was used for 
assessing the confidence in the identification of individual proteins (Cox, 2015). Match 
between the runs feature was enabled and label-free protein quantitation was performed using 
the MaxLFQ algorithm (Cox et al., 2014). 
All statistical analysis were performed using Perseus bioinformatics. Student t-tests were used 
to compare two samples with permutation based FDR (5%) for multiple hypothesis testing.  
Dynamic light scattering  
Bicelles samples with different ratios of DMPC, POPS, and Cyclofos-6 were freshly prepared, 
with or without integrin TMcyto incorporation. The samples were measured by DLS 
(DynaPro® NanoStar™ from WYATT Technology corp.). Each sample was measured at 4°C, 
acquisition time was set to 5 seconds for 10 times and in each measurement contained three 
repeats. All samples were measured in three independent experiments. Hydrodynamic radius 
was calculated with DYNAMICS V7.1.7.16 (WYATT Technology corp.).  
Surface biotinylation  
3x 106 cells were seeded into 10 cm dishes and incubated overnight at 37°C. After washing 3 
times with ice-cold PBS 3mL of Sulfo-NHS-LC-Biotin (0.2mg/mL in PBS, Thermo) was 
added to each plate and incubated for 60 minutes in the cold room. Cells were wash twice with 
ice-cold PBS and lysed with 1 mL lysis buffer (50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% 
Triton X-100, 0.1% sodium deoxycholate, 1mM EDTA and protease inhibitors (Roche)) for 
10 minutes on ice. After clearing the lysates by centrifugation, biotinylated proteins were pulled 
down with streptavidin-Sepharose beads (GE Healthcare) for 3 hours at 4°C. After washes with 
lysis buffer, samples were analyzed by SDS-PAGE and western blotting. 
Immunoprecipitation 
For crosslink IP, Raw 264.7 cells were trypsinized and treated with EDTA or PMA (phorbol 
12-myristate 13-acetate, Calbiochem 524400) in suspension for 30 mins at 37°C. Cells were 
washed with PBS and then incubated with DSP (1mM in PBS) Dithiobis[succinimidyl 
propionate], Life technology 22585) at room temperature for 30 minutes followed by 
quenching of non-reacted crosslinker with 50mM Tris for 30 minutes at room temperature. 
Cells were then washed twice with PBS, lysed in lysis buffer and cleared by centrifugation. β2 
integrin antibody was incubated with lysate at 4°C overnight and incubated with protein A/G 
Sepharose (Santa Cruz sc-2003) for 2 hours at 4°C with gentle agitation. After several washes 
with lysis buffer, proteins were subjected to SDS-PAGE and western blotting.  
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Figure legends 
 
Figure 1 Integrin transmembrane-cytoplasmic (TMcyto) tail incorporated into bicelles. (A) 
The chemical structures of selected phospholipids used and cartoons of the lipid distribution 
within bicelles are shown. (B) Translational hydrodynamic radius (nm) represented the size of 
different bicelles (q=0.25: 3.53±0.16nm; q=4: 19.93±0.16nm; q=2*: 8.44±0.72nm, 
mean±s.e.m., n=3) measured by dynamic light scattering (DLS). (C) Western blot analysis of 
pull-downs with recombinant His-tagged integrin TMcyto-α5 or -β1 proteins with or without 
bicelle incorporation with antibodies against Talin and Kindlin-2. Western blots were 
quantified by Image J (mean±s.e.m., n=3, * P < 0.05,). 
 
Figure 2 Workflow for the bicelle incorporation of recombinant integrin TMcyto proteins 
followed by pull-down and proteomic analysis. Purified heterodimeric or monomeric integrin 
TMcyto were immobilized to Ni-NTA beads, and incorporated into bicelles solution (q=0.25). 
The bicelles size was increased by adding 5.2 times volume of q=4 bicelles followed by the 
pull-down of proteins from with hypotonic BMDM lysate. Interactors were identified by LC-
MS/MS and analyzed by MaxQuant LFQ based intensity.  
 
Figure 3 Interactome analysis of single α and β integrin subunits. (A, B) Number of proteins 
binding significantly to α (A) and β tails (B). (C) Volcano plots of  t-test difference vs p value; 
statistically significant interactors are labelled in red. (D) Overlap of proteins identified with 
the different α and β tails subunits illustrated as a Venn diagram. (E) Alignment of mouse 
integrin α and β TMcyto segments used in pull-down experiment. 
 
Figure 4 Integrin TMcyto constructs used to mimic the associated integrin conformation. (A) 
Schematic representation of the integrin TMcyto constructs used. CG (Cysteine-Glycine) 
stabilize the dimer formation; GGGG (Glycine-Glycine-Glycine-Glycine) increase the 
flexibility of the integrin TMcyto. (B) Recombinant His-FosαM, His-Junβ2, and Flag-Junβ2 
were expressed and purified with Ni-NTA or flag-M2 beads as monomer (lane 2, 3, 4). His-
FosαM and Flag-Junβ2 were co-incubated and purified by Ni-NTA. Note, His-FosαIIb pulled-
down Flag-Junβ2 indicating heterodimer formation in the optimal one-to-one ratio (lane 1). 
(C) Hydrodynamic radii of the indicated bicelles determined by DLS. Note the size differences 
of q=0.25, q=4, q=2* bicelles and the size increase after integrin TMcyto incorporation 
(mean±s.e.m. n=3).   
 
Figure 5 LCP1 interacted with inactive αMβ2 integrins to regulate integrin-mediated 
functions. (A) Volcano plot showing P values (-log10) versus protein ratio (log2 fold change) 
of αM vs αMβ2 interacting proteins. Proteins with significantly increased binding to either αM 
or αMβ2 are labelled in red. (B) Number of identified proteins which bind to dimeric αMβ2, 
only bind to dimeric αMβ2, and do not interact with αMβ2 TMcyto tail proteins. (C) Western 
blot analysis of proteins pulled-down with either single αM and β2 integrin TMcyto or 
associated αMβ2 TMcyto proteins embedded in bicells. (D) β2 immunoprecipitation from Raw 
264.7 cells treated with EDTA (resting state) or PMA (activated state) after protein 
crosslinking. Immunoprecipitated proteins were analyzed by western blotting with antibodies 
against integrin β2 and LCP1. Note the reduced LCP1 binding to β2 integrin when integrins 
were activated with PMA. (E) Western blot analysis of control (shCtr) or two shLCP1-infected 
(shLCP1-1 and shLCP1-2) Raw 264.7 cells. (F, G) Mac1 (αMβ2 integrin) surface expression 
level was analyzed by FACS (F) or by surface biotinylation and pull-down of biotinylated 
proteins with streptavidin agarose beads (G) (mean±s.e.m., n=3, * P < 0.05). (H) Western blot 
analysis of cell lysates derived from shCtrl or LCP1-depleted PLB-985 cells. LCP1 levels were 
restored in the LCP1-depleted cell lines (shLCP1-1, shLCP1-2) by re-expressing shRNA-
resistent LCP1-GFP or GFP alone. (I) αMβ2 integrin surface levels in the indicated LCP1-
depleted and rescued differentiated- PLB-985 cell lines determined by FACS (mean±s.e.m., 
n=2, n.s. not significant, * P < 0.05, ** P < 0.01). 
  
Figure 6 LCP1 depletion cells increased adhesion on fibrinogen and ICAM. (A, B) Increased 
adhesion of LCP1-depleted Raw264.7 cells on fibrinogen (A) (10µg/ml) and ICAM (B) 
(4µg/ml). Cells were seeded for 30 minutes without or with PMA treatment and the number of 
adherent cells was determined by crystal violet staining. Relative values compared to control 
cells (shCtr) are shown (mean±s.e.m.,  n=3, * P < 0.05, n.s. not significant).   
 
Supplementary figure legends 
Figure S1 Bicelles characterization by LC-MS. (A, B) The relative molar ratio of lipids and 
detergent in q=0.25 (A), q=4 (B) bicelles was determined by LC-MS. Cyclofos-6 (blue), POPS 
(green), DMPC (red).  
Figure S2 DLS measurements of bicelles samples. (A) Hydrodynamic radii of bicelles after 
incorporation of the indicated integrin α and β subunits determined by DLS. (B) DLS 
measurement curves. 
Figure S3 Reproducibility of LC MSMS pull down data. Multi-scatter plot of the protein LFQ 
intensities showing the reproducibility within the triplicate measurements of different 
pulldowns. The indicated values correspond to Pearson correlation. 
Figure S4 LCP1 depletion in PLB985 cells. (A) shRNA-mediated knock-down of LCP1 in 
differentiated and undifferentiated PLB985 cells. Cell lysates were analyzed by Western blot 
with antibodies against LCP1 and GAPDH. Cells were infected with shCtrl or two different 
LCP1 targeted shRNA (shLCP1-1 and shLCP1-2). (B, C) FACS analysis of LCP1-depleted or 
control infected, differentiation PLB985 cells for αMβ2 surface expression level (B) and 
activated αMβ2 levels (C). The bar graph shows mean±s.e.m.  (n=3, * P < 0.05, ** P < 0.01 
n.s. not significant).  
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ART I C L E S
Sorting nexin 17 prevents lysosomal degradation of β1
integrins by binding to the β1-integrin tail
Ralph Thomas Böttcher1,2, Christopher Stremmel1,2, Alexander Meves1,3, Hannelore Meyer1,3, Moritz Widmaier1,
Hui-Yuan Tseng1 and Reinhard Fässler1,4
Integrin functions are controlled by regulating their affinity for ligand, and by the efficient recycling of intact integrins through
endosomes. Here we demonstrate that the Kindlin-binding site in the β1-integrin cytoplasmic domain serves as a molecular switch
enabling the sequential binding of two FERM-domain-containing proteins in different cellular compartments. When β1 integrins
are at the plasma membrane, Kindlins control ligand-binding affinity. However, when they are internalized, Kindlins dissociate
from integrins and sorting nexin 17 (SNX17) is recruited to free β1-integrin tails in early endosomes to prevent β1-integrin
degradation, leading to their recycling back to the cell surface. Our results identify SNX17 as a β1-integrin-tail-binding protein
that interacts with the free Kindlin-binding site in endosomes to stabilize β1 integrins, resulting in their recycling to the cell
surface where they can be reused.
Integrins are the main family of adhesion molecules mediating cell
interactions with the extracellular matrix1 (ECM). A hallmark of
integrins is their ability to tune their affinity for ligand by shifting their
extracellular domain between different conformations. Key molecules
that increase ligand-binding affinity are the FERM (4.1, ezrin, radixin,
moesin)-domain-containing proteins Talins and Kindlins2,3. Talins
bind the membrane-proximal NPxY motif of β-integrin cytoplasmic
tails and Kindlins the membrane-distal NxxY motif and the adjacent
threonine residues4–9.
Increasing evidence indicates that integrin trafficking through the
endosomal pathway affects their function, cell surface distribution,
signalling through integrin-associated growth factor receptors and
the turnover of ECM proteins such as fibronectin10,11. In contrast
to the well-established mechanisms for integrin recycling10,12–14,
the mechanisms for integrin degradation are not well understood.
Fibronectin-bound α5β1 integrin was recently shown to be internalized,
sorted into multivesicular endosomes and degraded in lysosomes in
a ubiquitin- and endosomal sorting complex required for transport
(ESCRT)-dependent manner15.
Here, we identified the FERM-domain-containing protein SNX17 as
a β1-tail-binding protein that, following β1-integrin internalization and
Kindlin dislodgement, is recruited to the free β1 tails in early endosomes
to prevent β1-integrin degradation by lysosomes.
1Department of Molecular Medicine, Max Planck Institute for Biochemistry, 82152 Martinsried, Germany. 2These authors contributed equally to this work. 3Present
addresses: Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA (A.M.); Institute of Medical Microbiology, Immunology and Hygiene, Technical
University Munich, 81675 Munich, Germany (H.M.).
4Correspondence should be addressed to R.F. (e-mail: Faessler@biochem.mpg.de)
Received 22 December 2011; accepted 10 April 2012; published online 6 May 2012; DOI: 10.1038/ncb2501
RESULTS
β1-integrin TT788/789AA and Y795A substitutions cause
peri-implantation lethality in mice
Thr 788 and 789 and Tyr 795 in the β1-integrin tail are required for
binding Kindlins6,9,16. To investigate their significance in vivo they
were substituted with alanines in mice. Although mice heterozygous
for the mutation were normal, their intercross failed to produce
live homozygous offspring (TT/AA: + /+: 35%, (TT/AA)/+: 65%,
(TT/AA)/(TT/AA): 0%,N =100; Y795A:+/+: 33%, (Y795A)/+:67%,
(Y795A)/(Y795A): 0%, N = 100). Timed mating revealed severely
malformed or resorbed embryos (Fig. 1a,b and Supplementary
Fig. S1a) at embryonic day (E) 7.5 (+/+: 25%, (TT/AA)/+: 53%,
(TT/AA)/(TT/AA): 17%, resorbed: 5%, N = 36) characterized by
defects in cell polarity, laminin111 deposition and cavitation (Fig. 1b).
As the defects of the β1 TT/AA and β1 Y795A were identical, we mainly
show results for β1 TT/AAmice and cells.
Embryoid bodies generated from embryonic stem (ES) cells
derived from littermate wild-type (β1 wt) and homozygous TT/AA
(β1 TT/AA) blastocysts confirmed the in vivo findings. After 2–4
days in suspension culture, β1 wt ES cells developed embryoid
bodies consisting of an outer primitive endoderm layer, a basement
membrane and an undifferentiated core, which converted into a
layer of pseudo-stratified primitive ectoderm and a central cavity
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Figure 1 The β1-TT/AA-integrin tail mutation leads to severe defects.
(a) Bright-field images of E7.5 embryos with and without implantation
chamber. Wild type, wt. (b) Left and central panels show whole-mount
pictures of E7.5 embryos stained for β1 integrin (red) and laminin111
(green). Nuclei were counterstained with DAPI (blue). Right panels show
haematoxilin and eosin (HE) staining of E7.5 embryo sections. em,
embryo; de, decidua; ac, amniotic cavity; am, amnion; al, allantois; ch,
chorion; ec, ectoplacental cone; fg, foregut; hg, hindgut; ex, exocoelomic
cavity. (c) Western blot for β1 integrin, Talin-1, Kindlin-1, Kindlin-2
and actin of embryonic stem (ES) cell lysates, including a control
lane for Kindlin-1 from a wt keratinocyte lysate. (d) Expression of
integrin subunits on ES cells determined by FACS (mean± s.d.; n = 4;
∗P= 0.0134, ∗∗P= 0.0011, ∗∗∗P< 0.0001). (e) Integrin activation on
ES cells measured by 9EG7 binding and corrected for total β1-integrin
expression (mean±s.d.; n=4; ∗∗∗P=0.0003). (f) Expression of β1-integrin
mRNA in ES cells measured by quantitative real-time PCR (n = 2).
(g) Adhesion assay of ES cells on different substrates (mean±s.d.; n =3;
∗∗P<0.01 and ∗∗∗P<0.005). P values, Student’s t -test; ns, not significant.
Scale bars, 100 µm. Uncropped images of blots are shown in Supplementary
Fig. S6.
on day 4–6 (Supplementary Fig. S1b). In contrast, β1 TT/AA ES cells
formed compact aggregates covered by a discontinuous basement
membrane and few endoderm cells, which lost their polarizedβ-catenin,
E-cadherin and F-actin distribution, and lacked a central cavity
(Supplementary Fig. S1b,c).
β1 TT/AA ES cells adhered less to feeder cells (Supplementary
Fig. S1d) and had reduced levels of the mature (relative molecular
mass, 125,000; Mr125K) β1 integrin, whereas Kindlin-2 and Talin-1
expression were normal (Fig. 1c). Fluorescence-activated cell sorting
(FACS) analysis confirmed reduced β1-integrin surface levels to about
40% in β1 TT/AA ES cells and revealed decreased levels of α5 and α6
integrins, whereas β3 and αv levels were unaffected (Fig. 1d). Kindlin-2
binding to the β1-integrin tail is required for activating the 9EG7
epitope in ES cells7. The level of 9EG7 antibody binding to β1 TT/AA
was reduced after adjusting to total β1 levels but could be normalized
to wt levels with manganese (Fig. 1e). The reduced β1-TT/AA-integrin
levels were not due to insufficient messenger RNA transcription,
as we detected increased β1-integrin mRNA transcript levels in β1
TT/AA ES cells (Fig. 1f). ‘Plate-and-wash’ adhesion assays revealed
a significantly diminished level of attachment of β1 TT/AA ES cells to
ECM substrates (Fig. 1g). Similar results were observed in β1 Y795A
ES cells (Supplementary Fig. S1e–g).
To determine whether the reduced level of β1 TT/AA and β1
Y795A surface expression occurs in other cell types, we characterized
fibroblasts expressing β1 wt, β1 TT/AA or β1 Y795A integrins.
We generated β1-null fibroblasts from floxed β1 parental cells re-
expressing either β1 wt, β1 TT/AA or β1 Y795A complementary
DNAs. We also isolated fibroblasts from β1 flox/wt and β1 flox/TT/AA
littermates and deleted the floxed alleles by adenoviral Cre transduction
(Supplementary Fig. S2a,b). Fibroblasts from both cell systems behaved
similarly in all assays. Fibroblasts expressing β1 TT/AA or β1 Y795A
integrins showed a reduced level of β1 surface expression despite
increased mRNA levels (Supplementary Fig. S2c–f and data not
shown). Immunoblotting showed a reduced expression level of the
mature (Mr125K) β1-TT/AA-integrin polypeptide, whereas the level
of immature form (Mr105K) was increased when compared with
cells expressing β1 wt (Supplementary Fig. S2g). In line with our ES
cell results, we observed significantly less 9EG7 antibody binding to
β1-TT/AA-expressing fibroblasts (Supplementary Fig. S2h).
These findings show that the TT/AA or Y795A β1 tail substitutions
reduce β1 cell-surface levels and suggest defects in integrin processing
or turnover.
The distal NxxY motif and the adjacent TT788/789 control
β1-integrin turnover
Surface levels of transmembrane proteins are controlled by the
synthesis rate, maturation and export of the polypeptide to the cell
surface, internalization, recycling and degradation. To determine
whether the TT/AA substitutions alter β1-integrin maturation in the
secretory pathway, β1-wt- and β1-TT/AA-expressing fibroblasts were
NATURE CELL BIOLOGY VOLUME 14 | NUMBER 6 | JUNE 2012 585
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Figure 2 TT788/789 regulate β1 recycling and degradation. (a) Pulse-chase
analyses of β1-integrin maturation in cells expressing wt or β1 TT/AA
integrins. Cells were collected and analysed by immunoprecipitation after
metabolic labelling with [35S]methionine/cysteine and chased for the
indicated time points. Maturation curves show immature β1 integrin as a
percentage of the total β1 integrin (right) and were drawn from densitometric
scans of the autoradiograms (left). (b) Quantification of β1-integrin
internalization in β1-wt- and β1-TT/AA-expressing cells by capture-ELISA
(mean± s.d.; n = 4). (c) Quantification of β1-integrin recycling in β1-wt-
and β1-TT/AA-expressing fibroblasts by capture-ELISA (mean±s.d.; n =5;
∗P< 0.05 and ∗∗P< 0.01). (d) Western blot analysis of β1-wt- and
β1-TT/AA-expressing cells treated with either proteasome (MG132) or
lysosome inhibitor (chloroquine) for 20 h. Actin served as a loading control.
(e,f) Degradation of cell-surface integrins was determined by biotinylating
cell-surface proteins and incubating for the indicated time points, followed
by biotin pulldown and western blot analysis (e) or quantification by
capture-ELISA (f) (mean± s.d.; n = 4; ∗∗∗P< 0.0001). (g) Lysosomal
inhibition by bafilomycin prevents degradation of β1 TT/AA integrin.
Degradation was measured by surface biotinylation and incubation of the
cells for 14 h in the presence or absence of bafilomycin. (h) Degradation
of β1-integrin mutants (wt, TT/AA, Y783A and Y795A) was determined by
biotinylating cell-surface proteins and incubating for 0 h and 15h, followed
by biotin pulldown and western blot analysis. All P values, Student’s t -test.
Uncropped images of blots are shown in Supplementary Fig. S6.
pulse labelled with [35S]methionine/cysteine. Owing to the higher
β1-TT/AA-integrin mRNA levels, β1 TT/AA cells expressed more
immature β1 integrin in the initial pulse-labelling phase; however, the
immature,Mr105K-sized β1-integrin polypeptide disappeared in both
cell types with the same kinetics, indicating that the TT/AA mutation
does not affect the initial processing of the β1 polypeptide (Fig. 2a).
The increased ratio between the Mr105K- and the Mr125K-sized β1
polypeptides in β1 TT/AA fibroblasts and the increased persistence
of the Mr125K β1 wt polypeptide indicated marked differences in
β1 TT/AA turnover. As integrin turnover is affected by intracellular
trafficking, we compared β1 wt and β1 TT/AA internalization and
recycling by surface labelling with cleavable biotin. Whereas β1 wt
and β1 TT/AA integrins internalized with the same kinetics, the TT/AA
substitutions showed a decreased recycling rate back to the plasma
membrane (Fig. 2b,c). The similar time constant at the start of recycling
together with the significantly different plateaux of recycled β1 wt and
β1 TT/AA integrins indicates that the recycling machinery is normal
whereas the number of recycling integrins (reflected by the different
plateaux) is lower in β1-TT/AA-expressing cells.
To determine whether reduced recycling of β1 TT/AA to the cell
surface results from increased degradation, we treated β1 wt and
β1 TT/AA fibroblasts with the lysosomal inhibitor chloroquine or
the proteasomal inhibitor MG132. Lysosome inhibition rescued the
mature β1 TT/AA to wt levels and stabilized the corresponding
α5 subunit, whereas proteasome inhibition had no effect on β1
TT/AA and α5 stability (Fig. 2d). We also determined the degradation
kinetics of the surface β1 integrins by surface labelling of β1 wt
and β1 TT/AA cells with biotin, followed by the measurement of
biotinylated proteins after pulldown with streptavidin beads and
immunoblotting or capture enzyme-linked immunosorbent assay
(ELISA).Whereas β1 wt was slowly degraded with an estimated half-life
of over 20 h, degradation of β1 TT/AA occurred quickly with a 4–5 h
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Figure 3 Kindlin-2-dependent regulation of β1-integrin surface levels.
(a) β1 surface expression in β1-wt- and β1-TT/AA-expressing fibrob-
lasts after overexpression of Kindlin-2–eGFP determined by FACS
(mean ± s.d.; n = 11; ∗∗∗P < 0.0001; ns, not significant). (b) β1
surface levels in control (Kind (f/f)) and Kindlin-1 and -2 double
null (Kind(−/−)) fibroblasts determined by FACS (mean± s.d.; n = 3;
∗∗∗P< 0.0001). (c) Western blot analysis of cell lysates from platelets,
keratinocytes and Kind (−/−) fibroblasts with antibodies against the three
Kindlin family members. Actin and GAPDH served as loading control.
(d,e) Quantification of β1-integrin internalization (d) and recycling (e) in
β1 wt and β1 TT/AA cells with and without Kindlin-2–eGFP overexpression
by capture-ELISA (mean± s.e.m.; n = 8 (d) and n = 10 (e)). (f,g) Quan-
tification of surface β1-integrin stability in Kindlin-2–eGFP-overexpressing
(f) and Kind(−/−) cells (g). Degradation of cell-surface β1 integrin was
determined by biotinylating cell-surface proteins and incubating for the
indicated time points, followed by capture-ELISA (mean± s.d.; n = 4
(f); n = 3 (g); ns, not significant). (h) β1-integrin mRNA expression
in Kindlin-2–eGFP-overexpressing fibroblasts measured by quantitative
real-time PCR (n=2). All P values, Student’s t -test. Uncropped images of
blots are shown in Supplementary Fig. S6
half-life (Fig. 2e,f). This was specific to β1 integrin as the degradation
rates of β3 integrin and the transferrin receptor (Tfr) were similar
in both cell types (Fig. 2e). Furthermore, bafilomycin rescued the
degradation of biotinylated β1 TT/AA, confirming that the instability of
β1 TT/AA results from lysosomal degradation (Fig. 2g). To determine
whether the β1-tail NxxY motifs are also required for β1-integrin
stability, we expressed β1 Y783A and β1 Y795A integrins in β1-null
cells. Biotinylated β1 protein was detectable after 15 h in β1-wt- and
β1-Y783A-expressing cells, but was almost completely degraded in
β1-TT/AA- and β1-Y795A-expressing cells (Fig. 2h).
These experiments indicate that the TT788/789 and distal NxxY
sequence control turnover of surface β1 integrins.
Kindlin-2 regulates β1 surface levels by controlling β1-integrin
mRNA levels
As the TT788/789 and the membrane-distal NxxY motif in β1 integrin
tails are required for Kindlin binding6,9,16, we investigated whether
disrupting this interaction was responsible for the reduced β1 TT/AA
surface levels, recycling and stability. As reported, overexpression of
Kindlin-2–eGFP inβ1 wt cells significantly increasedβ1-integrin surface
levels17, but not in β1-TT/AA-expressing fibroblasts, probably because
their mRNA levels are already upregulated (Fig. 3a). Conversely,
β1-integrin surface levels were significantly diminished in fibroblasts
lacking the kindlin-1 and -2 genes (Fig. 3b,c). Despite increased β1 sur-
face levels in Kindlin-2-overexpressing cells, internalization, recycling
(Fig. 3d,e) and stability of surface β1 integrins were normal (Fig. 3f).
Furthermore, the degradation of surface β1 integrins was unchanged in
fibroblasts lacking Kindlin-1 and -2 (Fig. 3g). Instead, the β1-integrin
mRNA levels were increased in Kindlin-2–eGFP-overexpressing cells
(Fig. 3h). Internalization and recycling assays could not be performed
with cells lacking Kindlin-1 and -2, as their adhesion to ECM substrates
was very weak and cells were lost during the assays. Collectively, these
data show that Kindlin-2 increases β1-integrin surface expression
primarily by upregulating β1-integrinmRNA levels.
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SNX17 interacts with the TT788/789–Y795 motif of the β1
cytoplasmic domain
To understand how TT788/789 and the membrane-distal NxxY
motif regulate recycling, stability and surface expression of β1
integrins, we screened for new β1-tail-interacting protein(s) using
stable isotope labelling by amino acids in cell culture18 (SILAC)
followed by pulldown experiments with synthesized full-length β1 wt,
β1 TT/AA cytoplasmic domain or scrambled peptides (to identify
nonspecific interactors) and mass-spectrometry-based proteomics19.
Among proteins with high light-to-heavy isotope ratios indicative
for specific binding, were known β1-tail-interacting proteins such as
Talin-1, Talin-2, Kindlin-2, Dab2 and ILK, and also SNX17 (Fig. 4a
and Supplementary Table S1). Only four of these proteins failed to bind
when compared with a β1-TT/AA-integrin tail, and of those Kindlin-2
and SNX17 showed the highest ratios (Fig. 4a). SNX17 belongs to
the sorting nexin (SNX) family of adaptor proteins whose hallmark
is a phox-homology (PX) domain known to mediate association
with phosphatidylinositol-3-monophosphate (PtdIns(3)P)-enriched
endosomes20. Similarly to Talin and Kindlin, SNX17 contains a FERM
domain with a QWmotif in the F3 subdomain required in Talin and
Kindlin for binding the β1 tail7,20,21. SNX17 has been implicated in
endocytic trafficking of transmembrane proteins including low-density
lipoprotein receptor family members LDLR and LRP1 (refs 22–24),
P-selectin25 and APP (ref. 26).
Consistent with the proteomic data, SNX17 and Kindlin-2 were
readily detected in peptide pulldowns with β1 wt but not with
β1 TT/AA, β1 Y795A, α5 or scrambled peptides (Fig. 4b). To
determine whether SNX17 directly interacts with the β1-integrin
tail, we performed integrin-tail-peptide-pulldown experiments with
recombinant wt GST–SNX17 or GST–SNX17 with a mutated QW
motif (GST–SNX17QW/AA). These experiments revealed that SNX17
binds directly to β1 wt but not β1 TT/AA, β1 Y795A or scrambled
peptides and showed that the interaction is specific because a QW
mutation in the F3 subdomain of SNX17 abolished binding (Fig. 4c).
SNX17 and Kindlin-2 share the binding site on the β1-integrin tail
and compete for β1-integrin-tail binding in vitro (Supplementary
Fig. S3a). However they do not co-localize in living cells, indicating
that they interact with the β1 tail in different subcellular compartments
(Fig. 4d). Co-localization studies in living cells revealed that SNX17
partially overlapped with the early endosomal antigen-1 (EEA1),
an early endosome marker, as well as with the Tfr, a recycling
endosomemarker (Fig. 4e, and Supplementary Fig. S3b). No significant
co-localization was observed with the lysosomal acid membrane
protein 1 (Lamp1) and Rab7 (Fig. 4f and Supplementary Fig. S3c,d).
Owing to the lack of suitable antibodies, we employed live-cell
microscopy to show co-localization of eGFP-tagged SNX17 with
antibody-labelled internalized β1 integrins (Fig. 4g) and with α5
integrin–eGFP (Supplementary Fig. S3e). We also observed co-
localization of SNX17–eGFP with β1 TT/AA-positive endosomes
(Supplementary Fig. S3f), which is probably due to the binding
of the PX domain to endosomal lipids. 9EG7 antibody labelling
revealed the presence of active β1 wt integrins in focal adhesions but
not in SNX17–eGFP-positive endosomes (Supplementary Fig. S3g),
suggesting that SNX17-bound β1 integrins are in a low-affinity
state. To demonstrate interactions of the endogenous proteins, we
surface labelled β1 integrins, enriched the endosomal β1-integrin
pool by inhibiting recycling with primaquine27 and co-precipitated
labelled β1 wt integrins with endogenous SNX17 (Fig. 4h). The
interaction was lost in cells expressing β1 TT/AA integrins (Fig. 4h).
These findings show that SNX17 is a β1-integrin-tail-binding protein,
that the interaction occurs in endosomes and that the SNX17 and
Kindlin-binding site overlap.
SNX17 is required for β1-integrin recycling and stabilization
To determine whether SNX17 regulates β1-integrin trafficking and/or
degradation we depleted SNX17 by short interfering RNA (siRNA)
transfection or by short hairpin RNA (shRNA) retroviral expression
(shSNX17-1 and shSNX17-2). SNX17 depletion decreased the mature
β1-integrin pool in whole-cell lysates (Fig. 5a) and reduced the β1
wt surface levels by 40% (Fig. 5b). Bafilomycin treatment rescued
the mature β1-wt-integrin pool, indicating enhanced lysosomal
degradation in SNX17-depleted cells (Fig. 5a). Immunoblotting and
capture ELISA of surface-biotinylated β1 integrins from control (shCtr)
and SNX17-depleted fibroblasts confirmed that β1 wt integrins were
degraded in the absence of SNX17 (Fig. 5c,d and Supplementary
Fig. S4a). The increased β1-integrin degradation was specific, as the
stability of the Tfr and of the SNX17-binding-deficient β1 TT/AA
integrin were unaffected by SNX17 downregulation (Fig. 5c and
Supplementary Fig. S4b). Expression of shRNA-resistant wt SNX17
restored stability and β1-integrin surface levels in SNX17-depleted
cells, whereas SNX17QW/AA did not (Fig. 5d–f and Supplementary
Fig. S4a). Similarly to β1 TT/AA cells, β1-wt-integrin internalization
was normal in SNX17-depleted cells (data not shown), whereas
recycling to the cell surface was significantly impaired (Fig. 5g).
Thus, SNX17 promotes recycling of β1 integrins and prevents
their degradation.
To monitor β1 wt trafficking in control and SNX17-depleted cells
and β1 TT/AA trafficking along the endocytic pathway, we labelled
surface β1 integrins with an antibody before internalization. At
10min after internalization, β1 wt- and β1 TT/AA-positive puncta
were evenly distributed in the cytoplasm and localized to the early
endosomal compartment (Supplementary Fig. S4c). At 30min, the
internalized β1 wt signal level in control cells was reduced, indicating
that β1 wt efficiently recycled to the cell surface. In contrast,
β1 TT/AA and β1 wt in SNX17-depleted cells co-localized with
Lamp1-positive lysosomes (Supplementary Fig. S4c), supporting the
observation that the β1-tail/SNX17 interaction prevents routing of β1
integrin into the lysosome.
To investigate whether SNX17 controls recycling or degradation
of β1 integrins, we performed recycling assays of β1 wt in
SNX17-depleted cells and of β1 TT/AA in the presence and
absence of bafilomycin. Bafilomycin treatment rescued the recycling
rates and the surface levels of β1 TT/AA and β1 wt in SNX17-
depleted cells (Fig. 5h and Supplementary Fig. S4d,e). Moreover,
internalized β1 TT/AA and β1 wt in SNX17-depleted cells no
longer accumulated in the late endosome/lysosome compartments
30min after internalization (Supplementary Fig. S4c). These findings
were corroborated by substituting all lysine residues of the α5
and β1 tails with arginines (β1 8xKR±TT/AA; α5 4xKR) to inhibit
ubiquitylation and ESCRT-mediated lysosomal degradation. The
lysine to arginine substitutions did not affect integrin internalization
(data not shown). However, expression of the β1 8xKR+TT/AA
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Figure 4 SNX17 requires TT788/789 for β1-integrin-tail binding. (a) Scatter
plot of β1-wt-tail peptide versus scrambled-peptide pulldown results. The
log2 SILAC ratio of proteins identified with at least 2 unique peptides in
each mass spectrometry run is plotted as the forward pulldown (x axis)
against the reverse labelling pulldown (y axis). Specific interaction
partners show inverse ratios between forward and reverse experiment,
grouping them into the upper left quadrant. Red dots indicate those
proteins that failed to bind to the β1-TT/AA-tail peptide in a separate
experiment. (b) Western blot showing Talin-1, Kindlin-2 and SNX17
binding to the biotinylated peptides indicated. Wcl, whole-cell lysate.
(c) Streptavidin-bead pulldown assay with the indicated biotinylated
β1-integrin cytoplasmic tail peptides and recombinant GST-tagged SNX17
or a GST-tagged SNX17QW/AA. (d) SNX17–mCherry-expressing cells
were transfected with Kindlin-2–eGFP and fluorescence distribution was
determined in living cells by spinning-disc confocal microscopy. Stills
of movies are shown. (e,f) Immunostaining of SNX17–eGFP-expressing
cells with EEA1 (e) and Lamp1 (f) antibodies. Nuclei were counterstained
with DAPI (blue). Correlation coefficient 0.300 ± 0.116 (EEA1),
−0.457 ± 0.141 (Lamp1); mean± s.d.; n = 44 (e); n = 25 (f).
(g) Localization of endogenous β1 integrin after surface labelling
with an anti-β1-integrin antibody and internalization for 15min in
SNX17–eGFP-expressing cells. The fluorescence intensity was determined
in living cells by spinning-disc confocal microscopy. A still of a movie is
shown. (h) Co-immunoprecipitation of endogenous β1 integrin and SNX17
from β1-wt- and β1-TT/AA-expressing cells pre-treated with or without
primaquine. Wcl, whole-cell lysate. Scale bars, 20 µm. In d–g, lower
panels show an enlargement of the area indicated by the white rectangle.
Uncropped images of blots are shown in Supplementary Fig. S6.
together with α5 4xKR rescued the instability and recycling rates
induced by the TT/AA mutation (Fig. 5i,j). Expression of the β1
8xKR+TT/AA along with the α5 wt was not sufficient to fully stabilize
the TT/AA mutation, indicating that ubiquitylation of either the
α5 or the β1 subunit can mediate α5β1 degradation (Fig. 5i). Thus,
SNX17 primarily functions to prevent β1-integrin degradation and not
β1-integrin recycling.
SNX17 is an important regulator of integrin-mediated
cell functions
As Kindlin and SNX17 share the β1-tail-binding site, mutations in
this site affect Kindlin- and SNX17-mediated functions. To determine
whether SNX17 influences integrin-mediated functions, we analysed
cell spreading and migration in SNX17-depleted cells. Indeed, β1-
TT/AA- and β1-Y795A-expressing cells and SNX17-depleted fibroblasts
did not spread to the same extent as β1 wt cells (Fig. 6a and
Supplementary Movie S1) and were less motile in single-cell migration
assays (Fig. 6b and Supplementary Movie S2). Scratch-wound assays
confirmed the decreased cell velocity of β1-TT/AA-expressing and
SNX17-depleted cells and indicated a higher persistence when
compared with β1 wt fibroblasts (Fig. 6c). Fibroblasts lacking β1
integrins barelymigrated under these conditions (Fig. 6b,c). Expression
of shRNA-resistant wt SNX17 in SNX17-depleted cells rescued the
spreading and migration defects, whereas SNX17QW/AA did not
(Fig. 6a,b). Despite these differences, focal adhesion size and F-actin
distribution were not significantly altered in cells expressing β1 TT/AA
integrins or lacking SNX17 (Supplementary Fig. S5). Interestingly,
expression of β1 8xKR±TT/AA+ α54xKR restored cell spreading
but not cell migration (Fig. 6d,e). Thus, SNX17 modulates several
integrin-mediated functions in fibroblasts.
DISCUSSION
The present study identified a spatiotemporally controlled series of
β1-integrin/protein interactions in which the TT788/789 and the
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Figure 5 Depletion of SNX17 reduces surface levels of β1 integrins.
(a) Western blot analysis of control (siCtr) or two siSNX17-transfected cells
(siSNX17-1 and siSNX17-2) treated with or without bafilomycin for 20 h.
Actin served as loading control. (b) Quantification of β1 surface levels in
control and SNX17-depleted cells determined by FACS (mean±s.d.; n =9;
∗∗∗P<0.0001). (c,d) Degradation of cell-surface integrins was determined
by biotin pulldown and western blot analysis (c) or capture-ELISA (d)
(mean± s.d.; n = 5). SNX17 levels in the shSNX17-2 knockdown cell
line were restored by re-expressing either siRNA-insensitive wt SNX17 or
SNX17QW/AA. (e) Western blot analysis of cell lysates derived from the
indicated β1-integrin-expressing and SNX17-depleted cells. SNX17 levels
were restored in the SNX17-depleted cell lines by re-expressing either
siRNA-insensitive wt SNX17 or SNX17QW/AA. (f) β1-integrin surface levels
in SNX17-depleted cells were restored by re-expressing siRNA-insensitive
wt SNX17 but not with SNX17QW/AA (mean±s.d.; n=3; ∗∗P=0.0079; ns,
not significant). (g) Quantification of β1-integrin recycling in SNX17-depleted
cells by capture-ELISA (mean± s.e.m.; n = 7; ∗∗∗P< 0.0008). Note the
strong reduction in the level of β1-integrin recycling after SNX17 depletion.
(h) β1-integrin recycling is restored to wt levels in β1 TT/AA cells treated with
bafilomycin. The quantity of biotinylated β1 integrin remaining within the
cells was determined by capture-ELISA using β1-integrin-specific antibodies
(mean± s.e.m.; n = 3). (i) Quantification of the stability of cell-surface
β1 integrins by capture-ELISA. The indicated cell lines were surface
biotinylated and incubated under starving conditions (mean±s.d.; n =3).
(j) Quantification of β1-integrin recycling determined by capture-ELISA.
Cells express either α5 wt and β1 wt or α5β1 with K> R-mutant tails
(mean±s.e.m.; n=4). All P values, Student’s t -test. Uncropped images of
blots are shown in Supplementary Fig. S6.
membrane-distal NxxY motif of the β1-integrin tail control the
functions of β1 integrins at the plasma membrane and subsequently
their sorting from early endosomes back to the plasma membrane.
Kindlins bind these motifs with the F3-FERM subdomain and the
plasma membrane with the PH domain and promote β1-integrin
activity and linkage to actin dynamics28,29. Following internalization,
β1 integrins release Kindlins from their tails and are transferred
into early endosomes where the free Kindlin-binding site recruits
SNX17, which prevents β1-integrin routing to lysosomes (Fig. 6f).
Thus, the consecutive usage of the Kindlin-binding site first by
Kindlins at the plasma membrane and then by SNX17 at early
endosomes could couple integrin function with integrin quality
control. If so, one would predict that a major role of integrin
internalization and recycling is to sort functional integrins for re-use
and non-functional integrins (for example, damaged by actomyosin-
mediated tension) for degradation.
SNX17 is a member of the SNX family of proteins, which contain a
PX domain that serves as a phosphoinositide-binding motif to aid SNX
recruitment to phosphoinositide-enriched endosomal membranes30.
SNX17 harbours the characteristic PX domain at the amino terminus
and a FERM domain at the carboxy terminus, which binds NPxY
motifs with its phosphotyrosine (PTB)-related F3 subdomain20. The
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Figure 6 SNX17 is required for β1-integrin function. (a) Quantification
of spreading area of the indicated cell lines (mean± s.e.m. of
two independent experiments, n = 40 cells). (b) Quantification of
single-cell migration velocity of the indicated cell lines extracted from
time-lapse microscopy recordings by single-cell tracking (mean± s.d.
of three independent experiments, n = 82 cells; ∗∗∗P< 0.0001; ns,
not significant). (c) Migration analysis of β1 wt, β1 (−/−), β1 TT/AA
and SNX17-depleted cells in a scratch assay by time-lapse video
microscopy. The movement of individual cells into the wound was
followed using cell-tracking software and representative trajectories
are shown (left panels). The speed (distance migrated per minute;
upper right) and persistence of migration of cells (lower right) were
quantified from the track plots (means±s.d. of 52 cells analysed in six
individual wounds of two independent experiments; ∗∗∗P< 0.0001; ns,
not significant). (d) Quantification of spreading area of the indicated
cell lines (mean±s.e.m. of two independent experiments, n =40 cells).
(e) Quantification of single-cell migration velocity of the indicated cell
lines extracted from time-lapse microscopy recordings by single-cell
tracking (mean± s.d. of three independent experiments, n = 60 cells;
∗∗∗P< 0.0001; ∗P< 0.0325). All P values, Mann–Whitney U -test.
(f) Model of serial Kindlin and SNX17 binding to the β1-integrin
cytoplasmic domain to regulate integrin affinity and trafficking. Kindlins
bind the β1-integrin tail with their FERM domain and to PIP2/PIP3
in the plasma membrane (red) with their PH domain to regulate the
ligand affinity of integrins. Following integrin internalization, Kindlins
are dislodged and SNX17 is recruited to the unoccupied Kindlin-binding
site in the β1 tail in endosomes to prevent β1-integrin degradation and
to promote their recycling back to the cell surface. The β1-tail/SNX17
interaction in endosomes is supported by the interaction of the SNX17
PX domain with PtdIns(3)P enriched in endosomal membranes (blue).
recruitment of SNX17 to NPxY motifs was shown to be required for
turnover of several transmembrane proteins including the low-density
lipoprotein receptor22,23 (LDLR), LDLR-related protein 1 (LRP1;
refs 24,31), P-selectin25,32 and the amyloid precursor protein (APP;
ref. 26). However, whether SNX17 promotes their trafficking to
the plasma membrane or prevents their degradation is still unclear.
We found that inhibition of lysosomal degradation restored β1
TT/AA recycling rates, indicating that the primary function of
SNX17 binding to β1-integrin tails is to prevent their degradation
rather than to promote recycling (Fig. 6f). How SNX17 inhibits
lysosomal degradation of β1 integrin is unclear and needs to be
addressed in future. One possibility is that SNX17 prevents integrin
sorting into inner vesicles of multi-vesicular bodies, a pre-requisite
for degradation by the lysosome, for example by recruiting a
deubquitinase that removes ubiquitin moieties from integrin tails
required to interact with components of the ESCRT machinery33.
Alternatively, it is possible that SNX17 prevents access of the ESCRT
machinery to β1 integrins.
The lethality of the β1 TT/AA and distal Y795A mice results
from a combination of functional impairments including defective
integrin activation, abnormal actin dynamics and decreased integrin
recycling. The reduced adhesion, spreading and migration of SNX17-
depleted cells indicate that β1 functions are severely impaired when
their degradation rate is not controlled by SNX17. The reduced
β1-TT/AA-integrin surface levels may also affect other functions
including surface expression and signalling of growth factor receptors,
co-internalization and re-secretion of fibronectin, and maybe other
ECM proteins11,34. 
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Mouse strains. The targeting constructs with the β1-integrin threonine-to-alanine
mutation in positions 788 and 789 (β1 TT/AA) and the tyrosine-to-alaninemutation
in position 795 (β1 Y795A) were generated as previously described35. All animal
studies were approved by the Regierung von Oberbayern.
Antibodies. The following antibodies were used for western blotting (WB) and
immunofluorescence (IF): actin (A-2066, Sigma; 1:3,000 for WB), β1 integrin
(MAB1997, MB1.2, Chemicon; 1:400 for IF), β3 integrin (04-1060, EP2417Y,
Millipore; 1:1,000 for WB), β-catenin (C2206, Sigma; 1:800 for IF), E-cadherin
(13-1900, ECCD-2, Zymed; 1:200 for IF), laminin111 (ab30320, Abcam: 1:400
for IF), EEA1 (610457, BD Transduction Laboratories; 1:100 for IF), GAPDH
(CB1001, 6C5, Calbiochem; 1:5,000 for WB), Kindlin-2 (K3269, Sigma; 1:1,000
for WB), Lamp1 (provided by L. Huber, Medical University Innsbruck, Austria;
1:100 for staining), paxillin (610051, 349, BD Transduction Laboratories), SNX17
(10275-1-AP, Proteintech; 1:1,000 for WB), Talin-1 (T3287, 8d4, Sigma; 1:1,000 for
WB), Tfr (13-6,800, H68.4, Invitrogen, 1:1,000 for WB) and ubiquitin (3936, P4D1,
Cell Signaling; 1:1,000 for WB). Kindlin-1 (1:5,000 for WB), Kindlin-3 (1:5,000 for
WB) and β1-integrin (1:10,000 for WB) antibodies used for western blotting are
home-made36,37. Phalloidin (A12379 and A22287, Molecular Probes; 1:400 for IF)
was used to stain F-actin. DAPI (Sigma) was used to stain nuclei.
The following antibodies were used for flow cytometry: β1-integrin PE (102207,
HMβ1-1, BioLegend; 1:400), β1-integrin biotin (555004, Ha2/5, BD Pharmingen;
1:400), β1-integrin 9EG7 (550531, 9EG7, BD Pharmingen; 1:100), β3-integrin PE
(12-0611, 2C9.G3, eBioscience; 1:400), β4-integrin PE (MCA2369, 346-11A, Serotec;
1:400), α2-integrin FITC (554999, Ha1/29, BD Pharmingen; 1:400), α5-integrin PE
(557447, 5H10-27, BD Pharmingen; 1:400), α5-integrin biotin (557446, 5H10-27,
BD Pharmingen), α6-integrin PE (555736, GoH3, BD Pharmingen) and αv-integrin
PE (551187, RMV-7, BD; 1:400).
Plasmids and constructs. Point mutations into the β1-integrin (TT788/789AA,
Y783A, Y795A, 8xKR (K752R, K765R, K768R, K770R, K774R, K784R, K794R,
K798R), 8xKR+TT788/789AA), α5-integrin (4xKR (K1022R, K1027R, K1038R,
K1042R)) and SNX17 (QW360/361AA) cDNA were introduced by site-directed
mutagenesis. For stably expressing the β1-integrin cDNAs (wt, TT788/789AA,
Y783A, Y795A, 8xKR, 8xKR+TT/AA), the human α5 integrin (wt, 4xKR, α5–eGFP)
and the mouse SNX17 (wt, Flag-tagged, eGFP-tagged and mCherry-tagged),
we used the retroviral expression vector pCLMFG or pLZRS. For recombinant
expression of GST-tagged SNX17, wt SNX17 and SNX17QW360/361AA, cDNA
was cloned into the pGEX-6P-1 vector (GE Healthcare). Lamp1–mRFP and
Rab7–mRFP vectors were obtained from J. Norman (Beatson Institute, Glasgow,
UK), and Rab5a–GFP was provided by L. Huber (Medical University Innsbruck,
Austria) and transiently expressed by transfection with Lipofectamine 2000
(Invitrogen).
For stably depleting SNX17 expression, shRNA target sequences were introduced
into the pSuper.Retro vector (OligoEngine) to produce retroviral particles: 5′-
GTACATGCAAGCTGTTCGG-3′ (shSNX17-1), 5′-GATTGTGCTCAGAAAGAGT-
3′ (shSNX17-2).
To obtain a GFP-tagged Kindlin-2, the Kindlin-2 cDNA (ref. 36) was ligated
in frame with the GFP using sequence- and ligation-independent cloning38. The
CAG promoter, GFP fusion and SV40 polyA were flanked by ITR elements; thus,
co-transfection of this construct with a sleeping beauty SB100x expression vector39
resulted in transposase-mediated genomic integration of this DNA sequence.
Cell lines. Heterozygous β1 TT/AA mice were intercrossed with homozygous
β1-floxed mice and mouse embryonic fibroblasts were isolated from E9.5 embryos,
immortalized with the SV40 large T antigen and cloned before deletion of the floxed
β1-integrin allele by adenoviral Cre transduction. Disruption of the β1 allele and
expression of the β1 TT/AA were checked by PCR. To generate β1-null rescue cell
lines, β1 wt or β1 mutant variants were virally re-expressed in β1-null fibroblasts
derived from floxed β1 parental cells.
Fibroblasts homozygous for floxed kindlin-1 and -2 genes were isolated from
kidneys of 21-day-old double-floxed mice (whose generation will be described
elsewhere), immortalized as described above and cloned. To obtain Kindlin-1 and
-2 double-null cells, the floxed kindlin alleles were removed by adenoviral Cre
transduction.
Transient and stable transfection/transduction. Cells were transiently trans-
fected with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
protocol. To generate stable cell lines, VSV-G pseudotyped retroviral vectors
were produced by transient transfection of HEK293T (human embryonic kidney)
cells. Viral particles were concentrated from cell culture supernatant as described
previously40 and used for infection.
Embryo isolation and histological analysis. For whole-mount analysis, staged
embryos (E6.5 to E9.5) were dissected in ice-cold PBS. For histological analysis,
decidua swellings were isolated, fixed in 4%paraformaldehyde (PFA) and embedded
in paraffin. Sections were stained with haematoxilin and eosin or antibodies as
indicated.
Whole-mount immunohistochemistry. Embryoswere dissected in cold PBS and
fixed in 4% PFA for 2 h at 4 ◦C. Samples were incubated in 0.5% NP-40/PBS for
20min and in PBSST (0.1% Triton X-100 and 5% BSA in PBS) for 2 h at 4 ◦C
and then incubated with the primary and secondary antibody, both overnight at
4 ◦C. Nuclei were stained with DAPI solution for 30min. Finally, embryos were
dehydrated by increasingmethanol concentrations, cleared in benzyl alcohol/benzyl
benzoate (1:2) and imaged with a confocal microscope (DMIRE2; Leica) using Leica
Confocal Software (version 2.5 Build 1227). After imaging, embryoswere rehydrated
for genotyping.
ES cells and embryoid bodies. ES cells were isolated and cultured as previously
described41. Embryoid bodies were generated as described previously41.
Metabolic labelling. Cells were grown overnight to 80% confluency and incubated
for 30min at 37 ◦C in methionine/cysteine-free labelling media containing 10%
dialysed FBS. For pulse labelling, the cells were incubated for 30min at 37 ◦C
in labelling medium containing [35S]methionine/cysteine (200 µCi/10 cmplate,
EasyTag Express 35S Protein Labeling Mix, PerkinElmer). After labelling, the cells
were either immediately collected (time 0) or chased for 4 h, 8 h and 22 h in regular
growth medium containing 10% FBS. Cells were lysed in immunoprecipitation
buffer (50mM Tris–HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.1% sodium
deoxycholate, 1mM EDTA and protease inhibitors) and cleared by centrifugation.
For β1 immunoprecipitation, lysates were first incubated with β1 antibodies for 1 h
on ice followed by incubation with protein G Sepharose (Sigma) for 2 h at 4 ◦C with
gentle agitation. After several washes with lysis buffer, proteins were eluted from the
beads by boiling with Laemmli sample buffer and subjected to SDS–PAGE. The gels
were fixed, dried and exposed to film.
Turnover of surface integrins. The half-life of surface proteins was determined
by biotinylation. Briefly, fibroblasts were grown to 80% confluence, washed twice
in cold PBS and surface biotinylated with 0.2mgml−1 sulpho-NHS-LC-biotin
(Thermo Scientific) in PBS for 45min at 4 ◦C. Following washes with cold PBS,
the cells were incubated in regular growth medium for 0, 5, 10 and 15 h at 37 ◦C.
Cells were lysed in immunoprecipitation buffer and biotinylated proteins were
pulled down with streptavidin–Sepharose (GE Healthcare). After three washes
with lysis buffer, samples were analysed by SDS–PAGE and western blotting. For
capture-ELISA, cells were lysed in a low volume of lysis buffer (75mMTris, 200mM
NaCl, 7.5mM EDTA and 7.5mM EGTA, 1.5% Triton X-100, 0.75% Igepal CA-630
and protease inhibitors).
Integrin-trafficking assays. Integrin-trafficking assays were performed as de-
scribed previously42.
Capture ELISA. Maxisorb 96-well plates (Life Technologies) were coated
overnight with anti-β1-integrin antibody (MAB1997, Chemicon; 1:250) in
carbonate buffer at 4 ◦C. Unspecific binding was blocked by 5% BSA in PBS/0.1%
Tween-20 (PBS-T) for 1–2 h at room temperature before adding 50 µl cell lysate
for incubation overnight at 4 ◦C to capture integrins. Following extensive washes
with PBS-T, plates were incubated with streptavidin–HRP in 1% BSA in PBS-T
for 1 h at 4 ◦C. Biotinylated β1 integrin was detected after several washing steps by
chromogenic reaction with ABTS peroxidase substrate (Vector Laboratories).
Selective immunoprecipitations. Selective isolation of β1 integrins on the cell
surface and in endocytic vesicles was achieved by cell-surface immunoprecipitation.
Cell-surface β1 integrins of live cells were labelled with a rabbit anti-β1-integrin anti-
body (home-made; 1:1,500) for 1 h on ice. After two washes with ice-cold PBS to re-
move unbound antibody, cells were incubated for 20min inmediumwith orwithout
0.5mMprimaquine to inhibit integrin recycling to the cell surface42. Cells were then
washed twice with PBS, lysed in immunoprecipitation buffer and cleared by centrifu-
gation.β1-integrin immune complexeswere pulled downby incubationwith protein
G Sepharose (Sigma) for 2 h at 4 ◦C with gentle agitation. After several washes with
lysis buffer, proteins were subjected to SDS–PAGE and western blot analysis.
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SILAC-based peptide pulldowns. Pulldowns were performed as described
previously43 with β1 wt cytoplasmic tail peptides (758–598: HDRREFAKFEKEKM-
NAKWDTGENPIYKSAVTTVVNPKYEGK-OH), β1 TT/AA tail peptide (HDR-
REFAKFEKEKMNAKWDTGENPIYKSAVAAVVNPKYEGK-OH), β1 Y795A tail
peptide (HDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKAEGK-OH), a
scrambled peptide (EYEFEPDKVDTGAKGTKMAKNEKKFRNYTVHNIWESRK-
VAP-OH) and α5 peptide (KLGFFKRSLPYGTAMEKAQLKPPATSDA-OH). All
peptides were desthiobiotinylated. Before use, peptides were immobilized on 75 µl
Dynabeads MyOne Streptavidine C1 (10mgml−1, Invitrogen).
After cell-lysate generation and incubation with tail peptides, proteins were
eluted and precipitated as described previously43. The protein pellet was dissolved
in SDS–PAGE sample buffer and separated on a 4–15% gradient SDS–PAGE gel.
The gel was stained with Coomassie blue using the GelCode Blue Safe Protein Stain
reagent (Thermo Scientific) and used for mass analysis.
Expression and purification of recombinant proteins. Plasmids encoding
GST–SNX17 or GST–SNX17QW/AA were transformed into BL21(DE3) Arctic
Express Escherichia coli, and protein expression was induced with 1mM IPTG.
Afterwards, cells were pelleted, lysed and centrifuged. Supernatants were incubated
with glutathione Sepharose beads (GST-binding resin, Novagen) and GST-tagged
proteins were eluted according to the manufacturer’s instruction.
Plasmid coding for His-tagged Kindlin-2 was transformed into BL21 T1 pRARE
bacteria. Supernatants were generated as described above, incubated with His-Select
Ni Affinity gel (Sigma) and His-tagged Kindlin-2 was eluted and subjected to gel
filtration for further purification.
For pulldowns, synthetic peptides were immobilized on 20 µl Dynabeads MyOne
Streptavidine C1 (10mgml−1, Invitrogen) for 3 h at 4 ◦C, incubated with 2% BSA
in Mammalian Protein Extraction Reagent (Thermo Scientific) for 30min to block
unspecific binding before adding 50 ng recombinant GST-tagged SNX17 protein
and further incubation on a rotator for 2 h at 4 ◦C. For competition experiments,
50 ngGST–SNX17 and 500 ngHis–Kindlin-2 or 500 ng BSAwere incubated with the
tail peptides for 3 h at 4 ◦C. After three washes with RIPA buffer, proteins were eluted
from the beads by boiling with 80 µl SDS–PAGE sample buffer for 5min, separated
by SDS–PAGE gel and blotted with SNX17 antibody.
Quantitative PCR. RNA was isolated from cells using the RNeasy mini
kit (Qiagen) and 1 µg of total RNA was transcribed into cDNA using the
iScriptcDNA Synthesis kit (Bio-Rad). Quantitative PCR assays were per-
formed with the iCycleriQ (Bio-Rad) using SYBR green and the follow-
ing primers: β1 integrin-forward (5′-atgccaaatcttgcggagaat-3′), β1 integrin-
reverse (5′-tttgctgcgattggtgacatt-3′), β3 integrin-forward (5′-ccacacgaggcgtgaact
c-3′), β3 integrin-reverse (5′-cttcaggttacatcggggtga-3′), GAPDH-forward (5′-
tcgtggatctgacgtgccgcctg-3′), GAPDH-reverse (5′-caccaccctgttgctgtagccgtat-3′).
Immunofluorescence microscopy. For immunostaining, cells were cultured
on glass coated with 10 µgml−1 fibronectin (Calbiochem). For the detection of
endosomes, cells were fixed with 4% PFA/PBS for 15min on ice, washed with PBS
and permeabilized with 0.01% saponin/PBS for 10min on ice. Cells were blocked
with 3% BSA/PBS for 1 h followed by incubation with the primary antibody in
3% BSA/0.01% saponin/PBS overnight at 4 ◦C and secondary antibodies for 1 h
at room temperature in the dark. All other staining was performed as described
previously44.
To determine the endocytic trafficking of β1 integrins from the cell surface
by surface labelling, cells were washed with cold PBS and incubated with
an anti-β1-integrin antibody (102202, HMβ1-1, BioLegend; 1:400) for 30min
on ice. Surface-bound antibody was allowed to internalize for different times
at 37 ◦C in regular growth medium. At each time point, the samples were
washed with cold PBS and the remaining antibody at the cell surface was
removed by two acid washes (0.2M acetic acid/0.5M NaCl/PBS) for 2min on
ice. Subsequently, the cells were fixed, permeabilized and stained as described
above.
Images were collected at room temperature by confocal microscopy (DMIRE2;
Leica) with a×63/1.4 objective using the Leica Confocal Software (version 2.5, build
1227) or collected with an AxioImager Z1 microscope (Zeiss) with a ×63/1.4 oil
objective.
Time-lapse videomicroscopy of cell spreading andmigration. Cell spreading
and single-cell migration assays were done as described previously44. Cell spreading
was also measured with cells seeded on fibronectin-coated glass slides, fixed with
4% PFA at 37 ◦C at indicated time points and stained with phalloidin–Alexa488 for
F-actin. Images were taken with an AxioImager Z1 microscope (Zeiss, Germany)
with a ×20 objective and the spreading area was calculated using MetaMorph 7
(Molecular Devices) imaging software.
For single-cell migration, the acquired images were analysed using the manual
tracking plugin of ImageJ and the Chemotaxis and Migration Tool (v2.0) of the
QWT project.
Cell-wounding assays were performed with confluent monolayers of cells
cultured in fibronectin-coated 6-well dishes. Cells were serum-starved overnight
before wounds were applied with a 200 µl plastic micropipette followed by thorough
washing with PBS. Wound closure was imaged in serum-free medium at 15min
intervals overnight. The acquired images were analysed using the manual tracking
plugin of ImageJ and the Chemotaxis andMigration Tool (v2.0) of the QWTproject.
Images of live cells were recorded at 37 ◦C and 5%CO2 on a Zeiss Axiovert 200M
(Zeiss, Germany) equippedwith×10/.3,×20/.4 and×40/.6 objectives, amotorized
stage (Märzhäuser) and an environment chamber (EMBL Precision Engineering)
with a cooled CCD (charge-coupled device) camera (Roper Scientific). Image
acquisition and microscope control were carried out with MetaMorph software
(Molecular Devices).
Statistics. Statistical analysis was performed using the GraphPad Prism software
(version 5.00, GraphPad Software). Statistical significance was determined by the
unpaired t -test or Mann–Whitney U -test as indicated. Results are expressed as the
mean± s.d. unless indicated otherwise.
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Figure S1 Defects of β1 TT/AA and β1 Y795A ES cells. (a) Brightfield images 
of E7.5 embryos without implantation chamber. (b) Upper panels show 
brightfield images of EBs on the 5th day of suspension culture. Lower panels 
show cryo-sections of EBs on the 5th day of suspension culture stained for 
β1 integrin (red) and laminin111 (green). Nuclei were counterstained with 
DAPI (blue). (c) Cryo sections of EBs on the 5th day of suspension culture 
stained for β-catenin, E-cadherin, F-actin and laminin111. Nuclei were 
counterstained with DAPI (blue). (d) ES cell colonies on feeder cells. (e) 
Expression of integrin subunits on ES cells determined by FACS (mean ± 
SD; n=5; ***p (student’s t-test)≤0.0005; ns=not significant). (f) Integrin 
activation on ES cells measured by 9EG7 binding and corrected for total β1 
integrin expression (mean ± SD; n=5; **p (student’s t-test)=0.0043; ns=not 
significant). (g) Expression of β1 integrin mRNA in ES cells measured by qRT-
PCR (n=2). Scale bar, 100 µm (a, b, d), 50 µm (c).
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S2 Characterization of fibroblasts expressing β1 TT/AA integrin. (a, 
b) Scheme depicting the generation of β1 wt and β1 TT/AA fibroblasts. β1 
wt and β1 TT/AA fibroblasts were either obtained by retroviral expression 
of β1 variants in β1 null cells (a) or by immortalization of fibroblasts 
from mouse embryos (b). (c, d) Surface expression of different α and β 
integrin subunits on β1 wt and β1 TT/AA fibroblasts determined by FACS 
(mean ± SD; n=6 (c); n=4 (d); *p (student’s t-test)<0.05, **p (student’s 
t-test)=0.0022, ***p (student’s t-test)<0.0001; ns=not significant). (e, 
f) β1 integrin mRNA levels determined by qRT-PCR (mean ± SD; n=3 
with two independent cDNAs; *p (student’s t-test)=0.015, **p (student’s 
t-test)=0.0032). (g) Western blot analysis of fibroblast cell lines with 
antibodies against β1 integrin and actin. (h) β1 integrin activation 
measured by 9EG7 binding and corrected for β1 integrin expression (mean 
± SD; n=4; **p (student’s t-test)=0.0097).
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S3 SNX17 localization in fibroblasts. (a) Streptavidin-bead pull-
down assay with a biotinylated wild-type β1 integrin cytoplasmic tail 
peptide and recombinant GST-tagged SNX17 and His-tagged Kindlin-2. (b) 
Immunostaining of SNX17-EGFP expressing cells for Tfr (red). Nuclei were 
counterstained with DAPI (blue) (correlation coefficient 0.032 ± 0.121; 
mean ± SD of 13 cells analyzed). (c, d) SNX17-EGFP expressing cells were 
transfected with Lamp1-mRFP (c) and Rab7-mRFP (d) and the fluorescence 
distribution was determined in living cells by spinning disk confocal 
microscopy. Stills of movies are shown (correlation coefficient Rab7-mRFP 
-0.454 ± 0.106; mean ± SD of 15 cells analyzed). (e) Distribution of SNX17-
mCherry and α5 integrin-EGFP in living cells determined by spinning disk 
confocal microscopy. A still of a movie is shown. (f) Distribution of β1 TT/
AA integrins in SNX17-EGFP expressing cells after surface labeling with an 
anti-β1 integrin antibody and internalization for 15 min. Cells were fixed, 
stained and the fluorescence was determined with confocal microscopy. 
(g) Localization of active β1 integrins after surface labeling with a 9EG7 
antibody and internalization for 15 min in SNX17-EGFP expressing cells. The 
fluorescence was determined with confocal microscopy. Scale bars, 20 µM.
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S4 SNX17 regulates β1 integrin surface levels. (a) Stability of 
surface β1 integrin in the indicated cell lines determined by surface 
biotinylation followed by capture-ELISA (mean ± SD; n=3). SNX17 
levels were restored in SNX17-depleted cells by re-expressing either 
siRNA-insensitive wt SNX17 or SNX17QW/AA. (b) SNX17-depleted β1 
TT/AA expressing cells were surface biotinylated and incubated for the 
indicated time points, before biotinylated proteins were pulled-down with 
streptavidin-sepharose and analyzed by western blotting. (c) Localization 
of endogenous β1 integrin after surface labeling with an anti-β1 integrin 
antibody and internalization for 10 and 30 min in β1 wt, β1 TT/AA and 
SNX17-depleted cells, respectively treated with or without bafilomycin. 
Cells either expressed Rab5a-GFP or were fixed and stained with antibodies 
against Lamp1. Nuclei were counterstained with DAPI (blue). Scale bar, 20 
µM. (d) Bafilomycin normalizes the recycling of β1 wt in SNX17-depleted 
cells. The quantity of biotinylated β1 integrin remaining within the cells 
was determined by capture-ELISA using β1 integrin specific antibodies 
(mean ± s.e.m.; n=3). (e) Quantification of β1 surface levels by FACS in 
indicated cell lines treated for 8 h with and without bafilomycin (mean ± 
SD; n=3; *p (student’s t-test)=0.0133, ***p (student’s t-test)<0.0006; 
ns=not significant).
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S5 Focal adhesions and the actin cytoskeleton are not affected 
in β1 TT/AA, β1 Y795A and SNX17-depleted cells. β1 wt, β1 TT/AA, β1 
Y795A and SNX17-depleted β1 wt cells were stained with an antibody 
against paxillin (red) and fluorescently labelled phalloidin to visualize 
F-actin (green). Nuclei were counterstained with DAPI (blue). Scale bar, 
50 µM.
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S6 Full scans of the key immunoblots. Boxes indicate cropped images used in the figures and numbers indicate the molecular weight.
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S6 continued
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Figure S6 continued
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Supplementary Movie 1 Time-lapse video recording of spreading β1 (-/-), β1 wt β1 TT/AA, and SNX17-depleted cells on FN (pictures taken every 10 min, 
imaging period 4 hrs).
Supplementary Movie 2 Time-lapse video recording of migrating β1 wt, β1 TT/AA, SNX17-depleted cells (shSNX17) and SNX17-depleted cells rescued with 
wild-type SNX17 (shSNX17 + SNX17) on FN (pictures taken every 10 min, imaging period 6 hrs).
Supplementary Table 1 List of β1 interactors from the SILAC-based β1 wt tail peptide versus scrambled peptide pull-down. 
List of the proteins that showed an increased binding (>2.0 fold) to the β1 wt tail peptide against the scrambled peptide. Protein names, gene names, SILAC-
ratios and intensities are listed.
© 2012 Macmillan Publishers Limited.  All rights reserved. 
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Trafficking of α5β1 integrin to lysosomes and its subsequent degradation is influenced by ligand occupancy
and the binding of SNX17 via its protein 4.1, ezrin, radixin, moesin (FERM) domain to the membrane-distal
NPxY motif in the cytoplasmic domain of β1 integrin in early endosomes. Two other sorting nexin (SNX) family
members, namely SNX27 and SNX31, share with SNX17 next to their obligate phox domain a FERM domain,
which may enable them to bind β integrin tails. Here we report that, in addition to SNX17, SNX31 but not
SNX27 binds several β integrin tails in early endosomes in a PI3 (phosphatidylinositide 3)-kinase-dependent
manner. Similarly like SNX17, binding of SNX31 with β1 integrin tails in early endosomes occurs between the
FERM domain and the membrane-distal NPxY motif in the β1 integrin cytoplasmic domain. Furthermore,
expression of SNX31 rescues β1 integrin surface levels and stability in SNX17-depleted cells. In contrast to
SNX17, expression of SNX31 is restricted and found highly expressed in bladder and melanoma tissue.
Altogether, these results demonstrate that SNX31 is an endosomal regulator of β integrins with a restricted
expression pattern.
© 2014 Elsevier Ltd. All rights reserved.Introduction
Integrins constitute a major family of adhesion
molecules. They are composed of an α subunit and a
β subunit, which together mediate interactions of
cells with proteins of the extracellular matrix.
Although cell adhesion depends on integrin surface
expression, the residence time of integrins on the
cell surface is short and terminated by internalization
followed by their routing into the endosomal network,
where they are sorted into specific recycling or
degradative pathways [1,2]. The endosomal traffick-
ing of integrins regulates cell behavior by controlling
integrin stability, integrin availability and distribution
on the cell surface, and signaling of growth factor
receptors that traffic together with integrins [1].
The pathways controlling the recycling of α5β1
integrin are heavily investigated and quite well
understood. Less well known are the mechanisms
underlying the degradation of α5β1 integrin or theer Ltd. All rights reserved.consequences when integrin degradation is misregu-
lated. The trafficking of α5β1 integrin to lysosomes and
its subsequent degradation is influenced by ligand
occupancy [3,4] and controlled by the binding of
SNX17 [5,6]. Ligand-bound α5β1 integrin is ubiquiti-
nylated, sorted to lysosomes, and degraded when
CLIC3 is absent [3,4], while in the presence of CLIC3,
lysosomally targetedα5β1 integrins recycle back to the
plasma membrane [3]. Inactive α5β1 integrins are
routed to early endosomes where they recruit SNX17
to the membrane-distal NPxY motif in the β1 integrin
tails to prevent routing of β1 integrins to the lysosome
resulting in their recycling back to the cell surface [5].
SNX17 belongs to the large family of sorting nexin
(SNX) proteins characterized by the presence of a
phox (PX) homology domain, which mediates the
association with mono-phosphoinositide-enriched
membranes of the early endocytic network [7,8].
SNX proteins are structurally classified into different
subfamilies depending on their additional proteinJ. Mol. Biol. (2014) 426, 3180–3194
3181SNX31 Regulates β1 Integrin Stabilitydomains [7,8]. The SNX-protein 4.1, ezrin, radixin,
moesin (FERM) subfamily consists of three members,
SNX17, SNX27, and SNX31 [9], and is defined by the
presence of a FERM domain capable of binding NxxY
motifs in integral membrane proteins [10]. The recruit-
ment of SNX17 to NxxY motifs is required for the
retrieval of β1 integrins and several other transmem-
brane proteins from the degradation pathway [5,6,11–
14]. SNX27 is distinct from SNX17 and SNX31 as it
harbors an additional PDZ domain that can engage
PDZ binding motifs at the C-terminus of transmem-
brane proteins [15]. It has recently been shown that
SNX27 prevents lysosomal routing of β2 adrenergic
receptors and transmembrane proteins required for
maintaining cellular nutrient homeostasis through
binding to theSNX-BAR retromer [16,17]. Furthermore,
loss of SNX27 was also shown to contribute to
excitatory synaptic dysfunction in Down's syndrome
patients by affecting glutamate receptor recycling [18].
Unlike SNX17 and SNX27, the functional properties of
SNX31 are unknown. A genome-wide mutation study
identified several driver coding mutations within
SNX31 in human melanoma [19]. Whether they play
a role in melanoma, however, is not known.
In the present study, we investigated whether the
SNX-FERM subfamily members are able to bind
integrins and control integrin stability. We report that
(i) SNX17 and SNX31 but not SNX27 bind different β
integrin cytoplasmic domains; (ii) this interaction de-
pends on an intact FERM domain in SNX31 and the
membrane-distal NPxY motif in the β1 integrin tail;
(iii) SNX31 is highly expressed in bladder and primary
skin melanoma; (iv) SNX31 is recruited to early endo-
somes in a PI3 (phosphatidylinositide 3)-kinase-
dependent manner where it co-localizes with β1
integrins; and (v) SNX31 rescues β1 integrin surface
levels and stability in SNX17-depleted mouse fibro-
blasts. Our findings show that both SNX17 andSNX31
are engaged in fine-tuning the surface levels of β1
integrins.Results
SNX17 and SNX31 but not SNX27 bind various β
integrin subunits
The SNX-FERM subfamily of PX domain containing
proteins is defined by the presence of a FERM domain
capable of binding NxxY motifs in integral membrane
proteins [9] (Fig. 1a). A sequence alignment of its three
murine family members, SNX17, SNX27, and SNX31,
revealed that SNX17 and SNX31 are most closely
related, sharing 37% identity, while SNX27 is more
distantly related sharing 14% and 13% identity with
SNX17 and SNX31, respectively (Fig. 1b and c). The
identity within the FERM domain ranges between 22%
and 36% (Fig. 1d).SNX17 regulates turnover and recycling of α5β1
integrin through a direct binding of its FERM domain to
the membrane-distal NxxY motif of β1 integrin
cytoplasmic tails [5]. To test whether the other two
members of the SNX-FERM subfamily, SNX27 and
SNX31, also bind integrin tails, we expressed Flag-
tagged SNX27 and Flag-tagged SNX31 in mouse
fibroblasts either expressing endogenous SNX17 or
depleted of SNX17 (Fig. 2a), lysed the cells, and
performed pull-down experiments with several β
integrin tail peptides (Fig. 2b–d). As expected, all
wild-type β cytoplasmic tail peptides pulled down the
integrin activating protein Talin [20] (Fig. 2b–d). As
shownpreviously, SNX17 bound theβ1 integrin tail [5],
less efficiently theβ2 integrin tail, andmore strongly the
β3,β5, andβ6 integrin tails (Fig. 2b and c). Flag-tagged
SNX31 showed robust binding to the β5 and β6 tails
and less efficient binding to β1, β2, and β3 tails (Fig. 2b
and d). In contrast, SNX27 bound neither β integrin tail
peptide tested (Fig. 2c and d). Importantly, siRNA-
mediated depletion of endogenous SNX17 did not
change the binding profile of Flag-tagged SNX31 or
Flag-tagged SNX27 (Fig. 2d).
The F3-FERM subdomain of Talin, Kindlin, and
SNX17 is essential for β integrin tail binding [5,21,22].
A conserved QW motif present in the F3-FERM
domain of SNX17 and SNX31 is crucial for the
SNX17–β1 integrin interaction. To test whether the
QW motif in SNX31 is also required for β integrin tail
binding, we substituted both residues with alanines
(QW356/357AA), stably expressed the mutant cDNA
in mouse fibroblasts, and performed pull-down exper-
iments with the β1 integrin tail peptide. The experi-
ments revealed that Talin, SNX17, and wild-type
SNX31 bound the β1 integrin wild-type tail peptide,
while SNX31-QW/AA failed to bind the β1 tail peptide,
indicating that SNX31 shares the integrin tail binding
mode with SNX17 (Fig. 3a). As expected, we only
observed background binding of the integrin tail
binding proteins to the scrambled peptide (Fig. 3a).
We also investigated whether SNX31 binding requires
an intact proximal and/or distal NPxY motif in the β1
integrin tail by substituting the tyrosine residue with an
alanine residue in either the membrane-proximal
NPxY motif (β1 Y783A) or membrane-distal NxxY
motif (β1 Y795A). As shown previously for SNX17 [5],
Flag-tagged SNX31 binding was strongly reduced to
β1 Y795A, while binding to β1 Y783A was only
moderately reduced (Fig. 3b). To determine whether
SNX31 directly interacts with the β1 integrin tail, we
performed integrin tail peptide pull-down experiments
with recombinant wild-type GST (glutathione S-trans-
ferase)-tagged SNX31 or the integrin-binding-deficient
GST-tagged SNX31-QW/AA. The results of the pull-
down experiments revealed that SNX31bounddirectly
to β1 wild type while we observed very weak or no
binding to β1 Y795A or scrambled peptides (Fig. 3c).
Importantly, the QW/AA substitution in SNX31 abol-
ished binding to wild-type β1 integrin tail (Fig. 3c). As
Fig. 1. Sequence alignment of the three murine SNX-FERM subfamily members. (a) Predicted domain structures of the
three mouse SNX-FERM family members. (b) Sequence alignment of mouse SNX17, SNX27, and SNX31. The location of
PX, FERM, and PDZ subdomains are indicated. Amino acids conserved in all three SNX-FERM proteins are shown in red,
and amino acids similar across the three proteins are indicated in yellow. (c and d) Matrix of pairwise identity percentages
of the three SNX-FERM family members using the entire sequences (c) or the FERM domains (d).
3182 SNX31 Regulates β1 Integrin Stabilitywe cannot rule out that the SNX-FERM proteins bind
differently to full-length integrins than to the cyto-
plasmic tail peptides, we finally investigated if theinteraction of SNX31 with β1 integrins can also be
demonstrated with the endogenous full-length β1
integrin. For this, we expressed either SNX17 only or
Fig. 2. SNX31 and SNX17 but not SNX27 interact with several β integrin cytoplasmic domains. (a) Western blot
analysis of control mouse fibroblasts (shCtr) and SNX17 knockdown (shSNX17) cells used for pull-down experiments
stably expressing different Flag-tagged SNX-FERM proteins with antibodies against the Flag-tag and SNX17. Actin served
as loading control. (b and c) Biotinylated β integrin cytoplasmic tail peptides were analyzed for binding of endogenous
SNX17, Flag-tagged SNX27, and Flag-tagged SNX31 by Western blotting. The indicated biotinylated β integrin
cytoplasmic tail peptides were immobilized on Streptavidin beads and subsequently incubated with protein lysates of cells
expressing Flag-tagged SNX31 (b) or Flag-tagged SNX27 (c). After washing, we analyzed the pulled-down proteins by
Western blotting for the binding of the different FERM-SNX family members. Binding of Talin, a known β integrin
cytoplasmic interactor, served as positive control showing the functionality of the tail peptides. Whole cell lysate was
loaded next to the pull-down samples to show expression of the different proteins. Wcl, whole cell lysate; marker,
molecular mass standard. (d) Western blot showing Flag-tagged SNX27 and Flag-tagged SNX31 binding to the
biotinylated integrin tail peptides in lysates of SNX17-depleted cells. A second cell lysate sample was loaded to show the
SNX17 depletion and the expression levels of Flag-tagged proteins. Wcl, whole cell lysate.
3183SNX31 Regulates β1 Integrin StabilitySNX17 together with Flag-tagged SNX31 in mouse
fibroblasts and enriched the endosomal pool of
antibody-labeled and internalized surface β1 integrins
with primaquine, which was shown to inhibit recycling/
exocytosis [23]. Immunoprecipitation of the endoso-
mally enrichedβ1 integrins co-precipitated SNX17 and
SNX31 while they did not bind to the transferrin re-
ceptor (TFR) under the same conditions (Fig. 3d).
Interestingly, co-expression of Flag-tagged SNX31
reduced the amount of endogenous SNX17 bound to
β1 integrins, showing that SNX31 can compete with
SNX17 for β1 binding (Fig. 3d). In line with our peptide
pull-down data, neither SNX17 nor SNX31 was co-
immunoprecipitated with β1 Y795A integrin (Fig. 3d).
Altogether, these findings indicate that SNX17
and SNX31 but not SNX27 directly bind β integrin
cytoplasmic domains. This interaction requires anintact SNX-FERM domain and the membrane-distal
NxxY motif within the integrin cytoplasmic tail.
Expression pattern of SNX31 in mouse tissues
and human cell lines
The function, expression pattern, and subcellular
localization of SNX31 are not known.We first analyzed
RNA-seq expression data of coding RNAs from 27
different human tissues [24] and microarray data of
191 mouse samples [25] that indicated a restricted
SNX31 expression pattern. In human tissues, SNX31
was highly expressed in bladder; weakly expressed in
esophagus, heart, prostate, and testis; and absent in
all other organs tested. Similarly, SNX31 exhibited the
highest expression in mouse bladder and was 30–100
times less expressed in the mouse prostate and
Fig. 3. SNX31 requires an intact FERM domain for β1 integrin tail binding. (a) Streptavidin-bead pull-down of
biotinylated β1 integrin wild type and scrambled cytoplasmic tail peptides incubated with cell lysates containing wild-type
Flag-tagged SNX31 or Flag-tagged SNX31-QW/AA. SNX31 binding to the β1 integrin cytoplasmic tail peptides was
analyzed by Western blotting with an antibody against the Flag-tag. Binding of Talin, Kindlin-2, and SNX17 to the β1
integrin wild-type tail peptide indicated equal loading and functionality of the peptide. Wcl, whole cell lysate. (b)
Streptavidin-bead pull-down of indicated wild type and mutant biotinylated β1 integrin tail peptides incubated with cell
lysates expressing Flag-tagged SNX31 and subsequent Western blotting for Talin, Kindlin-2, and Flag-tagged SNX31. Bar
graph shows the quantification of Flag-tagged SNX31 binding to the mutant biotinylated β1 integrin tail peptides relative to
its binding to the β1 wild-type peptide. Western blot images were analyzed with ImageJ software for quantification
[mean ± SEM (standard error of the mean) (n = 5); ***p (student's t-test) b 0.001, n.s. = not significant]. (c)
Streptavidin-bead pull-down assay with the indicated biotinylated β1 integrin cytoplasmic tail peptides and recombinant
GST-tagged SNX31 or a GST-tagged SNX31-QW/AA. Synthetic peptides were immobilized on Streptavidin beads and
incubated with 2% BSA for 30 min to block unspecific binding prior to adding 150 ng recombinant GST-tagged SNX31 or
GST-tagged SNX31 QW/AA protein for 2 h at 4 °C. Protein binding to the β1 integrin cytoplasmic tail peptides was
analyzed by Western blotting with an antibody against the GST-tag. (d) Co-immunoprecipitation of Flag-tagged SNX31
with endogenous, endosomally enriched wild-type β1 integrin. Cell surface β1 integrins (either β1 wild type or β1 Y795A
integrin) or transferrin receptors were antibody labeled on ice followed by incubation of the cells for 10 min at 37 °C in
medium with 0.2 mM primaquine to enrich for receptor antibody complexes in endosomes. After cell lysis, β1 integrin
immune complexes were pulled-down, subjected to SDS-PAGE and Western blot analysis. Wcl, whole cell lysate.
3184 SNX31 Regulates β1 Integrin Stabilitycornea. To confirm this data and to elucidate the
relative expression levels of the three subfamily
members in different tissues, we performed quantita-
tive reverse transcription (RT)-PCR on RNA samples
derived from several mouse tissues and widely usedhuman cancer cell lines. While SNX17 and SNX27
were expressed in all mouse tissues and human cell
lines analyzed, high SNX31 expression was restricted
to the bladder and RT4 human urinary bladder cells
(Fig. 4a–c). Significantly lower SNX31 mRNA levels
3185SNX31 Regulates β1 Integrin Stabilitywere present in A2780 cells and vascular smooth
muscle cells while SNX31 transcripts were absent in
primary mouse keratinocytes, immortalized mouse
fibroblasts, and melanocytes (Fig. 4b and c).
Since whole exome sequencing of human melano-
mas identified several mutations in SNX31 [19], we
decided todeterminewhetherSNX17orSNX31mRNA
expression changes during melanoma progression. To
this end, we isolated total RNA from biopsies of benign
melanocytic nevi and in-transit melanoma metastases
and determined SNX17 and SNX31 mRNA levels by
quantitative PCR (Fig. 5a). We found that SNX17
expressionwasnot significantly changed in benign nevi
versusmetastatic melanoma, whileSNX31 expression
was decreased in metastatic melanoma. To further
delineate whether SNX17 or SNX31 RNA levels
correlate with metastasis, we measured their mRNA
levels in biopsies of primary skin melanoma, which
either have or lack sentinel lymph node (SLN)
metastasis. While SNX17 mRNA levels remained
unchanged in primary melanoma with and without
SLN metastasis, SNX31 levels decreased in melano-
ma with SLN metastasis (p b 0.0025) (Fig. 5b).Fig. 4. SNX31 mRNA levels in mouse tissues and human
levels in mouse tissues (a), mouse cell lines (b), and human cel
was extracted from organs of 6-week-old C57BL/6 mice, rever
SNX-FERM family members was determined by quantitative R
to GAPDH (mean ± SEM; n = 3). (b and c) Quantitative RT-PC
with cDNA derived from total RNA obtained from the indicated c
to GAPDH (mean ± SEM; n = 3). B16F10 (melanocyte cell li
muscle cell line), 1205LU (metastatic melanoma cell line), A27
(breast adenocarcinoma cell lines), U2OS (osteosarcoma cellTogether, these results show that SNX31 exhibits a
restricted expression pattern across tissues and cell
lines and decreases in invasive primary melanoma.
SNX31 localizes to early endosomes in a
PI3-kinase-dependent manner
SNX family members localize via their PX domains
to PI(3)P-rich membranes [1,8]. While SNX17 and
SNX27 were shown to be recruited to endosomes in a
PX-domain-dependentmanner [14,26], the distribution
of SNX31 in cells is unknown. We determined the
subcellular localization of SNX31 by transfecting HeLa
cells with eGFP (enhanced green fluorescent
protein)-tagged SNX31 followed by immunostaining
with antibodies against endosomal and lysosomal
marker proteins. SNX31 overlapped with the early
endosomal antigen 1 (EEA1), a marker for early endo-
somes, and weakly with transferrin receptor (TFR), a
marker for recycling endosomes [Fig. 6a and b; cor-
relation coefficients: 0.44 ± 0.10 (EEA1) and 0.19 ±
0.05 (TFR)]. In contrast, no apparent co-localization
was observed with the lysosomal acid membranecell lines. SNX17, SNX27, and SNX31 mRNA expression
l lines (c) measured by quantitative RT-PCR. (a) Total RNA
se transcribed into cDNA, and the expression of the three
T-PCR. Shown is the abundance of each transcript relative
R was performed for all three SNX-FERM family members
ell lines. Shown is the abundance of each transcript relative
ne), RT4 (urinary bladder cells), vSMC (vascular smooth
80 (ovarian carcinoma cell line), MDA-MB-231 and MCF-7
lines), and HeLa (cervical cancer cells).
Fig. 5. SNX31 expression during melanoma progression. (a and b) SNX31 expression is reduced in metastasizing
melanoma. (a) SNX17 and SNX31 RNA copy number in benign nevi and in-transit melanoma metastases. Total RNA was
extracted from 6 benign nevi and 6 in-transit metastases of FFPE patient-derived biospecimens, pooled, and reverse
transcribed into cDNA; the expression SNX17 and SNX31 was determined by quantitative RT-PCR. SNX copy number
was normalized to 25,000 copies of housekeeping genes [mean ± SD; ***p (student's t-test) b 0.0001, n.s. = not
significant]. (b) SNX17 and SNX31 RNA copy number in a consecutive series of 33 and 110 patients with primary
cutaneous melanoma, respectively. All patients had an SLN biopsy performed to rule out metastasis to regional lymph
nodes. SNX17 and SNX31 mRNA levels were determined by quantitative RT-PCR. SNX copy number was normalized to
25,000 copies of housekeeping genes. SNX31 copy number is reduced in melanoma that metastasize to SLN
(*p b 0.0025 by Mann–Whitney U-test). Red line: average. Black line: mean.
3186 SNX31 Regulates β1 Integrin Stabilityprotein 1 (Lamp1) and the late endosomal protein
Rab7 [Fig. 6c and d; correlation coefficients: −0.01 ±
0.08 (Lamp1) and − 0.02 ± 0.06 (Rab7) ] .
Co-transfection of eGFP and mCherry fusion proteins
of SNX17, SNX27, and SNX31 revealed that all three
subfamily members co-localize in the early endosome
compartment [Fig. 6e and f; correlation coefficients:
0.56 ±0.07 (SNX17 versus SNX27) and 0.69 ± 0.08
(SNX31 versus SNX17)]. Since the early endosomal
localization of SNX17 and of SNX27 depend on the
interaction of their PXdomainswithPI(3)Ps [14,26], we
testedwhether the activity of PI3 kinases is required for
SNX31 localization by treating HeLa cells with the PI3
kinase inhibitor wortmannin, which reduces the level of
endosomal PI(3)P [27]. Live-cell microscopy and
immunostainings revealed that wortmannin induced
a rapid dislodgment of eGFP-tagged SNX17 and
eGFP-tagged SNX31 from early endosomes (Fig. 7a,
b, and d). In contrast, eGFP-tagged SNX27 was less
sensitive to PI3 kinase inhibition and remained bound
to intracellular membranes over a longer period of time
(Fig. 7c and d). We also analyzed whether the
localization of SNX-FERM proteins to endosomes
requires the PX domain by substituting a conserved
arginine residue in SNX17 (R36), SNX27 (R194), and
SNX31 (R37) critical for PI(3)P binding [9] with
glutamine. Subsequent immunostaining revealed that
an intact PX domain is indeed necessary for endoso-
mal localization as eGFP-tagged SNX17-R36Q,
SNX27-R194Q, and SNX31-R37Q lost their typicalpunctate staining pattern and instead showed a
uniform distribution throughout the cytoplasm
(Fig. 7e). In linewith our observation that eGFP-tagged
SNX27 was less sensitive to PI3 kinase inhibition, we
observed a weak residual endosomal pool of
SNX27-R194Q while similar mutations in SNX17 and
SNX31 completely abolished their endosomal locali-
zation (Fig. 7e).
Together, these data show that the SNX-FERM
subfamily members SNX17, SNX27, and SNX31
associate via their PX domains with early endosomes
in a PI3-kinase-dependent manner.
SNX31 rescues β1 integrin stability and surface
levels in SNX17-depleted cells
β1 integrins are widely used to elucidate general
mechanisms of integrin trafficking. Furthermore, it has
been shown recently that SNX17 is an essential
regulator of β1 integrin stability [5,6]. The interaction of
SNX31 with β1 integrin tails in vitro and its localization
to early endosomes suggest a role in β1 integrin
trafficking and/or degradation. To test whether SNX31
and β1 integrins co-localize, we performed live-cell
microscopy in mouse fibroblasts expressing eGFP-
tagged SNX31. These experiments revealed that
eGFP-tagged SNX31 and internalized antibody-
labeled β1 integrins co-localized in puncta-like struc-
tures reminiscent of endosomes (Fig. 8a). Next we
investigated whether SNX31 can rescue the
3187SNX31 Regulates β1 Integrin Stabilitydiminished β1 integrin stability in SNX17-depleted
cells by stably re-expressing wild-type Flag-tagged
SNX17, Flag-tagged SNX27, or Flag-tagged SNX31.
As expected, depletion of SNX17 significantly de-
creased the pool of mature β1 integrin (molecular
mass: 125 kDa) in whole cell lysates (Fig. 8b) and the
β1 integrin surface levels (Fig. 8c). The reduction in β1
integrin levels was accompanied with a decrease in α5
integrin levels (Fig. 8b). Importantly, expression ofFig. 6. SNX31 localizes to early endosomes. (a–c) HeLa ce
seeded onto fibronectin (5 μg/ml) overnight, fixed and stained w
(b), and Lamp1 (c). Nuclei were counterstained with DAPI (
microscopy. Scale bars represent 20 μm. Correlation coeff
(n = 14), and −0.01 ± 0.08 (Lamp1) (n = 11); mean ± SD. Fluo
the red lines using LSM software. (d) Co-expression of SNX
transfected with eGFP-tagged SNX31 and mRFP-tagged Rab
distribution was determined in living cells by spinning disk conf
represents 20 μm. Correlation coefficient: −0.02 ± 0.06; mea
family members in living cells. HeLa cells were transiently tra
SNX27 (e) or eGFP-tagged SNX31 and mCherry-tagged SN
seeded onto fibronectin-coated (5 μg/ml) glass-bottom dish
spinning disk confocal microscopy. A still of a movie is shown
along the red lines using LSM software. Scale bars represent 2
SNX27) (n = 6) and 0.69 ± 0.08 (SNX31 versus SNX17) (n =Flag-tagged SNX31 in SNX17-depleted cells normal-
ized thepool ofmatureβ1 integrin andα5 integrin levels
in cell lysates and β1 integrin on the cell surface, while
the integrin-binding-deficient Flag-tagged SNX31-QW/
AA or Flag-tagged SNX27 showed no effect (Fig. 8b
and c). To elucidate whether re-expressed SNX31
normalized β1 integrin surface levels by improving
protein stability, we determined the degradation kinet-
ics of the surface β1 integrins by surface labeling withlls transiently transfected with eGFP-tagged SNX31 were
ith antibodies against EEA1 (a), transferrin receptor (TFR)
blue). Images were obtained by laser scanning confocal
icients: 0.44 ± 0.10 (EEA1) (n = 13), 0.19 ± 0.05 (TFR)
rescence intensity line scan profiles were generated along
31 and Rab7 in HeLa cells. HeLa cells were transiently
7, seeded onto fibronectin overnight before fluorescence
ocal microscopy. A still of a movie is shown. The scale bar
n ± SD (n = 11). (e and f) Co-localization of SNX-FERM
nsfected with eGFP-tagged SNX17 and mCherry-tagged
X17 (f). Twenty-four hours after transfection, cells were
es and fluorescence distribution was determined using
. Fluorescence intensity line scan profiles were generated
0 μm. Correlation coefficients: 0.56 ± 0.07 (SNX17 versus
11); mean ± SD.
3188 SNX31 Regulates β1 Integrin Stabilitybiotin followed by capture ELISA. While β1 integrins
were rapidly degraded in SNX17-depleted fibroblasts,
expression of Flag-tagged SNX31 rescued β1 integrin
stability, although less efficiently compared to Flag-
tagged SNX17. In contrast, Flag-tagged SNX31-QW/
AA and Flag-tagged SNX27 had no effect (Fig. 8d).
These findings indicate thatSNX31can compensate
the lossof SNX17 andpreventβ1 integrin degradation.Discussion
Integrins are constantly endocytosed from the
plasma membrane and sorted in early endosomes for
degradation or recycling back to the plasmamembrane
[1]. A key player of β1 integrin endosomal sorting is the
SNX-FERM protein SNX17, which directly binds β1
integrin tails in early endosomes and thereby prevents
degradation by a still unknown mechanism. In the
present study, we investigated whether the other two
members of the SNX-FERM subfamily, SNX27 and
SNX31, share the properties of SNX17. We found that
this is the case for SNX31, while SNX27 neither
interacts with β integrin tails nor stabilizes cell surface
β1 integrins. SNX31 is a novel SNX family member
highly expressed in bladder and in primary melanoma
where it is frequently mutated [19].
The tails of α and β integrins bind a large number
of proteins, which enable integrin activation, clustering,
signaling, endocytosis, and recycling [28]. Since
integrin tails are short, protein binding is often
mutually exclusive and either occurs at temporally
distinct stages of adhesion site maturation or in
different subcellular compartments. TheKindlin binding
site in the membrane-distal NPxY motif of β1 integrin
tails is occupied by Kindlin at the plasma membrane to
increase integrin affinity for its ligands and by SNX17 in
early endosomes to prevent degradation [5,16,29,30].
We found that SNX31 is also able to bind the
membrane-distal NPxY motif of integrin β1 tails in
endosomes where it rescues β1 integrin stability in
SNX17-depleted cells. The FERM domain is key
for binding β integrin tails. Many NxxY integrin tailFig. 7. SNX31 localization to early endosomes is PI3 kinase
(a), eGFP-tagged SNX31 (b), and eGFP-tagged SNX27 (c) loca
the PI3 kinase inhibitor wortmannin. HeLa cells transiently tra
were seeded on fibronectin-coated (5 μg/ml) glass-bottom dis
spinning disk confocal microscopy. Wortmannin (0.4 μM) was a
for additional 8 min. Inverted images from selected time poi
disappearance of vesicular staining accompanied with an
treatment. (d) Quantification of vesicular staining of eGFP-t
SNX27 before and 8 min after DMSO or wortmannin (0.4 μM)
staining compared to cells before treatment [mean ± SEM, 10 c
U-test) b 0.001, **p (Mann–WhitneyU-test) = 0.0015, n.s. = not
eGFP-tagged wild-type SNX-FERM family members or version
seeded on fibronectin and incubated for 24 h before fixation a
were counterstained with DAPI (blue). Images were obtained by
20 μm.binding proteins including Talin, Kindlins, SNX17, and
SNX31 contain FERM domains. A third SNX member,
SNX27, also contains a FERM domain but is unable
to bind β integrin tail peptides and to stabilize β1
integrins. Although we cannot rule out that SNX27
interacts with full-length integrins, our findings are in
agreement with the inability of SNX27 to bind integrins
in peptide arrays [10] and to influence β1 integrin
surface levels in HeLa cells [6]. In contrast to SNX17
and SNX31, SNX27 shows preferential binding to
phosphorylated NxxY motifs in peptides and receptors
[10]. The levels of phosphorylated β1 integrin in
non-transformed cells are not detectable [31], which
might explain why SNX27 fails to associate with NxxY
motifs in integrins and hence fails to influence their
behavior.
In SNX17 knockdown cells, re-expression of SNX17
or expression of SNX31 regulated β1 integrin levels in
comparable manners. Bladder and melanoma cells
express SNX31 and SNX17 that both bind to the
membrane-distal NPxY motif on the β1 integrin tail.
Therefore, it is conceivable that SNX17 and SNX31
compete for β1 integrin binding in early endosomes.
This could provide cells with back-up proteins that are
functionally interchangeable. Alternatively, it could be
that SNX17 and SNX31 regulate the stability of
different integrin heterodimers when co-expressed in
cells depending on their relative expression levels and
their affinity for different β integrins and co-regulatory
proteins. In line with this hypothesis, we observed
differential binding patterns of SNX17 and SNX31 to
different β integrin tail peptides. A similar finding was
made with the three members of the Kindlin family,
which bind specific β integrin tails to regulate their
function; for example, the β1 and β3 integrin tails
associate with Kindlin-1 and Kindlin-2, while the β5
integrin tail binds Kindlin-1 but not Kindlin-2 [32,33].
Unfortunately, we were unable to deplete SNX31 with
several siRNAs or shRNAs in bladder carcinoma RT4
cells that co-express SNX17 and SNX31. It therefore
remains to be analyzed if SNX17 and SNX31 exhibit a
similar specificity for bindingβ integrin subunits in living
cells or regulate the stability of distinct integrins.dependent. (a–c) Montage showing eGFP-tagged SNX17
lization in HeLa cells before and after addition of DMSO or
nsfected with eGFP-tagged SNX-FERM family members
hes and fluorescence distribution was determined using
dded 90 s after start of the recording and cells were imaged
nts of these time lapse recordings are shown. Note the
increase of diffuse cytoplasmic signal after wortmannin
agged SNX17, eGFP-tagged SNX31, and eGFP-tagged
treatment. Values are provided as percentage of vesicular
ells in four independent experiments; ***p (Mann–Whitney
significant]. (e) HeLa cells were transiently transfected with
s carrying point mutations in the PX domain. The cells were
nd immunostaining with an antibody against EEA1. Nuclei
laser scanning confocal microscopy. Scale bars represent
3189SNX31 Regulates β1 Integrin StabilitySNX17 and SNX31 are the only β integrin tail inter-
actors known so far that regulate lysosomal degrada-
tion of integrins. Rab21 and p120RasGAP bind to
several integrin α subunits and their knockdowns affect
integrin recycling without decreasing integrin protein
levels [34,35]. Although other proteins such as syntaxin6 or CLIC3 were shown in cell depletion studies to
regulate lysosomal β1 integrin degradation [3,36,37],
their loss is more likely affecting more general aspects
of endosome properties such as vesicle fusion or
maintenance of intracellular membranes rather than
specific functionsof integrins. Themechanismbywhich
Fig. 8. SNX31 compensates for the loss of SNX17. (a) Co-localization of endogenous β1 integrin and eGFP-tagged
SNX31. Mouse fibroblasts expressing eGFP-tagged SNX31 were grown on fibronectin-coated (5 μg/ml) glass-bottom
dishes. Cells were incubated on ice and endogenous β1 integrin was surface labeled for 1 h with a fluorescently labeled
anti-β1 integrin antibody. Surface-bound antibody was allowed to internalize for 15 min at 37 °C and subsequently imaged
in living cells by spinning disk confocal microscopy. A still of a movie is shown. (b) Control mouse fibroblasts (shCtr),
SNX17 knockdown (shSNX17) cells, and rescue cell lines stably expressing different SNX-FERM proteins were analyzed
for their β1 and α5 integrin expression levels by Western blotting. Actin served as loading control. (c) Quantification of β1
integrin surface levels in the indicated cell lines determined by FACS [mean ± SD, n = 4; **p (student's t-test) = 0.0059,
*p (student's t-test) = 0.0206]. (d) SNX31 prevents degradation of cell surface β1 integrins in the absence of SNX17. The
indicated cell lines were surface biotinylated for 1 h on ice and then incubated for 0 h, 12 h, and 24 h at 37 °C. Cells were
lysed at each time point and biotinylated β1 integrin was determined by capture-ELISA [mean ± SD; n = 3; **p (student's
t-test) = 0.002].
3190 SNX31 Regulates β1 Integrin StabilitySNX17 and SNX31 prevent lysosomal degradation of
β1 integrin is unclear. SNX27 prevents lysosomal
routing of transmembrane proteins such as β2 adren-
ergic receptor or the glucose transporter GLUT1 by
recruiting the SNX-BAR retromer, a protein complex
that transports transmembrane proteins from endo-
somes to the trans-Golgi network [16,17,38]. Since
SNX17 and SNX31 do not interact with the SNX-BAR
retromer [16], the mechanisms that prevent integrin
degradation must be fundamentally different.
Our expression analyses revealed that SNX17 and
SNX27 transcripts were detectable in all tissues and
cell lines analyzedwhileSNX31 expressionwas highly
restricted with high expression in bladder and in
melanoma.Malignantmelanoma is a highlymetastatic
cancer that is considered one of the most aggressiveand treatment-resistant human cancers [39]. A recent
study identified several driver coding mutations within
SNX31 in human melanoma [19]. While the identified
mutations were distributed over the entire protein,
several accumulated in the FERM domain of SNX31.
However, the consequences of the mutations for
SNX31 function have not been analyzed. Our expres-
sion data further support a role of SNX31 inmelanoma
formation and metastasis; SNX31 expression is
significantly lower in in-transit melanoma metastases
compared to benign melanocytic nevi and SNX31
levels are also decreased in melanoma with SLN
metastasis. Interestingly, melanoma cells seem to
loose SNX31 expression after immortalization as we
failed to detect SNX31mRNA in all mouse and human
melanoma cell lines tested. How the reduced SNX31
3191SNX31 Regulates β1 Integrin Stabilityexpression levels ormutationswithin its FERMdomain
affect melanoma pathology is unknown and it remains
to be elucidated whether it is the consequence of
aberrant trafficking of integrins and/or other
transmembrane cargo.Materials and Methods
Antibodies
The following antibodies were used for Western blotting
and cell staining: Actin (A-2066, Sigma), β1 integrin
(MAB1997, Chemicon), EEA1 (BD Transduction Laborato-
ries), Flag M2-HRP (Sigma), GST (71097-3, Novagen),
Kindlin-2 (K3269, Sigma), Lamp1 (Abcam), SNX17
(10275-1-AP, Proteintech), Talin (T3287, clone 8d4, Sigma),
transferrin receptor (13-6800, Invitrogen), and transferrin
receptor (ab63335, Abcam). 4′,6-Diamidino-2-phenylindole
(DAPI) (Sigma) was used for immunohistochemistry.
The following antibodies were used for flow cytometry:
β1 integrin PE (HMbeta1-1, BioLegend) and β1 integrin
biotin (Ha2/5, BD Pharmingen).Plasmids
Point mutations into SNX31 (QW356/357AA, R37Q),
SNX17 (R36Q), and SNX27 (RW498/499AA, R194Q)
cDNA were introduced by site-directed mutagenesis. For
stable expression of the mouse SNX31 (wild type, QW356/
357AA) and the human SNX27 (wild type, RW498/499AA)
cDNAs, we cloned the cDNAs into the retroviral expression
vector pCLMFG or pLZRS. For expression of eGFP-tagged
SNX17, SNX27 and SNX31 cDNAs were cloned into the
pEGFP(N1 and N3) vector (Clonetech). SNX17 expression
plasmids have been described before [5]. For recombinant
expression of GST-tagged SNX31, Flag-tagged SNX31, and
Flag-tagged SNX31, QW360/361AA cDNA was cloned into
the pGEX-6P-1 vector (GE Healthcare).Cell lines
β1(-/-), β1 wild type and SNX17 knockdown mouse
fibroblast cell lines have been described mouse fibroblast
[5]. Cell lines were cultured in Dulbecco's modified Eagle's
medium supplemented with 10% (v/v) serum at 37 °C and
10% CO2. Human RT4 cells were a kind gift from Roman
Nawroth (Technical University of Munich) and were
cultured in RPMI supplemented with 10% (v/v) serum
and 1% (v/v) non-essential amino acids.Transient and stable transfection/transduction
Cells were transiently transfected with Lipofectamine
2000 (Invitrogen) according to the manufacturer's protocol.
To generate stable cell lines, we produced VSV-G (vesicular
stomatitis virusG glycoprotein) pseudotyped retroviral vectors
by transient transfection of 293T (human embryonic kidney)
cells. Viral particleswere concentrated from cell culture super-
natant as previously described [40] and used for infection.Turnover of surface integrins and capture ELISA
The half-life of surface proteins was determined by
biotinylation as previously described [5]. Briefly, fibroblasts
were grown to 80% confluence, washed twice in cold PBS
(phosphate-buffered saline), and surface-biotinylated with
0.2 mg/ml sulfo-NHS-LC-biotin (Thermo Scientific) in PBS
for 45 min at 4 °C. Following washes with cold PBS, we
incubated the cells in Dulbecco's modified Eagle's medium
containing 0.2% fetal bovine serum for 0, 11, and 24 h at
37 °C.Cellswere lysed in a lowvolumeof lysis buffer [75 mM
Tris, 200 mM NaCl, 7.5 mM ethylenediaminetetraacetic
acid and 7.5 mM ethylene glycol bis(β-aminoethyl ether)
N,N′-tetraacetic acid, 1.5% Triton X-100, 0.75% Igepal
CA-630, and protease inhibitors]. Lysates were passed
through a 27-gauge needle 10 times and centrifuged
10 min at 4 °C.We used 50 μl of the supernatant for capture
ELISA.
For capture ELISA, Maxisorb 96-well plates (Life
Technologies) were coated overnight with anti-β1 integrin
antibody (MAB1997, Chemicon) in 50 mM carbonate
buffer (pH 9.6) at 4 °C. Prior to adding the cell lysate, we
blocked unspecific binding with 5% BSA (bovine serum
albumin) in PBS/0.1% Tween-20 (PBS-T) for 1–2 h at
room temperature. We incubated 50 μl cell lysate over-
night at 4 °C to capture integrins. Following extensive
washes with PBS-T, we incubated plates with Streptavi-
din-HRP in 1% BSA in PBS-T for 1 h at 4 °C. Biotinylated
β1 integrin was detected after several washing steps by
chromogenic reaction with ABTS peroxidase substrate
(Vector Laboratories).Quantitative PCR
RNA was isolated from cells using the RNeasy mini kit
(Qiagen) and 500 ng of total RNA was transcribed into
cDNA using the iScript cDNA Synthesis kit (Bio-Rad).
Quantitative PCR assays were performed with the
LightCycler 480 II (Roche) using SYBR green and the
following primers: human SNX17-forward AGTACAT
GCAAGCTGTTCGG, human SNX17-reverse AGCT
ACAGCCTCCAGGACAT, human SNX27-forward
AATGGTGTGTCCGACGTAGA, human SNX27-reverse
TTTGCTGCGATAGCCTGATA, human SNX31-forward
TGCTGGCAGTGGTTTGTTAT, human SNX31-reverse
CTGCTGGCTTTGTTGAATGT, human GAPDH-forward
AGGGCTGCTTTTAACTCTGGT, human GAPDH-reverse
CCCCACTTGATTTTGGAGGGA, mouse SNX17-forward
CATTGCTCGAGTCACCAGAC, mouse SNX17-reverse
CATCCAGGCAGCTGAGATTA, mouse SNX27-forward
AGAGCTCTCAGGGAGGAACA, mouse SNX27-reverse
GTTTGGAGCAATGAAGGGAT, mouse SNX31-forward
GCCAACCTAGCCAGAAAGTC, mouse SNX31-reverse
AAGTGGATAAATGCCTGGATG, mouse GAPDH-for-
ward TCCTGCACCACCAACTGCTTAGC, and mouse
GAPDH-reverse TGGATGCAGGGATGATGTTCTGG.
Study of patient-derived pigmented lesions was ap-
proved by the internal review board of Mayo Clinic
(IRB11-6390). We selected 6 benign nevi and 6 in-transit
metastasis of FFPE (formalin fixed, paraffin-embedded)
patient-derived biospecimens randomly from the Mayo
Clinic Tissue Archive. Primary skin melanoma that was
included here had an invasion depth (Breslow) of ≥1 mm
3192 SNX31 Regulates β1 Integrin Stabilityor 0.75–0.99 mm plus any of the following three risk
factors: mitotic index N 0 mm [2], tumor ulceration present,
or patient age b 40 years. All included primary melanoma
patients had an SLN biopsy performed within 90 days of
their diagnosis. Consecutive patients were from 2008 to
2012. FFPE blocks were effaced and up to 100 microns of
tissue was collected. RNA was extracted and reverse
transcribed into cDNA using commercially available kits.
Quantitative PCR was performed using standard techniques.
RNA copy number was determined by running standards of
diluted and linearized DNA containing the desired amplicon
and ranging from 5 to 5 million in copy number. SNX copy
number was normalized to 25,000 copies of housekeeping
genes. Oligonucleotides for SNX amplification were as follows:
SNX17-forward: AGCCAGCAAGCAGTGAAGTC;SNX17-re-
verse: TCAGGTGACTCAAGCAGTGG; SNX31-forward:
TAACCATGGACCCAAACGTG; SNX31-reverse: CTCAAC-
GAAGACATCACTTCTCA.Peptide pull-downs
Pull-downs were performed with the following peptides:
β1 wild-type cytoplasmic tail peptide (HDRREFAKFEKE
KMNAKWDTGENPIYKSAVTTVVNPKYEGK-OH), β1
scrambled peptide (EYEFEPDKVDTGAKGTKMAKNE
KKFRNYTVHNIWESRKVAP-OH), β2 wild-type cytoplas-
mic tail peptide (TDLREYRRFEKEKLKSQWNNDNPLFK
SATTTVMNPKFAES), β3 wild-type cytoplasmic tail
peptide (HDRKEFAKFEEERARAKWDTANNPLYKEATS
TFTNITYRGT), β5 wild-type cytoplasmic tail peptide
(HDRREFAKFQSERSRARYEMASNPLYRKPISTHTVD
FAFNKFNKSYNGSVD-OH), and β6 wild-type cytoplasmic
tail peptide (HDRKEVAKFEAERSKAKWQTGTNPLYRG
STSTFKNVTYKHREKHKAGLSSDG -OH). All peptides
were desthiobiotinylated. Prior to use, peptides were
immobilized on Dynabeads MyOne Streptavidin C1
(10 mg/ml, Invitrogen) for 3 h at 4 °C.
Fibroblasts expressing Flag-tagged SNX27 and Flag-
tagged SNX31 were lysed on ice in Mammalian Protein
Extraction Reagent (Thermo Scientific) and 0.5–1 mg of
cell lysate was incubated with the indicated peptides
overnight at 4 °C. After three washing steps with lysis
buffer, we boiled the beads in SDS-PAGE sample buffer
and loaded the supernatant on a 8% SDS-PAGE gel.Expression and purification of GST-tagged proteins
Plasmids encoding GST-tagged SNX31 or GST-tagged
SNX31-QW/AA were transformed into Rosetta competent
bacteria. Protein expression was induced with 1 mM
IPTG and the cells were grown for 3 h at 30 °C. Bacteria
were pelleted, washed once with PBS, resuspended in TBS
(50 mM Tris–HCl, with 150 mM NaCl, pH 7.4) containing
protease inhibitors (Protease Inhibitor Cocktail Tablets,
Merck), sonicated with a tip sonicator, and thereafter
incubated with 100 μg/ml Lysozyme (Sigma) and 50 μg/ml
DNase I (Sigma) at 4 °C for 3 h. Lysates were centrifuged
with 14,000 rpm at 4 °C for 20 min. Supernatants were then
incubated with 1 ml glutathione Sepharose beads (GST-bind-
ing resin) for 3 h at 4 °C.GST-taggedproteinswere boundand
eluted according to manufacturer's instruction.
For pull-downs, synthetic peptides were immobilized on
Dynabeads My One Streptavidin C1 (10 mg/ml, Invitrogen)for 3 h at 4 °C, incubated with 2%BSA inMammalian Protein
Extraction Reagent (Thermo Scientific) for 30 min to block
unspecific binding prior to adding 150 ng recombinant
GST-tagged SNX31 protein, and further incubated on a
rotator for 2 h at 4 °C.After 3washeswithMammalianProtein
Extraction Reagent, proteins were eluted from the beads by
boiling with 70 μl SDS-PAGE sample buffer for 5 min,
separated by SDS-PAGE gel, and blotted with antibodies
against the GST-tag.
Selective immunoprecipitation
Selective isolation of β1 integrins in endocytic vesicles by
cell surface immunoprecipitation has been described previ-
ously [5]. Briefly, cell surface β1 integrins of live cells were
labeled with an anti-β1 integrin antibody (1:1500, homemade)
or with an anti-transferrin receptor antibody (1:1000, Abcam)
for 1 h on ice followed by two washes with ice-cold PBS to
remove unbound antibody. To enrich β1 integrin and
transferrin receptor antibody complexes in endosomes, we
incubated cells for 10 min in medium with 0.2 mM prima-
quine. After two PBS washes, cells were lysed in IP buffer
[50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100,
0.1% sodium deoxycholate, 1 mM ethylenediaminetetraace-
tic acid, and protease inhibitors] and cleared by centrifugation.
The receptor immune complexes were pulled-down by
incubation with Protein G Sepharose (Sigma) for 2 h at 4 °C
with gentle agitation and subjected to SDS-PAGE and
Western blot analysis.
Immunofluorescence
For immunostaining, we cultured cells on glass cover-
slips coated with 10 μg/ml fibronectin (Calbiochem). Cells
were fixed with 4% PFA/PBS for 15 min on ice, washed
with PBS, and permeabilized with 0.01% saponin/PBS for
10 min on ice. After blocking unspecific binding with 3%
BSA/PBS for 1 h, we incubated the fixed cells with the
primary antibody in 3% BSA/0.01% saponin/PBS over-
night at 4 °C. After several PBS washes, the fluorescently
labeled secondary antibodies were incubated for 1 h at
room temperature in the dark. Images were collected at
room temperature by Zeiss LSM 780 confocal microscope
(Zeiss, Germany) equipped with a 100×/1.4 objective.
To determine the endocytic trafficking of β1 integrins from
the cell surface by surface labeling, we seeded cells on
fibronectin-coated (5 μg/ml) glass cover dishes (Cellview,
Advance TC, Greiner). Cells were washed with cold PBS and
incubated with an anti-β1 integrin antibody (HMbeta1-1,
BioLegend) for 30 min on ice. Surface-bound antibody was
allowed to internalize for 15 min at 37 °C in regular growth
medium and subsequently imaged with a 63×/1.4 objective
on a Zeiss Observer Z1 microscope equipped with a CSU10
spinning disc scanhead (Yokogawa) and a Coolsnap HQ2
camera (Roper scientific) run by Metamorph software
(Molecular Devices, Downingtown, PA). The system was
implemented by Visitron Systems.
Sequence alignment
Sequence alignment was made with CLUSTAL Omega
undESPript 3.0 (ESPript†) [41]. Thematrix of pairwise identity
percentages was generated using the LALIGN software.
3193SNX31 Regulates β1 Integrin StabilityAnalysis of RNA-seq and microarray data
RNA-seq of coding RNA from 27 different human tissues
[24] and the GeneAtlas MOE430 gcrma of 191 mouse
samples [25] were analyzed via the EMBL-EBI expression
atlas‡ and BioGPS§, respectively.
Statistics
Statistical analysis was performed using the GraphPad
Prism software (version 5.00, GraphPad Software).
Statistical significance was determined by two-tailed
student's t-test or Mann–Whitney U-test as indicated.
Results are expressed as the mean ± SD if not indicated
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Abstract 
We developed an integrative adhesome analysis by combining a focal adhesion 
enrichment index with integrin tail interactome to identify novel FA proteins. Using this 
approach we identified the evolutionarily conserved Kank protein family as novel FA 
proteins. Interestingly, Kank2 concentrates at the lateral border of FAs (which we term the 
FA belt), a previously unrecognized FA sub-compartment. Mechanistically, Kank directly 
binds the talin R7 domain through its evolutionarily conserved KN motif and promotes talin 
activation in a force- and F-actin-independent manner. Consequently, Kank2 induces 
and/or maintains the formation of active integrins and destabilizes talin-actin connection. 
Our data identify Kank family proteins as novel type of talin activator, which specifically 
stabilize integrin-talin complexes that are uncoupled from the actomyosin system. 
  
Introduction 
Mesenchymal migration relies on integrin receptors, a large family of α/β heterodimers 
that couple the extracellular matrix (ECM) to the actin cytoskeleton 1. To allow cell 
adhesion and migration, integrins have to be activated. Integrin activation is characterized 
by shifting the unbound form of the integrin from a low to a high affinity conformation 
followed by ligand binding 2. Ligand bound integrins then cluster and assemble a 
mechano-sensitive macro-protein complex (called the adhesome) around their 
cytoplasmic domains 3, 4. The initial adhesion complex are small, short-lived nascent 
adhesions (NAs) formed at the periphery of cell protrusions. A limited number of NAs 
subsequently couple to F-actin and actomyosin-mediated pulling forces reinforce the 
integrin-ligand interaction and promote the recruitment of more proteins to form large, 
mature focal adhesions (FAs). The dynamic engagement between integrin and 
actomyosin serves as a molecular clutch that promotes both forward membrane protrusion 
and rearward traction force to drive cell migration 5. 
Talin and kindlin directly bind to β integrin cytoplasmic tails and play key roles in integrin 
activation and coupling to actin 6. Talin is a large, ~270 kD protein composed of an N-
terminal FERM (protein 4.1, ezrin, radixin, moesin) domain, also called talin head domain 
(THD), and a long C-terminal rod domain consisting of 13 helical bundles (R1-R13 
domains). The THD is divided into four subdomains (F0, F1, F2, F3). The F3 subdomain 
of the THD binds β integrin tails and negatively charged lipids on the plasma membrane, 
and mediates integrin activation. The rod domain contains two F-actin binding sites, 
several binding sites for RIAM, numerous binding sites for vinculin and a dimerization 
domain at the extreme C-terminus 7. The F-actin binding through talin rod couples the 
integrin/talin complexes to actomyosin, which is required for adhesion re-enforcement and 
rigidity sensing. 
Talin cycles between plasma membrane, where it activates integrins, and cytosol, where 
it adopts an auto-inhibited form, presumably as a compact globular dimer 8 with an 
intramolecular interaction between the F3 subdomain and the R9 domain 9, 10. Since this 
interaction masks the integrin binding site, talin requires an activation step that disrupts 
the auto-inhibitory head-rod interaction. A prime candidate for talin activation is the Rap1 
effector protein RIAM (Rap1–GTP-interacting adapter molecule), which binds the R8 
helical bundle 11, relieves the autoinhibitory interaction and recruits talin to the plasma 
membrane 12, 13. A second, potential talin activator is PtdIns(4,5)P2 10. A splice isoform of 
phosphatidylinositol 4-phosphate 5-kinase type Iγ (PIPKIγ90) locally synthesizes 
PtdIns(4,5)P2 upon recruitment to FAs through direct binding to talin F3 subdomain 14. 
Finally, the actin retrograde flow was shown to induce the high affinity state of αLβ2 (LFA-
1) on T cells 15, although it is not clear whether talin is the target of the actin flow. However, 
it is clear from genetic studies that talin activation is a highly redundant process, as neither 
RIAM- nor PIPKIγ90-deficient mice have apparent phenotypes 16, 17. 
In the present paper we developed a FA enrichment index to identify novel FA proteins 
through high-resolution quantitative mass spectrometry (MS). We identified the 
evolutionarily conserved Kank protein family as novel FA proteins. Kank family proteins 
consist of 4 members (Kank1-4) characterized by an N-terminal Kank (KN) motif, several 
central coil-coil domains and C-terminal ankyrin repeats 18. Kank1 was shown to restrict 
microtubule outgrowth at cell cortex by recruiting Kif21a to liprin β1 19. Overexpressed 
Kank proteins inhibit stress fiber formation and migration probably by downregulating 
RhoA 20. A single Kank ortholog in C.elegans, called VAB19, controls epidermis-muscle 
attachment 21, neuronal migration 22 and basement membrane sliding during vulval 
morphogenesis 23. The Kank3 knockdown in zebrafish leads to epidermal detachment 24. 
We found that Kank localizes to the outer border of FAs (which we term the FA belt) and 
to central fibrillar adhesion, and induces and/or maintains the formation of active integrins 
at sites lacking actomyosin coupling. Mechanistically, Kank directly binds the talin R7 
domain through its evolutionarily conserved KN motif and promotes talin activation in a 
force- and F-actin-independent manner. Our data identify Kank as novel talin activator, 
which specifically stabilizes integrin-talin complex that are uncoupled from the actomyosin 
system. 
  
Results 
Kank is a novel FA protein 
To identify highly enriched proteins in integrin adhesion sites, we seeded mouse kidney-
derived fibroblasts for 3 hours on FN, isolated whole cell lysates and the crosslinked FA 
fraction and quantified their proteome using high-resolution mass spectrometry combined 
with the label free protein quantification algorithm (MaxLFQ) (suppl. Fig. 1a). We identified 
7954 proteins in the total proteome and 2378 proteins in the corresponding FA-enriched 
protein fractions. Proteins that were highly abundant in the total proteome were over-
represented in the FA-enriched subproteome (suppl. Fig. 1b) pointing to an abundance-
dependent unspecific enrichment. We used the false discovery rate (FDR) controlled 2D 
annotation enrichment algorithm to systematically compare the relative abundance of 
functional categories between the total proteome and the FA-enriched subproteome and 
found that proteins involved in cell adhesion including the known adhesome proteins as 
well as ECM components were strongly enriched in the FA-enriched subproteome, while 
proteins from intracellular organelles and cytosol such as the endoplasmic reticulum, 
mitochondria, proteasome were significantly underrepresented in the FA-enriched protein 
fraction (suppl. Fig. 1c). To identify true FA proteins, we determined the enrichment for 
each protein of the FA fraction relative to the total proteome abundance (FA enrichment 
index; FAEI) by calculating ratios of MS-intensity in the FA-enriched subproteome and the 
total proteome (n=2378; Table S1, suppl. Fig. 1a). The FAEI fits a typical Gaussian 
distribution (Fig. 1a) with a correlation coefficient of R2 >0.98. Among the proteins in the 
upper 10% quartile of the FAEI distribution (Table S1), were several novel proteins that 
have been shown to regulate potentially integrin-regulated processes such as cell 
adhesion or migration. They include the Kank family member Kank2 (Fig. 1a), three 
kinases (Csnk1a1, Taok1 and CDK11b) and two phosphatases (Ptp4a2 and Ppp1cc, 
Table S1). 
To identify novel adhesome proteins that associate with β1 integrin tails, we overlaid the 
FAEI with MS results of β1 integrin tail peptide pulldowns from whole cell lysate. Several 
known FA proteins enriched with β1 tail peptide pulldown including talin, kindlin and the 
members of the IPP complex showed high FAEI scores. Proteins such as Dab2 25, known 
to bind β1 tails during endocytosis, or SNX17 26, known to bind β1 tails in the endosomal 
compartment displayed a low FAEI score. Interestingly, Kank2 was among the proteins 
that showed a high FAEI score and strong β1 tail binding (Fig. 1a, b). Unlike kindlin2 or c-
Src, which preferentially bind β1 and β3 integrin tails respectively, Kank2 bound β1 and 
β3 tails with similar efficiencies (Fig. 1c). Immunostaining with polyclonal anti-Kank2 
antibodies revealed Kank2-positive puncta closely attached to mature FAs (Fig.1d arrow 
heads). The nuclear signal is likely unspecific, as it remained in Kank2-depleted cells (data 
not shown). Interestingly, Kank2-specific immunostaining signals were absent from small 
NAs. The absence of Kank2 from NAs was confirmed by inhibiting myosin-II with 
blebbistatin. While blebbistatin-treated cells showed no Kank2 co-localisation with paxillin 
in NAs at protruding cell membranes (Fig. 1d), Kank2 and paxillin overlapped in thin and 
long trailing tails (Fig. 1d). Using line intensity profile measurements we observed that 
endogenous Kank2 puncta peaked at the outer border of FAs (termed FA belt) where 
conventional FA proteins including talin, kindlin-2, ILK, paxillin and vinculin showed ~50% 
of their plateau intensity (Fig. 1e-g). 
To test whether the localisation of Kank2 to the FA belt depends on the presence of a 
specific FN-binding integrin class, we overexpressed Kank2-GFP in cells expressing α5β1 
and/or αvβ3 and αvβ5 integrins 27, seeded them on FN and determined Kank2 localisation. 
The experiments revealed that overexrpessed Kank2-GFP localized to the FA belt in β1 
as well as αv-class integrin expressing fibroblasts (suppl. Fig 1d), indicating that FA belt 
localization of Kank2 is integrin class-independent. 
Kank is targeted to FAs via the KN motif 
To determine the protein domain(s) of Kank2 that is(are) responsible for Kank2 
recruitment to FA belt, we generated GFP-tagged Kank2 expression constructs lacking 
evolutionarily conserved domains (Fig. 2a): the Kank2ΔKN-GFP lacked the Kank (KN) 
motif; the Kank2ΔCoil-GFP lacked the liprin-binding coiled-coil domain; the Kank2(1-670)-
GFP lacked the Kif21a-binding C-terminal ankyrin repeats; and the Kank2ΔKNΔCoil-GFP 
lacked the KN and coil-coil domains. The constructs were stably transduced into FN-
cultured, Kank2-depleted cells (Fig. 2b), and immunostained for paxillin and for F-actin 
with phalloidin. Similar to endogenous Kank2, full length Kank2-GFP localized to the belt 
of paxillin-positive FAs and to fibrillar adhesions. In sharp contrast, Kank2ΔKN-GFP did 
not concentrate on FA belts and fibrillar adhesion but accumulated outside FAs (Fig. 2c-
e) co-localizing with liprin β1 (suppl. Fig. 2a). Kank2ΔCoil-GFP and Kank2(1-670)-GFP 
localized to FA belts and to fibrillar adhesions (Fig. 2c-e), indicating that liprin β1 or Kif21a 
are not required for FA belt localization of Kank2. Interestingly however, Kank2 could 
recruit liprin-β1 to FA belt through the coiled-coil domain (suppl. Fig.2a). Kank2ΔKNΔCoil-
GFP was diffusely distributed throughout the cytosol (Fig. 2c). To test whether the KN 
motif alone is sufficient for FA belt localization, we transduced Kank2-depleted cells with 
a GFP-tagged KN construct and found a complete overlap of GFP with paxillin (Fig. 2c). 
These findings indicate (i) that the KN motif is essential to localize Kank2 to FA belts and 
fibrillar adhesions, (ii) that neither the coil-coil nor the ankyrin repeats are required for 
Kank2 targeting to the FA belt or exclusion from the FA center, and (iii) that the KN motif 
peptide is not sufficient to restrict Kank2 localisation to the FA belt. 
To test whether the Kank2-KN motif associates with β1 integrin cytoplasmic tails, we 
performed β1 tail pull downs with lysates from Kank2-depleted cells expressing the GFP-
tagged Kank2 expression constructs (Fig. 2a,b) and found that Kank2-GFP and KN-GFP 
but not GFP or Kank2ΔKN-GFP associated with β1 integrin tail peptides (Fig. 2f,g). In line 
with the high sequence conservation of the KN motifs from Kank1-4, the GFP-tagged KN 
motifs from Kank1, Kank3 and Kank4 localized to paxillin-positive FAs (suppl. Fig. 2b). 
Interestingly, when expressed at similar levels as judge by GFP intensity, Kank1-GFP and 
Kank3-GFP localized to FA belts, while Kank4-GFP did not show a clear FA belt 
localization, probably due to its additional diffused localization in the cytoplasm (suppl. 
Fig. 2c).  
The talin rod binds the KN motif of Kank2 
Pull down experiments of Kank2 with different wild type and mutant integrin tail peptides 
from wild type fibroblast lysates revealed that β2 integrin tails had the highest affinity for 
Kank2, β1 tails an intermediate affinity and β5 tails the lowest affinity (Fig. 3a). 
Interestingly, the binding profile of Kank2 overlapped with that of talin but not kindlin-2 
(Fig. 3a), suggesting that talin and Kank2 are co-recruited to integrin tails. In line with this 
hypothesis, β1 tails, in which the tyrosine-783 was substituted with alanine (β1-Y783A), 
neither pulled down Kank2 nor talin, but still kindlin-2 (Fig. 3a). To identify novel Kank2 
interacting proteins, we expressed GFP alone or GFP-tagged Kank2 in fibroblasts, 
performed GFP pull-downs and determined their interactors by MS. In line with a previous 
report, we identified liprin β1 as a binding partner of Kank2 19. Furthermore, talin-1 and 
two dynein light chain isoforms (Dynll1/LC8a and Dynll2/LC8b) were also among Kank2 
interacting proteins (Fig. 3b). Strikingly, while β1 integrin tails specifically recruited talin 
and Kank2 in tyrosine 783-dependent manner, deletion of talin-1 and talin-2 genes in 
fibroblasts completely abolished Kank2 recruitment to β1 integrin tails (Fig. 3c), indicating 
that Kank2 recruitment to integrin tails is indeed talin-dependent. To test whether Kank2 
forms a complex with talin through the KN motif, we performed GST pull downs with 
recombinant GST-KN motif and recombinant talin head domain (THD) or full length talin-
1 (suppl. Fig. 3a). These experiments revealed that the GST-KN motif efficiently pulled 
down full length talin-1 but not the THD (Fig. 3d) indicating that Kank2 is recruited to β 
integrin tails through a direct interaction between the KN motif and the talin rod. 
Fluorescence correlation microscopy measurements revealed a binding affinity of 230±70 
nM (mean ± error represents 95% confidence interval) between recombinant full length 
talin and fluorescently labelled KN peptide (suppl. Fig. 3b). To further narrow down the 
KN-binding site on the talin rod we expressed different GFP-tagged Talin rod domains in 
fibroblasts, prepared cell lysates, incubated the cell lysates with the recombinant GST-KN 
motif and immunoprecipitated protein complexes with anti-GFP antibodies. The 
experiments revealed that the R7R8 domains of the talin rod bind the GST-KN motif 
(suppl. Fig. 3c). Altogether these findings show that the KN motif of Kank2 can directly 
bind the R7R8 domains of Talin. 
Kank2 induces Talin and β1 integrin activation 
The R7R8 domains were shown to bind RIAM, actin and vinculin 28, all of which can induce 
and/or maintain the active, integrin binding state of talin. Therefore, we tested whether 
Kank2 binding to the R7R8 domains also controls talin-integrin interactions. First, we 
incubated normal fibroblast cell lysates with bacterially expressed, recombinant GST-KN 
polypeptides or chemically synthesized KN peptides and subsequently performed β1 
integrin tail pulldowns. The experiments revealed that GST-KN as well as the synthesized 
KN peptide efficiently displaced endogenous Kank2 from β1 integrin tail peptides and 
strongly increased talin binding but affected neither kindlin2 nor Dab2 binding (Fig. 4a; 
suppl. Fig. 4a-d). Second, we depleted Kank2 using specific shRNA and found that Kank2 
depletion decreased binding of endogenous talin to β1 integrin tail peptides by ~30% (Fig. 
4b), while overexpression of full length Kank2-GFP but not Kank2ΔKN-GFP increased 
talin binding to β1 integrin tails in a dose-dependent manner (suppl. Fig. 4e, f). Third, we 
incubated equal molar (10nM) recombinant full length talin protein with either GST-KN or 
GST and performed integrin tail peptide pulldown assays in vitro. We observed that the 
GST-KN protein but not GST significantly increased talin binding to β1 integrin tails and 
that GST-KN was co-recruited with talin to β1 integrin tail (Fig. 4c). Finally, co-expression 
of talin-GFP with Cherry-tagged Kank2, Kank2ΔKN and Kank2-KN in Kank2-depleted 
fibroblasts revealed that Kank2 as well as Kank2-KN enhanced localization of talin-GFP 
to kindlin2-positive adhesion sites, while Kank2ΔKN or Cherry left talin-1-GFP to a large 
extent in the cytosol (Fig. 4d,e). These findings clearly indicate that Kank2 induces and/or 
maintains talin binding to integrin β tails through the KN motif. 
Since the activation of talin is a pre-requisite for integrin activation we next tested whether 
Kank2 regulates integrin activation. To this end, we overexpressed Kank2-GFP, 
Kank2ΔKN-GFP, KN-GFP or GFP in fibroblasts, seeded them on FN and immunostained 
them with the activation epitope reporting antibody 9EG7. We found that overexpressed 
Kank2-GFP or KN-GFP co-localized with 9EG7-positive β1 integrins and increased active 
β1 integrin clusters in the central cell area, while overexpression of Kank2ΔKN-GFP had 
no influence on the active integrin clusters at the ventral cell cortex compared with GFP 
alone (Fig.4f,g).  
 
Kank2 regulates Talin turnover, adhesion remodeling and cell 
migration 
It has been shown that overexpression of Kank2 proteins suppressed stress fiber 
formation 18. We next co-stained 9EG7 epitope with phalloidin in cell expressing GFP or 
Kank2-GFP. We noticed that Kank2-GFP strongly co-localized with active integrin clusters 
that were apparently not linked with thick stress fibers (suppl. Fig.5a). While Kank2-GFP 
overexpression consistently increased active β1 integrin clusters, the phalloidin-stained F-
actin in 9EG7-positive area is significantly reduced (suppl. Fig.5b, c), suggesting that 
Kank2 may dislodged F-actin from talin. It has been has been shown that talin binding to 
F-actin plays the dominant role in immobilizing talin within adhesion sites 29, 30. To test 
whether Kank2 regulates talin turnover, we performed fluorescence recovery after 
photobleaching (FRAP) in central adhesion sites of Kank-2-deplted fibroblasts expressing 
Kank2-mCherry, Kank2ΔKN-mCherry, KN-mCherry or mCherry alone. While neither 
Kank2ΔKN, nor the KN motif alone affected the mobile fraction of talin in comparison with 
mCherry control, expression of full length Kank2 increased the mobile fraction of Talin 
from 63.8±9.0% to 92.4±7.5% (Fig. 5a-c) suggesting that talin is almost completely 
decoupled from F-actin by full length Kank2. Interestingly, however, when we calculated 
the recovery rates of talin-GFP by measuring κ (1/τ1/2) we noticed that full length Kank2 
but not Kank2ΔKN reduced the recovery rates of Talin by ~50% (Fig.5b,d), which indicates 
that Talin associated with Kank2 undergoes a more stable association to β integrin tails. 
While the KN motif alone did not change the mobile fraction of Talin in adhesion sites, it 
reduced Talin recovery rates in comparison to mCherry, although not to the same extent 
as full length Kank2 (Fig. 5d). 
Next we examined whether Kank2-induced talin turnover changes adhesion dynamics. To 
this end, we expressed talin-TagRFP in Kank2-depleted cells rescued with either Kank2-
GFP or Kank2ΔKN-GFP and imaged individual adhesion sites over a period of 10 min. In 
Kank2 expressing cells, talin- TagRFP-positive central adhesions underwent rapid lateral 
sliding movements and shape remodeling (Fig. 5e; suppl. Movie 1). In sharp contrast, in 
cells expressing Kank2ΔKN, talin-TagRFP-positive central adhesions remained largely 
immobile before disassembly (Fig. 5e; suppl. Movie 2). As revealed in color-overlaid time 
lapse images, Kank2-GFP but Kank2ΔKN-GFP induced adhesion sliding throughout the 
cell (Fig, 5f). Tracking the mass center of the adhesion sites revealed that expression of 
full length Kank2 induced a significantly higher adhesion sliding velocity in comparison to 
expression of Kank2ΔKN (Fig, 5g). Moreover, we observed rapid extensional growth of 
the adhesion structure in cells expressing full length Kank2 (suppl. Fig. 5d; suppl. Movie 
3), suggesting that Kank2 is able to promote de novo assembly of adhesion structure. 
Altogether these findings suggest that Kank2 regulates talin turnover and adhesion 
remodeling both by stabilizing talin-integrin complexes and by destabilizing talin-actin 
linkage. 
Increased adhesion sliding is correlated with reduced migration 31. To test whether Kank2 
influences integrin-mediated 2D random cell migration, we depleted ~90% of Kank2 using 
2 independent shRNA in fibroblasts (Fig. 6a). Kank2 depletion significantly increased cell 
migration velocity (Fig. 6b), while directional persistence or β1 integrin expression 
remained unaffected (Fig.6a and data not shown). Conversely, overexpression of Kank2 
(Fig. 6c) reduced migration velocity, regardless whether serum was present or absent 
during the experiment (Fig. 6d). Finally, the accelerated migration speed of Kank2 
knockdown cells was normalized by re-expressing full length Kank2-AcGFP but not 
Kank2ΔKN-AcGFP or Kank2-KN-AcGFP as measured by mean square displacement (Fig. 
6.e,f). Together these result indicate that Kank2 suppresses cell migration by stabilizing 
talin-integrin complex in the absence of stress fiber coupling. 
  
Discussion 
Recent advances in focal adhesion isolation and proteomic analysis provided 
comprehensive profiling of integrin adhesome 4. However, the protein enrichment analysis 
based on spectral counting or label free quantification (LFQ) in biochemical fractions are 
biased by the protein abundance in the raw material 32. By normalizing the LFQ intensities 
in purified FA with total expression level, we derived the FA enrichment index (FAEI), 
which reflects the enrichment of each protein in the FA fraction regardless of its expression 
level. Combined with β1 integrin tail interactome, we identified Kank2 as a novel 
component in integrin binding complex. The evolutionarily conserved Kank family proteins 
have been implicated in cell-ECM adhesion. For instance, Kank homologue, vab19 in 
C.elegans act synergistically with integrin to restrict basement membrane sliding during 
vulval morphogenesis 23. Importantly, mutations of Kank1, Kank2 and Kank4 in human 
lead to nephrotic syndrome 33, which is often caused by defects in integrin-mediated 
adhesion or hyper-activated Rho GTPase 34, 35. Kank1 deletion results in cerebral palsy 
type 2, spastic quadriplegic (CPSQ2) which could be due to neuronal migration defects 36. 
Kank2 is connected to integrin through talin as Kank2 recruitment to integrin tail was 
abolished in talin-1 and talin-2 double knockout cells. We found direct interaction between 
KN motif in Kank2 and R7 domain in talin rod. Talin is autoinhibited in the cytoplasm by 
intramolecular interaction between F3 domain in talin head the R9 in talin rod. Its activation 
is thought to be mediated by Rap1-RIAM complex and PI(4,5)P2 at the plasma membrane. 
Activated talin couples integrin with actomyosin system through direct and indirect F-actin 
binding. The affinity between KN motif and full length Talin measured with FCS is 
230±70nmol, in the same range of talin auto-inhibitory interaction. R7 and R8 domains 
have unique folding with R8 domain inserted in R7 domain. Strikingly, Kank2 binding to 
talin induced talin activation. Notably, Kank-mediated talin activation could be 
reconstituted in either cell lysate or recombinantly in vitro in a force and F-actin-
independent manner. Accordingly, Kank2 promotes translocation of overexpressed talin 
from cytosol to adhesion sites in KN motif-dependent manner. Consistent with the role of 
talin in integrin activation, overexpression of Kank2 but not KN motif deletion mutant 
induced more active β1 integrin clusters in adherent cells. Since R7R8 domain also 
contains high affinity binding sites for RIAM, vinculin and F-actin, all of which are 
implicated in talin activation, our data indicate that R7R8 fusion domain contains talin 
activation motifs where protein interactions disturb talin auto-inhibitory conformation. 
Whether other proteins (e.g. DLC1 and synemin) 37, 38 that also bind R7R8 domain have 
similar talin activation activity needs further investigation. 
Intriguingly, endogenous and ectopically expressed Kank2 as well as other Kank 
homologs concentrate at the lateral border of focal adhesions (FA belt) and fibrillar 
adhesions but not in nascent adhesions. This localization relies on the interaction with 
talin as KN motif deletion mutant failed to associate with adhesion border but localized to 
liprin-β1-positive cortical complex ~200nm away from FA border. Thus Kank2 marks the 
FA belt as a novel FA sub-compartment. The FA belt localization of Kank2 is independent 
of integrin subtype since Kank2 concentrates at FA belt in cell expressing only α5β1 
integrin or αVβ3/β5 integrins. Notably, KN motif alone was not restricted to FA border but 
also penetrated into the center of FA, indicating that an unknown structural or functional 
feature in full length Kank2 excludes it from FA center. It has been shown that RIAM and 
vinculin compete for talin binding and localize to nascent adhesion and focal adhesion 
respectively in mutually exclusive manner 39, 40. Similarly, Kank2 may be excluded from 
FA center by steric hindrance with other talin interacting molecules. 
FA center is linked to thick stress fibers and exerts mechanical tension. Overexpression 
of Kank proteins has been shown to attenuate stress fiber formation at least partially 
through down-regulating RhoA activity probably by recruiting RhoGDI 33. We hypothesize 
that Kank proteins may locally dislodge F-actin from talin-integrin complex. In comparison 
with the dynamic interaction between talin head domain and integrin, the F-actin binding 
through talin rod plays a dominant role in talin immobilization within FA. Our FRAP analysis 
of talin dynamics revealed that Kank2 but not KN motif deletion mutant increased the talin 
mobile fraction from ~65% to ~94%. Thus Kank2 almost induced complete mobilization of 
talin within adhesion, indicating that it destabilized talin’s linkage to F-actin. On the other 
hand, Kank2 but not KN motif deletion mutant slowed the talin recovery rate in the mobile 
fraction, indicating a reduced off-rate due to stabilized talin-integrin complex. Consistent 
with its FA center localization, KN motif reduced talin recovery rate but failed to mobilize 
talin. These data suggests that Kank2 uncoupled talin-mediated integrin activation from 
actomyosin linkage. Consistent with this hypothesis, Kank2 co-localized with active β1 
integrin clusters that appeared not linked to stress fibers. Mechanistically it is difficult to 
envision how Kank2 controls talin coupling to F-actin. Since Kank2 interacts with central 
region in Talin rod, calpain-dependent cleavage between talin head and rod is unlikely to 
be the cause. Kank2 binding may directly pose steric hindrance for F-actin binding on talin. 
Post-translational modification may also be involved since methylation of Talin C-terminal 
F-actin binding site by methyltransferase Ezh2 partially liberates Talin from F-actin 41. 
Kank2 may also locally inhibit RhoA activity through RhoGDI and thus suppress F-actin 
filament assembly.  
Integrin-mediated cell migration is driven by the molecular clutch between integrins and 
actomyosin system 5. The migration velocity is determined by the balance between clutch 
engagement and adhesiveness 42, 43. Stationary fibroblasts exhibit more sliding adhesions, 
reflecting uncoupled actomyosin connection to ECM and reduced catch-bond interaction 
31. DNA hairpin-based digital force sensor revealed that certain adhesion plaques in the 
cell do not apply force to their ECM ligands 44. Consistent with our FRAP analysis, Kank2-
GFP and talin-1-TagRFP positive adhesion structures underwent rapid sliding movement 
and shape deformation, suggesting a slip-bond behavior. In sharp contrast, in cells 
expressing mutant Kank2 lacking KN motif, talin-1-TagRFP-labeled adhesions remained 
static and underwent only slight uniaxial movement likely along stress fiber. Our 
observations suggest that Kank2 could maintain adhesive structure with a slip-bond 
interface and prevented its conversion to a catch-bond interface. While the catch-bond 
interface applies pulling force to drive cell migration, slip-bond interface provides frictional 
adhesiveness that inhibits cell migration. In this sense, the excessive basement 
membrane sliding in vab-19 mutant in C.elegans may be caused by reduced cell 
adhesiveness and increase cell traction force on the ECM. Indeed, Kank2 overexpression 
strongly suppressed random cell migration velocity. Conversely, Kank2 knockdown led to 
increase cell migration speed. Although KN motif alone is able to activate talin, it is 
required in the full length Kank2 but not sufficient by itself to reduce cell migration velocity 
in Kank2-depleted cells.  
Besides regulating talin activation and talin-actin linkage, Kank proteins may control cell 
migration by regulating local ECM degradation. We have identified liprin-β1 and two 
dynein light chain subunits dynll1 and dynll2 as Kank2 binding partners. Kank1 has been 
shown to interact with liprin-β1 and restrict cortical microtubule (MT) growth by recruiting 
Kif21a 19. Although we did not find Kif21a in Kank2 interactome probably due to its low 
expression in fibroblasts, dynein motors are also involved in MT capture on cell cortex 45. 
Liprin-β1 forms large protein complex containing at least liprin-α, ELKS and LL5, which 
captures MT plus end protein CLASPs and mediates focal exocytosis of MT1-MMP around 
FAs 19, 46-48. Local metalloprotease exocytosis then facilitates FA disassembly. Although 
liprin interaction is not required for Kank2’s FA belt localization, Kank2 could recruit liprin-
β1 to FA belt. Moreover, in the absence of talin binding, Kank2ΔKN mutant fully 
colocalized with liprin-β1. Thus, Kank2 is not only able to participate into both integrin-talin 
and liprin complex but also further bridge these two complexes. Whether Kank proteins 
coordinate integrin activation with local exocytosis will be investigated in the future. 
Despite the importance of talin activation, neither PIPKIγ90 knockout mice nor RIAM 
knockout mice display obvious developmental defect 16, 17, suggesting that Talin activation 
mechanisms may be highly redundant in vivo. Moreover, RIAM knockdown decreased 
melanoma cell migration 49 whereas a Talin mutant with disrupted auto-inhibition led to 
delayed dorsal epidermal closure in drosophila 50.  Together with these observations, our 
data support the existence of redundant and more importantly, functionally distinct talin 
activation mechanisms. Different talin activation modes have different migratory effects 
according to differential actomyosin or membrane coupling. 
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Figure legends 
Figure 1. Identification of Kank2 as a novel component in 
integrin complex. 
(a) Histogram of focal adhesion enrichment index (FAEI). (b) Scatter plot of β1 integrin tail 
peptide binding proteins overlay with coloration according to FAEI. The log2 SILAC ratio 
of proteins are plotted as the forward pulldown (x axis) against the reverse labelling 
pulldown (y axis). (c) Westernblot analysis of proteins complex assembled around β1 and 
β3 integrin tail peptides. (d) Mouse kidney fibroblasts are plated on fibronectin for 3hours, 
then treated with or without blebbistatin for 1hour, fixed and immunostained for 
endogenous Kank2, paxillin (Pxn, red), F-actin with phalloidin (blue) and DAPI (grey). 
Scale bar, 10μm. (e) Line profile analysis of focal adhesion stained with anti-Talin and 
anti-vinculin antibody together with Kank2. (f) Theoretical definition of the lateral border of 
focal adhesion and distance to FA border in line profile analysis. (g) Measurement of the 
distance between Kank2-postive puncta and FA border using different conventional FA 
protein markers including ILK, kindlin, vinculin, talin and paxillin. The Kank2-positive 
puncta structures locates at the lateral border of focal adhesion in line profile analysis. 
Figure 2. KN motif is essential for Kank2 localization at FA 
border and recruitment to integrin tail complex. 
(a) Domain organization of Kank2 protein and illustration of truncation/deletion mutant 
design. (b) Westernblot analysis of the expression level of endogenous Kank2 and 
reconstituted GFP-tagged Kank2 constructs using anti-Kank2 antibody and ant-GFP 
antibody in cell with stable Kank2 knockdown and reconstitutions with GFP-tagged Kank2 
truncation/deletion mutants. Vinculin is used as loading control. (c) Immunofluorescence 
of GFP-tagged Kank2 constructs (green) co-stained with anti-Paxillin antibody (Pxn, red), 
phalloidin (blue) and DAPI (grey). Scale bar, 10μm. (d) Line profile analysis for localization 
of full length Kank2 and Kank2ΔKN mutant. (e) Quantification of the distance between 
indicated Kank2 wild type and mutants’ localization to FA border indicates KN motif is 
required for FA association. Student t-test ***P<0.0001. (f)&(g) Integrin tail peptide 
pulldown and westernblot analysis showed that GFP-tagged full length Kank2 and KN 
motif along but not Kank2ΔKN mutant or GFP control could be recruited to integrin tail 
complex. Kank2 constructs were detected with anti-GFP antibody. Kindlin2 was used as 
positive control.  
Figure 3. Kank2 is recruited to integrin tail complex through 
direct interaction with Talin. 
(a) Westernblot (upper panel) and densitometry analysis (lower panel) of the recruitments 
of endogenous Kank2, kindlin2 and talin to wildtype β1, β2, β5 integrin tail and β1 integrin 
tail with tyrosine to alanine mutation at the position of tyrosine 783 in full length β1 integrin 
(β1 Y783A). β1 scrambled peptide (β1 scr) was used as universal control. Note that the 
binding profiles of Kank2 and talin completely overlapped with each other. (b) Scatter plot 
of LFQ-intensity ratio between Kank2-GFP pulldown and GFP control pulldown identified 
Ppfibp1, Dynll1, Dynll2 and talin-1 as strongest Kank2 binding partners. (c) Westernblot 
(upper panel) and densitometry analysis (lower panel) of the recruitments of endogenous 
Kank2, kindlin2 and talin to wildtype β1 tail and β1 Y783A mutant tail peptides from 
wildtype cells (Talin-1/2 flox/flox) or talin knockout cells (Talin-1/2 DKO). Kank2 
recruitment to integrin tail strictly depends on the presence of talin. Student t-test 
***P<0.0001.  (d) GST pulldown of GST-KN fusion protein or GST control with full length 
recombinant talin-1 or talin-head domain (THD). 
Figure 4. Kank2 activates talin and promote integrin activation 
(a) Westernblot (left panel) and densitometry analysis (right panel) of the recruitments of 
endogenous Kank2, talin, kindlin-2 and Dab2 to β1 integrin tail peptide in the presence of 
exogenous KN-GST or GST recombinant protein. GST-KN recombinant protein replaced 
endogenous Kank2 but promoted Talin recruitment without affecting kindlin-2 or Dab2 
binding. (b) Westernblot (left panel) and densitometry analysis (right panel) of the 
recruitments of endogenous Kank2, talin and kindling-2 to β1 integrin tail in control cells 
or Kank2-knockdown cells. (c) Westernblot (left panel) and densitometry analysis (right 
panel) show that purified GST-KN promotes recombinant talin-1 binding to β1 integrin tail 
in vitro. (d) Talin-AcGFP (shown in rainbow LUT) was co-transfected with Cherry-tagged 
full length Kank2, Kank2ΔKN mutant, KN motif along or cherry control into Kank2 
knockdown cells. Cells are fixed and stained for kindling-2 (blue). Scale bar, 10μm. (e) 
Quantification of talin-AcGFP intensity ratio between kindling-2-positive adhesion area 
and kindling-2-negative cytosolic region in (d) revealed that Kank2 promoted talin 
localization to adhesion sites through KN motif. (f) Kank2 knockdown cells were 
transfected with GFP-tagged full length Kank2, Kank2ΔKN mutant, KN motif along or GFP 
control (green), plated on fibronectin and stained for active integrin with 9EG7 antibody 
(shown in rainbow LUT). Scale bar, 10μm. (g) Kank2 promote active integrin cluster 
formation through KN motif. 9EG7 staining intensity per cell area is quantified from (f). 
Student t-test *P<0.05, **P<0.01, ***P<0.0001. 
Figure 5. Kank2 regulate Talin turnover and adhesion dynamics. 
(a) Representative timelapse images of Talin-1-AcGFP (shown in rainbow LUT) in FRAP 
experiments. Talin-1-AcGFP was co-transfected with Cherry-tagged full length Kank2 or 
Kank2ΔKN mutant into Kank2 knockdown cells. AcGFP signal is bleached in region of 
interest (ROI, red circle). (b) Fluorescence recovery curves corresponding to FRAP 
experiments in (a). Mean fluorescence intensity in ROI is plotted as the percentage of the 
initial intensity after normalization to cytosolic background. Fluorescent recovery curves 
from 6 FRAP experiments are fitted with one-phase association model (mean±s.d.). (c) 
Full length Kank2 but not Kank2ΔKN mutant or KN motif along increased talin-1 mobile 
fraction in adhesion sites. Mobile fraction is quantified from 10 independent FRAP 
experiment (mean ± sd. one-way ANOVA Tukey test, ***P<0.001). (d) Full length Kank2 
and KN motif along but not Kank2ΔKN mutant reduced talin-1-AcGFP recovery rate. 
Recovery rate is quantified from 10 independent FRAP experiment (mean ± sd. one-way 
ANOVA Tukey test, *P<0.05, **P<0.01, ***P<0.0001). (e) Timelapse images of talin-1-
TagRFP (rainbow LUT) and Kank2-GFP or Kank2ΔKN-GFP. Talin-1-Tag-RFP was co-
transfected with Cherry-tagged full length Kank2 or Kank2ΔKN mutant into Kank2 
knockdown cells. Scale bar, 5μm. (f) Color overlay of talin timelapse images from 0min 
(red), 5min (green) and 10min (blue). (g) Sliding velocities of talin-positive adhesion sites 
were plotted as box and whisker (min to max). Student t-test ***P<0.001.  
Figure 6. Kank2 regulates cell migration through talin. 
(a) Westernblot analysis of Kank2 and β1 integrin (Itgb1) expression in cells expressing 
scrambled shRNA control or two different Kank2 shRNA. Β-actin is used as loading control. 
(b) Kank2 knockdown increased velocity of 2-D random migration on fibronectin. Data is 
illustrated as box and whisker (minimal to maximal value). Student t-test ***P<0.0001. (c) 
Westernblot analysis of Kank2 and β1 integrin (Itgb1) expression in cells expressing GFP 
control or Kank-GFP fusion protein. Β-actin is used as loading control. (d) Kank2 
overexpression decreased velocity of 2-D random migration on fibronectin with or without 
serum stimulation. Data is illustrated as box and whisker (minimal to maximal value). 
Student t-test ***P<0.0001. (e) Single cell tracking is plotted for Kank2 knockdown cells 
rescued with wild type Kank2, Kank2 lacking KN motif, KN motif alone or GFP control. (f) 
Mean square displacement analysis showed that only full length Kank2 restored normal 
cell migration speeds in Kank2 knockdown cells. 
  
Supplementary figure legends 
Suppl. Figure 1 
(a) Experiment work flow for mass spectrometry analysis and focal adhesion enrichment 
index (FAEI) calculation. (b) Histogram of LFQ intensity distribution of total proteome for 
all quantified proteins in whole cell lysates and those identified in isolated adhesion 
revealed that adhesion isolation method tends to enrich high abundance proteins. (c) 
False discovery rate (FDR) controlled 2D annotation enrichment analysis of the relative 
abundance of functional categories between the total proteome and the FA-enriched 
subproteome. (d) Kank2-EGFP was overexpressed in cells expressing only α5β1 or 
αvβ3/β5 integrins and stained for paxillin (Pxn, red), F-actin with phalloidin (blue) and DAPI 
(grey). Scale bar, 10μm. 
Suppl. Figure 2 
(a) Immunofluorescence of GFP-tagged Kank2 constructs (green) co-stained with anti-
paxillin antibody (Pxn, blue), anti-liprin β1 antibody (red) and DAPI (grey). Scale bar, 10μm. 
(b) GFP-tagged KN motifs from Kank1, Kank3 and Kank4 are transfected into Kank2 
knockdown cells and co-stained with anti-Paxillin antibody (Pxn, red), F-actin with 
phalloidin (blue) and DAPI (grey). Scale bar, 10μm. (c) GFP-tagged Kank1, Kank3 and 
Kank4 are transfected into normal fibroblasts and co-stained with anti-paxillin antibody 
(Pxn, red), F-actin with phalloidin (blue) and DAPI (grey). Scale bar, 10μm. 
Suppl. Figure 3 
(a) SDS-PAGE analysis of purified full length talin-1, talin head domain, GST-KN fusion 
protein and GST. (b) Fluorescence correlation spectroscopy measurement of complex 
formation between atto488-leabeled KN peptide and full length talin-1. (c) Different GFP-
tagged talin rod truncations were overexpressed. Cell lysates were mixed with GST-KN 
motif and immunoprecipitated with anti-GFP antibody and analyzed with westerblot. 
Suppl. Figure 4 
(a-d) Westernblot (a, c) and densitometry analysis (b, d) of the recruitments of 
endogenous Kank2, talin, kindlin-2 to β1 integrin tail peptide in the presence of 
recombinant KN-GST (a, b) or chemically synthesized KN peptide (c, d). GST-KN 
recombinant protein and KN peptide replaced endogenous Kank2 but promoted talin 
recruitment without affecting kindlin-2 binding in a dose-dependent manner. (e, f) 
Westernblot and densitometry analysis of the recruitments of talin to β1 integrin tail in the 
presence of different doses of overexpressed full length Kank2 or Kank2ΔKN mutant. 
Student t-test ***P<0.0001. 
Suppl. Figure 5 
(a) Kank2 knockdown cells reconstituted with GFP control or Kank2-GFP were stained for 
active integrin with 9EG7 antibody (red) and F-actin with phalloidin (grey). Lower enlarged 
boxed region shows that Kank2 strongly colocalized with 9EG7 but not phalloidin (see 
arrow heads). (b) Kank2 promote active integrin cluster formation. 9EG7 staining intensity 
per cell area is quantified from (a). Student t-test ***P<0.0001. (c) Quantification of F-actin 
linked to active β1 integrin. Phalloidin intensity in 9EG7-positive area is quantified from (a) 
and plotted as box and whisker (min to max). Student t-test ***P<0.001. (d) Timelapse 
images of Talin-1-TagRFP (rainbow LUT) and Kank2-GFP. Scale bar, 5μm. 
 
  
Supplementary material and methods 
Focal adhesion isolation 
Focal adhesion isolation with chemical crosslinking was performed as previously 
described with minor modification. Serum-starved cells were plated on plastic dishes 
coated with10 μg ml−1 fibronectin at density of 1.5X106 cells per 10cm dish for 3hours. 
Cells were washed with PBS and crosslinked with 0.5mM DSP and 0.05mM DPDPB at r.t. 
for 5min and the crosslinker was quenched and washed with buffer containing 134mM 
NaCl, 50mM TrisHCl. Crosslinked cells were lysed with RIPA buffer (50mM Tris-Hcl pH7.5, 
150mM NaCl, 1% Triton-X100, 0.2% SDS, 0.5% sodium deoxycholic acid, and EDTA-free 
protease inhibitor cocktail) for 30min at 4˚C. Plates were sprayed with high pressure water 
for 60 second to remove cellular material that was not covalently bound. Crosslinked 
materials were released in 3ml of lysis buffer (150mM NaCl, 50mMTrisHCl 7.5, 0.1%SDS) 
at 60°C for 60 minutes and precipitated with cold acetone. Protein pellets were re-
dissolved in lysis buffer. Whole cell lysates were collected immediately after crosslinking 
and quenching in 100mM TrisHCl pH7.5, 4%SDS, 100mM DTT. Samples were snap-
freezed in liquid nitrogen for further mass spectrometry sample processing. Experiments 
were performed in triplicate. 
Mass spectrometry analysis 
For focal adhesion enrichment index analysis, isolated focal adhesion fractions and total 
cell lysates were collected in parallel and samples were processed in FASP method. To 
calculate the FA enrichment index (FAEI), proteins with at least one valid LFQ intensity 
value in three replicates were filtered and matched according to uniprot ID. After 
imputation of missing values from normal distribution, ratios between average LFQ 
intensity in FA and average LFQ intensity in total proteome were calculated and fitted with 
a Gaussian distribution. FAEI is derived by normalizing mean value of Gaussian 
distribution to 0. 
For in gel digestion and mass spectrometry analysis of EGFP pulldown samples, the 
samples were loaded on a gel and run for approximately 1 cm length and stopped mainly 
to incorporate all the proteins onto the gel rather than separating the proteins. Then the 
whole lane up to where the gel was run was then cut into 1mmX1mm pieces and subjected 
to a standard in-gel digestion protocol. Briefly the gel pieces were destained in ethanol 
followed by sequential reduction and alkylation with 10 mM dithiothreitol (DTT) and 40 mM 
chloroacetamide (CAA). The gel pieces were then dried and incubated with digestion 
buffer containing 12.5 ng/μl of trypsin in 25mM Tris pH 8.5. Following overnight digestion 
the peptides were extracted and purified in StageTips and analyzed in LTQ-Orbitrap XL 
mass spectrometer. The raw data were processed using MaxQuant computational 
platform version 1.5.0.26. 
Antibodies. 
The following antibodies were used for western blotting (WB) and immunofluorescence 
(IF): GFP (A11122, Life Technologies, 1:1,1000 for WB), Kank2 (HPA015643, Sigma; 
1:2,000 for WB and 1:800 for IF), Dab2 (610464, BD Transduction Laboratories, 1:1,000 
for WB ), actin (A-2066, Sigma; 1:3,000 for WB), β1 integrin (MAB1997, MB1.2, Chemicon; 
1:800 for IF), GAPDH (CB1001, 6C5, Calbiochem; 1:5,000 for WB), Kindlin-2 (MAB2617, 
EMD Millipore 1:1,000 for WB and 1:800 for IF), paxillin (610051, 349, BD Transduction 
Laboratories, 1:800 for IF), talin-1 (T3287, 8d4, Sigma; 1:1,000 for WB, 1:200 for IF), talin-
head specific antibody (sc-15336, Santa Cruz Biotechnology; 1:1000 for WB). A home-
made β1-integrin antibodies was used for western blotting (1:10,000 for WB), Phalloidin 
(Alexa Fluor 546 and Alexa Fluor 647 conjugated, Molecular Probes; 1:50 for IF) was used 
to stain F-actin. DAPI (Sigma) was used to stain nuclei. 
Plasmids and constructs. 
cDNA encoding mouse Kank1 and Kank2 were cloned into pEGFP-N1 vector (Clontech) 
between XhoI and EcoRI sites. Mouse Kank3 was cloned into pEGFP-N1 vector between 
BglII and EcoRI sites. Mouse Kank4 was cloned into pEGFP-N1 vector between XhoI and 
AgeI sites. For retrovirus mediated overexpression, DNA fragment encoding Kank2 full 
length, Kank2ΔKN (a.a.31-56 deleted), Kank2ΔLID (a.a.181-240 deleted), 
Kank2ΔKNΔLID (a.a.31-56 and a.a.181-240 deleted), Kank2-1-670 (a.a 1-670) and KN 
motif (a.a. 29-72) were amplified via PCR and inserted between XhoI and EcoRI sites in 
pRetroQ-AcGFP-N1 vector. To generate NIH3T3 cells stably expressing Kank2-EGFP, 
AcGFP fragment was replaced with Kank2-EGFP or EGFP fragments from pEGFP-N1-
Kank2 with XhoI and NotI cutting sites.  
Plasmids for Talin-AcGFP and Talin-TagRFP expression in mammalian cells were 
generated from pLPCXmod-Talin-1-Ypet (gift from Dr. Carsten Grashoff). Ypet was 
replaced with either AcGFP sequence or TagRFP-T sequence. Various Talin rod 
truncations were amplified with PCR and inserted between XhoI and EcoRI sites in 
pEGFP-N1 vector.  
For retrovirus mediated stable knockdown of mouse Kank2, two shRNA targeting 
ATACTGTATTCTTGAGTCA (shKank2#1) and AGCCAGAAAGCCAAGCTAC 
(shKank2#2) in mouse Kank2 3’UTR region were cloned into pSuper.Retro.puro vector 
(OligoEngine) according to the manufacturer’s instruction.  
For recombinant protein production, cDNA encoding Kank2 KN motif (a.a 29-72) was 
inserted into pGEX-6P1 (GE Healthcare) between EcoRI and BamHI sites. Plasmid for 
recombinant Talin-1 head domain (a.a 405) was cloned in pCoofy vector. Plasmid for full 
length Talin-1 recombinant protein production (pET101-Talin-FL) was described before 
[citation].  
Cell lines. 
Mouse kidney fibroblasts carrying floxed αv and β1 alleles were cultured as previously 
described and used for focal adhesome analysis. Mouse kidney fibroblasts containing 
floxed β1-integrin allele were cultured as previously described. NIH3T3 mouse fibroblasts 
and hTert-RPE1 cells were cultured according to the recommendation of ATCC.  
Transient and stable transfection/transduction. 
Cells were transiently transfected with Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol. To generate stable cell lines, VSV-G pseudotyped retroviral 
vectors were produced by transient transfection of HEK293T (human embryonic kidney) 
cells. Viral particles were concentrated from cell culture supernatant as described 
previously and used for infection. 
Expression and purification of recombinant proteins. 
For GST fusion protein of KN motif, plasmids encoding GST–KN or GST alone were 
transformed into BL21 (DE3) and protein expression was autoinduced over night at 37˚C. 
5g biomass was lysed with high pressure homogenizer in GST binding buffer (TrisHCl 
50mM, NaCl 150mM, EDTA 1mM, DTT 1mM, pH 7.5). Protease inhibitor (AEBSF-HCl 
1mM, Aprotinin 2μg/ml, Leupeptin 1μg/ml, Pepstatin 1μg/ml) and nuclease (Benzonase) 
were added during the cell lysis. After clarification, supernatant were incubated with 
Glutathione Sepharose 4 Fast Flow (GE Healthcare) for 3.5hour at 4˚C followed by 3 times 
washing with GST binding buffer and elution with 50 mM Glutathione in the binding buffer. 
Elute fractions containing were pooled and desalted (Sephadex G-25 in Hi Prep 26/10) in 
buffer (TrisHCl 50mM, NaCl 150mM, 0.1mM DTT) and further purified with size-exclusion 
chromatography (Superdex 75 PC 3.2/30) in desalting buffer. 
Full length talin recombinant protein production was optimized based on previously 
published protocol. Briefly, pET101-Talin-FL was transformed into BL21 (DE3) Gold and 
induced 1 mM IPTG at 18˚C overnight. After lysis with high pressure homogenizer in lysis 
buffer (50mM TrisHCl pH7.8, 500mM NaCl, 30mM imidazole, 1mM DTT) and clarification 
of the supernatant, full length Talin was purified by Ni-NTA affinity chromatography (Ni 
SepharoseHigh Performance, GE Healthcare). Elute fractions with 500mM imidazole in 
lysis buffer were pooled and loaded on anion exchange (HiTrap Q HP, 6% highly cross 
linked agarose; strong anion -N+(CH3)3, GE Healthcare) in MES buffer (20mM MES 
pH6.3, 1mM DTT, gradient from 100mM KCl to 100mM KCl). Elute fractions were pooled 
and concentrated (Amicon Ultra 15, MWCO 100kD) and further purified by size-exclusion 
chromatography (Superdex 200 10/300 GL, GE Healthcare) in 50mM TrisHCl pH7.8, 
150mM KCl, 1mM DTT. Purified fractions were stored in presence of 50% glycerol in -
80˚C. 
Talin-1-head (a.a. 1-405) was cloned into pCoofy vector. The recombinant production of 
talin-1-head (a.a. 1-405) in E. coli Rosetta cells (Merck Millipore) was autoinduced at 24 °C 
for 22 h. After cell lysis and clarification of the supernatant, talin-1-head was purified by 
Ni-NTA affinity chromatography (Qiagen). Elute fractions containing talin-1-head were 
pooled, cleaved with SenP2 protease and purified by size-exclusion chromatography 
(Superdex 200 26/600, GE Healthcare) yielding unmodified murine talin dead domain. 
Immunoprecipitation and GST pulldown 
For immunoprecipitation of EGFP tagged proteins, cells were lysed in M-PER buffer and 
1mg cells lysates in were immunoprecipitated with µMACS GFP Isolation Kit (Miltenyi 
Biotec) according to the manufacturer’s protocol. Elutes were separated in SDS-PAGE for 
westernbloting or in-gel digestion and mass spectrometry analysis. 
For GST pulldown experiments, full length Talin and Talin-head recombinant protein were 
re-buffered in the GST binding buffer (137mM NaCl, 13mM KCl, 0.05% Tween-20, 50mM 
TrisHCl pH7.5) with Zebra Desalt Spin Columns (Thermo Scientific). 200nM GST or GST-
KN fusion proteins were incubated with 100nM full length Talin or 300nM Talin head for 
30min at 4˚C and then incubated with Glutathione Sepharose (GE Healthcare) for another 
1.5hour at 4˚C. Resin was washed three times with the GST binding buffer and eluted in 
2X laemmli buffer at 95˚C for 2min. Samples were analyzed in westernblot using antibody 
against Talin head and GST.  
Fluorescence correlation spectroscopy (FCS) 
The diffusion time as a function of talin protein concentration was measured by 
fluorescence correlation spectroscopy (FCS). FCS experiments were performed on a 
custom-build confocal microscopy. Prior to the experiment, the known diffusion coefficient 
of AlexaFluor 488 in water was used to calibrate the confocal volume (D = 400 µm2/s). To 
analyze the interactions between the atto488 fluorescently-labeled KN peptide and talin, 
the peptide was diluted to a final concentration of ~1 nM in buffer (20 mM HEPES, 150 
mM KCl, 0.5 mM EDTA, 1 mM DTT, pH 7.5) and 32 μM of talin was added. The reaction 
was incubated at room temperature for 3 minutes before subject to the FCS measurement. 
Lower concentrations in solution of talin were made by subsequent dilution in buffer 
containing 1nM of atto488-labeled KN peptide. The full dilution series was repeated three 
times.  The fluctuation of fluorescence arising from the fluorescent KN-talin complexes 
was monitored and auto-correlated using all three measurements and diffusion time was 
estimated by fitting with a single diffusing species. 
Integrin peptide pulldowns. 
Peptide pulldowns were performed as described previously with minor modifications with 
β1 wt cytoplasmic tail peptides 
(HDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK-OH), β1 Y795A tail 
peptide (HDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKAEGK-OH), β3 tail 
peptide (HDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT-OH), β5 tail 
peptide (HDRREFAKFQSERSRARYEMASNPLYRKPISTHTVDFAFNKFNKSYNGSVD-
OH), β2 tail peptide (TDLREYRRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES-OH), 
a scrambled peptide (EYEFEPDKVDTGAKGTKMAKNEKKFRNYTVHNIWESRKVAP-
OH). All peptides were desthiobiotinylated. Before use, peptides were immobilized on 
20 μl Dynabeads MyOne Streptavidine C1 (10 mg ml−1, Invitrogen) in washing buffer 
containing 137mM NaCl, 13mM KCl, 50mM TrisHCl at pH 7.4, 0.05% Tween-20 for 2hours 
at 4˚C. Beads were washed twice with washing buffer and once with M-PER buffer. 0.5mg 
cell lysate at 1mg/ml collected in M-PER buffer was incubated with the beads for 5hours 
at 4˚C. After incubation with tail peptides, proteins were eluted with 2X laemmli buffer at 
95˚C for 5min. For in vitro Talin activation assay, 10nM recombinant talin diluted in the 
peptide pulldown washing buffer for 15min and then incubated with 10nM GST or GST-
KN motif for 1hour together with the Dynabeads at 4˚C. Beads were washed three times 
with the washing buffer and eluted with 2X laemmli buffer at 95˚C for 5min. 
Immunofluorescence microscopy.  
For immunostaining, cells were cultured on glass coated with 10 μg ml−1 fibronectin 
(Calbiochem) for 5hours in complete culture medium before fixed with cold 
methanol:acetone (1:1) for 5min at -20˚C (for endogenous Talin staining) followed by 
15min rehydration in PBS at r.t. or with 2% PFA/PBS for 15min at r.t. For PFA fixed 
samples, fixed cells were permeabilized with 0.1% Triton-X100/PBS for 30min at r.t. Cells 
were blocked with 5%BSA/PBS for 1 h at r.t. followed by incubation with the primary 
antibodies in 5%BSA/PBS overnight at 4˚C and secondary antibodies for 1 h at r.t. Images 
were collected at room temperature on a ZEISS (Jena, Germany) LSM780 confocal laser 
scanning microscope equipped with a ZEISS Plan-APO 63x/NA1.46 oil immersion 
objective.  
Fluorescence recovery after photobleaching and fluorescence live cell imaging 
Fluorescence recovery after photobleaching (FRAP) and fluorescence live cell imaging 
were performed on a ZEISS (Jena, Germany) LSM780 confocal laser scanning 
microscope equipped with a ZEISS Plan-APO 63x/NA1.46 oil immersion objective with 
environmental control (5% CO2 and humidification). Cells were transfected with indicated 
plasmids and cultured on 10 μg ml−1 fibronectin coated glass-bottom live cell imaging 
chamber (ibidi) for 24 hours. For FRAP experiments, region of interest was bleached with 
full laser power at 488nm for 30 iterations and fluorescence recovery was monitored for 
5min with 20second interval with 1% laser power. No significant photobleaching was 
observed during the post-bleaching phase. FRAP data was extracted with build-in 
package in Carl Zeiss ZEN software and analyzed in GraphPad Prism 6. FRAP curves 
were fitted in one phase association model: Y=Y0 + (Plateau-Y0)*(1-exp(-K*x)). For 
fluorescence live cell imaging, cells were imaged for 10min with 20second interval with 1% 
laser power. 
 
Time-lapse video microscopy of 2D-random cell migration. 
Indicated cells were seeded sparsely on 6-well plate coated with 5μg/ml fibronectin in the 
absence of serum for 2hours, then the cell migrations were recorded at 37 °C and 
5% CO2 for 6hours with 5min time interval on a Zeiss Axiovert 200 M (Zeiss, Germany) 
equipped with ×10/.3, ×20/.4 and ×40/.6 objectives, a motorized stage (Märzhäuser) and 
an environment chamber (EMBL Precision Engineering) with a cooled CCD (charge-
coupled device) camera (Roper Scientific). Image acquisition and microscope control were 
carried out with MetaMorph software (Molecular Devices). The acquired images were 
analyzed using the manual tracking plugin of ImageJ and the Chemotaxis and Migration 
Tool (ibidi).  
Statistics. 
Statistical analysis was performed in GraphPad Prism software (version 5.00, GraphPad 
Software). Results are illustrated as the mean±sd. unless otherwise indicated. 
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Integrin α3β1 regulates kidney collecting duct 
development via TRAF6-dependent K63-linked 
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ABSTRACT The collecting system of the kidney develops from the ureteric bud (UB), which 
undergoes branching morphogenesis, a process regulated by multiple factors, including 
integrin–extracellular matrix interactions. The laminin (LM)-binding integrin α3β1 is crucial 
for this developmental program; however, the LM types and LM/integrin α3β1–dependent 
signaling pathways are poorly defined. We show that α3 chain–containing LMs promote 
normal UB branching morphogenesis and that LM-332 is a better substrate than LM-511 for 
stimulating integrin α3β1–dependent collecting duct cell functions. We demonstrate that 
integrin α3β1–mediated cell adhesion to LM-332 modulates Akt activation in the develop-
ing collecting system and that Akt activation is PI3K independent but requires decreased 
PTEN activity and K63-linked polyubiquitination. We identified the ubiquitin-modifying en-
zyme TRAF6 as an interactor with the integrin β1 subunit and regulator of integrin α3β1–de-
pendent Akt activation. Finally, we established that the developmental defects of TRAF6- 
and integrin α3–null mouse kidneys are similar. Thus K63-linked polyubiquitination plays a 
previously unrecognized role in integrin α3β1–dependent cell signaling required for UB 
development and may represent a novel mechanism whereby integrins regulate signaling 
pathways.
INTRODUCTION
The kidney develops from two distinct embryonic components: the 
ureteric bud (UB), which forms the multibranched collecting system, 
and the metanephric mesenchyme, which gives rise to the neph-
rons. The formation of the collecting system occurs by iterative 
branching morphogenesis of the UB, a process regulated by multi-
ple factors, including integrin-dependent cell–extracellular matrix 
(ECM) interactions.
Laminins (LMs), trimeric proteins consisting of α, β, and γ chains, 
are the principal ECM components that regulate UB development. 
There are five α chains, four β chains, and three γ chains, which can 
form 15 LM trimers (Aumailley et al., 2005). The γ1, α5, and α3 LM 
chains are expressed in UB-derived structures (Zent et al., 2001; 
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The contribution of integrin α3β1 to the development of the kid-
ney collecting system has been investigated; however, the involve-
ment of its LM substrates and the signaling pathways mediated by 
LM/α3β1 integrin interactions are poorly defined. In this study, we 
show that the α3 chain containing LMs is essential for normal UB 
branching morphogenesis. We also demonstrate that integrin α3β1 
mediates renal CD cell functions by activating Akt via a mechanism 
that is PI3K independent but requires K63-linked polyubiquitination. 
Finally, we show that the ubiquitin ligase TRAF6 interacts with the 
integrin β1 subunit and regulates integrin-dependent Akt activation. 
Thus we conclude that K63-linked polyubiquitination plays a previ-
ously unrecognized role in regulating integrin α3β1–dependent cell 
signaling that is required for UB development.
RESULTS
The LM α3 chain is required for normal UB development
The γ1 and α5 LM chains have been shown to be required for 
normal UB development in vivo (Liu et al., 2009; Yang et al., 
2011); however, the role for the α3-containing LMs is undefined. 
We previously showed that LM-332 is expressed in early develop-
ment of the rat UB (Zent et al., 2001). We verified that α3-
containing LMs are expressed in the developing mouse UB in E15 
and E19 mouse kidneys by performing immunohistochemistry 
with antibodies directed against the LM α3 chain, found in LM-
311, LM-321, and LM-332, and the LM γ2 chain that is specific for 
LM-332 (Figure 1, A–D). We subsequently defined the role of LM 
α3 chain in UB development by examining kidneys of LM α3–null 
mice, which die at birth due to a skin-blistering condition, on an 
undefined background, (Ryan et al., 1999). We found that 40% of 
these mice (12/30) had developed one kidney when examined at 
birth (postnatal day 1 [P1]). This phenotype was lost as the mice 
were bred onto a pure C57/Bl6 background. However, examina-
tion of embryonic kidneys of LM α3–null mice on this background 
revealed mild hypoplasia/dysplasia of the papilla at E18 (Figure 1, 
E and F), which became more evident in newborn mice (Figure 1, 
G and H) and is manifested by fewer but more dilated tubules in 
the papilla. LM α3 deletion also significantly decreased tubule 
proliferation in the papilla (Figure 1, I–K), suggesting that a pro-
liferative defect accounts in part for the abnormal phenotype. 
Thus α3-containing LMs appear to play a distinct role in UB de-
velopment in vivo.
Deleting the integrin α3 subunit in the UB causes branching 
morphogenesis defects and renal papilla dysplasia/
hypoplasia and impairs Akt and p38 MAPK signaling
Deletion of the β1 integrin subunit in the UB results in a severe 
branching morphogenesis defect in vivo (Zhang et al., 2009), and 
organ culture experiments predicted that integrin α3β1 is a major 
contributor to UB development (Zent et al., 2001). However, when 
the integrin α3 subunit was specifically deleted in the UB using the 
Hoxb7Cre mouse, only a mild to moderate CD defect character-
ized by absence or flattening of the papilla was noted (Liu et al., 
2009). Owing to this discrepant result, we used Hoxb7Cre;Itgα3flox/
flox mice that were generated using different targeting strategies 
(Kobayashi et al., 2005; Sachs et al., 2006) to those published (Liu 
et al., 2009; see Materials and Methods for details). These mice had 
a normal lifespan despite complete deletion of the integrin α3 sub-
unit in the UB (Figure 2M). The kidneys had a mild UB branching 
morphogenesis defect that was first evident at E15 (Figure 2, A 
and B). At E18 and P1, the papillae of kidneys from 
Hoxb7Cre;Itgα3flox/flox mice were hypoplastic/dysplastic with fewer 
and more dilated CDs when compared with kidneys from controls 
Chen et al., 2004; Miner and Yurchenco, 2004). The γ1 chain, found 
in 10 of the LMs, is critical for UB development, as mice lacking this 
chain in the UB have a severe kidney branching morphogenesis de-
fect (Yang et al., 2011). The LM α5 chain, found in LM-511 and LM-
521, is also necessary for normal UB development, as LM α5–null 
mice have a mild branching morphogenesis defect (Liu et al., 2009). 
The role of the α3 chain–containing LMs (LM-332, LM-321, and 
LM-311) in UB development in vivo is less well defined, as their im-
portance in branching morphogenesis has only been shown utilizing 
LM-332 inhibitory antibodies in an ex vivo organ culture model (Zent 
et al., 2001).
Integrins are heterodimeric transmembrane matrix receptors con-
sisting of αβ subunits that exhibit different ligand-binding proper-
ties. Twenty-four integrins are found in mammals, and four of them—
α3β1, α6β1, α6β4, and α7β1—primarily bind to LMs. While integrins 
α3β1, α6β1, and α6β4 are expressed in the developing UB (Zent 
et al., 2001), integrin α3β1 is the major receptor that mediates UB 
formation (Liu et al., 2009). The global integrin α3–null mouse, which 
dies at birth, presents with an abnormal renal papilla outgrowth evi-
dent at embryonic day 18.5 (E18.5; Kreidberg et al., 1996). Specific 
deletion of the integrin α3 subunit in the UB using the Hoxb7Cre/ 
green fluorescent protein (GFP) mouse results in adult mice with ab-
sent or dramatically flattened papillae (Liu et al., 2009). This abnor-
mality was proposed to be due to alterations in expression of Wnt7b 
and Wnt4 in vivo (Liu et al., 2009). Integrin α3β1–dependent phos-
phoinositide 3-kinase (PI3K)/Akt signaling was shown to control ex-
pression of Wnts in collecting duct (CD) cells, suggesting this signal-
ing pathway modulates Wnts in UB development (Liu et al., 2009). 
However, the mechanism whereby integrin α3β1 regulates the Akt 
signaling pathway is currently unknown.
The PI3K/Akt pathway, which plays a central role in multiple bio-
logical functions, is stimulated downstream of numerous cell recep-
tors, including growth factor receptors and integrins. Activation of 
this pathway is complex. PI3K phosphorylates PI(4,5)P2 (PIP2) to 
form PI(3,4,5)P3 (PIP3), which is required for the recruitment of Akt 
from the cytosol to the plasma membrane (Cantley, 2002). The dual-
specificity protein phosphatase PTEN negatively regulates this pro-
cess by dephosphorylating PIP3 to PIP2 (Song et al., 2012). Src-in-
duced phosphorylation of Akt at Tyr315/Tyr326 is required to 
precondition Akt for membrane binding (Jiang and Qiu, 2003). At 
the membrane, Akt is phosphorylated on Thr308 within its catalytic 
domain by phosphoinositol-dependent kinase 1 (PDK1) and at 
Ser473 within its C-terminal regulatory domain by mammalian tar-
get of rapamycin complex 2 (mTORC2), resulting in its full activation 
(Guertin and Sabatini, 2007; Bayascas, 2008).
A less well-recognized mechanism of regulation of Akt activity is 
polyubiquitination. Specifically, K63-linked polyubiquitination, exe-
cuted by the E3 ligase tumor necrosis factor (TNF) receptor–associ-
ated factor 6 (TRAF6), promotes Akt translocation to the membrane 
and is essential for Akt phosphorylation (Yang et al., 2009, 2010). Of 
the six known TRAF proteins, TRAF6 has several unique features 
that contribute to its diverse physiological functions. Unlike other 
TRAFs, which mediate signaling only from the TNF receptor super-
family, TRAF6 also participates in signal transduction from the Toll-
like receptor/interleukin-1 receptor superfamily (Wu and Arron, 
2003) and other receptors, including TGF-β receptors (Landstrom, 
2010). TRAF6 induces K63-linked polyubiquitination of itself and 
downstream signaling molecules (Wang et al., 2012). It is unclear 
how the K63-linked polyubiquitination of Akt results in its recruit-
ment to the plasma membrane and its subsequent activation. More-
over, the role of TRAF6-mediated K63-linked polyubiquitination in 
integrin-dependent signaling is undefined.
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examined whether similar abnormalities occurred in the develop-
ing collecting system of Hoxb7Cre;Itgα3flox/flox mice. As for the 
β1-null mice, we noted a decrease in Akt and p38 phosphoryla-
tion in the UB of Hoxb7Cre;Itgα3flox/flox mice; however, FAK 
(unpublished data) and ERK1/2 (Figure 2M) activation were 
(Figure 2, C–H). Hypoplastic/dysplastic papillae persisted into 
adulthood of the Hoxb7Cre;Itgα3flox/flox mice (Figure 2, I–L).
As deleting the β1 integrin subunit in the UB resulted in mark-
edly decreased activating phosphorylation of focal adhesion ki-
nase (FAK), Akt, ERK1/2, and p38 MAPK (Zhang et al., 2009), we 
FIGURE 1: The LM α3 chain is required for normal UB development. (A–D) Embryonic mouse kidneys (E15, E19) stained 
with antibody against the LM α3 or LM γ2 chain. The UB is designated by the arrows (100× magnification). 
(E–H) H&E-stained kidneys of WT and LM α3–null mice at E18 and postnatal day 1 (P1). Magnification is 40× 
(E and F) and 100× (G and H). The arrows indicate the hypoplastic dysplastic papilla with dilated CDs present in the LM 
α3–null relative to WT mice. (I and J) Embryonic mouse kidneys (E19) stained with Ki67 antibody (100× magnification). 
(K) Bar graph of the average numbers of Ki67-positive tubular cells per HPF 100× magnification field of inner medullary 
CDs (6 HPF, 3 mice of each genotype) with SEM, *, p < 0.05 between WT and LM α3–null.
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note, deletion of α3 integrin subunit resulted in decreased ex-
pression of β1 and increased expression of α6 integrin subunits 
(Figure 2M). These data suggest that α3 is the major integrin sub-
unit that interacts with the β1 subunit in the renal papilla and that 
there is compensatory expression of the integrin α6 subunit upon 
its deletion.
unaffected. Consistent with diminished Akt activation, there was 
decreased Akt-dependent phosphorylation of glycogen synthase 
kinase 3 beta (GSK-3β) at Ser9 (Figure 2M). These data suggest 
that integrin α3 subunit regulates a limited number of integrin 
β1–dependent signaling pathways in the developing kidney col-
lecting system, specifically the Akt and p38 MAPK pathways. Of 
FIGURE 2: Hoxb7Cre:Itgα3flox/flox mice have defective UB development and decreased activation of Akt, GSK-3β, 
and p38 MAPK. (A–L) H&E stained kidneys of WT mice (Itgα3flox/flox) and mice lacking integrin α3 in the UB 
(Hoxb7:Itgα3flox/flox) at various stages of development. Magnification is 40× (A–F, I, and J) and 100× (G, H, K, and L). 
Note the mild branching defect from E15 onward and the hypoplastic papilla, which is characterized by fewer but 
dilated CDs in the Hoxb7:Itgα3flox/flox mice from E18 onward (arrows). (M) Lysates of papillae (20 μg total protein/lane) 
from 3-d-old Itgα3flox/flox and Hoxb7:Itgα3flox/flox mice were analyzed by Western blotting for levels of integrin subunits 
α3, α6, and β1; phospho-AktSer473, phospho-GSK-3β, phospho-p38, and phospho-ERK1/2. Bands of phosphorylated and 
total proteins as well as β-actin (loading control) were measured by densitometry. The amount of phosphorylated 
proteins was normalized to total protein and β-actin levels and presented as mean ±SEM from at least three animals; 
*, p < 0.05 between Hoxb7:Itgα3flox/flox and Itgα3flox/flox samples.
Volume 26 May 15, 2015 Integrin α3β1 and K-63 ubiquitination | 1861 
these signaling pathways more strongly when it interacted with 
LM-332 than with LM-511.
The role of p38 MAPK on integrin α3β1–dependent CD cell ad-
hesion and migration on LM-332 was investigated by inhibiting its 
activity with SB203580 in Itgα3f/f CD cells. Inhibition of p38 MAPK, 
which was verified by decreased phosphorylation of MAPK-APK2, a 
specific downstream target of p38 MAPK (Figure 4B), resulted in a 
severe adhesion and migration defect (Figure 4, C and D). These 
data confirmed a role of p38 MAPK for integrin α3β1–dependent 
adhesion to and migration on LM-332.
Akt signaling pathway is critical for integrin α3β1–
dependent CD cell adhesion and migration on LM-332
Because deleting the integrin α3 subunit caused increased basal 
Akt signaling and the inability to activate this pathway further, we 
defined the functional significance of Akt activation on integrin 
α3β1–dependent CD cell adhesion and migration on the preferred 
integrin α3β1 substrate LM-332. This was done by inhibiting its ac-
tivity using two distinct Akt small interfering RNAs (siRNAs) or Akt 
inhibitor IV in Itgα3f/f CD cells (Figure 5, A and B) and then defining 
the ability of these cells to adhere and migrate (Figure 5, C and D). 
These treatments resulted in a significant decrease in cell adhesion 
to and migration on LM-332 (Figure 5, C and D). We confirmed that 
adhesion of CD cells to LM-332 was dependent on Akt signaling by 
restoring normal basal cell adhesion by transducing the cells with an 
adenovirus expressing constitutively active myristoylated Akt (Figure 
5E). Analysis of signaling pathway activation revealed that Akt in-
hibitor IV treatment prevented phosphorylation of Akt and its down-
stream target GSK-3β (Figure 5B).
Integrin α3β1–dependent CD cell adhesion to and migration 
on LM-332 requires PI3K-independent Akt activation
A key regulator of Akt activity is PI3K, which phosphorylates PIP2 to 
PIP3 to create membrane sites for the Akt pleckstrin homology do-
main binding that allows for Akt recruitment to the plasma mem-
brane, where it is activated (Cantley, 2002). To determine whether 
PI3K activity plays a role in integrin α3β1–dependent adhesion to and 
migration on LM-332, we inhibited PI3K activity by infecting the 
Itgα3fl/fl cells with adenovirus carrying a catalytic subunit deletion 
PI3K mutant, ad-delta p85 (Figure 6A). Surprisingly, both cell adhe-
sion and migration were not affected by this form of PI3K inhibition 
(Figure 6, B and C). Similar results were obtained with the selective 
PI3K inhibitor LY294002 (Figure 6, B and C). Signaling pathway analy-
sis revealed that LY294002 prevented Akt phosphorylation at the 
PI3K/PDK1-dependent Thr308 site (Figure 6D); however, phosphory-
lation of Ser473, which is performed by mTORC2 and serves as an 
indication of full Akt activation (Cantley, 2002; Guertin and Sabatini, 
2007), was not affected (Figure 6D). Taken together, these data dem-
onstrate that, in CD cells, Akt activity required for integrin α3β1–de-
pendent adhesion to and migration on LM-332 is PI3K independent.
We next defined the mechanisms whereby integrin α3β1 regu-
lates PI3K-independent activation of Akt in response to adhesion to 
LM by measuring the PIP3 levels in Itgα3f/f and Itgα3−/− CD cells upon 
plating on LM-332. Basal levels of PIP3 in Itgα3−/− CD cells were sig-
nificantly higher than those detected in Itgα3f/f CD cells (Figure 6E). 
However, following plating on LM-332, Itgα3f/f CD cells showed a 
dramatic increase in PIP3 levels (∼1000-fold). In contrast, decreased 
levels of PIP3 were noted in Itgα3−/− CD cells (Figure 6E).
In addition to PI3K, the amount of PIP3 in cellular membranes is 
regulated by PTEN (Cantley, 2002; Song et al., 2012). We therefore 
determined whether PTEN is responsible for the observed differ-
ences in PIP3 levels. Indeed, the higher basal amount of PIP3 in 
Integrin α3–null CD cells have severe adhesion, migration, 
proliferation, and signaling defects on LM-332
To study the mechanisms whereby LM/integrin α3β1 interactions 
regulate collecting system development, we isolated CD cells from 
Itgα3flox/flox mice (Itgα3f/f) and deleted the integrin α3 subunit in vitro 
by infecting the cells with adeno-cre (Itgα3−/−). As seen in the renal 
papilla, integrin α3 deletion led to increased integrin α6 and de-
creased integrin β1 expression (Figure 3, A and B). Interestingly, the 
increased α6 integrin subunit was associated with β1 and the level of 
integrin α6β4 was unchanged (Figure 3C). There was no change in 
expression of α1, α2, α5, or αv integrin subunits (unpublished data), 
suggesting that the expression levels of the collagen- and arginine–
glycine–aspartic acid (RGD)-binding integrins were unaffected. Thus, 
as in the renal papilla, α3 appears to be the principal integrin subunit 
that interacts with the β1 subunit in CD cells, and there is compen-
satory expression of the integrin α6 subunit upon its deletion.
On the basis of our in vivo studies and those of others demon-
strating that Hoxb7Cre;Itgα3flox/flox mice have similar phenotypes to 
LM α5– and α3–null mice (Miner and Li, 2000; Liu et al., 2009; Figure 
1), we defined whether integrin α3β1 controls CD cell adhesion, mi-
gration, and proliferation by interacting with LM-511 and/or LM-332. 
Severe defects in all these cell functions were detected for Itgα3−/− 
CD cells plated on LM-332. In contrast, the defects on LM-511, while 
significant, were not as severe (Figure 3, D–G), suggesting that 
LM-332 is a preferred substrate for integrin α3β1. To confirm the 
specific role of integrin α3β1 and the α6-containing integrins on CD 
cell adhesion to LM-332 and LM-511, we performed adhesion assays 
in the presence of a blocking anti-Itgα6 antibody (Figure 3H). Block-
ing α6-containing integrins did not affect adhesion of Itgα3f/f CD 
cells to LM-332 but decreased adhesion of these cells to LM-511. 
Adhesion of Itgα3−/− CD cells to both LMs was decreased by the ad-
dition of anti-Itgα6 antibody (Figure 3H). Thus α6-containing integ-
rins play a role in CD cell binding to LM-511 in the presence and 
absence of integrin α3β1; however, they only affect CD cell adhesion 
to LM-332 in the absence of integrin α3β1. LM-332 and LM-511 
were verified as specific substrates for integrin α3β1, as no differ-
ences between Itgα3f/f and Itgα3−/− cells were found when these 
assays were performed on collagen I, fibronectin, vitronectin, or 
LM-111 (Supplemental Figure 2).
Integrin α3β1–dependent adhesion to LM-332 and LM-511 
activates Akt and p38 signaling pathways in CD cells
As our in vivo data demonstrated decreased Akt and p38 activa-
tion in the Hoxb7Cre;Itgα3flox/flox mice (Figure 2M), we performed 
in vitro replating assays to define whether the defects observed in 
cell function were mediated by abnormalities in integrin α3β1-LM–
dependent signaling. Itgα3−/− CD cells failed to significantly in-
crease Akt phosphorylation when plated on LM-332 or LM-511 
(Figure 4A). A similar defect in Akt-dependent phosphorylation of 
GSK-3β was also seen when Itgα3−/− CD cells were plated on LM-
332 or LM-511 (Figure 4A). It is important to note that the basal 
levels of Akt and Akt-dependent GSK-3β phosphorylation were 
significantly higher in Itgα3−/− than in Itgα3f/f CD cells (an approxi-
mately twofold difference; Figure 4A). There were also less marked 
but significant abnormalities in p38 signaling characterized by 
less-sustained activation in Itgα3−/− CD cells plated on either LM-
332 or LM-551 compared with Itgα3f/f CD cells (Figure 4A). No 
difference in ERK1/2 activation was seen between the two CD cell 
populations. These results suggest that integrin α3β1 mediates 
LM-dependent activation of both Akt and p38 pathways; however, 
the effects on Akt are more profound. As with cell adhesion, 
migration, and proliferation (Figure 3, D–G), integrin α3β1 induced 
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FIGURE 3: Integrin α3β1 promotes CD cell adhesion, migration, and proliferation on LM-332 and LM-511. (A) Lysates 
from Itgα3−/− and Itgα3f/f CD cells (20 μg total protein/lane) were immunoblotted for integrin β1, α3, and α6 subunits. 
β-actin served as a loading control. (B) Surface expression of integrin β1, α3, and α6 subunits was determined on 
Itgα3−/− and Itgα3f/f CD cells by flow cytometry using R-phycoerythrin (PE). (C) Lysates from Itgα3−/− and Itgα3f/f CD cells 
(100 μg total protein) were immunoprecipitated with anti-Itgα6 antibody or normal rabbit IgG and immunoblotted for 
integrin subunits β1 and β4. Adhesion (D and E), migration (F), and proliferation (G) of Itgα3f/f and Itgα3−/− CD cells on 
LM-332 and LM-511 were evaluated as described in Materials and Methods. Mean measurements ±SEM of four to six 
independent experiments are shown; *, p ≤ 0.05 between Itgα3f/f and Itgα3−/− CD cells. (H) Itgα3f/f and Itgα3−/− CD cells 
were treated with blocking anti-Itgα6 antibody and plated on LM-332. Adhesion was evaluated as described in 
Materials and Methods. Mean measurements ± SEM of three independent experiments are shown; *, p ≤ 0.05 between 
CD cells and CD cells treated with blocking anti-Itgα6 antibody.
Volume 26 May 15, 2015 Integrin α3β1 and K-63 ubiquitination | 1863 
FIGURE 4: Integrin α3β1–dependent adhesion induces activation of Akt and p38 pathways. (A) Itgα3f/f and Itgα3−/− CD 
cells were plated in serum-free medium on LM-332 or LM-511 (both at 1 μg/ml). Cells were lysed at 30 and 60 min after 
plating, and lysates were analyzed by Western blotting for levels of phosphorylated AktSer473, GSK-3β, p38, and ERK1/2 
(20 μg total protein/lane). Levels of phosphorylated proteins were measured by densitometry, normalized to total 
protein and β-actin levels, and expressed as fold change relative to cells left in suspension, “0” time point. Values are 
the mean ± SEM of three independent experiments; *, p ≤ 0.05 between Itgα3f/f and Itgα3−/− CD cells. (B–D) Itgα3f/f CD 
cells were treated with dimethyl sulfoxide (DMSO; control) or the p38 inhibitor SB203580 (10 μM) for 1 h, after which 
the cells were trypsinized; resuspended in serum-free medium; and subjected to replating (B), adhesion (C), or migration 
(D) assays on LM-332 (1 μg/ml). (B) Cell signaling was evaluated by immunoblotting cell lysates for phosphorylated 
AktSer473, GSK-3β, p38, and MAPK-APK2 (20 μg total protein/lane). β-actin served as a loading control. Adhesion (C) and 
migration (D) were evaluated as described in Materials and Methods. Mean measurements ± SEM of three independent 
experiments are shown; *, p ≤ 0.05 between Itgα3f/f treated with DMSO and SB203580.
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FIGURE 5: Integrin α3β1–dependent adhesion and migration on LM-332 are regulated by Akt activation. Itgα3f/f CD 
cells were transfected with nonsilencing or Akt siRNA (100 nM for 48 h) (A and C–F) or treated with the Akt inhibitor IV 
(5 μM for 1 h) or DMSO (control) (B–D). The effect of the siRNA on AKT expression is shown by immunoblotting cell 
lysates for total Akt, with β-actin serving as a loading control (A). (B–D) Control cells or cells treated with Akt inhibitor IV 
were subjected to replating, after which cell lysates were immunoblotted for phosphorylated AktSer473 and GSK-3β and 
total Akt (20 μg total protein/lane), with β-actin serving as a loading control (B). Treated and untreated cells were 
evaluated for adhesion (C) or migration (D) on LM-332 (1 μg/ml) and evaluated as described in Materials and Methods. 
Mean measurements ± SEM of four to six independent experiments are shown; *, p ≤ 0.05 between control Itgα3f/f cells 
and Itgα3f/f cells with inhibitors. (E and F) Itgα3f/f CD cells were transfected with either nonsilencing or Akt siRNA, with 
control (ad-GFP) or myristilated Akt (100 plaque-forming units/cell for 24 h) (myrAkt) (E) and subjected to an adhesion 
assay as described in C (F). Mean measurements ± SEM of four to six independent experiments are shown; *, p ≤ 0.05 
between control Itgα3f/f cells and Itgα3f/f cells transfected with Akt siRNA; *, p ≤ 0.05 between Itgα3f/f cells with Akt 
siRNA and Itgα3f/f cells with Akt siRNA and myristilated Akt.
Volume 26 May 15, 2015 Integrin α3β1 and K-63 ubiquitination | 1865 
We next defined the functional effects of down-regulating TRAF6 on 
integrin α3β1–dependent cell adhesion to LM-332 and found that 
decreased TRAF6 expression significantly decreased Itgα3f/f CD 
cells adhesion to this substrate (Figure 7F). As this decreased adhe-
sion was similar to that induced by the Akt inhibitor IV (Figure 7F), 
we postulated that TRAF6 might regulate cell adhesion by altering 
the activation state of Akt. This possibility was confirmed by the fact 
that introduction of a constitutively active Akt (ad-myrAkt) restored 
the adhesion defects caused by TRAF6 down-regulation (Figure 7F).
TRAF6 deficiency causes renal papilla dysplasia/hypoplasia 
and defects in Akt signaling
Our in vitro data suggested that integrin α3β1 regulates Akt activa-
tion by altering TRAF6 function in CD cells. We therefore investi-
gated whether TRAF6-dependent activation of Akt regulates kidney 
collecting system development in vivo by analyzing the phenotype 
of kidneys from TRAF6-deficient (KO) mice. Previous investigation of 
these animals has demonstrated that TRAF6 is essential for normal 
bone formation (Lomaga et al., 1999), establishment of the immune 
system and inflammatory response (Lomaga et al., 1999; Naito 
et al., 1999), development of the central neuron system (Lomaga 
et al., 2000) and epidermal appendixes (Naito et al., 1999). The kid-
neys of TRAF6 KO newborn mice were noticeably smaller than wild-
type (WT) animals (Figure 8, A and B). When we examined the kid-
neys of TRAF6 KO newborn mice in detail, we noted a slight 
branching morphogenesis defect in the renal collecting system and 
a mildly dysplastic papilla (Figure 8, C and D) resembling the defects 
observed in the Hoxb7Cre;Itgα3flox/flox (Figure 2, E–H) and the con-
stitutive Itgα3-null mice (Kreidberg et al., 1996). As deleting the α3 
integrin subunit in the UB resulted in markedly decreased activation 
of Akt signaling (Figure 2M), we examined whether similar abnor-
malities occurred in the developing collecting system of TRAF6 KO 
mice. As in Hoxb7Cre;Itgα3flox/flox mice, we noted a decrease in Akt 
activation of phosphorylation in the collecting system of the TRAF6 
KO mice (Figure 8E). Consistent with decreased Akt activation, 
there was decreased Akt-dependent phosphorylation of GSK-3β at 
Ser9 (Figure 8E). These data suggest that TRAF6 regulates activity 
of the Akt signaling pathway in the developing kidney collecting 
system.
TRAF6 forms a complex with α3β1 integrin and Akt
Finally, we defined how α3β1 integrin and TRAF6 interact with each 
other to mediate K63-linked polyubiquitination of Akt. This question 
was addressed by immunoprecipitating integrin α3 or β1 subunits 
from Itgα3f/f and Itgα3−/− CD cells grown on uncoated cell culture 
plates. The immunoprecipitates were immunoblotted for integrin β1 
and α3 subunits or TRAF6 (Figure 9, A and B). The β1 integrin sub-
unit was present in α3 immunoprecipitates from Itgα3f/f but not 
Itgα3−/− CD cells (Figure 9A). TRAF6 was not detected in Itgα3 im-
munoprecipitates from Itgα3f/f or Itgα3−/− CD cells (Figure 9A). We 
believe this is a result of very low immunoprecipitation efficiency. In 
this regard, Figure 9A shows that ∼5% of integrin α3 immunopre-
cipitates with the anti-Itgα3 antibody, which allows us to detect 
bound integrin β1. However, since TRAF6 likely binds inferiorly to 
integrin α3β1 via the cytoplasmic tail of integrin β1, it does not allow 
for TRAF6 detection. As expected, there were fewer β1 and no α3 
integrin subunits in the Itgβ1 immunoprecipitates from Itgα3−/− 
compared with Itgα3f/f CD cells (Figure 9B). TRAF6 was immunopre-
cipitated from lysates of Itgα3f/f but not Itgα3−/− CD cells (Figure 9B). 
We next defined the integrin subunit to which TRAF6 binds by per-
forming affinity chromatography of CD cell lysates with His-tagged 
β1, α3, or α5 (used as negative control) transmembrane and 
Itgα3−/− CD cells (Figure 6E) correlated with lower basal PTEN levels 
(Figure 6F) and higher basal Akt activity (Figure 4A). Following plat-
ing on LM-332, PTEN levels decreased in Itgα3f/f CD cells but in-
creased in Itgα3−/− CD cells (Figure 6F). By contrast, PIP3 levels and 
Akt activity increased in Itgα3f/f CD cells, but decreased in Itgα3−/− 
CD cells (Figures 6E and 4A). These data suggest that integrin α3β1 
regulates PIP3 levels and, in turn, Akt activation by regulating PTEN 
levels.
There are two signaling events in the canonical pathway of Akt 
activation that precede and follow the membrane-anchoring step: 
Src-dependent Akt phosphorylation preconditions Akt for mem-
brane binding, and PDK1-mediated phosphorylation activates mem-
brane-bound Akt (Cantley, 2002; Jiang and Qiu, 2003; Bayascas, 
2008). No differences in Src or PDK1 activation were noted between 
Itgα3f/f and Itgα3−/− CD cells plated on LM-332 (Figure 6F), suggest-
ing that these kinases were not responsible for the differences in Akt 
activation between the two cell populations. As Src and PDK1 activi-
ties are regulated by PI3K, these data further confirm that integrin 
α3β1 regulates Akt activity via a PI3K-independent mechanism(s).
Integrin α3β1–dependent K63-linked polyubiquitination 
of Akt is mediated by TRAF6
K63-linked polyubiquitination of Akt is also an essential step in Akt 
activation (Yang et al., 2009, 2010). While the mechanism is unclear, 
it has been postulated that K63-linked polyubiquitination increases 
Akt binding to PI(3,4,5)P3 on the membrane or creates docking sites 
for Akt to interact with other signaling proteins (Wang et al., 2012). 
We therefore checked for differences in K63-linked polyubiquitina-
tion between Itgα3f/f and Itgα3−/− CD cells plated on LM-332 by 
immunoblotting for K63-linked polyubiquitination of Akt immuno-
precipitates (Figure 7A). K63-linked polyubiquitination of Akt in-
creased over time when Itgα3f/f CD cells were plated on LM-332, 
while no significant change was noted in the Itgα3−/− CD cells (Figure 
7A). Of note, the basal level of Akt K63-linked polyubiquitination 
was significantly higher in Itgα3−/− than in Itgα3f/f CD cells (an ap-
proximately twofold difference; Figure 7A). To verify the specificity 
of the Akt K63-linked polyubiquitination, we measured Akt K48-
linked polyubiquitination in Itgα3f/f and Itgα3−/− CD cells and found 
that this was unaffected by adhesion to LM-332 (Figure 7B). Thus 
integrin α3β1–dependent CD cell adhesion to LM specifically in-
creases K63-linked polyubiquitination of Akt.
TRAF6 was recently identified as a unique E3 ligase for Akt that 
is responsible for K63-linked Akt polyubiquitination, which facilitates 
Akt membrane recruitment and subsequent Akt phosphorylation 
and activation (Yang et al., 2009; Wang et al., 2012). We therefore 
determined whether the ubiquitination activity of TRAF6 was al-
tered by integrin α3β1–dependent adhesion to LM-332 by measur-
ing TRAF6 K63-linked autopolyubiquitination (Lamothe et al., 2007). 
This was indeed the case, as K63-linked polyubiquitination of TRAF6 
increased significantly when Itgα3f/f CD cells adhered to LM-332, 
while no increase above basal levels was seen in Itgα3−/− CD cells 
(Figure 7C). Of note, the basal level of TRAF6 K63-linked polyubiq-
uitination was significantly higher in Itgα3−/− than in Itgα3f/f CD cells 
(an approximately twofold difference; Figure 7C), which would ex-
plain the increased basal Akt ubiquitination and activation observed 
in Itgα3−/− CD cells (see Figure 4A for details).
The functional significance of TRAF6 activity for integrin α3β1–
dependent Akt activation was then defined by down-regulating its 
expression in Itgα3f/f CD cells using an siRNA approach (Figure 7D). 
Reduced TRAF6 expression resulted in a severe defect in Akt phos-
phorylation (Figure 7D) and decreased K63-linked polyubiquitina-
tion of Akt when Itgα3f/f CD cells were plated on LM-332 (Figure 7E). 
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FIGURE 6: Integrin α3β1–dependent CD cell adhesion to and migration on LM-332 requires PI3K-independent Akt 
activation. (A–D) Itgα3f/f CD cells were infected with ad-GFP or ad-delta p85 (100 plaque-forming units/cell for 24 h) 
(A); or treated with DMSO (control) or the PI3K inhibitor LY294002 (25 μM for 1 h). Cells were subjected to adhesion 
(B), migration (C), or the replating assay on LM-332 (1 μg/ml) for evaluation of phospho-AktThr308, phospho-AktSer473, and 
phospho-GSK-3β. β-actin served as a loading control. Western blot of cellular lysates shows that infection with ad-delta 
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observations that the UB of constitutive integrin α3–null kidneys at 
E15 was indistinguishable from WT mice and that a difference was 
seen only at E18, when the null kidneys demonstrated a failure of 
papillary outgrowth (Kreidberg et al., 1996; Liu et al., 2009). These 
discrepancies could be due to differences in mouse backgrounds or 
because the Hoxb7Cre and integrin α3flox/flox mice were generated 
using different strategies.
Deleting the α3 integrin subunit in the UB in vivo and in CD cells 
resulted in decreased expression of the β1 and increased expression 
of the α6 integrin subunits, suggesting that α3 is the major integrin 
subunit that interacts with the β1 subunit in the renal papilla and 
there is compensatory expression of the integrin α6 subunit upon its 
deletion. The increased α6 expression might explain the mild phe-
notypic defects observed when the integrin α3 subunit is deleted 
from the UB (Kreidberg et al., 1996; Liu et al., 2009) and why it is 
significantly less severe than that seen when kidneys or isolated UBs 
are grown in the presence of α3-blocking antibodies (Zent et al., 
2001). This possibility is further supported by our in vitro data show-
ing that α6β1 integrin contributes to increased CD cell binding to 
LM-332 and LM-511, especially in the absence of integrin α3β1 ex-
pression. Although it is not proven, we speculate that the α6β1 
compensation occurs through a distinct TRAF6-independent 
mechanism.
We show that LM-332 is the preferred LM for CD cell adhesion, 
migration, proliferation, and adhesion-dependent cell signaling. 
These data are consistent with findings demonstrating a role for LM-
332 in regulating proliferation and cyst formation of cells isolated 
from a patient with autosomal polycystic kidney disease (Joly et al., 
2003) and adhesion and migration of Madin-Darby canine kidney 
cells (Mak et al., 2006; Moyano et al., 2010; Greciano et al., 2012). 
These in vitro data also support the idea that LM-332 is a preferred 
ligand for integrin α3β1 signaling in renal tubule development, 
maintenance, and recovery from injury (Joly et al., 2003, 2006).
We report that integrin α3β1 primarily regulates Akt and p38 
signaling, as activation of these two pathways was diminished in the 
developing UB of Hoxb7Cre;Itg α3flox/flox mice and when Itgα3−/− CD 
cells were plated on LM-332 and LM-511. These data contrast with 
the Hoxb7Cre;Itgβ1flox/flox mice and Itgβ1−/− CD cells, where phos-
phorylation of FAK and ERK1/2, as well as of Akt and p38, was se-
verely affected (Zhang et al., 2009). Our results suggest that integ-
rins other than α3β1 play additional roles in UB development and 
that specific β1-containing integrins regulate the precision of signal-
ing in the kidney collecting system.
We show that integrin α3β1–LM-332 interactions induce Akt ac-
tivation by mechanisms that are independent of PI3K, Src, and 
PDK1, but dependent on PTEN and K63 polyubiquitination (Figure 
10). Our data suggest that PTEN is responsible for the low basal 
levels of PIP3 and Akt activity in Itgα3f/f cells, which dramatically in-
crease upon integrin α3β1 binding to LM-332, while we observe 
opposite effects in Itgα3−/− CD cells under the same conditions. 
These results are consistent with previous studies demonstrating 
cytoplasmic tail peptides. Interestingly, TRAF6 and kindlin 2 (which 
is known to bind specifically to β1 integrin) bound to integrin β1 but 
not to α3 or α5 cytoplasmic tails (Figure 9C). Together these data 
suggest that TRAF6 binds to the cytoplasmic tail of the β1 integrin 
subunit, and this interaction requires the presence of the α3 integrin 
subunit in cells expressing intact β1 integrin.
We next defined whether TRAF6 associates with Akt and whether 
this association is regulated by integrin α3β1 interactions with LM. 
When CD cells were plated on LM-332, more Akt coimmunoprecipi-
tated with TRAF6 in a time-dependent manner in Itgα3f/f compared 
with Itgα3−/− cells. These data suggest that that TRAF6 and Akt form 
a complex following integrin α3β1–dependent adhesion (Figure 9D).
DISCUSSION
Integrin α3β1 plays an important role in UB development in vivo 
due to its interactions with α5-containing LMs, and in vitro studies 
suggested these effects are mediated by its ability to regulate PI3K/
Akt-dependent Wnt signaling (Liu et al., 2009). In this study, we 
show that α3-containing LMs, in addition to the α5 LMs, play a cru-
cial part in UB development and that integrin α3β1 regulates both 
Akt and p38 activation in the UB in vivo. We also demonstrate that 
LM-332 is the preferred ligand for mediating integrin α3β1–depen-
dent CD cell functions and signaling. Finally, and most importantly, 
we establish that the integrin β1 cytoplasmic tail interacts with 
TRAF6, which is an E3 ligase for K63-linked polyubiquitination, and 
this interaction regulates integrin α3β1–dependent Akt activation 
and cell functions. Thus these studies define a novel functionally 
important LM–integrin α3β1 interaction in UB development and 
identify K63-linked polyubiquitination as a critical new mechanism 
whereby integrins modulate cell signaling.
We previously demonstrated that LM-332 is expressed during 
initial UB formation and that it plays a significant role in in vitro cell 
and organ culture models of UB development (Zent et al., 2001). 
Consistent with these findings, we demonstrate in this study that the 
α3 and γ2 LM chains are expressed during UB development and 
that deleting the α3 LM chain results in a severe renal development 
abnormality in outbred mice (with 40% of mice not developing one 
kidney) and a mild to moderate branching defect in pure C57/Bl6 
mice. Interestingly, no phenotype was observed in the developing 
UB of the LM γ2–null mice (unpublished data), suggesting functional 
redundancy of the α3 LMs in UB development. The mild to moder-
ate phenotype in LM α3–null mice is similar to that seen in LM α5–
null mice (Liu et al., 2009) and much less severe than when the LM 
γ1 chain was selectively deleted in the developing UB (Yang et al., 
2011). Our finding that LM α3 plays a role in UB development might 
explain the less severe than expected phenotype in the LM γ1–null 
mice, as LM-332 could be compensating for the LM γ1 deletion 
(Yang et al., 2011).
When we deleted the integrin α3 subunit in the UB, we observed 
a mild to moderate branching morphogenesis defect at E15 that 
persisted into adulthood. These results differ slightly from previous 
p85 resulted in marked decrease in phospho-AktThr308 (D). Adhesion and migration were evaluated as described in 
Materials and Methods. Mean measurements ± SEM of three independent experiments are shown. (E and F) Itgα3f/f and 
Itgα3−/− CD cells were plated on LM-332 (1 μg/ml) as described in Figure 4A. PIP3 levels were detected using the PIP3 
Mass ELISA Kit as described in Materials and Methods. Mean measurements ± SEM of three independent experiments 
are shown; *, p ≤ 0.05 between Itgα3f/f and Itgα3−/− CD cells (E). Cell lysates (20 μg total protein/lane) were analyzed by 
Western blotting for levels of total PTEN and phosphorylated and total Src and PDK1 (20 μg total protein/lane) (F). 
Levels of phosphorylated and total proteins were evaluated as described in Figure 4A. Values are the means ± SEM of 
three independent experiments; *, p ≤ 0.05 between Itgα3f/f and Itgα3−/− CD cells.
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FIGURE 7: Akt activation by integrin α3β1 is regulated by TRAF6-dependent K63-linked polyubiquitination. 
(A–C) Itgα3f/f and Itgα3−/− CD cells were plated on LM-332 (1 μg/ml) as described in Figure 4A. Cell lysates (100 μg total 
protein) were immunoprecipitated with anti-Akt antibodies and immunoblotted for K63-linked ubiquitination and Akt 
(A) or K48-linked ubiquitination and Akt (B). Cell lysates (100 μg total protein) were immunoprecipitated with antibodies 
to TRAF6 and immunoblotted for K63 ubiquitination or TRAF6 (C). Levels of ubiquitinated proteins were measured by 
densitometry, normalized to total protein, and expressed as fold change relative to cells left in suspension (0 time 
point). A representative of three experiments with quantification at the bottom is shown. (D and E) Itgα3f/f CD cells 
were transfected with nonsilencing or TRAF6 siRNA (20 nM for 48 h) and subjected to the replating assay on LM-332 
(1 μg/ml). Cell lysates (40 μg total protein/lane) were immunoblotted for TRAF6, phospho-AktSer473, and Akt (D). Levels 
of phosphorylated and total proteins were evaluated as described in Figure 4A. Values are the means ± SEM of three 
independent experiments; *, p ≤ 0.05 between cells transfected with nonsilencing and TRAF6 siRNA. The same cell 
lysates (200 μg total protein) were immunoprecipitated with antibodies to Akt and immunoblotted for K63-linked 
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Akt translocation to the membrane and is essential for Akt activating 
phosphorylation following growth factor and cytokine stimulation 
(Yang et al., 2009, 2010). We also show that TRAF6 regulates integ-
rin α3β1–dependent signaling. TRAF6 E3 ligase activity was in-
creased upon integrin α3β1–dependent adhesion to LM and it was 
required for Akt activating phosphorylation and cell adhesion to LM. 
These data are consistent with evidence that TRAF6 K63-linked au-
topolyubiquitination is the regulatory mechanism for TRAF6 activa-
tion and that TRAF6-dependent K63-linked polyubiquitination is a 
that the collagen-binding β1 integrins can regulate PTEN expres-
sion in fibroblasts (Xia et al., 2008; Nho and Kahm, 2010), which 
suggests that this might be a generalized mechanism whereby β1 
integrin regulates Akt activation. It is yet to be determined how in-
tegrin α3β1 regulates PTEN in CD cells.
We demonstrate that K63-linked polyubiquitination is a novel 
mechanism whereby integrin α3β1–LM-332 interactions induce Akt 
activation (Figure 10). These results are consistent with the observa-
tions that TRAF6-dependent K63-linked polyubiquitination assists in 
FIGURE 8: TRAF6 KO mice have defective UB development and decreased activation of Akt signaling. (A–D) H&E 
stained kidneys of newborn (P1), WT mice (TRAF6 WT), and TRAF6-deficient mice (TRAF6 KO). Magnification 40× (A and 
B) and 100× (C and D). Note the mild branching defect and hypoplastic papilla in the TRAF6 KO mice (arrows). 
(E) Lysates of papillae from newborn WT and TRAF6 KO mice (20 μg total protein) were analyzed by Western blotting 
for levels of TRAF6, phospho-AktSer473, and phospho-GSK-3β. β-actin was used as a loading control. The amount of 
phosphorylated proteins was evaluated as in Figure 2. *, p ≤ 0.05 between WT and TRAF6 KO mice.
polyubiquitination or Akt (E). Changes in protein ubiquitination were evaluated as described in A. A representative of 
three experiments with quantification at the bottom is shown. (F) Itgα3f/f CD cells were transfected with nonsilencing or 
TRAF6 siRNA (20 nM for 48 h), or treated with Akt inhibitor IV (5 μM for 1 h), and/or transduced with ad-myrAkt 
(100 plaque-forming units/cell for 24 h) and subjected to adhesion assay. Adhesion was evaluated as described in 
Materials and Methods. Mean measurements ± SEM of three independent experiments are shown; *, p ≤ 0.05 between 
cells transfected with nonsilencing and TRAF6 siRNA or treated with the Akt inhibitor IV.
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not bound to LM. After the cells adhere to LM, TRAF6 is activated in 
an integrin-dependent manner by mechanisms that are yet to be 
determined.
In conclusion, this study demonstrates that integrin α3β1 in-
teractions with both α3- and α5-containing LMs regulate UB de-
velopment by functionally modulating the Akt signaling pathway. 
In addition, we show that K63-linked polyubiquitination plays a 
previously unrecognized role in integrin α3β1–dependent cell 
signaling required for UB development and that this may be a 
novel general mechanism whereby integrins regulate signaling 
pathways.
MATERIALS AND METHODS
Reagents, adenovirus vectors, siRNAs, and antibodies
Human laminin 332 (LM-332) was produced, purified, and evaluated 
as previously described (Tripathi et al., 2008). LM-111 was produced 
as previously described (McKee et al., 2007, 2009). Collagen I was 
purchased from BD Biosciences (San Jose, CA); fibronectin and vit-
ronectin were purchased from Sigma-Aldrich (St. Louis, MO). Akt 
inhibitor IV, PI3K inhibitor LY294002, and p38 inhibitor SB203580 
were purchased from Calbiochem (San Diego, CA).
LM-511 was produced as a heterotrimer of mouse LM α5, 
hemagglutinin (HA)-tagged human LM β1, and human LM γ1, as 
key requirement for Akt activation downstream of other receptors 
such as the TNFα receptor (Chen, 2012). Our in vivo data from 
TRAF6 KO mice confirm that the regulatory role of TRAF6 for Akt 
activity in the renal collecting system is associated with develop-
mental abnormalities. Thus it is plausible that our in vitro mecha-
nism delineating that α3β1 integrin controls TRAF6-dependent 
K63-linked polyubiquitination of Akt (Figure 10) explains the pheno-
type of the Hoxb7Cre;Itgα3flox/flox mice.
Finally, we found that TRAF6 is present in integrin β1 immuno-
precipitates from Itgα3f/f but not Itgα3−/− CD cells and that this inter-
action is independent of integrin α3β1 binding to ligand. Affinity 
chromatography with free integrin tails showed that TRAF6 binds 
only to the integrin β1 but not the α3 cytoplasmic tail. These data 
suggest that, although the TRAF6/α3β1 integrin complex forms 
through an interaction of TRAF6 and the β1 integrin subunit in CD 
cells, the α3 integrin subunit is required. These data may explain the 
interesting observation that there were increased basal levels of Akt 
activating phosphorylation, Akt K63–linked polyubiquitination, and 
TRAF6 K63–linked polyubiquitination in Itgα3−/− compared with 
Itgα3f/f CD cells. We speculate that, in Itgα3−/− CD cells, integrin 
α3β1 does not interact with TRAF6 and therefore cannot alter its 
activity. By contrast, in cells expressing the α3 integrin subunit, inte-
grin α3β1 acts as a repressor of TRAF6 activity when the integrin is 
FIGURE 9: TRAF6 forms a complex with α3β1 integrin and Akt. (A and B) Cell lysates from Itgα3f/f and Itgα3−/− CD cells 
(1.0 mg total protein) were immunoprecipitated with protein G-Sepharose–coupled antibody to α3 (A) or β1 (B) integrin 
subunits. Immunoprecipitates were subjected to Western blot analysis with antibodies to TRAF6 or α3 or β1 integrin 
subunits. Input was 20 μg total protein lysates (2%). (C) Ni-NTA magnetic agarose beads (control), α3-TM-Cyto domains, 
α5-TM-Cyto domains, or β1-TM-Cyto domains bound to Ni-NTA magnetic agarose beads were incubated with Itgα3f/f 
cell lysates and then immunoblotted with antibodies to TRAF6, kindlin 2, or His. (D) Itgα3f/f and Itgα3−/− CD cells were 
trypsinized and replated on LM-332 (1 μg/ml) as described in Figure 4A. Cell lysates (200 μg total protein) were 
immunoprecipitated with antibodies to TRAF6 and immunoblotted for Akt or TRAF6. Levels of Akt and TRAF6 were 
measured by densitometry, normalized to TRAF6 levels, and expressed as fold change relative to cells left in suspension 
(0 time point). Values shown are representative of three experiments.
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The following antibodies were used in Western immunoblot 
analyses: integrin α3 (AB1920 [Millipore, Temecula, CA] and AF2787 
[R&D Systems]); integrin β1 (AB1952; Millipore); integrin β4 (AF4054; 
R&D Systems); integrin α6 (3750), phospho-AktThr308 (9275), phos-
pho-AktSer473 (9271), total Akt (9272), phospho-GSK-3βSer9 (9322), 
total GSK-3β (9315), phospho-p38Thr180/Tyr182 (9211), total p38 (9212), 
phospho-ERK1/2Thr202/Tyr204 (9101), total ERK1/2 (9102), phospho-
PDK1Ser241 (3438) and total PDK1 (5662), phospho-SrcTyr416 family 
(2101), total Src (2108), PTEN (9552), K48-linkage specific polyubiq-
uitin (8081), and K63-linkage specific polyubiquitin (5621) (all from 
Cell Signaling Technologies); TRAF6 (ab94720; Abcam, Cambridge, 
MA); kindlin 2 (MAB2617; Millipore); and His (620-0203; Bio-Rad). 
Antibodies for TRAF6 (H-274; Santa Cruz Biotechnology), Akt (4685; 
Cell Signaling), integrin β1 (MAB1997; Millipore), integrin α3 
(AF2787; R&D Systems), and integrin α6 (H-87; Santa Cruz Biotech-
nology) were used for immunoprecipitation. Antibody to β-actin 
(A4700, Sigma-Aldrich) was used to evaluate protein loading. Anti-
mouse β1 (550530), α1 (555001), α2 (553819), α5 (553350), α6 
(555734), and αv (550024) integrin antibodies were purchased from 
BD Biosciences. R-phycoerythrin–conjugated secondary antibodies 
were purchased from Invitrogen (Carlsbad, CA). Antibodies to inte-
grin α6 (555734; BD Biosciences) were used in adhesion assays.
Laminin subunits α3 and γ2 global knockout mice
All animal experiments were approved by the Vanderbilt University 
Institutional Animal Use and Care Committee. LM α3 global knock-
out mice were kindly provided by W. Carter (University of Washing-
ton; Ryan et al., 1999). LM γ2 knockout mice were a gift from J. Uitto 
(Thomas Jefferson University; Meng et al., 2003).
TRAF6-deficient mice
Generation of the global TRAF6 KO mice on 129SV background 
was previously described (Naito et al., 1999). The genotyping 
was verified by PCR amplification of the genomic DNA with the 
previously described (McKee et al., 2007). The complete mouse LM 
α5 cDNA in an LZ10 plasmid (kindly provided by Jeffrey Miner, 
Washington University, St. Louis, MO) was excised with EcoR1 and 
ligated into the expression vector pcDNA3.1 puro. HEK293 cells 
stably expressing the human β1 LM subunit containing an N-termi-
nal HA tag and the γ1 LM subunit (McKee et al., 2007, 2009) were 
transfected with the LM α5 construct. Stable clones secreting the 
LM into media were selected and expanded. Recombinant LM-511 
protein was purified by affinity chromatography from conditioned 
medium of HEK293 cells on an HA matrix (E6779; Sigma-Aldrich) 
and eluted per manufacturer’s conditions with 0.1 M glycine (pH 2.8). 
Protein was concentrated in Amicon ultra 15 filters (100K mwco, 
ufc900024; Millipore, Billerica, MA) and dialyzed in 50 mM Tris 
(pH 7.4), 90 mM NaCl, and 0.125 mM EDTA. The homogeneity of 
purified LM-511 was confirmed by Coomassie blue staining of SDS–
PAGE (Supplemental Figure 1A). The correct folding of LM-511was 
confirmed by a polymerization assay (Supplemental Figure 1B; 
McKee et al., 2007), and LM-511activity was assessed by binding 
with recombinant α7β1 and α6β1 integrins (Supplemental Figure 
1C; McKee et al., 2012).
Adenoviruses with vectors encoding GFP, ad-GFP, the dominant-
negative catalytic subunit deletion mutant PI3K, ad-delta p85, and 
constitutively active myristoylated Akt (ad-myrAkt) were propagated 
in HEK293 cells, purified by column chromatography, quantitated, 
and used for cell infection based on particle yield as previously de-
scribed (Tan et al., 2006).
SignalSilence Akt siRNA I (sequence [5′-3′] UGCCCUUCUA-
CAACCAGGA) and SignalSilence Akt1 siRNA I (mouse-specific, 
sequence [5′-3′] GCUCAAGAAGGACCCUACA) were purchased 
from Cell Signaling Technology (Danvers, MA). Silencer Select 
predesigned TRAF6 siRNAs (sequences [5′-3′] CAUUAAGGAUGA-
UACAUUAtt and AGAAAAGAGUUGUAGUUUUtt) and Silencer 
Select Negative control #1 siRNA were bought from Ambion 
(Carlsbad, CA).
FIGURE 10: LM-332/integrin α3β1 interactions induce Akt activation by TRAF6-mediated K63-linked polyubiquitination. 
Integrin α3β1 interactions with LM induce the formation of a TRAF6/α3β1 integrin complex through binding of TRAF6 
to the cytoplasmic tail of β1 integrin subunit. This complex is required for TRAF6 activation and triggers K63-linked 
polyubiquitination of Akt, which facilitates Akt translocation to the cellular membrane. Integrin α3β1 interactions with 
LM also induce PTEN inactivation that results in an increase of PIP3 and Akt anchoring to the membrane, where it is 
phosphorylated and fully activated.
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Cell adhesion
Cell adhesion assays were performed in 96-well plates as previously 
described (Chen et al., 2004). Cells (1 × 105) were seeded in serum-
free medium onto plates containing different concentrations of 
ECM for 60 min. Nonadherent cells were removed; the remaining 
cells were fixed, stained with crystal violet, and solubilized; and the 
optical densities of the cell lysates were read at 570 nm (OD570). 
Adhesion was calculated as percent of positive control (adhesion to 
serum).
Cell migration
Cell migration was assayed as previously described (Chen et al., 
2004). Transwells with 8-μm pores were coated with different ECM 
components, and 1 × 105 cells were added to the upper well in se-
rum-free medium. Cells that migrated through the filter after 4 h 
were counted.
Cell proliferation
Cell proliferation was assessed by measuring incorporation of 5-bro-
modeoxyuridine (BrdU) in an enzyme-linked immunosorbent assay–
based 5-Bromo-2′-deoxy-uridine Labeling and Detection Kit III 
(Roche Applied Science, Indianapolis, IN) as previously described 
(Linkous et al., 2010). BrdU incorporation was quantified by a change 
of absorbance (OD) at 405 nm.
Cell replating assays
Cell replating assays were performed on CD cells that were trypsin-
ized, washed, suspended in serum-free DMEM, plated on LM-332 
or LM-511 (1 μg/ml), and harvested 0, 30, and 60 min later. Cells 
were washed in PBS and lysed using M-PER reagent with protease 
and phosphatase inhibitor cocktails (Sigma-Aldrich). Protein extracts 
(20–40 μg) were subjected to Western immunoblot analysis.
When chemical inhibitors were used, they were added 1 h before 
the assays. Adenoviral infection of cells was performed at 10–100 
plaque-forming units/cell as previously described (Tan et al., 2006), 
and the assays were performed 24 h later. For silencing experi-
ments, cells were transfected with nonsilencing siRNA (20 nM, trans-
fection control) or Akt siRNA (100 nM) or TRAF6 siRNA (20 nM) us-
ing Lipofectamine RNAiMAX according to the manufacturer’s 
instructions. Transfected cells were used 48 h later.
Evaluation of PIP3 levels
CD cells were subjected to the replating assay using 150-mm cell 
culture plates coated with LM-332 (1 mg/ml) and were harvested 
at 0, 30, and 60 min after plating. Lipids were extracted using 
a modified Bligh and Dyer method as previously described 
(Yazlovitskaya et al., 2008). PIP3 levels were detected using the 
PIP3 Mass ELISA Kit (Echelon, Salt Lake City, UT) according to the 
manufacturer’s instructions.
Immunoprecipitation
For immunoprecipitation, antibody or corresponding normal immu-
noglobulin G (IgG) were covalently bound to protein A/G Sepha-
rose (Thermo Scientific) as previously described (Persons et al., 
1999). Immunoprecipitations were performed with 0.1 mg (for inte-
grin α6), 0.2 mg (for Akt and TRAF6), or 1.0 mg (for integrins α3 or 
β1) of total cell lysates overnight at 4ºC with rotating, after which the 
bound immune complexes were washed, resuspended in SDS–
PAGE sample buffer, heated at 95°C for 10 min, cleared by centrifu-
gation, and subjected to Western immunoblot analysis. For immu-
noprecipitation of integrins α3 or β1, cells were grown on uncoated 
cell culture surfaces where integrin α3β1 is not ligated by ligand.
following primers: forward primer, 5′-CGTGCCATGTAATGCA-
TTCTG-3′; reverse primer, 5′-CGAGATGTCTCAGTTCCATC-3′; and 
reverse mutant primer to amplify the TRAF6 gene deleted se-
quence, 5′-CACTCAGCACCATTTCCTAACCT-3′. Mice were bred as 
heterozygotes, and age-matched WT and TRAF6 KO littermates 
were used in experiments.
Generation of HoxB7Cre:Itgα3flox/flox mice
Integrin α3flox/flox (Itgα3flox/flox) mice (Sachs et al., 2006), were crossed 
with the HoxB7Cre mice (generous gift of A. McMahon, University 
of Southern California; Kobayashi et al., 2005). Age-matched litter-
mates homozygous for the integrin Itgα3flox/flox gene, but lacking 
Cre (Itgα3flox/flox mice), were used as controls. The expression of in-
tegrin α3 and activation of signaling pathways in the developing 
mouse CDs was determined using Western immunoblot analysis.
Western blot analysis
Papillae from individual 3-d-old pups were isolated and lysed using 
a Polytron homogenizer in T-PER reagent (Thermo Scientific, 
Waltham, MA) with protease inhibitors and phosphatase inhibitors 
cocktail 1 and 2 (Sigma-Aldrich). Cell lysates were prepared using 
M-PER reagent (Thermo Scientific). Lysates were centrifuged at 
17,000 × g for 15 min at 4ºC, and total protein concentration was 
determined using BCA reagent (Thermo Scientific). Protein extracts 
were subjected to Western immunoblot analysis and developed us-
ing the Western Lightning Chemiluminescence Plus detection sys-
tem (Perkin Elmer-Cetus, Wellesley, MA) according to the manufac-
turer’s protocol. Densitometry was performed using the ImageJ 
program. For quantification of levels of protein phosphorylation, 
OD of bands for phosphoprotein was normalized to total protein 
and β-actin.
Morphological and immunohistochemical analysis
Whole mouse embryos or kidneys were removed, fixed, stained 
with hematoxylin and eosin (H&E) and evaluated by light micros-
copy as previously described (Mathew et al., 2012). For analysis of 
LM-332 expression, tissue sections were treated with antigen-re-
trieval citra buffer for 10 min, blocked with 5% normal goat serum in 
phosphate-buffered saline (PBS) for 1 h at room temperature, and 
incubated with primary rabbit anti-rat LMγ2 antibody (Giannelli 
et al., 1999). After incubation with biotinylated anti-rabbit antibody 
for 1 h at room temperature, LM332 was visualized using ABC 
reagent (a preformed avidin/biotinylated enzyme complex that 
was developed with 3,3’-diaminobenzidine horseradish peroxidase 
substrate). Slides were counterstained with hematoxylin. Similarly, 
tissue sections were probed with rabbit anti-rat LMα3 antibody 
(M3.3). Ki67 staining and scoring was performed as previously de-
scribed (Mathew et al., 2012).
Generation of integrin α3−/− CD cells
CD cells were isolated from 5- to 6-wk-old Itgα3flox/flox mice as de-
scribed by Husted et al. (1988) and immortalized with pSV40 plas-
mid. Loci for the α3 integrin subunit in CD cells were deleted with 
adenovirus expressing Cre recombinase. CD cells were grown in 
DMEM/F12 containing 10% fetal bovine serum and 1% penicillin/
streptomycin.
Flow cytometry analysis
Flow cytometry analysis was performed as previously described 
(Zhang et al., 2009). CD cells were incubated with anti-mouse β1, 
β4, α1, α2, α6, and αv integrin antibodies followed by fluorescein 
isothiocyanate–conjugated secondary antibodies.
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Pull-down assay
N-terminally 6×His-tagged integrin β1-TM-Cyto (transmembrane-
cytoplasmic domains, mouse residues from 719 to 798 of the 
full-length protein), α5-TM-Cyto (mouse residues from 993 to 1053 
of the full-length protein), and α3-TM-Cyto (mouse residues from 
991 to 1053 of the full-length protein) were cloned into a pET15b 
vector and transformed into BL21 (DE3) Arctic Express Escherichia 
coli. After protein induction with 1 mM isopropyl β-d-1-
thiogalactopyranoside, cells were pelleted by centrifugation, resus-
pended in TBS buffer (Tris 50 mM, NaCl 150 mM, pH 7.4) with 
100 μg/ml lysozyme and 50 μg/ml DNase, and rotated at 4°C for 
2 h. Cell lysates were treated with Empigen (30% solution; 1 ml per 
10 ml of lysate) at 4°C for 1 h with rotation and centrifuged. Super-
natants were incubated with Ni-NTA magnetic agarose beads 
(Qiagen) at 4°C for 3 h, washed three times with TBS buffer, and in-
cubated with CD cell lysates (lysis buffer: 1% NP40, Tris 50 mM, 
NaCl 150 mM, pH 7.4, protease inhibitor cocktail [Sigma-Aldrich]) 
overnight at 4°C. After three washes with lysis buffer, proteins were 
eluted from the beads by being boiled with 80 μl SDS–PAGE sample 
buffer for 5 min and were subjected to Western blot analyses with 
antibodies to TRAF6, kindlin 2, or His.
Statistical analyses
The mean and SEM of each treatment group were calculated for all 
experiments. At least four independent experiments (some in tripli-
cates each) were performed. Student’s t test was used to compare 
two groups. All statistical tests were two-sided, and statistical analy-
sis was done with the use of SigmaStat software (Systat Software, 
San Jose, CA). Statistical significance was defined as p ≤ 0.05.
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